data_2gtj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gtj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 38.5 mm-40 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.477 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 1.3 pp -77.62 -28.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.849 0.833 . . . . 0.0 108.842 -174.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.467 ' HA ' HD23 ' A' ' 21' ' ' LEU . 15.4 mtpp -70.0 -41.49 74.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.352 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -85.04 -22.52 28.98 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.153 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.5 tppt? -76.36 -48.61 19.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.546 -175.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.527 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 13.8 t80 -94.45 -26.49 16.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.889 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? 70.91 90.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.518 1.127 . . . . 0.0 108.882 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.47 -44.96 5.71 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.28 80.2 p . . . . . 0 CA--C 1.552 1.048 0 C-N-CA 125.699 1.599 . . . . 0.0 112.384 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.246 0.874 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.662 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -57.18 134.04 21.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 123.714 0.634 . . . . 0.0 111.81 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.1 mm -89.2 -38.22 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.621 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 54' ' ' ILE . 32.8 m80 -162.02 156.66 22.49 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -100.57 117.1 34.02 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 84' ' ' ILE . . . -92.43 155.83 17.6 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.7 0.762 . . . . 0.0 110.293 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -107.11 131.17 54.42 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.41 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.56 115.72 5.46 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.8 t -79.34 -12.05 59.93 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.946 0.779 . . . . 0.0 110.025 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -158.35 171.7 19.7 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.665 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 5.5 p-10 -105.67 104.86 14.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.698 0.761 . . . . 0.0 110.653 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.02 158.98 15.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 17.4 19.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.827 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 83.22 59.88 2.1 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.204 -0.998 . . . . 0.0 114.476 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.04 145.91 17.55 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 63.65 34.22 12.5 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.362 0.665 . . . . 0.0 109.635 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.581 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 14.3 m120 64.77 82.6 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.387 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 15.9 tt0 -140.86 -176.87 4.83 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 54.7 tp -95.65 145.17 25.47 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.4 m -94.98 119.58 33.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CG ' HD12 ' A' ' 52' ' ' ILE . 28.3 p90 -153.28 157.85 40.74 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.665 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 42.7 mmtm -107.97 146.78 31.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.062 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.75 118.59 2.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.912 0.885 . . . . 0.0 110.001 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 15.8 76.85 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.919 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 28.9 tt0 -69.01 -33.08 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.402 0.601 . . . . 0.0 111.58 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 80.07 122.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 110.214 -174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.461 HD12 ' CG ' ' A' ' 46' ' ' PHE . 4.7 mt -125.76 162.19 29.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.662 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 35.5 mt-10 -116.49 134.82 54.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 119.211 0.914 . . . . 0.0 109.093 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 65' ' ' TRP . 9.0 tp -93.05 127.15 45.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -56.61 4.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.527 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.3 tpm_? -116.18 121.97 43.67 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.524 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -118.74 -26.86 2.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.026 174.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.6 p -85.39 136.34 33.5 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.412 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t0 67.3 33.58 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.66 1.184 . . . . 0.0 110.918 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.23 128.58 93.78 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.296 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.44 -27.59 1.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.049 1.832 . . . . 0.0 114.147 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 17.5 mm-40 -109.14 -6.09 15.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.28 -18.7 56.14 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.762 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -86.3 161.39 18.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.594 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.1 m0 -98.44 163.45 12.68 Favored 'General case' 0 C--O 1.199 -1.58 0 C-N-CA 123.565 0.746 . . . . 0.0 109.633 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 21' ' ' LEU . 55.7 tp -104.06 108.84 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.032 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.34 144.86 18.44 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 73' ' ' SER . 22.1 ttp180 -115.74 149.32 38.65 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.248 0.547 . . . . 0.0 110.419 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.523 ' OG1' HD12 ' A' ' 44' ' ' LEU . 89.7 m -98.17 156.52 16.64 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.84 -33.73 17.75 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -79.67 -1.81 39.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 77.14 86.14 0.42 Allowed Glycine 0 C--O 1.221 -0.695 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.8 m -152.7 127.19 9.34 Favored 'General case' 0 N--CA 1.394 -3.229 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.604 ' HB3' HD13 ' A' ' 66' ' ' LEU . 83.7 m-85 -115.59 100.08 7.8 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -174.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -102.29 5.09 52.04 Favored Glycine 0 C--O 1.188 -2.737 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.616 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.581 ' HE1' ' HB3' ' A' ' 42' ' ' ASN 0.314 0.3 OUTLIER 46.01 75.18 0.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 123.068 1.414 . . . . 0.0 112.844 -179.874 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.6 pt -61.94 141.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.038 0 CA-C-N 112.199 -2.273 . . . . 0.0 113.125 -174.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -77.71 114.78 16.9 Favored 'General case' 1 N--CA 1.365 -4.711 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 166.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 ' CG ' ' A' ' 65' ' ' TRP . 34.0 p -35.53 -38.78 0.12 Allowed 'General case' 0 C--N 1.244 -3.99 0 C-N-CA 127.91 2.484 . . . . 0.0 113.628 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -66.67 -19.84 65.85 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.41 0.684 . . . . 0.0 111.675 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.5 -5.87 59.04 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 121.835 -0.54 . . . . 0.0 111.357 -175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 77' ' ' ILE . 30.1 m -135.79 167.84 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.377 0.608 . . . . 0.0 110.992 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -133.96 116.17 15.24 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 31' ' ' ALA . 2.3 pp -81.53 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.315 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.306 -1.299 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.554 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 46.4 mt-10 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.738 0.78 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.547 ' HA ' ' HE1' ' A' ' 76' ' ' TYR . 2.5 pt -88.69 -32.35 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.858 -170.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.0 ptmt -91.22 -9.44 45.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.591 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 13.4 tmtt? -92.89 -23.96 18.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 169.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.3 tppt? -82.56 -58.44 2.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.035 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 9.8 t80 -92.52 -33.98 14.25 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.4 tttm 75.11 93.48 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.34 1.025 . . . . 0.0 110.656 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.642 HD11 HD21 ' A' ' 66' ' ' LEU . 1.5 mm? -100.09 -28.82 12.85 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.864 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.268 69.0 p . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 126.663 1.985 . . . . 0.0 115.964 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.41 133.55 31.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.86 0.838 . . . . 0.0 111.612 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.498 HD12 HH21 ' A' ' 56' ' ' ARG . 62.6 mt -98.46 -32.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.52 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.7 m80 -162.58 165.83 25.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.87 116.39 31.87 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.672 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -95.64 150.52 20.26 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-O 121.771 0.796 . . . . 0.0 111.047 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -107.31 133.61 51.59 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' A' ' 52' ' ' ILE . . . -64.41 117.03 6.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 31.3 t -79.8 -18.08 51.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 124.294 0.996 . . . . 0.0 110.321 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.6 t -152.93 161.0 43.08 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.964 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 1.8 p-10 -94.51 109.57 21.45 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.016 0.912 . . . . 0.0 108.769 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.26 152.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -93.91 9.04 39.01 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.064 -178.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.87 58.24 8.57 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.801 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.31 162.23 14.48 Favored Glycine 0 C--O 1.2 -1.982 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.815 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 6.4 mmpt? 57.71 34.28 24.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.843 1.321 . . . . 0.0 111.691 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 76' ' ' TYR . 42.6 m-80 66.01 51.81 1.28 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.89 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' OE1' ' HE3' ' A' ' 78' ' ' LYS . 1.2 mp0 -110.04 179.45 4.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.831 171.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.1 tt -97.75 151.26 20.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -94.87 126.57 40.28 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.189 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 14.2 p90 -158.57 163.27 37.17 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.952 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.964 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.2 mmtt -110.7 148.27 32.62 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -52.06 119.79 4.71 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.748 0.655 . . . . 0.0 109.548 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.58 13.69 69.71 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.742 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 12.9 tp10 -63.12 -32.01 73.29 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.95 0.5 . . . . 0.0 110.901 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 77.63 99.32 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.018 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 82' ' ' VAL . 12.1 mt -106.69 165.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 113.399 -1.728 . . . . 0.0 106.742 -173.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -127.63 136.48 51.69 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.52 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.7 tp -93.24 130.68 41.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.11 -37.84 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.369 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.498 HH21 HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -137.86 134.71 35.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.911 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.529 HD11 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.69 -13.32 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 123.954 0.902 . . . . 0.0 110.39 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -117.16 159.04 23.23 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.11 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.14 70.78 0.59 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.219 1.408 . . . . 0.0 110.089 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 15.3 p30 -127.75 139.3 34.91 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.671 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 23.6 Cg_exo -68.66 -49.2 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.938 2.426 . . . . 0.0 113.105 177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.91 -23.45 25.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 111.681 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.18 8.53 58.79 Favored Glycine 0 C--N 1.312 -0.772 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.73 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 12.7 ptmt -89.32 162.26 15.92 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.568 ' HB2' HG13 ' A' ' 77' ' ' ILE . 46.6 m0 -93.79 176.41 6.36 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 21' ' ' LEU . 59.7 tp -121.2 112.57 18.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.73 14.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.745 ' HA ' ' O ' ' A' ' 73' ' ' SER . 48.5 ttp180 -133.56 153.69 51.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.322 0.582 . . . . 0.0 110.285 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.6 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.2 m -100.0 153.82 18.89 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -30.04 12.62 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -81.68 -12.06 58.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.812 0.339 . . . . 0.0 111.855 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.59 92.59 1.56 Allowed Glycine 0 C--N 1.315 -0.591 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.745 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.7 m -153.73 118.05 4.87 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.522 ' HB3' HD12 ' A' ' 66' ' ' LEU . 48.2 m-85 -114.59 94.95 5.01 Favored 'General case' 1 C--N 1.222 -4.972 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -173.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.577 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -111.18 103.41 1.58 Allowed Glycine 3 N--CA 1.359 -6.434 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.547 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -45.52 100.55 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 113.133 -1.534 . . . . 0.0 108.293 173.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.568 HG13 ' HB2' ' A' ' 65' ' ' TRP . 2.0 pt -81.4 142.0 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.249 0 C-N-CA 124.341 1.057 . . . . 0.0 113.482 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 18.7 ptpt -79.28 119.01 21.74 Favored 'General case' 1 N--CA 1.361 -4.911 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 165.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.453 HG23 ' CD2' ' A' ' 65' ' ' TRP . 50.5 p -36.11 -39.46 0.17 Allowed 'General case' 1 C--N 1.242 -4.1 0 C-N-CA 127.732 2.413 . . . . 0.0 112.894 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.84 -13.35 62.06 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 123.274 0.63 . . . . 0.0 112.341 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.78 -9.08 50.59 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.359 -0.838 . . . . 0.0 111.112 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.569 HG12 HD11 ' A' ' 52' ' ' ILE . 31.5 m -133.91 167.22 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 122.152 0.977 . . . . 0.0 111.974 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.4 mt-10 -132.89 111.62 11.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.672 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.1 pt -75.36 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.686 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--N 1.288 -2.086 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.208 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 121.013 0.435 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 74' ' ' TYR . 4.3 pt -79.72 -31.45 13.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.419 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 2.7 mptp? -68.62 -23.8 64.49 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 121.357 0.599 . . . . 0.0 110.768 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -103.6 6.49 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.997 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 8.8 ttmm -121.62 -43.42 2.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.098 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 2.9 t80 -94.6 -33.8 12.87 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 87.4 tttt 68.13 88.51 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.653 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 66' ' ' LEU . 1.2 mm? -98.09 -29.98 12.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.675 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 124.985 1.314 . . . . 0.0 113.379 -179.287 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 55' ' ' ILE . 11.7 pt20 . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.55 136.21 25.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.2 0.524 . . . . 0.0 109.636 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 54' ' ' ILE . 49.9 mm -91.29 -35.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.79 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.799 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.405 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.2 m80 -168.64 162.56 11.91 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.26 121.14 41.33 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.653 ' HB1' HG21 ' A' ' 84' ' ' ILE . . . -96.14 155.79 16.61 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-O 121.758 0.789 . . . . 0.0 110.027 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 32' ' ' LYS . 4.2 ttmp? -107.04 128.08 54.04 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -68.36 109.39 3.63 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.52 -22.5 32.44 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.23 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.4 m -133.19 144.01 49.56 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.848 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.43 104.55 16.56 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.321 1.058 . . . . 0.0 109.281 172.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 39' ' ' GLY . 8.5 p -114.47 151.49 16.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.682 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.388 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -97.97 7.24 46.65 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.201 0.6 . . . . 0.0 111.942 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 75.25 59.04 3.73 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.609 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.11 151.14 17.01 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 tttm 62.0 32.87 17.58 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.934 0.873 . . . . 0.0 108.687 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 90.6 m-20 66.55 86.64 0.13 Allowed 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.385 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.554 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 22.4 tt0 -147.09 -175.73 4.94 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.575 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.67 154.53 17.89 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.481 ' H ' HD21 ' A' ' 44' ' ' LEU . 3.6 m -101.89 120.19 40.0 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.436 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 18.5 p90 -151.06 161.77 42.12 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.731 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 73.2 mmtt -107.2 151.19 25.76 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.118 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -55.59 111.65 0.95 Allowed 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.57 24.96 14.49 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.406 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -75.91 -39.96 55.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.144 0.577 . . . . 0.0 111.162 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 76.34 108.08 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.915 1.686 . . . . 0.0 109.04 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.571 HD13 ' CG1' ' A' ' 82' ' ' VAL . 8.1 mt -116.87 162.71 14.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -173.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.47 135.24 54.85 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.0 tp -93.48 128.54 44.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -113.33 -42.24 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.568 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 1.8 tpm_? -128.52 128.23 43.92 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.55 HD11 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -126.07 -6.74 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 123.612 0.765 . . . . 0.0 109.637 177.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -112.13 150.84 30.21 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.521 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 t70 56.24 56.53 5.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.743 1.258 . . . . 0.0 109.535 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 17.7 p-10 -105.83 106.31 56.19 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.535 -1.666 . . . . 0.0 112.486 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 16.6 Cg_exo -66.76 -23.52 48.3 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.814 3.009 . . . . 0.0 115.072 -173.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -111.08 0.17 16.81 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.915 0.864 . . . . 0.0 109.852 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 17.49 80.19 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.688 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.0 ptmt -110.33 161.68 15.39 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.516 ' CD2' HG21 ' A' ' 79' ' ' THR . 40.4 m0 -96.63 176.18 6.11 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 122.383 0.273 . . . . 0.0 110.367 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 74' ' ' TYR . 64.5 tp -117.37 111.77 19.79 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.74 155.43 16.32 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.184 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.1 ttp180 -136.45 148.26 47.63 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.7 m -101.41 157.96 16.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.79 30.36 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 119.243 0.928 . . . . 0.0 113.174 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmt_? -64.01 -26.0 68.37 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.071 0.948 . . . . 0.0 110.2 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.67 89.05 1.44 Allowed Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.4 m -153.56 122.31 6.37 Favored 'General case' 0 N--CA 1.387 -3.582 0 N-CA-C 100.422 -3.918 . . . . 0.0 100.422 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.577 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 67.4 m-85 -114.61 96.52 5.79 Favored 'General case' 1 C--N 1.225 -4.806 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -175.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -111.04 105.31 1.86 Allowed Glycine 3 N--CA 1.357 -6.567 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 177.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -49.38 96.49 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.291 -1.455 . . . . 0.0 108.88 169.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.562 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.7 pt -76.09 143.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.276 0 C-N-CA 125.631 1.572 . . . . 0.0 113.518 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -78.93 115.88 18.89 Favored 'General case' 1 N--CA 1.371 -4.411 0 N-CA-C 102.811 -3.033 . . . . 0.0 102.811 166.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.516 HG21 ' CD2' ' A' ' 65' ' ' TRP . 68.9 p -36.02 -35.96 0.08 Allowed 'General case' 0 C--N 1.244 -3.995 0 C-N-CA 128.167 2.587 . . . . 0.0 113.962 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -70.16 -15.13 62.91 Favored 'General case' 0 CA--C 1.567 1.625 0 C-N-CA 123.361 0.665 . . . . 0.0 112.636 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.92 -13.84 38.11 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.571 ' CG1' HD13 ' A' ' 52' ' ' ILE . 28.4 m -127.89 165.5 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-O 121.297 0.57 . . . . 0.0 110.888 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -133.8 117.3 16.72 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.653 HG21 ' HB1' ' A' ' 31' ' ' ALA . 2.1 pp -77.96 134.1 29.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 119.504 -0.879 . . . . 0.0 109.936 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--N 1.301 -1.515 0 CA-C-O 121.365 0.602 . . . . 0.0 110.416 179.626 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 122.493 1.139 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.579 ' HA ' ' HH ' ' A' ' 76' ' ' TYR . 2.7 pp -87.15 -25.18 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.417 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.626 ' HB3' ' HD3' ' A' ' 17' ' ' LYS . 10.5 tptm -64.3 -41.65 96.76 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.286 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 3.4 mppt? -98.02 12.46 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.699 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' LYS . 8.2 tppt? -105.67 -57.04 2.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.695 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 1.8 t80 -80.11 -25.07 40.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 49.5 mtpt 70.09 89.4 0.1 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.989 1.316 . . . . 0.0 110.6 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.526 HD11 HD21 ' A' ' 66' ' ' LEU . 1.3 mm? -98.74 -18.63 17.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.804 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 70.7 p . . . . . 0 C--N 1.306 -1.299 0 C-N-CA 126.061 1.744 . . . . 0.0 114.32 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.22 -0.484 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.12 136.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.379 0.609 . . . . 0.0 109.464 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.88 -33.66 3.53 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.057 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.557 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.6 m80 -161.82 168.65 22.73 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -173.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.72 115.67 30.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.679 ' HB2' HG21 ' A' ' 84' ' ' ILE . . . -98.12 155.12 17.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-O 122.281 1.038 . . . . 0.0 111.352 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 34.1 ttpt -107.91 128.83 54.97 Favored 'General case' 0 C--N 1.256 -3.465 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -64.84 116.03 5.92 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.87 -17.4 35.7 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.451 0.643 . . . . 0.0 109.658 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.1 t -144.33 156.07 44.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 8.2 p-10 -94.43 101.92 13.86 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.16 0.981 . . . . 0.0 110.169 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG11 ' CE1' ' A' ' 46' ' ' PHE . 7.3 p -112.42 153.35 14.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.35 42.94 3.13 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 111.406 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 74.39 58.84 4.08 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.14 176.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.06 126.6 8.02 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 64.4 34.79 10.12 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.598 0.713 . . . . 0.0 109.79 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.527 ' ND2' ' HE1' ' A' ' 76' ' ' TYR . 12.2 t30 71.52 87.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.702 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 20.2 tt0 -151.85 -172.45 4.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.102 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.1 tt -94.96 151.5 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.514 ' H ' HD21 ' A' ' 44' ' ' LEU . 50.1 m -102.77 118.58 37.14 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.401 ' CE1' HG11 ' A' ' 37' ' ' VAL . 20.3 p90 -154.89 177.22 11.54 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.618 0.767 . . . . 0.0 109.619 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 99.1 mttt -133.69 151.18 51.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.74 119.3 2.71 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 124.322 1.014 . . . . 0.0 110.9 176.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.44 12.7 59.41 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.937 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -79.23 -15.54 57.87 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 66.34 113.93 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 O-C-N 124.394 1.059 . . . . 0.0 111.208 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.552 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.5 mt -120.69 156.25 23.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.39 138.26 51.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 65' ' ' TRP . 7.8 tp -95.16 117.43 39.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -105.53 -27.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.404 -176.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 tpp180 -141.88 125.81 17.18 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.052 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.552 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -118.78 -38.95 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.738 -177.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -106.68 154.91 20.26 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.199 -172.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 82.82 10.91 0.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.894 1.677 . . . . 0.0 109.798 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.579 ' ND2' ' HA2' ' A' ' 63' ' ' GLY . 2.9 p-10 -54.57 123.95 46.73 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.213 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 21.3 Cg_exo -68.4 -40.69 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.088 2.526 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -99.74 -49.84 4.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.579 ' HA2' ' ND2' ' A' ' 60' ' ' ASN . . . 145.18 -2.59 1.15 Allowed Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.288 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 14.8 ptpt -100.69 163.67 12.23 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 122.572 0.349 . . . . 0.0 110.314 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.648 ' HB3' HD12 ' A' ' 54' ' ' ILE . 35.9 m0 -98.03 174.33 6.6 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 124.263 0.977 . . . . 0.0 111.103 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.532 ' O ' HD11 ' A' ' 54' ' ' ILE . 41.4 tp -115.05 108.31 16.5 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.06 157.97 14.62 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.2 ttp180 -136.09 147.11 47.69 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.171 0.51 . . . . 0.0 111.389 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.6 p -100.83 165.31 11.42 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.052 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.55 24.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.385 1.074 . . . . 0.0 113.641 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -78.04 -18.96 55.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.301 0.572 . . . . 0.0 111.384 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.69 92.09 1.38 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.1 m -151.96 129.11 11.14 Favored 'General case' 0 N--CA 1.392 -3.36 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.52 ' HB3' HD12 ' A' ' 66' ' ' LEU . 41.9 m-85 -119.73 61.31 0.84 Allowed 'General case' 1 C--N 1.226 -4.788 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -172.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -87.11 93.38 1.88 Allowed Glycine 1 N--CA 1.384 -4.82 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -176.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.579 ' HH ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -34.29 101.05 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 125.809 1.535 . . . . 0.0 110.324 174.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.717 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -78.07 137.01 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.342 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.661 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -73.67 114.05 11.49 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 103.576 -2.749 . . . . 0.0 103.576 166.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.521 HG23 ' CD2' ' A' ' 65' ' ' TRP . 81.4 p -36.11 -35.9 0.08 Allowed 'General case' 1 C--N 1.24 -4.189 0 C-N-CA 128.428 2.691 . . . . 0.0 113.471 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.6 t -69.04 -14.24 62.92 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.068 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.32 -7.14 51.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.443 -0.785 . . . . 0.0 111.137 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 77' ' ' ILE . 26.8 m -133.96 157.46 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.93 0.871 . . . . 0.0 112.365 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -120.3 110.69 16.86 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 31' ' ' ALA . 18.8 pt -79.82 163.03 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 C--N 1.282 -2.34 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.365 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 3.6 mp0 . . . . . 0 N--CA 1.442 -0.838 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.544 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 2.3 pp -87.98 -23.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 120.922 0.391 . . . . 0.0 110.125 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -48.1 -61.68 1.86 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.845 1.658 . . . . 0.0 112.711 -171.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -104.82 11.66 33.53 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.553 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 12.6 tppt? -84.87 -50.74 7.28 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 26.2 t80 -89.99 -28.99 18.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.628 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 8.0 mtmp? 75.0 88.25 0.09 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 125.577 1.551 . . . . 0.0 110.066 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.524 HD12 HD21 ' A' ' 66' ' ' LEU . 1.7 mm? -99.94 -69.9 0.75 Allowed 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.411 -2.41 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.131 173.679 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.715 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.9 p -76.85 134.67 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.349 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.77 -34.77 4.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.861 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 35.6 m80 -159.15 163.03 36.43 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.39 116.39 32.34 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.89 155.31 17.24 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 122.345 1.069 . . . . 0.0 111.67 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -106.85 126.47 52.35 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.06 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.405 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.53 109.4 2.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.537 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.6 t -80.94 -18.7 46.17 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.884 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -147.32 151.48 36.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.638 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -89.06 105.4 17.76 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.847 0.832 . . . . 0.0 109.662 173.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.32 162.28 12.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.905 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -125.18 31.52 5.58 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.537 0.684 . . . . 0.0 111.411 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 81.26 59.2 2.45 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.169 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.19 116.12 4.52 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 tttm 57.43 71.11 0.6 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.984 1.313 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.572 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 18.8 m120 51.47 79.47 0.1 Allowed 'General case' 0 C--O 1.245 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 111.493 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.3 tt0 -146.81 -175.45 4.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.645 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -97.59 155.24 17.06 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.556 ' H ' HD22 ' A' ' 44' ' ' LEU . 28.0 m -100.65 115.44 30.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.171 0.51 . . . . 0.0 109.69 174.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.5 p90 -149.48 158.22 43.98 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.819 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 59.4 mttm -110.84 152.93 26.11 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 123.695 0.622 . . . . 0.0 109.922 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 110.22 0.66 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.33 27.23 10.15 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.103 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.7 tp10 -80.11 -37.05 34.43 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.086 0.555 . . . . 0.0 111.117 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 72.21 112.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.182 1.793 . . . . 0.0 110.505 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.55 HD13 ' CG1' ' A' ' 82' ' ' VAL . 9.0 mt -119.88 160.68 20.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.117 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.715 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 44.8 mt-10 -117.83 134.36 55.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 66' ' ' LEU . 7.6 tp -90.14 126.53 42.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.22 -39.55 3.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.595 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -134.89 130.15 35.48 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 118.549 -1.261 . . . . 0.0 110.906 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.45 -1.93 5.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 123.934 0.894 . . . . 0.0 110.233 176.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.8 p -112.38 147.43 36.42 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.916 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 t70 67.08 28.59 8.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 122.75 1.262 . . . . 0.0 109.428 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 23.3 p-10 -77.98 115.05 47.28 Favored Pre-proline 0 C--N 1.302 -1.464 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.203 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 30.9 Cg_exo -62.63 -62.4 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.711 2.941 . . . . 0.0 113.877 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.35 -8.41 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.819 0.818 . . . . 0.0 110.874 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 7.88 68.05 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.0 ptmt -95.96 162.91 13.36 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.598 ' CD1' HG21 ' A' ' 57' ' ' ILE . 46.0 m0 -97.71 175.94 6.0 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 122.365 0.266 . . . . 0.0 110.529 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.538 ' O ' HD11 ' A' ' 54' ' ' ILE . 60.1 tp -120.54 114.18 21.38 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -120.24 159.81 15.03 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.4 ttp180 -134.68 152.81 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.0 m -111.82 165.44 12.06 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.23 -31.96 15.36 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -89.29 -6.86 56.42 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 118.372 -1.331 . . . . 0.0 111.091 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.24 97.2 1.25 Allowed Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.874 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.4 m -153.89 124.31 7.04 Favored 'General case' 0 N--CA 1.394 -3.27 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' HB3' HD11 ' A' ' 66' ' ' LEU . 39.9 m-85 -113.85 80.56 1.4 Allowed 'General case' 1 C--N 1.223 -4.908 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -175.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.645 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -97.46 101.97 2.64 Favored Glycine 3 N--CA 1.346 -7.334 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.572 ' HE1' ' HB3' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.92 100.34 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 113.198 -1.501 . . . . 0.0 108.121 168.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.6 pt -80.44 145.68 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.442 -3.204 0 C-N-CA 126.645 1.978 . . . . 0.0 113.515 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 117.58 22.25 Favored 'General case' 1 N--CA 1.359 -5.007 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 166.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.463 HG22 ' CG ' ' A' ' 65' ' ' TRP . 62.1 p -35.34 -38.2 0.09 Allowed 'General case' 0 C--N 1.251 -3.696 0 C-N-CA 129.05 2.94 . . . . 0.0 114.014 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 t -70.27 -9.89 57.32 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.308 1.043 . . . . 0.0 112.248 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.32 -10.18 36.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.427 -0.796 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.583 HG21 HD13 ' A' ' 77' ' ' ILE . 19.0 m -129.08 152.28 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-O 121.808 0.813 . . . . 0.0 112.29 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.5 mt-10 -119.14 107.05 12.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 10.2 pt -72.82 159.3 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.198 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--N 1.287 -2.13 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.095 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 35.0 mm-40 . . . . . 0 CA--C 1.501 -0.912 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.56 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 2.4 pp -72.3 -28.3 28.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.316 -172.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HA ' HD21 ' A' ' 21' ' ' LEU . 48.7 mtpt -67.91 -36.19 79.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.015 -172.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -107.53 -16.74 14.29 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.298 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 5.8 tppt? -71.32 -45.73 62.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.439 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 31.3 t80 -90.68 -30.61 17.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . 0.254 15.2 tptp 74.61 85.58 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.695 1.236 . . . . 0.0 111.392 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -98.99 -59.84 1.65 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.304 36.2 p . . . . . 0 C--N 1.318 -0.768 0 C-N-CA 125.792 1.637 . . . . 0.0 112.634 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.4 p -81.64 137.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.442 0.639 . . . . 0.0 111.159 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.42 -40.36 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.748 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.41 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.4 m80 -161.15 171.75 17.95 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.517 ' HB3' ' NE2' ' A' ' 51' ' ' GLN . 5.8 mp -107.86 126.33 52.54 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.685 ' HB3' HG21 ' A' ' 84' ' ' ILE . . . -102.68 156.6 17.52 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.418 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -107.1 133.51 51.6 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -65.99 103.22 0.9 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.9 t -71.2 -28.93 64.57 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.3 m -132.09 156.43 46.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.7 p-10 -81.38 112.03 18.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 171.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.739 HG21 ' HB3' ' A' ' 81' ' ' ALA . 30.8 t -112.62 140.89 30.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.789 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.34 -168.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -86.7 -14.61 42.01 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.341 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.78 60.49 3.16 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.983 -1.58 . . . . 0.0 110.432 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.17 131.89 10.85 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.83 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp 58.88 71.58 0.58 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.405 1.082 . . . . 0.0 110.658 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 56.29 61.45 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.114 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 46.5 mt-10 -134.16 -179.22 5.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.548 0.339 . . . . 0.0 111.133 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.61 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -98.46 140.96 31.93 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 p -94.6 115.73 27.92 Favored 'General case' 0 C--N 1.28 -2.443 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.161 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 29.1 p90 -145.47 177.12 9.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.478 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 9.3 mtmp? -134.81 142.53 46.69 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.6 tm0? -35.79 111.97 0.15 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 125.131 1.519 . . . . 0.0 110.376 173.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.09 19.97 40.77 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.648 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -73.33 -26.0 60.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.003 0.901 . . . . 0.0 113.227 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 30' ' ' LEU . 26.6 tp60 70.84 104.2 0.06 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.882 1.364 . . . . 0.0 108.813 -172.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.541 HD11 HG12 ' A' ' 82' ' ' VAL . 14.8 mt -110.74 165.95 5.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.63 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 24.9 mt-10 -122.65 141.11 52.1 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.8 tp -98.75 116.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.49 -41.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.387 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -133.7 136.54 44.74 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 117.782 -1.567 . . . . 0.0 111.497 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.02 -37.84 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.376 -1.283 . . . . 0.0 109.675 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -88.45 158.09 18.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t70 54.82 66.36 1.25 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 125.032 1.333 . . . . 0.0 109.192 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 31.5 p30 -112.11 136.93 21.3 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.166 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.6 Cg_exo -76.76 -32.3 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.431 2.087 . . . . 0.0 112.872 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.79 -34.89 6.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.74 -7.04 15.63 Favored Glycine 0 C--N 1.305 -1.142 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 11.4 ptmt -80.52 162.33 24.38 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.549 ' CD1' HG22 ' A' ' 57' ' ' ILE . 37.7 m0 -99.08 176.65 5.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.608 0.186 . . . . 0.0 110.801 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 21' ' ' LEU . 61.4 tp -116.39 110.93 19.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.83 158.84 14.07 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 73' ' ' SER . 66.4 ttt-85 -140.53 147.8 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.769 0.427 . . . . 0.0 109.88 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 7.1 p -101.03 165.54 11.27 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.12 65.2 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.087 0.47 . . . . 0.0 112.254 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -71.55 -14.97 62.26 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.338 0.655 . . . . 0.0 111.749 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.4 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 81.77 88.37 0.65 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.181 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.7 m -151.99 120.82 6.57 Favored 'General case' 0 N--CA 1.394 -3.269 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 66' ' ' LEU . 61.0 m-85 -108.91 90.74 3.38 Favored 'General case' 1 C--N 1.219 -5.076 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.61 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -107.05 104.81 2.21 Favored Glycine 3 N--CA 1.355 -6.748 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.56 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -46.0 96.99 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.351 -1.424 . . . . 0.0 108.29 169.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.5 pt -78.22 147.18 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.898 0 C-N-CA 125.713 1.605 . . . . 0.0 114.398 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.509 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -76.64 113.82 14.7 Favored 'General case' 1 N--CA 1.376 -4.143 0 N-CA-C 101.712 -3.44 . . . . 0.0 101.712 165.77 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.557 HG23 ' HA ' ' A' ' 64' ' ' LYS . 79.4 p -36.64 -41.92 0.33 Allowed 'General case' 0 C--N 1.246 -3.92 0 C-N-CA 127.769 2.427 . . . . 0.0 113.594 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -63.53 -20.42 65.61 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.258 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.739 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -82.97 -12.54 57.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.835 -0.54 . . . . 0.0 111.279 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.541 HG12 HD11 ' A' ' 52' ' ' ILE . 29.1 m -127.06 166.82 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.343 0.592 . . . . 0.0 111.847 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 58.3 mt-10 -133.26 107.91 8.43 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 31' ' ' ALA . 8.6 pt -75.53 155.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.391 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 C--N 1.291 -1.974 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.706 178.499 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 121.003 0.43 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 1.9 pp -67.54 -30.77 49.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-O 121.454 0.645 . . . . 0.0 111.422 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -76.48 -27.32 56.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.805 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -93.65 -8.93 39.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.019 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 12.6 tppt? -99.58 -67.01 0.87 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.073 0.463 . . . . 0.0 110.96 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.764 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 21.1 t80 -79.07 -32.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 -172.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 7.9 mtmp? 75.72 91.84 0.07 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.834 1.253 . . . . 0.0 109.692 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.35 -46.33 5.83 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.318 0.58 . . . . 0.0 109.772 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HG1' ' C ' ' A' ' 21' ' ' LEU . 62.6 p . . . . . 0 CA--C 1.546 0.826 0 C-N-CA 125.507 1.523 . . . . 0.0 114.877 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' C ' HG23 ' A' ' 55' ' ' ILE . 12.9 pt20 . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -53.95 133.7 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.64 -31.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.066 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.449 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.1 m80 -161.05 157.03 25.49 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.27 116.04 28.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -94.63 150.81 19.85 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 122.072 0.939 . . . . 0.0 111.127 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.81 128.27 54.11 Favored 'General case' 0 C--N 1.252 -3.652 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.84 116.05 5.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.9 t -81.87 -18.47 43.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.249 0.968 . . . . 0.0 109.846 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.9 m -144.61 156.09 43.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.42 102.02 14.7 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.25 153.75 14.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.718 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -98.1 8.33 44.95 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.387 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.62 59.77 1.87 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.678 -1.248 . . . . 0.0 111.896 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.77 143.8 16.7 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttp 65.05 29.59 12.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 108.757 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.411 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 2.4 t-20 63.14 86.97 0.11 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.28 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 31.0 tt0 -141.59 -173.6 3.82 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.257 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.647 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.2 tt -95.92 145.54 25.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 m -96.01 122.21 38.59 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 16.6 p90 -154.26 174.83 14.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 60.9 mtpt -127.33 147.79 50.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -51.98 125.68 16.13 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.669 0.605 . . . . 0.0 110.425 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.2 81.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.349 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -63.12 -30.9 71.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.504 0.668 . . . . 0.0 109.891 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 73.23 110.41 0.07 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.13 1.372 . . . . 0.0 111.298 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.518 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.4 mt -115.76 156.81 16.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 CA-C-N 113.557 -1.656 . . . . 0.0 106.671 -172.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 79.9 mt-10 -113.08 131.16 55.92 Favored 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.009 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.509 HD13 ' O ' ' A' ' 66' ' ' LEU . 6.6 tp -86.32 115.81 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.5 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -103.4 -32.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.984 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 1.078 ' HG3' HD11 ' A' ' 21' ' ' LEU . 18.1 mmt180 -134.93 112.4 10.61 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.723 HD13 ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.59 -19.31 6.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.038 -1.892 . . . . 0.0 107.092 171.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.519 HG23 HG12 ' A' ' 57' ' ' ILE . 12.0 p -99.01 141.94 31.12 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.396 -177.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t0 75.67 26.06 1.12 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.058 1.343 . . . . 0.0 108.92 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.428 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 10.0 p30 -66.01 126.02 91.11 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.587 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.764 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 62.2 Cg_endo -81.23 -45.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.398 2.065 . . . . 0.0 113.3 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -99.3 -5.52 29.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.021 0.438 . . . . 0.0 111.177 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 99.46 -22.3 41.3 Favored Glycine 0 C--N 1.308 -1.004 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.1 ptmt -72.0 161.49 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.152 -1.024 . . . . 0.0 109.21 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.447 ' CG ' HG22 ' A' ' 79' ' ' THR . 32.3 m0 -99.5 176.34 5.53 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.073 0.233 . . . . 0.0 110.924 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 21' ' ' LEU . 62.9 tp -120.36 114.33 21.68 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.08 156.18 15.81 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 73' ' ' SER . 2.1 ttp-105 -139.03 149.11 44.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 17.2 p -99.76 165.94 11.34 Favored 'General case' 0 C--N 1.266 -3.032 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.962 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.73 -30.08 42.47 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -0.07 54.92 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.34 0.866 . . . . 0.0 113.34 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.28 92.01 0.9 Allowed Glycine 0 C--N 1.319 -0.413 0 CA-C-O 121.554 0.53 . . . . 0.0 113.535 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 20.4 m -153.01 126.15 8.53 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.598 ' HB3' HD12 ' A' ' 66' ' ' LEU . 57.1 m-85 -117.81 86.68 2.57 Favored 'General case' 1 C--N 1.227 -4.727 0 CA-C-O 122.122 0.963 . . . . 0.0 108.649 -173.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.647 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.14 101.76 2.12 Favored Glycine 3 N--CA 1.359 -6.447 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.652 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -48.92 100.36 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.58 -1.31 . . . . 0.0 108.499 170.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.573 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.8 pt -80.41 148.29 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.843 0 C-N-CA 126.277 1.831 . . . . 0.0 113.074 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -77.42 119.59 21.24 Favored 'General case' 1 N--CA 1.368 -4.533 0 N-CA-C 102.647 -3.094 . . . . 0.0 102.647 163.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 64' ' ' LYS . 82.0 p -36.13 -38.59 0.14 Allowed 'General case' 1 C--N 1.243 -4.051 0 C-N-CA 128.017 2.527 . . . . 0.0 113.168 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.5 t -71.71 -14.15 61.94 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.208 0.603 . . . . 0.0 112.155 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.97 -11.2 57.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.42 -0.8 . . . . 0.0 110.937 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.518 ' CG1' HD12 ' A' ' 52' ' ' ILE . 16.9 m -129.35 167.41 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.556 0.693 . . . . 0.0 111.336 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 mt-10 -131.34 110.55 11.15 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.648 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -75.77 159.5 5.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.251 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 C--N 1.283 -2.32 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.621 -178.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 16' ' ' LYS . 7.7 pt -67.18 -27.87 40.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.001 0.905 . . . . 0.0 108.746 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.461 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.2 ptmt -79.55 -5.38 54.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.22 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -108.66 -19.94 13.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 2.8 tppt? -91.06 -68.0 0.82 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.031 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.671 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 3.1 t80 -89.12 -22.6 22.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 58.28 88.96 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.417 1.487 . . . . 0.0 111.206 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.653 HD11 HD23 ' A' ' 66' ' ' LEU . 1.9 mm? -95.65 -20.31 19.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.08 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 C--N 1.315 -0.917 0 C-N-CA 126.901 2.08 . . . . 0.0 114.666 179.263 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.403 ' C ' HG21 ' A' ' 55' ' ' ILE . 11.7 pt20 . . . . . 0 N--CA 1.439 -0.995 0 CA-C-O 121.007 0.432 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.71 132.59 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.432 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -99.98 -30.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.171 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.495 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.5 m80 -165.41 161.92 19.14 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.27 116.61 33.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.03 154.54 17.64 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.813 0.816 . . . . 0.0 111.072 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.98 129.5 55.11 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -64.53 109.75 2.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.491 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 40.3 t -87.74 -5.96 58.42 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.619 0.723 . . . . 0.0 109.071 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.4 m -148.99 163.3 37.9 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.635 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.614 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.1 t70 -108.68 100.64 9.86 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.664 1.186 . . . . 0.0 110.734 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG12 ' CZ ' ' A' ' 46' ' ' PHE . 11.4 p -115.62 148.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.292 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.04 30.16 7.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.38 0.61 . . . . 0.0 112.461 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.92 59.85 1.55 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.236 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.81 140.97 15.07 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.53 31.0 20.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.841 0.456 . . . . 0.0 109.828 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.51 95.61 0.04 OUTLIER 'General case' 0 C--O 1.247 0.932 0 C-N-CA 125.001 1.32 . . . . 0.0 109.767 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.5 tt0 -150.13 -173.73 4.52 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.755 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.608 HD11 ' H ' ' A' ' 75' ' ' GLY . 45.6 tp -95.45 147.83 23.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 p -100.3 115.46 29.99 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.388 0.613 . . . . 0.0 110.096 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CG ' HD12 ' A' ' 52' ' ' ILE . 32.7 p90 -151.78 168.7 24.25 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.808 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -124.44 147.63 48.18 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -176.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.418 ' N ' ' HD2' ' A' ' 47' ' ' LYS . 20.2 tt0 -51.45 121.84 6.99 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.804 0.335 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.77 29.94 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.295 -0.479 . . . . 0.0 114.147 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 27.6 mm-40 -85.61 -32.39 22.08 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.96 0.88 . . . . 0.0 113.047 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 73.95 111.83 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.524 1.154 . . . . 0.0 111.272 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD13 HD22 ' A' ' 44' ' ' LEU . 4.8 mt -118.49 173.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.782 -173.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.48 ' H ' HG21 ' A' ' 52' ' ' ILE . 24.6 mt-10 -128.94 134.05 48.07 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.7 tp -91.35 128.95 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG21 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -107.09 -53.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.749 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.671 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 20.2 ttm180 -127.62 137.78 52.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.495 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.74 -32.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 123.975 0.91 . . . . 0.0 112.07 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 p -102.81 164.1 11.83 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t70 71.45 19.57 5.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.876 1.322 . . . . 0.0 108.828 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 30.8 p-10 -80.51 118.1 70.84 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.869 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 12.1 Cg_exo -71.25 -33.29 11.56 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.737 2.958 . . . . 0.0 114.654 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -92.43 -17.07 25.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.135 0.493 . . . . 0.0 110.772 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.72 5.93 70.81 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.7 ptmt -102.88 162.59 12.81 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 77' ' ' ILE . 44.1 m0 -95.69 176.6 6.09 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 123.393 0.677 . . . . 0.0 110.676 -176.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.653 HD23 HD11 ' A' ' 21' ' ' LEU . 51.8 tp -117.04 113.58 22.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.37 147.93 18.9 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 69' ' ' THR . 43.9 ttp180 -120.9 154.33 36.02 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.038 0.447 . . . . 0.0 111.117 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.592 ' HG1' HD13 ' A' ' 44' ' ' LEU . 10.6 m -99.4 153.13 19.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.24 -34.5 32.62 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 119.242 0.928 . . . . 0.0 113.272 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -71.65 -15.37 62.23 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.503 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.33 87.67 1.17 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.9 m -153.56 122.77 6.55 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.56 ' HB3' HD11 ' A' ' 66' ' ' LEU . 77.5 m-85 -113.37 99.21 7.61 Favored 'General case' 1 C--N 1.222 -4.951 0 O-C-N 123.902 0.751 . . . . 0.0 109.828 -171.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.608 ' H ' HD11 ' A' ' 44' ' ' LEU . . . -104.19 101.69 2.01 Favored Glycine 1 N--CA 1.356 -6.633 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.71 103.19 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.884 0 CA-C-N 113.423 -1.389 . . . . 0.0 107.358 170.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.633 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.7 pt -87.71 143.89 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.97 0 C-N-CA 124.837 1.255 . . . . 0.0 113.728 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.09 117.6 18.81 Favored 'General case' 1 N--CA 1.371 -4.397 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 166.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.464 HG23 ' CG ' ' A' ' 65' ' ' TRP . 54.5 p -36.21 -39.48 0.18 Allowed 'General case' 0 C--N 1.244 -3.999 0 C-N-CA 128.868 2.867 . . . . 0.0 113.12 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -69.38 -12.61 61.8 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.255 1.022 . . . . 0.0 112.704 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.83 -12.75 41.06 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.591 -0.693 . . . . 0.0 110.997 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.473 ' CG1' HD11 ' A' ' 52' ' ' ILE . 27.7 m -130.92 164.65 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-O 121.251 0.548 . . . . 0.0 111.088 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.491 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 45.6 mt-10 -132.26 113.29 13.06 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -76.27 166.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.566 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 C--N 1.304 -1.41 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.004 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 C--O 1.222 -0.366 0 CA-C-O 120.902 0.382 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 74' ' ' TYR . 10.1 pt -68.8 -28.6 40.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.418 0.628 . . . . 0.0 110.903 -174.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . 25.7 mtpp -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.072 0.939 . . . . 0.0 108.493 -176.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.49 ' HB3' ' HZ2' ' A' ' 17' ' ' LYS . 7.4 mtpm? -114.72 9.07 16.33 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.921 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.511 ' HG2' ' CE1' ' A' ' 76' ' ' TYR . 11.9 tppt? -120.41 -60.88 1.64 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.209 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.7 t80 -91.53 -28.33 17.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.752 ' HZ2' ' HB3' ' A' ' 20' ' ' LYS . 3.1 ttpm? 65.45 90.0 0.09 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.521 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.51 HD12 HD21 ' A' ' 66' ' ' LEU . 1.7 mm? -98.73 -15.8 19.2 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.359 -174.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.307 80.4 p . . . . . 0 C--N 1.311 -1.075 0 C-N-CA 125.709 1.604 . . . . 0.0 113.079 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.7 p -80.04 134.78 26.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.508 0.671 . . . . 0.0 110.498 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.27 -38.86 11.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.987 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.6 m80 -161.65 165.01 28.87 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.57 124.76 49.4 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.617 ' HB3' HG21 ' A' ' 84' ' ' ILE . . . -99.34 158.89 15.4 Favored 'General case' 0 C--N 1.267 -2.99 0 CA-C-O 121.805 0.812 . . . . 0.0 111.831 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -106.83 125.58 51.19 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 109.88 2.15 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 41.9 t -84.69 -19.24 33.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.0 t -144.55 144.75 31.47 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.705 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.94 105.83 14.26 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.913 0.863 . . . . 0.0 111.234 174.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.31 151.35 18.12 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.425 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 66.78 1.11 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 121.896 0.855 . . . . 0.0 109.655 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 73.16 59.18 4.35 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.213 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.51 105.75 2.95 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 57.11 69.52 0.74 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.17 0.988 . . . . 0.0 110.95 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 54.49 83.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.781 0.832 . . . . 0.0 109.843 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 7.7 tt0 -149.59 -175.3 4.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.634 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.44 159.57 14.86 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.519 ' H ' HD22 ' A' ' 44' ' ' LEU . 14.8 m -101.42 118.68 37.46 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-O 121.566 0.698 . . . . 0.0 110.031 174.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.8 p90 -154.96 163.74 39.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.057 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 48.1 mtmt -117.72 156.17 28.71 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.86 116.07 1.8 Allowed 'General case' 0 CA--C 1.568 1.656 0 O-C-N 123.833 0.708 . . . . 0.0 109.325 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.99 17.58 40.24 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -80.34 -21.83 42.06 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 72.11 109.23 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.319 1.057 . . . . 0.0 110.871 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.6 mt -116.1 165.44 11.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 27' ' ' VAL . 8.0 mt-10 -116.66 136.78 52.69 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 66' ' ' LEU . 7.4 tp -98.58 119.69 46.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.38 -53.24 7.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.405 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.9 tpm_? -122.43 123.96 42.53 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.901 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.536 HG23 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -113.66 -23.75 4.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.498 0.666 . . . . 0.0 110.599 174.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 p -90.85 150.33 21.59 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.718 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 60.11 55.27 3.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.234 1.014 . . . . 0.0 108.513 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -95.82 109.22 45.18 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.71 -59.95 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 124.008 3.139 . . . . 0.0 114.307 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.22 -17.52 56.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.687 0.28 . . . . 0.0 111.497 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.11 5.69 49.53 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -105.43 159.4 15.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.106 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.536 ' CD1' HG23 ' A' ' 57' ' ' ILE . 38.3 m0 -90.41 174.35 7.61 Favored 'General case' 0 C--O 1.198 -1.612 0 C-N-CA 123.459 0.703 . . . . 0.0 110.578 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.745 HD12 ' HB3' ' A' ' 74' ' ' TYR . 58.0 tp -112.74 109.36 18.81 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.987 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.08 155.13 16.52 Favored Glycine 0 N--CA 1.426 -1.986 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.8 ttp180 -133.95 147.1 51.01 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.567 HG22 ' HB2' ' A' ' 73' ' ' SER . 13.4 t -104.17 163.87 12.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.58 -28.98 15.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.36 -21.02 56.61 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.491 0.663 . . . . 0.0 110.637 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.03 1.07 Allowed Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 59.6 m -152.54 125.5 8.5 Favored 'General case' 0 N--CA 1.386 -3.67 1 N-CA-C 100.03 -4.063 . . . . 0.0 100.03 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HB3' HD12 ' A' ' 66' ' ' LEU . 35.1 m-85 -110.6 82.7 1.63 Allowed 'General case' 1 C--N 1.21 -5.482 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.634 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -98.44 97.48 1.9 Allowed Glycine 2 N--CA 1.363 -6.22 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CE1' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.84 93.68 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.883 -1.659 . . . . 0.0 110.727 172.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -70.92 139.91 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 126.9 2.08 . . . . 0.0 113.617 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 118.03 18.2 Favored 'General case' 1 N--CA 1.353 -5.31 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 166.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.524 HG21 ' CD2' ' A' ' 65' ' ' TRP . 73.7 p -35.1 -39.1 0.1 Allowed 'General case' 1 C--N 1.229 -4.67 0 C-N-CA 129.116 2.966 . . . . 0.0 112.807 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -72.02 -5.86 38.13 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.752 0.821 . . . . 0.0 112.26 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.0 -2.62 34.06 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.625 -0.672 . . . . 0.0 111.122 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 77' ' ' ILE . 19.3 m -134.38 159.86 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-O 121.784 0.802 . . . . 0.0 112.722 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.1 mt-10 -125.94 102.89 7.47 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.617 HG21 ' HB3' ' A' ' 31' ' ' ALA . 2.4 pp -69.14 149.21 11.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 CA--C 1.487 -1.454 0 CA-C-O 121.143 0.497 . . . . 0.0 111.162 176.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.241 0.643 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.523 HG13 ' HG3' ' A' ' 16' ' ' LYS . 10.0 pt -81.31 -23.22 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.585 1.183 . . . . 0.0 109.17 -171.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HG3' HG13 ' A' ' 15' ' ' ILE . 74.0 mttt -82.19 -9.07 59.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.32 -1.763 . . . . 0.0 110.791 -173.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 0.07 19.45 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.008 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 3.8 tppt? -114.18 -58.5 2.14 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.382 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 60' ' ' ASN . 20.1 t80 -85.94 -33.46 21.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 66.82 94.23 0.07 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.531 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.809 HD12 HD21 ' A' ' 66' ' ' LEU . 2.0 mm? -99.76 -64.85 1.0 Allowed 'General case' 0 CA--C 1.46 -2.518 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.052 -173.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.395 -3.225 0 CA-C-N 111.678 -2.51 . . . . 0.0 111.115 178.817 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -74.76 132.0 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 109.891 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.48 -33.26 5.16 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.952 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.461 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.7 m80 -166.72 165.64 16.32 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.431 HD21 ' NE2' ' A' ' 51' ' ' GLN . 5.2 mp -107.63 116.01 31.18 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.24 159.34 15.32 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.944 0.878 . . . . 0.0 112.243 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.39 127.94 54.02 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.377 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB3' ' HD1' ' A' ' 46' ' ' PHE . . . -64.43 107.02 1.24 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 t -75.37 -19.12 59.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.438 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.0 p -153.15 159.58 42.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.621 0.724 . . . . 0.0 109.543 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.628 HG23 ' H ' ' A' ' 39' ' ' GLY . 11.4 p -115.72 152.54 17.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.631 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.78 8.75 39.34 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.967 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.628 ' H ' HG23 ' A' ' 37' ' ' VAL . . . 84.01 60.21 1.98 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.52 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.43 80.08 1.68 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.263 -174.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 66.72 82.9 0.17 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.328 1.051 . . . . 0.0 113.309 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 89.28 26.12 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 125.516 1.526 . . . . 0.0 113.114 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.82 174.81 6.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.403 0.621 . . . . 0.0 111.668 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 46.4 tp -96.42 147.91 23.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.531 1.533 . . . . 0.0 107.315 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -96.89 121.81 39.16 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 120.907 0.385 . . . . 0.0 110.313 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.451 ' CG ' HD11 ' A' ' 52' ' ' ILE . 26.9 p90 -155.66 160.04 40.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.616 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -108.91 152.42 24.95 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.48 117.14 5.79 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.907 0.754 . . . . 0.0 109.355 -176.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.78 30.03 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.567 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.94 -25.12 16.67 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.431 ' NE2' HD21 ' A' ' 30' ' ' LEU . 42.7 tt0 72.83 134.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 O-C-N 124.8 1.313 . . . . 0.0 113.041 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.488 HD13 ' CG1' ' A' ' 82' ' ' VAL . 5.3 mt -129.64 169.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.339 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -119.07 135.5 54.61 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 65' ' ' TRP . 8.1 tp -93.16 127.04 45.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -110.92 -56.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -119.09 131.9 55.97 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.921 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.498 HG23 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -116.83 -32.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.063 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 p -107.36 161.11 15.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 t70 64.79 69.16 0.5 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 125.522 1.529 . . . . 0.0 112.814 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 9.2 p30 -145.09 163.3 33.41 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.538 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -95.72 10.91 1.48 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.218 1.946 . . . . 0.0 115.416 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.558 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 8.4 tp10 -122.98 -29.91 3.86 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.985 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.05 57.61 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.6 ptmt -92.5 163.12 13.94 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 109.266 -177.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.533 ' CD2' HG21 ' A' ' 79' ' ' THR . 43.2 m0 -101.89 169.53 8.72 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.893 0.377 . . . . 0.0 110.592 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.809 HD21 HD12 ' A' ' 21' ' ' LEU . 45.7 tp -109.58 110.51 21.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.74 142.83 17.5 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 73' ' ' SER . 50.2 ttt-85 -124.32 155.02 39.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 124.319 0.658 . . . . 0.0 110.188 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 5.2 m -113.52 162.05 16.64 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.96 -28.97 7.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -172.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -69.99 -28.52 65.59 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.034 0.534 . . . . 0.0 111.577 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.485 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 96.07 69.0 1.01 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.4 m -136.62 117.09 13.75 Favored 'General case' 0 N--CA 1.383 -3.806 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.44 ' HB3' HD12 ' A' ' 66' ' ' LEU . 90.2 m-85 -116.68 105.1 12.05 Favored 'General case' 1 C--N 1.223 -4.925 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -172.027 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.84 0.75 48.42 Favored Glycine 0 C--O 1.181 -3.19 0 C-N-CA 118.372 -1.87 . . . . 0.0 116.255 -175.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.579 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.268 0.1 OUTLIER 51.2 80.44 0.08 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 123.103 1.43 . . . . 0.0 111.417 -176.976 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.588 HD13 HG22 ' A' ' 82' ' ' VAL . 2.0 pt -68.57 142.17 16.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.66 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HZ2' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -80.51 115.51 20.07 Favored 'General case' 1 N--CA 1.362 -4.831 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 165.525 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.533 HG21 ' CD2' ' A' ' 65' ' ' TRP . 73.1 p -34.95 -38.3 0.08 Allowed 'General case' 1 C--N 1.244 -4.008 0 C-N-CA 128.918 2.887 . . . . 0.0 114.422 -177.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -68.98 -7.1 32.11 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.951 0.9 . . . . 0.0 111.709 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.26 -6.86 43.59 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 121.466 -0.771 . . . . 0.0 110.657 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.588 HG22 HD13 ' A' ' 77' ' ' ILE . 26.3 m -137.52 167.88 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-O 121.618 0.723 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.628 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.8 pt -77.81 163.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.545 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.793 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 CA--C 1.494 -1.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.619 HG23 ' HB2' ' A' ' 74' ' ' TYR . 7.1 pt -62.89 -33.4 60.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.068 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' N ' HG13 ' A' ' 15' ' ' ILE . 9.4 mptt -80.02 -4.34 52.22 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.174 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -112.99 -13.79 13.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -98.51 -61.76 1.33 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.074 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -87.62 -26.56 23.0 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 mttp 66.07 83.8 0.16 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.804 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 66' ' ' LEU . 1.2 mm? -100.19 -69.76 0.76 Allowed 'General case' 0 CA--C 1.466 -2.273 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.388 -3.53 0 CA-C-N 111.881 -2.418 . . . . 0.0 112.272 175.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.803 HG23 ' HB3' ' A' ' 53' ' ' GLU . 12.1 p -94.05 145.3 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 HG13 HD12 ' A' ' 57' ' ' ILE . 45.5 mm -100.9 -38.9 6.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.446 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.5 m80 -160.64 168.57 24.65 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.19 118.38 36.86 Favored 'General case' 0 C--O 1.191 -1.998 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.0 155.75 16.96 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-O 122.14 0.971 . . . . 0.0 110.659 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -103.65 129.88 51.03 Favored 'General case' 1 C--N 1.243 -4.05 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -67.67 110.76 3.87 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.541 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 20.7 t -80.46 -18.29 49.15 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.629 0.728 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.6 m -144.33 155.09 43.65 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -93.97 105.01 17.04 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -114.74 163.46 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.445 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.501 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -107.8 10.17 28.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 100.26 61.08 0.82 Allowed Glycine 0 CA--C 1.491 -1.459 0 C-N-CA 118.262 -1.923 . . . . 0.0 109.459 -173.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.05 99.66 1.42 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -172.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.649 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.5 ttpm? 61.91 76.88 0.35 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.387 1.475 . . . . 0.0 110.741 -177.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 t30 57.7 70.49 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.002 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.647 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 39.8 tt0 -145.67 -175.07 4.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.876 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.552 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.52 153.73 17.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -102.27 128.06 48.98 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 120.962 0.411 . . . . 0.0 109.96 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -158.82 171.33 20.26 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.051 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 98.7 mttt -120.44 142.8 48.9 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.2 pt20 -54.99 124.48 16.9 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.53 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.61 10.34 55.6 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.717 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 6.9 tp10 -69.66 -37.87 76.87 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.883 0.849 . . . . 0.0 110.103 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 70.51 102.14 0.06 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 126.205 1.802 . . . . 0.0 108.851 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD13 ' CG1' ' A' ' 82' ' ' VAL . 13.1 mt -104.23 156.02 5.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.803 ' HB3' HG23 ' A' ' 27' ' ' VAL . 34.3 mt-10 -116.06 126.55 53.92 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -85.4 118.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.535 HG23 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -104.15 -38.35 4.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.67 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -132.73 130.51 40.1 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.811 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.606 HG23 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -125.81 -32.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.683 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -85.06 143.66 28.75 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.08 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 t70 66.99 53.41 0.82 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.818 1.295 . . . . 0.0 109.752 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -94.51 114.89 64.52 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.452 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.46 -53.67 0.28 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.917 1.745 . . . . 0.0 111.137 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.975 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 7.0 tp10 -66.56 -40.56 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.43 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.31 -18.11 18.48 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.975 ' HD2' ' HG2' ' A' ' 62' ' ' GLU . 14.0 ptmt -76.11 163.32 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.529 1.132 . . . . 0.0 109.299 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG23 ' A' ' 57' ' ' ILE . 27.6 m0 -95.31 164.84 12.66 Favored 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 122.862 0.465 . . . . 0.0 112.157 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -111.79 113.76 26.31 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -126.56 160.3 20.89 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' A' ' 73' ' ' SER . 54.5 ttp180 -131.47 152.72 50.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 24.7 m -112.76 164.59 13.19 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.04 -18.31 9.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.486 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 2.3 tmm_? -82.93 -24.98 32.81 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 83.9 1.66 Allowed Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.674 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.6 m -151.69 117.58 5.49 Favored 'General case' 0 N--CA 1.383 -3.824 0 N-CA-C 101.041 -3.689 . . . . 0.0 101.041 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.741 ' HB3' HD13 ' A' ' 66' ' ' LEU . 22.2 m-85 -109.97 83.23 1.72 Allowed 'General case' 1 C--N 1.219 -5.085 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -99.84 97.35 1.76 Allowed Glycine 2 N--CA 1.369 -5.808 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.596 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -40.82 100.75 0.02 OUTLIER 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 112.555 -1.822 . . . . 0.0 109.163 171.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -81.42 147.99 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.512 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.371 -177.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 9.6 ptpp? -76.35 118.45 19.06 Favored 'General case' 1 N--CA 1.358 -5.06 0 N-CA-C 102.915 -2.995 . . . . 0.0 102.915 163.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.497 HG21 ' CD2' ' A' ' 65' ' ' TRP . 69.6 p -36.46 -39.36 0.19 Allowed 'General case' 1 C--N 1.241 -4.151 0 C-N-CA 128.193 2.597 . . . . 0.0 113.026 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.1 -10.0 55.46 Favored 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 123.882 0.873 . . . . 0.0 112.25 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.77 -9.84 36.19 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.426 -0.796 . . . . 0.0 111.028 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.499 ' CG1' HD13 ' A' ' 52' ' ' ILE . 13.3 m -126.58 167.23 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.129 0.49 . . . . 0.0 111.482 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.98 113.02 9.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.9 pt -75.46 159.39 5.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.116 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.825 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 13.1 pt-20 . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 120.58 0.229 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 HG23 ' HH ' ' A' ' 76' ' ' TYR . 2.1 pp -64.52 -24.07 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 C-N-CA 124.785 1.234 . . . . 0.0 113.119 -169.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HA ' HD23 ' A' ' 21' ' ' LEU . 12.4 mptt -54.48 -58.82 5.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 124.125 0.891 . . . . 0.0 113.139 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -83.78 8.89 13.3 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 121.058 0.456 . . . . 0.0 111.783 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 30.5 mmmt -92.16 -61.34 1.64 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.663 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.4 t80 -86.58 -21.63 26.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 tttm 71.55 83.46 0.14 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.077 0.941 . . . . 0.0 110.134 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.6 -65.0 0.99 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.393 -177.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 5.1 t . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.136 1.775 . . . . 0.0 114.047 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.04 131.8 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 109.744 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -96.57 -33.51 4.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.95 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.48 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.8 m80 -165.13 174.03 10.78 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.87 116.55 30.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.288 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 84' ' ' ILE . . . -97.09 156.02 16.56 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-O 121.703 0.763 . . . . 0.0 111.688 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -107.12 123.95 48.98 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.52 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.36 106.16 1.31 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.9 t -87.25 -8.41 56.83 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.344 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -144.6 130.71 19.49 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . 7.2 p-10 -77.13 99.49 5.41 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.45 1.119 . . . . 0.0 108.339 172.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.78 163.25 11.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.566 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.51 25.37 7.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.787 0.327 . . . . 0.0 111.063 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 99.96 60.13 0.84 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.827 -1.178 . . . . 0.0 111.113 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 91.67 0.66 Allowed Glycine 0 C--N 1.316 -0.545 0 O-C-N 123.808 0.357 . . . . 0.0 112.948 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt 61.92 72.11 0.52 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.996 1.319 . . . . 0.0 109.797 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 58.48 80.15 0.19 Allowed 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.227 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 10.3 tt0 -145.1 -175.92 4.89 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.311 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 45' ' ' SER . 2.3 tt -96.44 149.59 21.55 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.431 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.2 m -98.21 115.3 28.05 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.342 0.591 . . . . 0.0 110.052 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.52 ' HD1' ' HB1' ' A' ' 33' ' ' ALA . 22.3 p90 -144.52 161.63 38.61 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.295 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mmpt? -114.92 154.74 28.16 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -53.49 126.16 20.54 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.075 0.859 . . . . 0.0 110.873 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.39 20.77 74.27 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.753 -0.658 . . . . 0.0 114.451 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 30.4 mm-40 -74.83 -30.37 61.36 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.725 0.762 . . . . 0.0 112.844 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.61 116.99 0.06 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.906 1.379 . . . . 0.0 109.032 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.525 HD12 ' CG1' ' A' ' 82' ' ' VAL . 12.8 mt -118.26 154.52 20.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.83 139.13 47.56 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.809 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.0 tp -94.77 126.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -47.55 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.959 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.663 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 22.9 ttt180 -130.47 133.58 46.41 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -125.0 -33.95 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.781 -178.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -100.01 150.12 22.77 Favored 'General case' 0 C--O 1.25 1.106 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.896 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.617 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.7 t70 62.32 69.27 0.62 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.566 1.166 . . . . 0.0 108.264 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.532 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 7.2 p30 -112.75 139.37 22.73 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.379 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 11.9 Cg_exo -73.61 -58.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.893 2.395 . . . . 0.0 114.345 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.93 -42.74 38.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.647 0.737 . . . . 0.0 111.07 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.532 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 121.13 17.86 3.97 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.673 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 16.2 ptmt -117.24 162.56 17.68 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.588 ' CD2' HG22 ' A' ' 79' ' ' THR . 35.8 m0 -97.21 171.37 8.49 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.103 0.561 . . . . 0.0 111.63 -173.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 21' ' ' LEU . 50.4 tp -112.11 105.88 14.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.44 161.02 12.83 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 73' ' ' SER . 53.8 ttp180 -138.81 153.64 48.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.204 0.525 . . . . 0.0 110.491 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.58 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 11.5 m -100.02 154.68 18.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.7 -33.25 60.7 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.91 0.777 . . . . 0.0 112.803 -173.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -2.77 41.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.19 96.76 0.79 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.431 0.462 . . . . 0.0 112.752 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 24.5 m -154.78 120.69 5.19 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.565 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 70.2 m-85 -117.43 94.32 4.5 Favored 'General case' 1 C--N 1.221 -5.019 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -177.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -109.52 11.92 33.07 Favored Glycine 1 CA--C 1.437 -4.836 0 C-N-CA 117.283 -2.389 . . . . 0.0 115.679 -173.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.673 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.275 0.1 OUTLIER 47.28 89.73 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.341 0 CA-C-O 122.764 1.269 . . . . 0.0 111.754 -178.413 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.666 HD12 HG23 ' A' ' 82' ' ' VAL . 2.3 pt -70.5 140.39 18.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.573 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 64' ' ' LYS . 7.5 ptpp? -80.1 118.55 21.91 Favored 'General case' 1 N--CA 1.372 -4.343 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.588 HG22 ' CD2' ' A' ' 65' ' ' TRP . 70.7 p -34.96 -33.05 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.939 0 C-N-CA 128.905 2.882 . . . . 0.0 114.435 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -77.02 -11.81 59.85 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 123.293 0.637 . . . . 0.0 112.229 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.24 -3.76 53.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.213 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.666 HG23 HD12 ' A' ' 77' ' ' ILE . 16.4 m -133.23 170.21 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 121.538 0.685 . . . . 0.0 110.93 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.45 107.56 7.18 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 31' ' ' ALA . 18.5 pt -80.81 165.62 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.508 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--N 1.287 -2.126 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.933 175.604 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.8 mt-10 . . . . . 0 CA--C 1.491 -1.311 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.579 ' HA ' ' HE1' ' A' ' 76' ' ' TYR . 1.9 pp -65.85 -29.66 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.386 0.612 . . . . 0.0 110.413 -173.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 55.4 mtpt -71.49 -34.86 70.52 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.062 -1.427 . . . . 0.0 112.011 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -102.45 -12.82 17.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.959 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 7.4 tppt? -82.32 -54.26 5.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.594 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 9.9 t80 -86.36 -28.09 23.85 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 25.7 ttpt 71.33 89.99 0.1 Allowed 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.565 1.146 . . . . 0.0 110.328 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.66 -56.47 2.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.316 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 C--N 1.312 -1.052 0 C-N-CA 124.701 1.2 . . . . 0.0 112.439 179.071 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.601 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.4 p -83.81 123.5 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.266 1.032 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.8 mm -85.71 -34.51 8.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -167.19 166.2 15.03 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp -105.01 116.21 31.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -90.18 154.06 20.04 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 122.087 0.946 . . . . 0.0 110.914 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -106.95 119.29 38.97 Favored 'General case' 0 C--N 1.254 -3.546 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -66.06 103.7 1.01 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -87.65 -10.98 49.79 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.3 m -136.12 130.55 33.49 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.765 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.464 ' HB2' ' H ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -76.7 102.89 6.39 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.69 0.757 . . . . 0.0 110.402 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.34 155.68 15.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.623 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 55.85 1.65 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.513 0.673 . . . . 0.0 111.413 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 86.35 60.5 1.73 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.694 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.42 78.42 1.62 Allowed Glycine 0 C--N 1.309 -0.964 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttm 67.32 81.21 0.2 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.857 1.263 . . . . 0.0 110.362 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 56.15 74.51 0.39 Allowed 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.604 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 7.4 tt0 -144.3 -175.52 4.66 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.142 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.535 ' HB3' ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -98.42 157.86 15.94 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -102.86 115.93 31.56 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.535 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 25.2 p90 -148.06 153.97 39.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.172 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 68.0 mttm -105.75 151.3 24.62 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.298 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.464 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -55.6 113.66 1.54 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.145 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.71 21.14 22.33 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.106 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.4 tp10 -73.05 -44.27 60.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.224 0.61 . . . . 0.0 111.638 -176.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 74.71 107.3 0.07 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.96 1.412 . . . . 0.0 109.218 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.584 HD11 ' CG1' ' A' ' 82' ' ' VAL . 7.6 mt -116.61 164.07 13.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 107.721 -172.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.601 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 21.9 mt-10 -116.68 133.38 56.08 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.7 tp -92.21 124.58 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.601 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.22 -37.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.592 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 31.7 ttm180 -136.77 133.56 36.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.619 175.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.614 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -127.27 -19.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 124.789 1.235 . . . . 0.0 111.832 -176.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -99.94 143.93 29.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 59.32 67.37 0.91 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.877 1.36 . . . . 0.0 110.296 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.518 HD22 ' HD1' ' A' ' 65' ' ' TRP . 8.4 m120 -86.68 130.94 47.02 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.331 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.594 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -55.61 -66.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.734 2.289 . . . . 0.0 112.219 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.681 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 42.4 mt-10 -94.43 -3.76 49.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.26 0.553 . . . . 0.0 110.932 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.99 -17.12 35.57 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.681 ' HD2' ' HB2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.31 152.48 34.52 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.693 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.535 ' HB2' HG13 ' A' ' 77' ' ' ILE . 34.6 m0 -87.08 177.06 7.32 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 124.282 1.033 . . . . 0.0 110.344 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 21' ' ' LEU . 52.5 tp -113.89 113.78 25.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.48 154.01 16.74 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 73' ' ' SER . 59.4 ttp180 -137.25 152.02 49.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.237 0.542 . . . . 0.0 110.786 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.576 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 21.6 m -100.71 157.15 16.9 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 175.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.43 14.94 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -73.6 -12.18 60.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 84.14 87.01 0.86 Allowed Glycine 0 N--CA 1.433 -1.546 0 CA-C-O 121.718 0.621 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.2 m -151.12 121.43 7.3 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 100.229 -3.989 . . . . 0.0 100.229 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.601 ' HE2' HG13 ' A' ' 55' ' ' ILE . 52.8 m-85 -115.84 90.21 3.28 Favored 'General case' 1 C--N 1.232 -4.501 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -171.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -106.56 96.84 1.16 Allowed Glycine 3 N--CA 1.375 -5.385 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.579 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -43.23 94.88 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 O-C-N 125.597 1.41 . . . . 0.0 110.869 174.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.635 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.6 pt -70.64 143.24 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.222 0 C-N-CA 127.2 2.2 . . . . 0.0 114.824 -174.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -78.46 116.63 18.99 Favored 'General case' 1 N--CA 1.351 -5.38 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 166.976 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.5 p -36.13 -29.86 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.955 0 C-N-CA 128.411 2.684 . . . . 0.0 113.83 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 t -84.14 -0.74 53.17 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 123.206 0.603 . . . . 0.0 111.649 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.53 -12.49 21.18 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 120.78 -1.2 . . . . 0.0 110.286 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.617 HG21 HD12 ' A' ' 77' ' ' ILE . 35.3 m -135.16 166.82 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.471 0.653 . . . . 0.0 110.757 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -140.24 123.03 16.43 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 171.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 pt -70.64 161.26 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.225 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--N 1.29 -2.014 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.591 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 31.0 mm-40 . . . . . 0 C--O 1.222 -0.364 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.578 HG22 ' HH ' ' A' ' 76' ' ' TYR . 2.4 pp -92.73 -28.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 20.8 ptmt -66.57 -41.96 87.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.008 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -94.18 -0.35 55.26 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.899 0.857 . . . . 0.0 109.77 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 76' ' ' TYR . 10.7 tppt? -85.53 -65.22 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 11.4 t80 -78.85 -25.94 44.06 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 32.2 mtmm 68.18 88.23 0.11 Allowed 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.497 1.119 . . . . 0.0 110.32 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.725 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -97.17 -25.65 15.23 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.318 -175.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 74.9 p . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 126.525 1.93 . . . . 0.0 113.896 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.417 ' O ' HG21 ' A' ' 55' ' ' ILE . 11.7 pt20 . . . . . 0 CA--C 1.526 0.021 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.3 p -81.77 133.01 30.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.172 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.55 -38.25 10.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.709 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 24.3 m80 -161.3 171.35 18.49 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.35 132.59 54.91 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.681 ' HB1' HG21 ' A' ' 84' ' ' ILE . . . -104.76 161.64 13.99 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.984 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -106.88 129.26 54.74 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.37 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 52' ' ' ILE . . . -74.05 102.41 4.18 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.421 ' SG ' ' HG3' ' A' ' 83' ' ' GLU . 69.2 m -86.29 -5.06 59.26 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.82 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -133.99 140.37 46.68 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.23 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -91.07 99.09 12.18 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.327 1.061 . . . . 0.0 108.994 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.85 150.05 16.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.5 33.94 5.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.733 0.778 . . . . 0.0 110.202 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 95.83 58.86 1.09 Allowed Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.823 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.13 117.27 4.76 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 65.46 37.12 6.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.353 1.061 . . . . 0.0 110.858 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 t30 63.71 89.21 0.09 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.313 1.054 . . . . 0.0 109.794 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.552 ' HG3' ' H ' ' A' ' 44' ' ' LEU . 2.1 tp10 -136.95 -172.98 3.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.045 -168.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.67 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.7 tt -95.08 148.15 22.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.415 ' H ' HD22 ' A' ' 44' ' ' LEU . 16.1 m -96.71 115.76 27.98 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.827 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 22.6 p90 -147.01 158.99 44.1 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.268 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 9.3 mtmp? -108.39 156.7 19.13 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.44 118.77 6.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.85 25.78 28.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 11.5 tp10 -74.56 -36.85 63.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 122.844 0.458 . . . . 0.0 110.66 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 72.41 109.17 0.07 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 125.448 1.499 . . . . 0.0 108.849 -172.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.565 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.7 mt -115.29 162.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.596 ' HB3' HG21 ' A' ' 27' ' ' VAL . 11.9 mt-10 -116.76 140.59 49.25 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.523 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.9 tp -101.77 125.01 55.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.417 HG21 ' O ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -111.02 -46.25 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.672 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.79 HH21 ' HB3' ' A' ' 59' ' ' ASP . 47.6 ttt180 -130.61 138.51 50.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.95 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 HD11 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.6 -37.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 123.805 0.842 . . . . 0.0 111.16 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 p -98.4 156.04 16.94 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.79 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.9 t70 67.3 71.59 0.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.439 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.713 HD22 ' HG2' ' A' ' 64' ' ' LYS . 32.0 t30 -154.16 117.44 2.61 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.218 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.31 -23.0 67.99 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.649 2.9 . . . . 0.0 114.073 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.89 -16.67 61.1 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.128 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.41 27.76 70.88 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.713 ' HG2' HD22 ' A' ' 60' ' ' ASN . 7.1 ptmt -118.79 161.4 20.2 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.534 ' HB2' HG13 ' A' ' 77' ' ' ILE . 42.5 m0 -99.86 176.46 5.43 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 -178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.725 HD22 HD11 ' A' ' 21' ' ' LEU . 62.8 tp -117.13 110.52 18.29 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.59 158.19 14.45 Favored Glycine 0 N--CA 1.419 -2.449 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.89 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.5 ttp180 -139.16 151.68 46.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -106.34 165.6 11.14 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.7 62.91 0.82 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.352 1.073 . . . . 0.0 111.664 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 71' ' ' ARG . 8.9 ptp180 -170.29 -27.4 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.911 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.29 88.52 1.96 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.7 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 26.3 m -152.72 117.91 5.2 Favored 'General case' 0 N--CA 1.381 -3.877 0 N-CA-C 100.805 -3.776 . . . . 0.0 100.805 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.544 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 64.5 m-85 -110.78 81.87 1.5 Allowed 'General case' 1 C--N 1.216 -5.221 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -173.125 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.67 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -101.57 99.09 1.87 Allowed Glycine 2 N--CA 1.347 -7.276 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -44.39 101.17 0.02 OUTLIER 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 112.185 -2.007 . . . . 0.0 108.215 169.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.592 HD11 HG22 ' A' ' 82' ' ' VAL . 2.0 pt -82.41 147.27 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.98 0 C-N-CA 126.822 2.049 . . . . 0.0 113.478 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HZ2' ' CD ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -80.93 118.83 22.76 Favored 'General case' 1 N--CA 1.354 -5.268 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 166.38 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.49 HG23 ' CG ' ' A' ' 65' ' ' TRP . 55.0 p -35.96 -39.81 0.18 Allowed 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 128.113 2.565 . . . . 0.0 112.984 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -72.09 -10.52 59.89 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.348 1.059 . . . . 0.0 112.891 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.04 -12.94 39.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.578 0.704 . . . . 0.0 110.159 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.592 HG22 HD11 ' A' ' 77' ' ' ILE . 30.7 m -130.97 173.48 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.785 0.802 . . . . 0.0 111.412 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 44.1 mt-10 -137.95 122.64 18.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.681 HG21 ' HB1' ' A' ' 31' ' ' ALA . 12.4 pt -86.48 158.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.935 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.616 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 pp -78.55 -27.04 14.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.4 0.619 . . . . 0.0 109.52 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -55.5 -55.43 31.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.213 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -87.6 4.43 43.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.539 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -94.46 -53.06 4.05 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.846 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t80 -90.25 -24.81 20.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp 70.71 86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.105 1.362 . . . . 0.0 110.616 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.749 HD12 HD21 ' A' ' 66' ' ' LEU . 1.4 mm? -99.05 -53.21 3.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.37 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--N 1.314 -0.962 0 C-N-CA 125.267 1.427 . . . . 0.0 113.66 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -71.78 130.14 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.885 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.6 mm -83.47 -40.32 15.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.754 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.533 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.0 m80 -160.72 167.79 26.15 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.04 120.48 41.89 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.659 ' HB3' HG23 ' A' ' 84' ' ' ILE . . . -98.24 151.35 20.55 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.495 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -107.61 135.38 49.15 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.83 112.78 3.42 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 49.5 t -86.07 -12.47 50.06 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.616 0.722 . . . . 0.0 109.925 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -149.34 155.93 41.27 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.831 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 4.5 p-10 -99.42 112.89 25.01 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.738 0.78 . . . . 0.0 109.088 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.48 163.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.085 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.61 21.43 7.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.895 0.379 . . . . 0.0 111.604 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.37 59.69 1.9 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.72 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.03 138.52 13.96 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm 66.91 33.65 5.79 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.92 0.867 . . . . 0.0 108.903 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 61.49 84.81 0.13 Allowed 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.235 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 19.4 tt0 -138.04 -175.22 4.02 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 73' ' ' SER . 0.7 OUTLIER -96.64 153.19 18.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.481 ' H ' HD23 ' A' ' 44' ' ' LEU . 8.6 p -105.89 124.87 50.27 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -157.9 166.92 31.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.398 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.831 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 66.9 mmtt -112.63 147.03 37.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 19.2 tt0 -52.24 124.27 12.75 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.295 0.638 . . . . 0.0 110.292 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 13.63 75.14 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.911 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 30.9 tt0 -70.89 -39.83 72.56 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 26.8 tt0 92.52 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.247 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.55 HD13 ' CG1' ' A' ' 82' ' ' VAL . 11.1 mt -120.27 160.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.375 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.63 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 17.4 mt-10 -116.22 142.59 46.63 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.533 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.3 tp -102.42 127.65 55.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.77 -49.2 6.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.846 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 10.8 ttm180 -126.48 140.49 52.42 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.112 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -128.85 -37.27 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 123.833 0.853 . . . . 0.0 111.016 -177.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 p -117.21 168.85 9.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.0 t70 60.43 65.5 1.06 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.466 1.127 . . . . 0.0 110.137 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -140.84 172.45 6.15 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.632 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -94.45 13.04 1.52 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.011 1.807 . . . . 0.0 114.272 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.71 ' HG3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 tm-20 -135.12 -72.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.56 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -25.76 2.14 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.71 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 13.7 ptmt -61.87 162.76 8.45 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.862 1.265 . . . . 0.0 110.779 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.554 ' CD1' HG22 ' A' ' 57' ' ' ILE . 49.0 m0 -102.31 166.6 10.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.98 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 21' ' ' LEU . 51.6 tp -112.7 108.11 17.02 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -113.28 160.73 12.97 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.735 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.3 ttp180 -135.29 141.2 45.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.646 0.736 . . . . 0.0 111.801 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 p -101.37 167.25 10.29 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.421 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.28 37.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.162 0.985 . . . . 0.0 113.292 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.74 -19.29 55.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.029 0.443 . . . . 0.0 110.188 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.94 86.25 0.87 Allowed Glycine 0 CA--C 1.489 -1.561 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.6 m -151.22 125.16 9.18 Favored 'General case' 0 N--CA 1.381 -3.884 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.554 ' HB3' HD12 ' A' ' 66' ' ' LEU . 50.0 m-85 -108.5 73.84 0.89 Allowed 'General case' 1 C--N 1.213 -5.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -176.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -92.44 97.64 2.3 Favored Glycine 2 N--CA 1.375 -5.429 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -178.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' HB3' ' HD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -44.04 96.38 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 125.408 1.299 . . . . 0.0 110.253 172.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.639 HD12 HG22 ' A' ' 82' ' ' VAL . 1.6 pt -77.38 144.82 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.436 -3.414 0 C-N-CA 126.625 1.97 . . . . 0.0 113.232 -175.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -79.95 118.4 21.66 Favored 'General case' 1 N--CA 1.359 -5.008 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 165.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 64' ' ' LYS . 69.3 p -35.8 -39.09 0.14 Allowed 'General case' 1 C--N 1.241 -4.12 0 C-N-CA 128.369 2.668 . . . . 0.0 112.815 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -69.85 -1.4 9.33 Favored 'General case' 0 CA--C 1.564 1.5 0 C-N-CA 124.085 0.954 . . . . 0.0 112.213 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.23 -8.47 21.26 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.737 -0.602 . . . . 0.0 111.213 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.639 HG22 HD12 ' A' ' 77' ' ' ILE . 22.3 m -137.05 165.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 CA-C-O 121.312 0.577 . . . . 0.0 112.221 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.557 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 50.4 mt-10 -129.47 119.59 24.01 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 31' ' ' ALA . 8.6 pt -89.55 162.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.173 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 C--N 1.297 -1.691 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.603 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.698 HG23 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -85.79 -26.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 122.33 -0.231 . . . . 0.0 111.326 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -54.86 -45.13 74.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 124.234 0.959 . . . . 0.0 112.818 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.28 -9.35 27.77 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.243 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -78.28 -63.84 1.3 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.648 -173.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.2 t80 -81.09 -24.46 37.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 38.1 ttpt 66.86 87.79 0.12 Allowed 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.384 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.534 HD11 ' HD2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -98.3 -65.54 0.96 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 C--N 1.317 -0.841 0 C-N-CA 125.025 1.33 . . . . 0.0 113.745 175.83 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.87 134.05 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.746 0.784 . . . . 0.0 109.271 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.41 ' HB ' HG22 ' A' ' 54' ' ' ILE . 36.2 mm -97.24 -35.2 5.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.435 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 28.3 m80 -168.38 169.98 10.22 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.53 119.49 39.33 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.06 158.17 15.92 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.025 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -106.99 127.82 53.8 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.644 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -67.65 106.76 2.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.0 m -83.58 -5.08 59.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.8 t -158.75 143.15 15.72 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.611 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -80.21 107.94 13.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.721 175.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.67 163.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.919 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.81 23.32 12.03 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.933 -0.48 . . . . 0.0 110.814 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.31 60.16 1.58 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.035 -1.555 . . . . 0.0 111.291 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.82 120.07 5.11 Favored Glycine 0 C--N 1.306 -1.113 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.086 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HE3' ' N ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER 63.65 45.71 4.47 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.287 0.635 . . . . 0.0 110.48 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.3 t30 63.49 85.95 0.13 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.041 0.936 . . . . 0.0 109.616 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.6 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 5.4 tt0 -145.67 -173.92 4.26 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.082 -174.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.658 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -95.72 155.67 16.65 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.454 ' H ' HD21 ' A' ' 44' ' ' LEU . 7.2 m -101.56 116.03 31.84 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.486 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 26.6 p90 -149.73 159.34 44.42 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.611 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 49.3 mttm -112.93 156.45 22.97 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -59.09 127.34 31.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.891 0.377 . . . . 0.0 110.078 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.89 21.14 61.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.088 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.5 mm-40 -88.57 -23.99 22.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 70.78 129.91 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.57 1.169 . . . . 0.0 111.363 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.783 HD13 HG11 ' A' ' 82' ' ' VAL . 7.8 mt -127.51 162.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -112.28 136.08 52.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 66' ' ' LEU . 9.7 tp -94.35 123.33 46.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.491 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.69 -36.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -135.5 130.13 34.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.713 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.611 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -130.85 2.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 124.578 1.151 . . . . 0.0 109.725 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -117.47 154.15 31.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.655 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 64.58 18.89 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.98 1.312 . . . . 0.0 111.337 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 21.4 p-10 -77.55 111.46 17.56 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.284 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 22.1 Cg_exo -66.56 -58.41 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.783 2.989 . . . . 0.0 113.134 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.5 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 23.8 tt0 -66.54 -30.58 70.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.984 0.421 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.62 12.24 25.08 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.325 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 12.9 ptmt -101.9 162.13 13.14 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.597 ' CD1' HG23 ' A' ' 57' ' ' ILE . 42.6 m0 -95.82 176.13 6.25 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 123.255 0.622 . . . . 0.0 110.577 -175.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.696 HD12 ' HB3' ' A' ' 74' ' ' TYR . 61.2 tp -119.21 113.7 21.28 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.92 157.32 15.12 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.7 ttt-85 -135.56 153.3 51.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.558 0.694 . . . . 0.0 111.61 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 35.2 m -105.61 154.37 20.51 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.23 -33.96 13.85 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -53.97 -43.02 69.57 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.207 1.004 . . . . 0.0 110.663 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.29 83.26 1.7 Allowed Glycine 0 N--CA 1.413 -2.834 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.196 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.652 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 49.6 m -151.53 123.3 8.01 Favored 'General case' 1 N--CA 1.376 -4.138 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB2' HG23 ' A' ' 15' ' ' ILE . 57.9 m-85 -113.87 92.67 4.06 Favored 'General case' 1 C--N 1.216 -5.221 0 O-C-N 125.108 1.505 . . . . 0.0 107.07 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.658 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -102.02 103.14 2.44 Favored Glycine 3 N--CA 1.359 -6.499 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.84 98.09 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 112.946 -1.627 . . . . 0.0 108.213 170.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.6 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.1 pt -85.15 143.46 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.814 0 C-N-CA 126.283 1.833 . . . . 0.0 114.127 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 18.4 pttm -77.62 118.34 19.92 Favored 'General case' 1 N--CA 1.372 -4.345 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 164.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.486 HG23 ' CG ' ' A' ' 65' ' ' TRP . 48.4 p -35.26 -38.49 0.1 Allowed 'General case' 1 C--N 1.236 -4.333 0 C-N-CA 129.253 3.021 . . . . 0.0 113.588 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.1 -15.49 63.75 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 0.0 112.698 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.99 48.81 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.954 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.783 HG11 HD13 ' A' ' 52' ' ' ILE . 30.3 m -137.11 172.07 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 CA-C-O 121.779 0.8 . . . . 0.0 111.411 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.79 122.81 17.89 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 pt -77.55 171.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.001 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.317 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.509 -0.623 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.462 HG13 ' HD2' ' A' ' 16' ' ' LYS . 1.4 pp -66.04 -31.08 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.4 mptt -69.28 -23.37 63.82 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.667 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.15 -29.91 11.86 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.243 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 6.9 tppt? -73.12 -61.15 1.92 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.845 0.355 . . . . 0.0 111.13 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -79.1 -34.17 43.76 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.622 ' HZ1' ' HB3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER 68.7 99.23 0.06 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.947 -178.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 1.008 HD11 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.79 -57.34 2.2 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.633 0.73 . . . . 0.0 110.15 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 29.2 p . . . . . 0 C--N 1.308 -1.205 0 C-N-CA 125.399 1.48 . . . . 0.0 113.098 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.419 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.7 pt20 . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.572 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -59.37 126.34 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 122.056 0.932 . . . . 0.0 111.174 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.2 -31.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.467 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 27.1 m80 -163.22 157.33 20.25 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.51 118.1 34.44 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -96.1 156.12 16.47 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-O 122.014 0.911 . . . . 0.0 111.202 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 35.1 ttpt -106.68 128.27 54.05 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.745 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.96 105.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.72 -18.33 61.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.674 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -160.53 156.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.41 119.25 20.02 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.02 163.72 10.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.601 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -102.06 -4.94 25.15 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.98 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 77.64 60.58 2.76 Favored Glycine 0 C--O 1.241 0.568 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.092 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.67 131.33 10.6 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 115.084 -0.558 . . . . 0.0 113.035 -172.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.8 69.97 0.68 Allowed 'General case' 0 C--O 1.249 1.041 0 C-N-CA 125.301 1.44 . . . . 0.0 109.743 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.05 68.62 0.83 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.223 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.555 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 31.9 tt0 -136.42 172.98 12.21 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.537 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 1.7 tt -97.9 141.29 31.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 p -98.78 118.24 35.07 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.864 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.443 ' HE2' HG21 ' A' ' 77' ' ' ILE . 22.5 p90 -142.35 170.11 16.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.708 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 98.3 mttt -119.55 161.44 20.6 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -63.62 129.29 39.56 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.43 46.53 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.345 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 31.6 mm-40 -89.42 -26.14 21.16 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 70.3 120.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.933 1.396 . . . . 0.0 111.307 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.598 HD13 ' CG1' ' A' ' 82' ' ' VAL . 8.9 mt -119.31 158.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.86 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.572 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 14.7 mt-10 -116.67 132.68 56.62 Favored 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.607 HG12 HG22 ' A' ' 57' ' ' ILE . 8.6 tp -93.08 125.7 45.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -110.13 -47.88 6.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.442 176.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 1.008 ' HG3' HD11 ' A' ' 21' ' ' LEU . 18.2 mmt180 -120.06 107.8 13.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.844 ' H ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -104.53 -30.16 2.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 113.252 -1.795 . . . . 0.0 107.192 172.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.497 HG21 HG12 ' A' ' 57' ' ' ILE . 15.6 p -86.68 142.05 28.49 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.565 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 71.55 31.09 2.32 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.451 1.12 . . . . 0.0 110.957 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 8.8 p30 -72.87 126.24 90.69 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.941 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 2.1 Cg_endo -80.58 -61.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.618 2.212 . . . . 0.0 113.256 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.4 tt0 -79.21 -2.96 43.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.302 0.572 . . . . 0.0 111.268 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 87.51 21.17 49.13 Favored Glycine 0 CA--C 1.497 -1.087 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.513 -176.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.678 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.3 ptmt -118.21 156.88 28.01 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.513 ' CD1' ' HA ' ' A' ' 57' ' ' ILE . 25.6 m0 -98.12 171.9 7.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.145 0.278 . . . . 0.0 110.94 -174.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.678 HD21 HD12 ' A' ' 21' ' ' LEU . 65.4 tp -111.1 107.33 16.66 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.46 158.57 14.23 Favored Glycine 0 N--CA 1.416 -2.664 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 73' ' ' SER . 45.8 ttp180 -135.17 144.73 47.19 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.694 0.797 . . . . 0.0 109.888 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -101.4 165.14 11.42 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.89 -29.78 65.34 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -74.83 -9.62 58.72 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.03 89.82 0.49 Allowed Glycine 0 N--CA 1.434 -1.454 0 CA-C-O 121.908 0.727 . . . . 0.0 111.754 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.1 m -153.16 117.46 4.9 Favored 'General case' 0 N--CA 1.389 -3.514 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 64.8 m-85 -110.76 96.67 6.31 Favored 'General case' 1 C--N 1.221 -4.999 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.471 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -110.98 11.85 29.36 Favored Glycine 1 CA--C 1.445 -4.313 0 C-N-CA 117.77 -2.157 . . . . 0.0 115.516 -174.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.678 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 48.13 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.853 1.311 . . . . 0.0 111.651 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.584 HD11 HG22 ' A' ' 82' ' ' VAL . 2.1 pt -67.8 145.92 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.1 0 C-N-CA 126.029 1.731 . . . . 0.0 113.584 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 8.7 ptpp? -81.36 112.99 19.15 Favored 'General case' 1 N--CA 1.379 -4.01 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 165.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.471 HG22 ' CG ' ' A' ' 65' ' ' TRP . 43.2 p -36.3 -36.75 0.1 Allowed 'General case' 0 C--N 1.251 -3.685 0 C-N-CA 128.006 2.522 . . . . 0.0 113.757 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.82 -9.88 56.36 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.802 0.841 . . . . 0.0 112.318 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.51 -6.38 49.84 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.652 -0.655 . . . . 0.0 109.979 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.598 ' CG1' HD13 ' A' ' 52' ' ' ILE . 31.3 m -131.17 162.77 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.94 111.36 11.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 14.3 pt -76.71 171.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.047 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 . . . . . 0 C--N 1.301 -1.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 171.278 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.7 mp0 . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 120.869 0.366 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.776 HG21 ' HH ' ' A' ' 76' ' ' TYR . 1.4 pp -90.22 -20.56 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HA ' HD22 ' A' ' 21' ' ' LEU . 37.9 mmtm -66.96 -54.8 18.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.808 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -79.99 1.92 25.67 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.847 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 9.3 tppt? -98.79 -53.41 3.3 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.873 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HE2' ' HG2' ' A' ' 56' ' ' ARG . 38.2 t80 -91.2 -27.98 18.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.939 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 42.2 tttt 77.59 90.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.686 1.195 . . . . 0.0 109.934 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.808 HD13 HD21 ' A' ' 66' ' ' LEU . 1.3 mm? -100.96 -41.66 6.72 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.607 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 126.656 1.982 . . . . 0.0 112.543 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.402 ' C ' HG23 ' A' ' 55' ' ' ILE . 13.6 pt20 . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.763 0.316 . . . . 0.0 110.526 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.17 134.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.322 1.058 . . . . 0.0 112.294 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.2 mm -102.19 -36.64 4.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.133 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.4 m80 -168.12 -178.19 3.59 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.75 139.6 45.89 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -112.46 158.32 20.01 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -107.01 130.42 54.65 Favored 'General case' 0 C--N 1.263 -3.154 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.585 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.88 112.61 3.35 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.561 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 39.9 t -82.35 -19.09 39.97 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 124.185 0.928 . . . . 0.0 109.635 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.13 156.73 46.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.862 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -96.39 107.85 20.29 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 173.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG13 ' CE1' ' A' ' 46' ' ' PHE . 10.4 p -113.19 145.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.66 12.42 21.2 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.775 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 78.84 46.85 8.16 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.714 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -96.9 151.52 19.86 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp 68.27 31.87 4.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.299 1.047 . . . . 0.0 108.833 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.456 ' ND2' ' HE2' ' A' ' 76' ' ' TYR . 0.2 OUTLIER 68.31 46.3 1.1 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.678 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -103.55 -175.16 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.615 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 tt -95.74 147.47 23.59 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.475 ' H ' HD21 ' A' ' 44' ' ' LEU . 5.7 m -96.05 115.48 27.5 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.777 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CE1' HG13 ' A' ' 37' ' ' VAL . 17.9 p90 -150.37 177.62 9.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.196 0.522 . . . . 0.0 111.006 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.862 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.5 mmtt -124.83 149.61 47.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.73 122.43 11.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 124.145 0.903 . . . . 0.0 108.737 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.42 23.88 52.69 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.759 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.5 mm-40 -78.64 -26.67 45.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 74.63 104.43 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.414 1.578 . . . . 0.0 110.33 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.425 ' HB ' ' HB1' ' A' ' 31' ' ' ALA . 7.9 mm -101.96 158.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.196 0 CA-C-N 111.697 -2.501 . . . . 0.0 105.659 -174.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -112.49 134.21 54.15 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.502 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 7.0 tp -99.75 121.04 49.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -106.1 -54.13 6.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.213 -178.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.558 ' HG2' ' HE2' ' A' ' 19' ' ' PHE . 53.9 ttt180 -121.43 138.39 54.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.729 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.37 -43.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.578 -176.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 p -117.8 158.66 24.38 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.112 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.51 68.73 0.16 Allowed 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.928 1.691 . . . . 0.0 111.302 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -148.42 144.43 18.59 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.93 12.52 2.22 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 122.848 2.365 . . . . 0.0 114.469 -175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.655 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -109.23 -64.7 1.22 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.6 -6.03 7.52 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.655 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -90.04 165.05 14.26 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.636 0.775 . . . . 0.0 110.535 177.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.55 ' CG ' HG23 ' A' ' 79' ' ' THR . 40.2 m0 -97.84 169.89 9.35 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.768 0.827 . . . . 0.0 110.741 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.808 HD21 HD13 ' A' ' 21' ' ' LEU . 54.6 tp -113.99 110.25 19.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.02 155.87 15.99 Favored Glycine 0 N--CA 1.419 -2.497 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.299 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.1 ttp180 -137.96 156.66 47.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.567 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 6.8 m -111.63 156.07 22.39 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.6 33.13 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.476 1.035 . . . . 0.0 113.05 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -69.8 -3.09 14.05 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.91 86.81 0.16 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 121.728 0.627 . . . . 0.0 112.134 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.0 m -151.78 117.67 5.48 Favored 'General case' 0 N--CA 1.391 -3.388 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.503 ' HB2' HG22 ' A' ' 15' ' ' ILE . 65.3 m-85 -113.37 90.06 3.25 Favored 'General case' 1 C--N 1.228 -4.701 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.186 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.615 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -104.72 102.19 2.04 Favored Glycine 3 N--CA 1.36 -6.416 0 N-CA-C 106.906 -2.478 . . . . 0.0 106.906 176.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.776 ' HH ' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -50.22 98.94 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.867 0 CA-C-N 113.195 -1.503 . . . . 0.0 107.247 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.707 HD12 HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -82.25 140.25 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.431 -3.611 0 C-N-CA 125.542 1.537 . . . . 0.0 114.713 -172.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -74.88 114.3 13.18 Favored 'General case' 1 N--CA 1.365 -4.705 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 167.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.55 HG23 ' CG ' ' A' ' 65' ' ' TRP . 72.9 p -36.28 -34.82 0.07 Allowed 'General case' 1 C--N 1.234 -4.428 0 C-N-CA 128.523 2.729 . . . . 0.0 114.299 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -66.0 -24.32 66.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.2 59.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.097 -0.377 . . . . 0.0 111.57 -174.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.707 HG23 HD12 ' A' ' 77' ' ' ILE . 30.0 m -136.39 165.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.512 0.672 . . . . 0.0 111.321 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.83 118.86 15.35 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.458 -2.052 . . . . 0.0 105.458 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.3 pp -72.46 146.97 10.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.647 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--N 1.282 -2.355 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.151 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.3 mm-40 . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.636 ' HA ' ' HH ' ' A' ' 76' ' ' TYR . 1.4 pp -71.85 -34.05 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 CA-C-O 120.889 0.376 . . . . 0.0 110.115 -173.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HA ' HD22 ' A' ' 21' ' ' LEU . 4.7 mptt -74.91 -30.97 61.43 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -90.5 -19.53 23.72 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.011 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.2 tppt? -77.26 -58.77 3.09 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.074 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.571 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.3 t80 -81.18 -22.79 38.65 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER 70.25 90.92 0.09 Allowed 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 125.548 1.539 . . . . 0.0 109.911 -179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.693 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -99.51 -67.48 0.85 Allowed 'General case' 0 CA--C 1.453 -2.765 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.939 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.404 -2.763 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.658 171.903 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 N--CA 1.438 -1.038 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.6 t -79.35 127.32 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -90.35 -37.21 9.22 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.637 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.869 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 37.6 m80 -168.88 170.64 8.98 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -172.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.32 127.32 55.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 172.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -100.46 159.63 14.99 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-O 121.739 0.781 . . . . 0.0 110.928 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.88 131.39 54.02 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.65 106.94 1.28 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.8 t -91.37 -5.8 53.92 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.194 0.997 . . . . 0.0 108.335 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.8 m -147.2 147.41 30.45 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.775 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.14 103.53 15.8 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.48 HG22 ' OE2' ' A' ' 43' ' ' GLU . 8.6 p -114.66 156.71 15.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.103 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.52 34.04 5.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.989 0.423 . . . . 0.0 110.51 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 99.9 60.65 0.84 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.131 -1.509 . . . . 0.0 113.251 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.79 95.66 1.14 Allowed Glycine 0 C--N 1.313 -0.721 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 57.24 78.44 0.23 Allowed 'General case' 0 C--O 1.252 1.215 0 C-N-CA 124.707 1.203 . . . . 0.0 111.041 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.49 71.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.407 1.067 . . . . 0.0 109.768 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.511 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 15.9 tt0 -132.72 -173.78 3.28 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.464 -172.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.629 ' HG ' ' N ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.15 151.07 20.17 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.9 m -97.95 124.68 42.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.411 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -159.64 160.99 34.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.722 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -117.56 151.37 37.29 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -53.39 123.26 11.48 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.17 0.919 . . . . 0.0 110.657 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.84 17.22 52.62 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.087 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -87.92 -30.69 19.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.954 0.877 . . . . 0.0 113.171 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 2.1 mp0 75.45 128.98 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.535 1.159 . . . . 0.0 112.386 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.579 HD11 ' CG1' ' A' ' 82' ' ' VAL . 10.9 mt -129.08 165.11 29.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -114.66 142.23 46.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.5 tp -100.69 124.24 54.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -110.51 -40.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.662 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.571 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 48.2 ttt180 -134.8 136.96 42.94 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.136 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.549 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.1 -36.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 124.439 1.096 . . . . 0.0 111.778 -177.243 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -96.64 154.84 17.05 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.93 67.86 0.72 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.907 1.283 . . . . 0.0 107.963 -174.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -134.39 115.4 12.7 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.626 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.91 -28.71 29.16 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.393 2.729 . . . . 0.0 115.394 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.11 -15.49 23.33 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.799 0.809 . . . . 0.0 110.146 -177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.01 0.19 83.5 Favored Glycine 0 C--N 1.308 -0.992 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.152 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 17.8 ptmt -95.06 161.68 14.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.545 ' CD2' HG21 ' A' ' 79' ' ' THR . 43.2 m0 -97.8 176.03 5.95 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.947 0.899 . . . . 0.0 111.478 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.693 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -115.52 108.72 16.82 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -111.43 156.57 15.48 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.563 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.773 ' HA ' ' O ' ' A' ' 73' ' ' SER . 62.5 ttt-85 -134.62 147.55 50.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.515 0.674 . . . . 0.0 111.593 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 27.0 m -100.75 162.13 13.12 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.0 18.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -89.16 3.15 52.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.66 87.86 0.33 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.773 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.8 m -152.48 117.75 5.25 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 79.9 m-85 -115.21 91.35 3.58 Favored 'General case' 1 C--N 1.224 -4.882 0 O-C-N 124.25 0.969 . . . . 0.0 108.459 -173.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.629 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -107.45 102.52 1.82 Allowed Glycine 2 N--CA 1.366 -5.992 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.636 ' HH ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -42.16 101.14 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 112.959 -1.621 . . . . 0.0 108.52 171.078 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.642 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.2 pt -85.39 145.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.948 0 C-N-CA 126.248 1.819 . . . . 0.0 113.312 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -80.92 122.79 27.68 Favored 'General case' 1 N--CA 1.348 -5.538 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 164.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.545 HG21 ' CD2' ' A' ' 65' ' ' TRP . 47.7 p -36.47 -30.71 0.02 OUTLIER 'General case' 1 C--N 1.243 -4.039 0 C-N-CA 128.341 2.656 . . . . 0.0 112.653 176.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -32.47 73.98 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.892 1.277 . . . . 0.0 110.835 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.49 -4.9 59.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.778 -172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 77' ' ' ILE . 28.9 m -133.97 159.35 42.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.46 0.648 . . . . 0.0 111.813 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.4 mt-10 -128.03 117.5 21.79 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 171.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.5 pt -78.38 160.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.388 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--N 1.289 -2.054 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 172.512 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.5 HG22 ' HH ' ' A' ' 76' ' ' TYR . 6.9 pt -67.33 -28.99 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.987 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -78.08 -7.37 56.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.223 0.535 . . . . 0.0 110.535 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -99.39 -30.1 12.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.23 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 4.3 tppt? -84.16 -65.55 1.0 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.065 -174.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.554 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 1.8 t80 -86.59 -28.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.0 ttmt 63.08 86.05 0.12 Allowed 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.613 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD12 HD23 ' A' ' 66' ' ' LEU . 1.3 mm? -93.69 -58.61 2.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.236 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 C--N 1.313 -1.013 0 C-N-CA 124.679 1.192 . . . . 0.0 114.165 -179.823 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.595 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.7 p -79.59 139.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.88 -40.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.508 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.519 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.0 m80 -159.89 166.45 30.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.05 116.51 32.1 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 84' ' ' ILE . . . -89.51 157.92 17.9 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 122.281 1.038 . . . . 0.0 112.196 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -107.74 126.18 52.3 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.329 -1.305 . . . . 0.0 107.918 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 52' ' ' ILE . . . -67.68 109.79 3.46 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 171.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.3 m -83.86 -5.72 59.27 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.474 0.484 . . . . 0.0 111.852 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.9 p -155.59 154.72 32.11 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.83 110.65 18.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.52 160.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -112.91 0.55 15.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.569 -169.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 76.77 61.19 2.77 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.706 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.42 122.47 7.22 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.767 -0.716 . . . . 0.0 111.469 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 62.6 71.9 0.51 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.421 1.088 . . . . 0.0 110.592 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.554 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . 96.6 m-20 53.04 73.01 0.38 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.336 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.558 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 41.8 tt0 -145.66 171.02 15.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.562 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -98.95 152.74 19.45 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.445 ' H ' HD21 ' A' ' 44' ' ' LEU . 3.6 m -101.61 127.64 48.25 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -156.78 170.82 21.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 99.2 mttt -119.78 153.87 35.07 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 123.93 15.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.42 13.21 65.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.685 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.6 tp10 -63.59 -37.54 87.73 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.46 0.704 . . . . 0.0 111.682 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 71.56 107.49 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.267 1.427 . . . . 0.0 108.637 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.565 HD11 ' CG1' ' A' ' 82' ' ' VAL . 15.8 mt -113.34 159.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.595 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 16.2 mt-10 -111.8 132.36 54.72 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -93.34 122.85 45.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.577 HG23 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -108.27 -36.57 3.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 32.4 ttm180 -140.79 137.87 33.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.723 175.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.549 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.86 -28.92 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 124.005 0.922 . . . . 0.0 111.816 -176.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.0 p -106.27 162.75 13.39 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.6 t70 58.29 71.2 0.6 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.795 1.283 . . . . 0.0 110.54 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 16.3 p30 -125.67 136.46 28.39 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.255 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 17.7 Cg_exo -69.4 -32.11 20.74 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.063 2.509 . . . . 0.0 113.851 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -101.8 -51.88 3.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.04 -2.47 5.14 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 16.4 ptpt -80.8 162.41 24.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.689 -0.756 . . . . 0.0 109.059 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 77' ' ' ILE . 41.3 m0 -99.25 176.75 5.43 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.76 0.824 . . . . 0.0 109.789 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.569 HD23 HD12 ' A' ' 21' ' ' LEU . 56.7 tp -117.47 112.12 20.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.21 157.11 15.22 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.121 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.724 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.6 ttp180 -135.82 156.91 48.06 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.0 110.805 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.9 m -111.95 155.72 23.25 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 68.34 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.286 1.041 . . . . 0.0 111.977 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -167.62 -35.29 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.011 -1.904 . . . . 0.0 107.66 175.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.03 90.18 1.98 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.724 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 2.5 m -151.92 116.76 5.15 Favored 'General case' 0 N--CA 1.386 -3.634 1 N-CA-C 100.097 -4.038 . . . . 0.0 100.097 -178.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.553 ' HB3' HD13 ' A' ' 66' ' ' LEU . 48.2 m-85 -116.75 89.41 3.1 Favored 'General case' 1 C--N 1.216 -5.214 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -175.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.02 104.13 2.5 Favored Glycine 3 N--CA 1.352 -6.957 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -51.31 97.51 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 O-C-N 125.305 1.238 . . . . 0.0 108.129 172.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.658 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.9 pt -76.17 137.49 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.437 -3.397 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.406 -173.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 22.5 pttm -79.16 112.51 16.44 Favored 'General case' 1 N--CA 1.369 -4.495 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 167.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.49 HG23 ' CD2' ' A' ' 65' ' ' TRP . 64.6 p -35.65 -34.16 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.437 0 C-N-CA 129.327 3.051 . . . . 0.0 114.818 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -62.93 -16.24 58.44 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.8 -17.11 39.17 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.698 -0.626 . . . . 0.0 111.723 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.565 ' CG1' HD11 ' A' ' 52' ' ' ILE . 30.4 m -135.96 168.18 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.752 0.786 . . . . 0.0 112.616 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -135.27 126.19 27.59 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.65 HG21 ' HB3' ' A' ' 31' ' ' ALA . 25.9 pt -84.77 164.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.137 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--N 1.291 -1.94 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 174.505 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.64 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -91.97 106.34 18.39 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -106.03 27.68 8.36 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 122.023 0.916 . . . . 0.0 108.815 -172.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -94.4 63.62 3.03 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.083 -174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -163.93 135.49 4.7 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -115.2 -33.65 5.27 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -143.69 179.35 7.2 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.614 1.565 . . . . 0.0 107.551 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.09 -0.47 41.72 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 170.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 67.82 84.96 0.15 Allowed 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.907 -1.951 . . . . 0.0 113.123 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.429 ' HB3' ' HE2' ' A' ' 10' ' ' LYS . 33.6 ttpt -113.44 26.06 10.74 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -91.77 4.81 51.96 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.385 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.543 ' HB2' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -83.72 46.58 1.18 Allowed 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 124.645 1.178 . . . . 0.0 110.595 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -60.71 -29.73 69.53 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.073 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 38.5 mm-40 -68.58 -29.1 67.57 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.543 HG12 ' HB2' ' A' ' 12' ' ' GLU . 1.3 pp -77.62 -28.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.849 0.833 . . . . 0.0 108.842 -174.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.467 ' HA ' HD23 ' A' ' 21' ' ' LEU . 15.4 mtpp -70.0 -41.49 74.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.352 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -85.04 -22.52 28.98 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.153 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.5 tppt? -76.36 -48.61 19.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.546 -175.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.527 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 13.8 t80 -94.45 -26.49 16.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.889 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? 70.91 90.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.518 1.127 . . . . 0.0 108.882 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.47 -44.96 5.71 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.28 80.2 p 68.81 -72.38 0.1 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.699 1.599 . . . . 0.0 112.384 -173.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.36 108.8 2.17 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.22 139.77 47.07 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.277 1.985 . . . . 0.0 111.877 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.43 HD11 HD13 ' A' ' 28' ' ' ILE . 42.4 pt -115.83 -171.23 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.311 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -96.01 169.65 9.83 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.662 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -57.18 134.04 21.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 123.714 0.634 . . . . 0.0 111.81 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 HD13 HD11 ' A' ' 25' ' ' ILE . 49.1 mm -89.2 -38.22 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.621 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 54' ' ' ILE . 32.8 m80 -162.02 156.66 22.49 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -100.57 117.1 34.02 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 84' ' ' ILE . . . -92.43 155.83 17.6 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.7 0.762 . . . . 0.0 110.293 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -107.11 131.17 54.42 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.41 ' HA ' HG11 ' A' ' 82' ' ' VAL . . . -64.56 115.72 5.46 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.8 t -79.34 -12.05 59.93 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.946 0.779 . . . . 0.0 110.025 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -158.35 171.7 19.7 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.665 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 5.5 p-10 -105.67 104.86 14.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.698 0.761 . . . . 0.0 110.653 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.02 158.98 15.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 17.4 19.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.827 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 83.22 59.88 2.1 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.204 -0.998 . . . . 0.0 114.476 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.04 145.91 17.55 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 63.65 34.22 12.5 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.362 0.665 . . . . 0.0 109.635 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.581 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 14.3 m120 64.77 82.6 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.387 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 15.9 tt0 -140.86 -176.87 4.83 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 54.7 tp -95.65 145.17 25.47 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.4 m -94.98 119.58 33.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CG ' HD12 ' A' ' 52' ' ' ILE . 28.3 p90 -153.28 157.85 40.74 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.665 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 42.7 mmtm -107.97 146.78 31.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.062 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.75 118.59 2.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.912 0.885 . . . . 0.0 110.001 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 15.8 76.85 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.919 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 28.9 tt0 -69.01 -33.08 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.402 0.601 . . . . 0.0 111.58 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 80.07 122.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 110.214 -174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.461 HD12 ' CG ' ' A' ' 46' ' ' PHE . 4.7 mt -125.76 162.19 29.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.662 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 35.5 mt-10 -116.49 134.82 54.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 119.211 0.914 . . . . 0.0 109.093 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 65' ' ' TRP . 9.0 tp -93.05 127.15 45.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -56.61 4.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.527 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.3 tpm_? -116.18 121.97 43.67 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.524 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -118.74 -26.86 2.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.026 174.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.6 p -85.39 136.34 33.5 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.412 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t0 67.3 33.58 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.66 1.184 . . . . 0.0 110.918 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.23 128.58 93.78 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.296 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.44 -27.59 1.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.049 1.832 . . . . 0.0 114.147 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 17.5 mm-40 -109.14 -6.09 15.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.28 -18.7 56.14 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.762 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -86.3 161.39 18.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.594 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.1 m0 -98.44 163.45 12.68 Favored 'General case' 0 C--O 1.199 -1.58 0 C-N-CA 123.565 0.746 . . . . 0.0 109.633 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 21' ' ' LEU . 55.7 tp -104.06 108.84 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.032 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.34 144.86 18.44 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 73' ' ' SER . 22.1 ttp180 -115.74 149.32 38.65 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.248 0.547 . . . . 0.0 110.419 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.523 ' OG1' HD12 ' A' ' 44' ' ' LEU . 89.7 m -98.17 156.52 16.64 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.84 -33.73 17.75 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -79.67 -1.81 39.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 77.14 86.14 0.42 Allowed Glycine 0 C--O 1.221 -0.695 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.8 m -152.7 127.19 9.34 Favored 'General case' 0 N--CA 1.394 -3.229 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.604 ' HB3' HD13 ' A' ' 66' ' ' LEU . 83.7 m-85 -115.59 100.08 7.8 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -174.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -102.29 5.09 52.04 Favored Glycine 0 C--O 1.188 -2.737 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.616 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.581 ' HE1' ' HB3' ' A' ' 42' ' ' ASN 0.314 0.3 OUTLIER 46.01 75.18 0.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 123.068 1.414 . . . . 0.0 112.844 -179.874 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.6 pt -61.94 141.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.038 0 CA-C-N 112.199 -2.273 . . . . 0.0 113.125 -174.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -77.71 114.78 16.9 Favored 'General case' 1 N--CA 1.365 -4.711 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 166.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 ' CG ' ' A' ' 65' ' ' TRP . 34.0 p -35.53 -38.78 0.12 Allowed 'General case' 0 C--N 1.244 -3.99 0 C-N-CA 127.91 2.484 . . . . 0.0 113.628 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -66.67 -19.84 65.85 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.41 0.684 . . . . 0.0 111.675 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.5 -5.87 59.04 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 121.835 -0.54 . . . . 0.0 111.357 -175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 77' ' ' ILE . 30.1 m -135.79 167.84 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.377 0.608 . . . . 0.0 110.992 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -133.96 116.17 15.24 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.752 HG21 ' HB2' ' A' ' 31' ' ' ALA . 2.3 pp -81.53 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.315 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.62 117.46 12.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -77.35 153.64 33.56 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.114 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.7 t70 89.23 -92.77 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.156 1.782 . . . . 0.0 110.529 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.2 t 168.16 -82.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.982 0.913 . . . . 0.0 108.773 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.9 mt -153.09 -54.95 0.12 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 103.439 -2.8 . . . . 0.0 103.439 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -148.4 77.3 1.39 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.404 -1.725 . . . . 0.0 108.4 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 45.5 tp -70.53 -28.42 64.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -100.32 102.71 14.03 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 170.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -124.4 89.53 3.09 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.3 1.048 . . . . 0.0 111.902 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.23 29.55 1.4 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.467 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 69.74 27.15 4.72 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.211 1.404 . . . . 0.0 111.607 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 . . . . . 0 C--N 1.307 -1.265 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.697 178.229 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--O 1.235 0.332 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -88.28 0.45 56.12 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 118.159 0.436 . . . . 0.0 112.009 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -145.62 158.46 43.84 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -93.4 171.32 8.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -119.36 159.08 24.86 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -89.76 94.24 9.76 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 173.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -98.88 -63.08 1.15 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.888 -173.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.882 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -178.48 -47.61 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 72.18 -68.92 0.2 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.565 1.546 . . . . 0.0 109.752 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.2 127.2 45.31 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -77.03 126.08 30.39 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 122.958 0.503 . . . . 0.0 111.224 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -107.23 -172.62 2.11 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.593 ' HB3' HG22 ' A' ' 15' ' ' ILE . 64.6 tt0 -80.04 -2.0 42.3 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 46.4 mt-10 83.72 29.45 0.08 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 127.038 2.135 . . . . 0.0 109.39 -175.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' A' ' 13' ' ' GLN . 2.5 pt -88.69 -32.35 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.858 -170.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.0 ptmt -91.22 -9.44 45.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.591 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 17' ' ' LYS . 13.4 tmtt? -92.89 -23.96 18.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 169.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.3 tppt? -82.56 -58.44 2.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.035 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 9.8 t80 -92.52 -33.98 14.25 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.4 tttm 75.11 93.48 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.34 1.025 . . . . 0.0 110.656 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.642 HD11 HD21 ' A' ' 66' ' ' LEU . 1.5 mm? -100.09 -28.82 12.85 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.864 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.268 69.0 p 64.97 -38.3 0.24 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.663 1.985 . . . . 0.0 115.964 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.08 162.31 24.24 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.41 117.43 4.47 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 122.68 2.253 . . . . 0.0 110.349 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.419 HG21 ' HB ' ' A' ' 55' ' ' ILE . 9.4 tp -109.95 140.71 27.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.979 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -98.05 175.99 5.92 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.248 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.41 133.55 31.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.86 0.838 . . . . 0.0 111.612 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.498 HD12 HH21 ' A' ' 56' ' ' ARG . 62.6 mt -98.46 -32.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.52 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.7 m80 -162.58 165.83 25.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.87 116.39 31.87 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.672 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -95.64 150.52 20.26 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-O 121.771 0.796 . . . . 0.0 111.047 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -107.31 133.61 51.59 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' A' ' 52' ' ' ILE . . . -64.41 117.03 6.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 31.3 t -79.8 -18.08 51.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 124.294 0.996 . . . . 0.0 110.321 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.6 t -152.93 161.0 43.08 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.964 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 1.8 p-10 -94.51 109.57 21.45 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.016 0.912 . . . . 0.0 108.769 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.26 152.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -93.91 9.04 39.01 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.064 -178.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.87 58.24 8.57 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.801 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.31 162.23 14.48 Favored Glycine 0 C--O 1.2 -1.982 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.815 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 6.4 mmpt? 57.71 34.28 24.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.843 1.321 . . . . 0.0 111.691 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 76' ' ' TYR . 42.6 m-80 66.01 51.81 1.28 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.89 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' OE1' ' HE3' ' A' ' 78' ' ' LYS . 1.2 mp0 -110.04 179.45 4.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.831 171.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.1 tt -97.75 151.26 20.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -94.87 126.57 40.28 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.189 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 14.2 p90 -158.57 163.27 37.17 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.952 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.964 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.2 mmtt -110.7 148.27 32.62 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -52.06 119.79 4.71 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.748 0.655 . . . . 0.0 109.548 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.58 13.69 69.71 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.742 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 12.9 tp10 -63.12 -32.01 73.29 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.95 0.5 . . . . 0.0 110.901 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 77.63 99.32 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.018 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.569 HD11 HG12 ' A' ' 82' ' ' VAL . 12.1 mt -106.69 165.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 113.399 -1.728 . . . . 0.0 106.742 -173.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -127.63 136.48 51.69 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.52 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.7 tp -93.24 130.68 41.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.419 ' HB ' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -115.11 -37.84 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.369 177.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.498 HH21 HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -137.86 134.71 35.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.911 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.529 HD11 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.69 -13.32 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 123.954 0.902 . . . . 0.0 110.39 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -117.16 159.04 23.23 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.11 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.14 70.78 0.59 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.219 1.408 . . . . 0.0 110.089 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 15.3 p30 -127.75 139.3 34.91 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.671 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 23.6 Cg_exo -68.66 -49.2 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.938 2.426 . . . . 0.0 113.105 177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.91 -23.45 25.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 111.681 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.18 8.53 58.79 Favored Glycine 0 C--N 1.312 -0.772 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.73 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 12.7 ptmt -89.32 162.26 15.92 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.568 ' HB2' HG13 ' A' ' 77' ' ' ILE . 46.6 m0 -93.79 176.41 6.36 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 21' ' ' LEU . 59.7 tp -121.2 112.57 18.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.73 14.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.745 ' HA ' ' O ' ' A' ' 73' ' ' SER . 48.5 ttp180 -133.56 153.69 51.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.322 0.582 . . . . 0.0 110.285 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.6 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.2 m -100.0 153.82 18.89 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -30.04 12.62 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -81.68 -12.06 58.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.812 0.339 . . . . 0.0 111.855 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.59 92.59 1.56 Allowed Glycine 0 C--N 1.315 -0.591 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.745 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.7 m -153.73 118.05 4.87 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.522 ' HB3' HD12 ' A' ' 66' ' ' LEU . 48.2 m-85 -114.59 94.95 5.01 Favored 'General case' 1 C--N 1.222 -4.972 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -173.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.577 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -111.18 103.41 1.58 Allowed Glycine 3 N--CA 1.359 -6.434 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.547 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -45.52 100.55 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 113.133 -1.534 . . . . 0.0 108.293 173.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.568 HG13 ' HB2' ' A' ' 65' ' ' TRP . 2.0 pt -81.4 142.0 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.249 0 C-N-CA 124.341 1.057 . . . . 0.0 113.482 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 18.7 ptpt -79.28 119.01 21.74 Favored 'General case' 1 N--CA 1.361 -4.911 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 165.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.453 HG23 ' CD2' ' A' ' 65' ' ' TRP . 50.5 p -36.11 -39.46 0.17 Allowed 'General case' 1 C--N 1.242 -4.1 0 C-N-CA 127.732 2.413 . . . . 0.0 112.894 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.84 -13.35 62.06 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 123.274 0.63 . . . . 0.0 112.341 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.78 -9.08 50.59 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.359 -0.838 . . . . 0.0 111.112 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.569 HG12 HD11 ' A' ' 52' ' ' ILE . 31.5 m -133.91 167.22 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 122.152 0.977 . . . . 0.0 111.974 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.4 mt-10 -132.89 111.62 11.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.672 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.1 pt -75.36 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.686 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.28 98.79 5.28 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -87.23 149.25 24.72 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.041 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' CG ' ' HZ3' ' A' ' 90' ' ' LYS . 14.2 t70 -126.89 87.7 2.7 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -111.52 -20.23 12.26 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.62 -172.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 92' ' ' LYS . 53.2 tp -145.92 107.17 4.19 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 90' ' ' LYS . 14.3 tppt? -71.31 -38.26 71.75 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.055 0.455 . . . . 0.0 110.396 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.52 97.15 6.54 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.15 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.467 ' HG2' HD21 ' A' ' 89' ' ' LEU . 98.1 mttt -85.45 127.55 34.43 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.06 102.16 14.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.239 0.542 . . . . 0.0 112.022 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -139.92 7.34 2.26 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.993 0.901 . . . . 0.0 108.947 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 62.0 tp -104.64 130.21 52.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.803 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--N 1.299 -1.615 0 CA-C-O 118.197 -0.906 . . . . 0.0 108.581 177.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.4 tptt 64.66 77.18 0.32 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.891 0.876 . . . . 0.0 110.832 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -111.27 90.02 3.22 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.54 113.56 26.29 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -124.84 15.4 8.63 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -171.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -118.4 -37.51 3.32 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -92.48 114.51 27.08 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.595 0.712 . . . . 0.0 110.81 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB3' ' HZ1' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -144.36 68.8 1.26 Allowed 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 171.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.623 ' HG3' ' HG3' ' A' ' 10' ' ' LYS . 9.9 pt-20 -57.44 -32.37 66.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.732 -1.576 . . . . 0.0 113.485 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.623 ' HG3' ' HG3' ' A' ' 9' ' ' GLU . 62.5 mttp -104.03 176.07 5.28 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.439 -176.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 70.42 93.17 0.08 Allowed 'General case' 0 C--N 1.322 -0.59 0 O-C-N 124.65 1.219 . . . . 0.0 109.574 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' HG12 ' A' ' 15' ' ' ILE . 5.5 mp0 -80.18 79.36 6.75 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.323 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 6.7 tp60 -72.4 -23.83 61.15 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.88 0.848 . . . . 0.0 110.046 -175.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -60.91 -30.0 69.93 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.24 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 74' ' ' TYR . 4.3 pt -79.72 -31.45 13.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.419 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 2.7 mptp? -68.62 -23.8 64.49 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 121.357 0.599 . . . . 0.0 110.768 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -103.6 6.49 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.997 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 8.8 ttmm -121.62 -43.42 2.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.098 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 2.9 t80 -94.6 -33.8 12.87 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 87.4 tttt 68.13 88.51 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.653 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 66' ' ' LEU . 1.2 mm? -98.09 -29.98 12.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.675 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p 60.24 23.89 13.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.985 1.314 . . . . 0.0 113.379 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.78 172.94 32.86 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -87.39 170.07 6.89 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.879 2.386 . . . . 0.0 111.167 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 55' ' ' ILE . 14.9 tt -163.62 154.98 2.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.309 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.417 ' O ' HG23 ' A' ' 55' ' ' ILE . 11.7 pt20 -83.63 178.41 7.98 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.255 0.622 . . . . 0.0 109.398 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.55 136.21 25.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.2 0.524 . . . . 0.0 109.636 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 54' ' ' ILE . 49.9 mm -91.29 -35.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.79 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.799 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.405 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.2 m80 -168.64 162.56 11.91 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.26 121.14 41.33 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.653 ' HB1' HG21 ' A' ' 84' ' ' ILE . . . -96.14 155.79 16.61 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-O 121.758 0.789 . . . . 0.0 110.027 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 32' ' ' LYS . 4.2 ttmp? -107.04 128.08 54.04 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -68.36 109.39 3.63 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.52 -22.5 32.44 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.23 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.4 m -133.19 144.01 49.56 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.848 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.43 104.55 16.56 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.321 1.058 . . . . 0.0 109.281 172.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 39' ' ' GLY . 8.5 p -114.47 151.49 16.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.682 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.388 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -97.97 7.24 46.65 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.201 0.6 . . . . 0.0 111.942 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 75.25 59.04 3.73 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.609 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.11 151.14 17.01 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 tttm 62.0 32.87 17.58 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.934 0.873 . . . . 0.0 108.687 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 90.6 m-20 66.55 86.64 0.13 Allowed 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.385 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.554 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 22.4 tt0 -147.09 -175.73 4.94 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.575 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.67 154.53 17.89 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.481 ' H ' HD21 ' A' ' 44' ' ' LEU . 3.6 m -101.89 120.19 40.0 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.436 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 18.5 p90 -151.06 161.77 42.12 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.731 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 73.2 mmtt -107.2 151.19 25.76 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.118 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -55.59 111.65 0.95 Allowed 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.57 24.96 14.49 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.406 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -75.91 -39.96 55.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.144 0.577 . . . . 0.0 111.162 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 76.34 108.08 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.915 1.686 . . . . 0.0 109.04 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.571 HD13 ' CG1' ' A' ' 82' ' ' VAL . 8.1 mt -116.87 162.71 14.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -173.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.47 135.24 54.85 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.0 tp -93.48 128.54 44.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.471 ' HB ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -113.33 -42.24 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.568 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 1.8 tpm_? -128.52 128.23 43.92 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.55 HD11 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -126.07 -6.74 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 123.612 0.765 . . . . 0.0 109.637 177.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -112.13 150.84 30.21 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.521 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 t70 56.24 56.53 5.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.743 1.258 . . . . 0.0 109.535 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 17.7 p-10 -105.83 106.31 56.19 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.535 -1.666 . . . . 0.0 112.486 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 16.6 Cg_exo -66.76 -23.52 48.3 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.814 3.009 . . . . 0.0 115.072 -173.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -111.08 0.17 16.81 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.915 0.864 . . . . 0.0 109.852 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 17.49 80.19 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.688 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.0 ptmt -110.33 161.68 15.39 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.516 ' CD2' HG21 ' A' ' 79' ' ' THR . 40.4 m0 -96.63 176.18 6.11 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 122.383 0.273 . . . . 0.0 110.367 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 74' ' ' TYR . 64.5 tp -117.37 111.77 19.79 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.74 155.43 16.32 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.184 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.1 ttp180 -136.45 148.26 47.63 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.543 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.7 m -101.41 157.96 16.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.79 30.36 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 119.243 0.928 . . . . 0.0 113.174 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmt_? -64.01 -26.0 68.37 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.071 0.948 . . . . 0.0 110.2 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.67 89.05 1.44 Allowed Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.4 m -153.56 122.31 6.37 Favored 'General case' 0 N--CA 1.387 -3.582 0 N-CA-C 100.422 -3.918 . . . . 0.0 100.422 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.577 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 67.4 m-85 -114.61 96.52 5.79 Favored 'General case' 1 C--N 1.225 -4.806 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -175.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -111.04 105.31 1.86 Allowed Glycine 3 N--CA 1.357 -6.567 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 177.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -49.38 96.49 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.291 -1.455 . . . . 0.0 108.88 169.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.562 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.7 pt -76.09 143.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.276 0 C-N-CA 125.631 1.572 . . . . 0.0 113.518 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -78.93 115.88 18.89 Favored 'General case' 1 N--CA 1.371 -4.411 0 N-CA-C 102.811 -3.033 . . . . 0.0 102.811 166.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.516 HG21 ' CD2' ' A' ' 65' ' ' TRP . 68.9 p -36.02 -35.96 0.08 Allowed 'General case' 0 C--N 1.244 -3.995 0 C-N-CA 128.167 2.587 . . . . 0.0 113.962 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -70.16 -15.13 62.91 Favored 'General case' 0 CA--C 1.567 1.625 0 C-N-CA 123.361 0.665 . . . . 0.0 112.636 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.92 -13.84 38.11 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.571 ' CG1' HD13 ' A' ' 52' ' ' ILE . 28.4 m -127.89 165.5 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-O 121.297 0.57 . . . . 0.0 110.888 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -133.8 117.3 16.72 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.653 HG21 ' HB1' ' A' ' 31' ' ' ALA . 2.1 pp -77.96 134.1 29.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 119.504 -0.879 . . . . 0.0 109.936 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.88 123.71 23.95 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.365 0.602 . . . . 0.0 110.416 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -85.54 146.06 27.08 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.815 -171.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -103.72 6.13 36.68 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 123.141 1.448 . . . . 0.0 107.275 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 t -122.22 176.24 5.95 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 113.743 -1.571 . . . . 0.0 107.082 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 mp 63.95 27.51 14.36 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.975 0.91 . . . . 0.0 110.679 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -83.93 100.18 10.85 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.153 0.501 . . . . 0.0 110.088 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.33 109.48 6.84 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -127.84 95.26 4.16 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.99 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.813 ' HE3' ' HA ' ' A' ' 93' ' ' LYS . 1.0 OUTLIER 57.63 95.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 125.1 1.36 . . . . 0.0 112.526 177.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.99 169.66 10.25 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.145 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.8 tp -154.14 109.78 3.19 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 C--N 1.296 -1.748 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.692 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 120.823 0.344 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -98.51 93.93 6.42 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 120.844 0.354 . . . . 0.0 110.152 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 3' ' ' LYS . 71.5 mmtt -132.59 102.0 5.53 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.493 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -93.18 17.97 10.17 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.861 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -80.71 104.09 10.99 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.464 0.649 . . . . 0.0 110.789 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -121.97 -149.48 0.43 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 61.36 65.95 0.92 Allowed 'General case' 0 C--O 1.248 0.998 0 C-N-CA 124.1 0.96 . . . . 0.0 111.439 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.19 132.07 44.01 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.981 178.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.57 107.44 15.8 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -173.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -88.89 106.56 18.48 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 171.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -142.44 146.53 34.91 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.177 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -178.77 4.79 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.148 0.499 . . . . 0.0 112.233 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.62 ' HA ' HE21 ' A' ' 13' ' ' GLN . 0.0 OUTLIER -70.83 -3.01 16.75 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 -174.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 30.0 mm-40 85.29 21.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 125.21 1.404 . . . . 0.0 108.879 -173.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.579 ' HA ' ' HH ' ' A' ' 76' ' ' TYR . 2.7 pp -87.15 -25.18 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.417 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.626 ' HB3' ' HD3' ' A' ' 17' ' ' LYS . 10.5 tptm -64.3 -41.65 96.76 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.286 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 3.4 mppt? -98.02 12.46 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.699 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 18' ' ' LYS . 8.2 tppt? -105.67 -57.04 2.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.695 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 1.8 t80 -80.11 -25.07 40.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 49.5 mtpt 70.09 89.4 0.1 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.989 1.316 . . . . 0.0 110.6 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.526 HD11 HD21 ' A' ' 66' ' ' LEU . 1.3 mm? -98.74 -18.63 17.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.804 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 70.7 p 69.88 -69.6 0.16 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 126.061 1.744 . . . . 0.0 114.32 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.12 -130.81 5.55 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.324 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.59 163.23 39.11 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.808 2.338 . . . . 0.0 111.984 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' A' ' 55' ' ' ILE . 8.9 tp -134.88 126.02 46.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -123.35 166.61 15.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.12 136.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.379 0.609 . . . . 0.0 109.464 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.88 -33.66 3.53 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.057 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.557 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.6 m80 -161.82 168.65 22.73 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -173.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.72 115.67 30.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.679 ' HB2' HG21 ' A' ' 84' ' ' ILE . . . -98.12 155.12 17.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-O 122.281 1.038 . . . . 0.0 111.352 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 34.1 ttpt -107.91 128.83 54.97 Favored 'General case' 0 C--N 1.256 -3.465 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -64.84 116.03 5.92 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.87 -17.4 35.7 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.451 0.643 . . . . 0.0 109.658 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.1 t -144.33 156.07 44.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 8.2 p-10 -94.43 101.92 13.86 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.16 0.981 . . . . 0.0 110.169 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG11 ' CE1' ' A' ' 46' ' ' PHE . 7.3 p -112.42 153.35 14.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.35 42.94 3.13 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 111.406 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 74.39 58.84 4.08 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.14 176.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.06 126.6 8.02 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 64.4 34.79 10.12 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.598 0.713 . . . . 0.0 109.79 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.527 ' ND2' ' HE1' ' A' ' 76' ' ' TYR . 12.2 t30 71.52 87.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.702 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 20.2 tt0 -151.85 -172.45 4.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.102 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.1 tt -94.96 151.5 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.514 ' H ' HD21 ' A' ' 44' ' ' LEU . 50.1 m -102.77 118.58 37.14 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.401 ' CE1' HG11 ' A' ' 37' ' ' VAL . 20.3 p90 -154.89 177.22 11.54 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.618 0.767 . . . . 0.0 109.619 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 99.1 mttt -133.69 151.18 51.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.74 119.3 2.71 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 124.322 1.014 . . . . 0.0 110.9 176.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.44 12.7 59.41 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.937 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -79.23 -15.54 57.87 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 66.34 113.93 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 O-C-N 124.394 1.059 . . . . 0.0 111.208 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.552 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.5 mt -120.69 156.25 23.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.39 138.26 51.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 65' ' ' TRP . 7.8 tp -95.16 117.43 39.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.511 ' HB ' HG13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.53 -27.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.404 -176.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 tpp180 -141.88 125.81 17.18 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.052 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.552 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -118.78 -38.95 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.738 -177.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -106.68 154.91 20.26 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.199 -172.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 82.82 10.91 0.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.894 1.677 . . . . 0.0 109.798 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.579 ' ND2' ' HA2' ' A' ' 63' ' ' GLY . 2.9 p-10 -54.57 123.95 46.73 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.213 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 21.3 Cg_exo -68.4 -40.69 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.088 2.526 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -99.74 -49.84 4.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.579 ' HA2' ' ND2' ' A' ' 60' ' ' ASN . . . 145.18 -2.59 1.15 Allowed Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.288 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 14.8 ptpt -100.69 163.67 12.23 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 122.572 0.349 . . . . 0.0 110.314 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.648 ' HB3' HD12 ' A' ' 54' ' ' ILE . 35.9 m0 -98.03 174.33 6.6 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 124.263 0.977 . . . . 0.0 111.103 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.532 ' O ' HD11 ' A' ' 54' ' ' ILE . 41.4 tp -115.05 108.31 16.5 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.06 157.97 14.62 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.2 ttp180 -136.09 147.11 47.69 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.171 0.51 . . . . 0.0 111.389 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.6 p -100.83 165.31 11.42 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.052 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.55 24.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.385 1.074 . . . . 0.0 113.641 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -78.04 -18.96 55.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.301 0.572 . . . . 0.0 111.384 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.69 92.09 1.38 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.1 m -151.96 129.11 11.14 Favored 'General case' 0 N--CA 1.392 -3.36 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' HB3' HD12 ' A' ' 66' ' ' LEU . 41.9 m-85 -119.73 61.31 0.84 Allowed 'General case' 1 C--N 1.226 -4.788 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -172.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -87.11 93.38 1.88 Allowed Glycine 1 N--CA 1.384 -4.82 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -176.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.579 ' HH ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -34.29 101.05 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 125.809 1.535 . . . . 0.0 110.324 174.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.717 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -78.07 137.01 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.342 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.661 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -73.67 114.05 11.49 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 103.576 -2.749 . . . . 0.0 103.576 166.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.521 HG23 ' CD2' ' A' ' 65' ' ' TRP . 81.4 p -36.11 -35.9 0.08 Allowed 'General case' 1 C--N 1.24 -4.189 0 C-N-CA 128.428 2.691 . . . . 0.0 113.471 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.6 t -69.04 -14.24 62.92 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.068 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.32 -7.14 51.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.443 -0.785 . . . . 0.0 111.137 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 77' ' ' ILE . 26.8 m -133.96 157.46 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.93 0.871 . . . . 0.0 112.365 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -120.3 110.69 16.86 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.679 HG21 ' HB2' ' A' ' 31' ' ' ALA . 18.8 pt -79.82 163.03 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -86.67 109.87 19.49 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -80.83 -52.58 7.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -167.17 61.45 0.08 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 m -95.7 -62.11 1.35 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.727 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.33 28.94 2.75 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 90' ' ' LYS . 4.4 tmtm? -71.97 -38.31 69.76 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.493 ' O ' HD11 ' A' ' 91' ' ' LEU . 3.3 pp -71.24 109.51 5.32 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.292 1.044 . . . . 0.0 111.167 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -119.94 146.7 45.56 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? 60.55 79.06 0.25 Allowed 'General case' 0 C--N 1.312 -1.053 0 O-C-N 124.409 1.068 . . . . 0.0 110.81 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -106.64 109.78 21.79 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.1 mt -71.42 106.51 3.95 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.542 0.686 . . . . 0.0 112.279 -172.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.41 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.712 0.292 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -91.39 -33.47 15.25 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.404 0.282 . . . . 0.0 111.689 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt 69.31 86.99 0.12 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -170.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.17 109.41 17.71 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.073 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . 45.0 mt-30 -115.69 128.82 56.18 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -96.22 -29.85 13.8 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.945 -173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -88.23 24.47 1.86 Allowed 'General case' 0 C--O 1.242 0.678 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.481 ' HD3' ' HB2' ' A' ' 5' ' ' GLN . 47.8 mtmt -80.62 -75.47 0.27 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.844 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -115.86 100.54 8.07 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.59 0.709 . . . . 0.0 109.865 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -146.19 -19.83 0.44 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.775 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt 74.49 150.88 0.11 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.767 1.227 . . . . 0.0 110.796 -177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.508 ' HB3' HG12 ' A' ' 15' ' ' ILE . 6.1 mm-40 -74.34 91.85 2.24 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.319 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 15.4 mm100 -91.09 -34.73 14.96 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.395 1.093 . . . . 0.0 109.19 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 3.6 mp0 -70.56 -12.06 61.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.438 -174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.544 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 2.3 pp -87.98 -23.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 120.922 0.391 . . . . 0.0 110.125 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 24.9 tptt -48.1 -61.68 1.86 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.845 1.658 . . . . 0.0 112.711 -171.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -104.82 11.66 33.53 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.553 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 12.6 tppt? -84.87 -50.74 7.28 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 26.2 t80 -89.99 -28.99 18.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.628 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 8.0 mtmp? 75.0 88.25 0.09 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 125.577 1.551 . . . . 0.0 110.066 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 HD12 HD21 ' A' ' 66' ' ' LEU . 1.7 mm? -99.94 -69.9 0.75 Allowed 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 m 54.02 84.37 0.06 Allowed 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.131 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.55 -143.47 15.15 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.232 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.76 127.82 16.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.518 2.812 . . . . 0.0 111.386 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.556 HD12 ' HB ' ' A' ' 55' ' ' ILE . 10.4 tp -136.35 127.14 42.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.92 162.27 39.63 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.715 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.9 p -76.85 134.67 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.349 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.77 -34.77 4.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.861 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 35.6 m80 -159.15 163.03 36.43 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.39 116.39 32.34 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.89 155.31 17.24 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 122.345 1.069 . . . . 0.0 111.67 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -106.85 126.47 52.35 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.06 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.405 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.53 109.4 2.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.537 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.6 t -80.94 -18.7 46.17 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.884 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -147.32 151.48 36.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.638 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -89.06 105.4 17.76 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.847 0.832 . . . . 0.0 109.662 173.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.32 162.28 12.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.905 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -125.18 31.52 5.58 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.537 0.684 . . . . 0.0 111.411 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 81.26 59.2 2.45 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.169 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.19 116.12 4.52 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 tttm 57.43 71.11 0.6 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.984 1.313 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.572 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 18.8 m120 51.47 79.47 0.1 Allowed 'General case' 0 C--O 1.245 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 111.493 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 4.3 tt0 -146.81 -175.45 4.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.645 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -97.59 155.24 17.06 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.556 ' H ' HD22 ' A' ' 44' ' ' LEU . 28.0 m -100.65 115.44 30.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.171 0.51 . . . . 0.0 109.69 174.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.5 p90 -149.48 158.22 43.98 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.819 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 59.4 mttm -110.84 152.93 26.11 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 123.695 0.622 . . . . 0.0 109.922 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 110.22 0.66 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.33 27.23 10.15 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.103 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.7 tp10 -80.11 -37.05 34.43 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.086 0.555 . . . . 0.0 111.117 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 72.21 112.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.182 1.793 . . . . 0.0 110.505 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.55 HD13 ' CG1' ' A' ' 82' ' ' VAL . 9.0 mt -119.88 160.68 20.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.117 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.715 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 44.8 mt-10 -117.83 134.36 55.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.538 HD11 ' O ' ' A' ' 66' ' ' LEU . 7.6 tp -90.14 126.53 42.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.556 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.22 -39.55 3.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.595 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -134.89 130.15 35.48 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 118.549 -1.261 . . . . 0.0 110.906 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.45 -1.93 5.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 123.934 0.894 . . . . 0.0 110.233 176.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.8 p -112.38 147.43 36.42 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.916 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 t70 67.08 28.59 8.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 122.75 1.262 . . . . 0.0 109.428 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 23.3 p-10 -77.98 115.05 47.28 Favored Pre-proline 0 C--N 1.302 -1.464 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.203 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 30.9 Cg_exo -62.63 -62.4 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.711 2.941 . . . . 0.0 113.877 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.35 -8.41 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.819 0.818 . . . . 0.0 110.874 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 7.88 68.05 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.0 ptmt -95.96 162.91 13.36 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.598 ' CD1' HG21 ' A' ' 57' ' ' ILE . 46.0 m0 -97.71 175.94 6.0 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 122.365 0.266 . . . . 0.0 110.529 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.538 ' O ' HD11 ' A' ' 54' ' ' ILE . 60.1 tp -120.54 114.18 21.38 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -120.24 159.81 15.03 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.4 ttp180 -134.68 152.81 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.0 m -111.82 165.44 12.06 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.23 -31.96 15.36 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -89.29 -6.86 56.42 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 118.372 -1.331 . . . . 0.0 111.091 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.24 97.2 1.25 Allowed Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.874 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.4 m -153.89 124.31 7.04 Favored 'General case' 0 N--CA 1.394 -3.27 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.479 ' HD1' ' HG3' ' A' ' 12' ' ' GLU . 39.9 m-85 -113.85 80.56 1.4 Allowed 'General case' 1 C--N 1.223 -4.908 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -175.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.645 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -97.46 101.97 2.64 Favored Glycine 3 N--CA 1.346 -7.334 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.572 ' HE1' ' HB3' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.92 100.34 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 113.198 -1.501 . . . . 0.0 108.121 168.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.6 pt -80.44 145.68 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.442 -3.204 0 C-N-CA 126.645 1.978 . . . . 0.0 113.515 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 117.58 22.25 Favored 'General case' 1 N--CA 1.359 -5.007 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 166.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.463 HG22 ' CG ' ' A' ' 65' ' ' TRP . 62.1 p -35.34 -38.2 0.09 Allowed 'General case' 0 C--N 1.251 -3.696 0 C-N-CA 129.05 2.94 . . . . 0.0 114.014 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 t -70.27 -9.89 57.32 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.308 1.043 . . . . 0.0 112.248 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.32 -10.18 36.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.427 -0.796 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.583 HG21 HD13 ' A' ' 77' ' ' ILE . 19.0 m -129.08 152.28 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-O 121.808 0.813 . . . . 0.0 112.29 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.5 mt-10 -119.14 107.05 12.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 10.2 pt -72.82 159.3 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.198 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.529 ' OD2' ' HA ' ' A' ' 88' ' ' SER . 28.4 t70 -94.11 101.64 13.66 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -51.94 -45.3 64.26 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 124.785 1.234 . . . . 0.0 112.23 -172.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 2.1 m-20 -116.0 88.7 2.94 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.529 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 50.8 m -74.26 104.94 5.22 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.0 tp 79.2 -39.4 0.22 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.916 1.686 . . . . 0.0 110.277 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . 46.8 tttm 70.11 79.94 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.607 1.163 . . . . 0.0 109.411 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.17 155.18 51.12 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.759 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -157.37 96.73 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 123.773 0.829 . . . . 0.0 109.275 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 76.3 174.77 0.22 Allowed 'General case' 0 C--O 1.245 0.831 0 C-N-CA 125.105 1.362 . . . . 0.0 110.623 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -113.86 28.51 8.7 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.719 0.771 . . . . 0.0 109.944 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.8 tp -69.23 -31.74 70.52 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.033 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 C--N 1.303 -1.417 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.216 -178.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 120.942 0.401 . . . . 0.0 112.016 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -120.82 114.54 21.76 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -93.73 118.93 32.07 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -140.51 73.66 1.43 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 168.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 67.29 166.99 0.23 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.194 -175.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.58 89.1 2.89 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.708 0.765 . . . . 0.0 111.209 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.76 109.11 20.6 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -133.03 94.83 3.43 Favored 'General case' 0 C--O 1.255 1.354 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.38 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 74.1 -59.64 0.55 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.197 1.399 . . . . 0.0 112.488 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 75.86 103.6 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.623 1.569 . . . . 0.0 112.011 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -97.33 12.15 34.06 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 83.09 140.31 0.06 Allowed 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 126.444 1.897 . . . . 0.0 111.079 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.2 -32.22 16.7 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.315 0.579 . . . . 0.0 111.175 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 35.0 mm-40 -59.63 -34.59 72.98 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.182 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.56 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 2.4 pp -72.3 -28.3 28.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.316 -172.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.473 ' HA ' HD21 ' A' ' 21' ' ' LEU . 48.7 mtpt -67.91 -36.19 79.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.015 -172.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -107.53 -16.74 14.29 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.298 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 5.8 tppt? -71.32 -45.73 62.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.439 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 31.3 t80 -90.68 -30.61 17.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . 0.254 15.2 tptp 74.61 85.58 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.695 1.236 . . . . 0.0 111.392 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.596 HD12 HD23 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -98.99 -59.84 1.65 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.304 36.2 p 62.75 100.23 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.792 1.637 . . . . 0.0 112.634 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.08 144.3 10.19 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -173.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.97 125.97 20.86 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 123.311 2.674 . . . . 0.0 111.599 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.3 tp -107.97 136.33 43.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.33 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -103.59 167.49 9.76 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.4 p -81.64 137.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.442 0.639 . . . . 0.0 111.159 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.42 -40.36 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.748 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.41 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.4 m80 -161.15 171.75 17.95 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.517 ' HB3' ' NE2' ' A' ' 51' ' ' GLN . 5.8 mp -107.86 126.33 52.54 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.685 ' HB3' HG21 ' A' ' 84' ' ' ILE . . . -102.68 156.6 17.52 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.418 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -107.1 133.51 51.6 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -65.99 103.22 0.9 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.9 t -71.2 -28.93 64.57 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.3 m -132.09 156.43 46.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.7 p-10 -81.38 112.03 18.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 171.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.739 HG21 ' HB3' ' A' ' 81' ' ' ALA . 30.8 t -112.62 140.89 30.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.789 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.34 -168.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -86.7 -14.61 42.01 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.341 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.78 60.49 3.16 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.983 -1.58 . . . . 0.0 110.432 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.17 131.89 10.85 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.83 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp 58.88 71.58 0.58 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.405 1.082 . . . . 0.0 110.658 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 56.29 61.45 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.114 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 46.5 mt-10 -134.16 -179.22 5.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.548 0.339 . . . . 0.0 111.133 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.61 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -98.46 140.96 31.93 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 p -94.6 115.73 27.92 Favored 'General case' 0 C--N 1.28 -2.443 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.161 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 29.1 p90 -145.47 177.12 9.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.478 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 9.3 mtmp? -134.81 142.53 46.69 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.6 tm0? -35.79 111.97 0.15 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 125.131 1.519 . . . . 0.0 110.376 173.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.09 19.97 40.77 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.648 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -73.33 -26.0 60.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.003 0.901 . . . . 0.0 113.227 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.517 ' NE2' ' HB3' ' A' ' 30' ' ' LEU . 26.6 tp60 70.84 104.2 0.06 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.882 1.364 . . . . 0.0 108.813 -172.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.541 HD11 HG12 ' A' ' 82' ' ' VAL . 14.8 mt -110.74 165.95 5.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.63 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 24.9 mt-10 -122.65 141.11 52.1 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.8 tp -98.75 116.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.49 -41.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.387 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -133.7 136.54 44.74 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 117.782 -1.567 . . . . 0.0 111.497 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.02 -37.84 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.376 -1.283 . . . . 0.0 109.675 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -88.45 158.09 18.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t70 54.82 66.36 1.25 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 125.032 1.333 . . . . 0.0 109.192 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 31.5 p30 -112.11 136.93 21.3 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.166 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.6 Cg_exo -76.76 -32.3 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.431 2.087 . . . . 0.0 112.872 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.79 -34.89 6.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.74 -7.04 15.63 Favored Glycine 0 C--N 1.305 -1.142 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 11.4 ptmt -80.52 162.33 24.38 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.549 ' CD1' HG22 ' A' ' 57' ' ' ILE . 37.7 m0 -99.08 176.65 5.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.608 0.186 . . . . 0.0 110.801 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.596 HD23 HD12 ' A' ' 21' ' ' LEU . 61.4 tp -116.39 110.93 19.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.83 158.84 14.07 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 73' ' ' SER . 66.4 ttt-85 -140.53 147.8 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.769 0.427 . . . . 0.0 109.88 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.453 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 7.1 p -101.03 165.54 11.27 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.12 65.2 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.087 0.47 . . . . 0.0 112.254 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -71.55 -14.97 62.26 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.338 0.655 . . . . 0.0 111.749 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.4 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 81.77 88.37 0.65 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.181 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.7 m -151.99 120.82 6.57 Favored 'General case' 0 N--CA 1.394 -3.269 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 66' ' ' LEU . 61.0 m-85 -108.91 90.74 3.38 Favored 'General case' 1 C--N 1.219 -5.076 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.61 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -107.05 104.81 2.21 Favored Glycine 3 N--CA 1.355 -6.748 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.56 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -46.0 96.99 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.351 -1.424 . . . . 0.0 108.29 169.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.5 pt -78.22 147.18 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.898 0 C-N-CA 125.713 1.605 . . . . 0.0 114.398 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.509 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -76.64 113.82 14.7 Favored 'General case' 1 N--CA 1.376 -4.143 0 N-CA-C 101.712 -3.44 . . . . 0.0 101.712 165.77 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.557 HG23 ' HA ' ' A' ' 64' ' ' LYS . 79.4 p -36.64 -41.92 0.33 Allowed 'General case' 0 C--N 1.246 -3.92 0 C-N-CA 127.769 2.427 . . . . 0.0 113.594 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -63.53 -20.42 65.61 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.258 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.739 ' HB3' HG21 ' A' ' 37' ' ' VAL . . . -82.97 -12.54 57.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.835 -0.54 . . . . 0.0 111.279 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.541 HG12 HD11 ' A' ' 52' ' ' ILE . 29.1 m -127.06 166.82 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.343 0.592 . . . . 0.0 111.847 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 58.3 mt-10 -133.26 107.91 8.43 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 31' ' ' ALA . 8.6 pt -75.53 155.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.391 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -97.25 108.86 21.68 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.706 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.46 -5.5 0.84 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.135 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 t70 48.9 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.166 1.787 . . . . 0.0 114.445 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.1 m -96.94 39.41 1.18 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.819 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.2 mt -71.28 -53.23 15.02 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.157 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 54.56 72.98 0.43 Allowed 'General case' 0 C--O 1.245 0.848 0 O-C-N 124.788 1.305 . . . . 0.0 110.07 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.56 123.93 18.44 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.091 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -77.11 125.87 30.03 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.138 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.16 174.98 10.11 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.424 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -114.64 -160.94 0.75 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.6 mt -75.88 106.42 7.45 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 119.005 0.82 . . . . 0.0 110.892 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.416 -2.132 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -179.613 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -92.26 95.93 9.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HG2' ' HG2' ' A' ' 4' ' ' GLU . 64.5 tttp -112.03 -63.31 1.44 Allowed 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.507 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 12.2 pt-20 170.35 151.69 0.04 OUTLIER 'General case' 0 C--O 1.246 0.876 0 C-N-CA 125.957 1.703 . . . . 0.0 107.43 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.53 134.98 57.19 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -48.16 -38.22 17.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.87 103.36 3.36 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -107.72 -82.55 0.55 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 50.39 30.82 4.82 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.699 1.2 . . . . 0.0 111.667 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -130.87 80.22 1.93 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -86.14 122.72 30.54 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.897 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' HG2' HG23 ' A' ' 15' ' ' ILE . 14.1 tt0 -133.02 56.87 1.83 Allowed 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.553 ' HG3' ' HD3' ' A' ' 16' ' ' LYS . 28.5 tt0 -74.96 -13.48 60.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.705 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -59.4 -29.92 68.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.827 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 1.9 pp -67.54 -30.77 49.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-O 121.454 0.645 . . . . 0.0 111.422 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.553 ' HD3' ' HG3' ' A' ' 13' ' ' GLN . 21.8 mtpp -76.48 -27.32 56.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.805 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -93.65 -8.93 39.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.019 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 12.6 tppt? -99.58 -67.01 0.87 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.073 0.463 . . . . 0.0 110.96 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.764 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 21.1 t80 -79.07 -32.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 -172.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.539 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 7.9 mtmp? 75.72 91.84 0.07 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.834 1.253 . . . . 0.0 109.692 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.35 -46.33 5.83 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.318 0.58 . . . . 0.0 109.772 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HG1' ' C ' ' A' ' 21' ' ' LEU . 62.6 p 56.88 21.41 6.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.507 1.523 . . . . 0.0 114.877 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.86 143.67 7.19 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.48 97.0 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.747 2.298 . . . . 0.0 111.109 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.437 HD13 ' HB ' ' A' ' 55' ' ' ILE . 2.3 pp -114.54 163.73 11.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.305 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' C ' HG23 ' A' ' 55' ' ' ILE . 12.9 pt20 -124.53 -172.69 2.61 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -53.95 133.7 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.64 -31.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.066 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.449 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.1 m80 -161.05 157.03 25.49 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.27 116.04 28.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -94.63 150.81 19.85 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 122.072 0.939 . . . . 0.0 111.127 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.81 128.27 54.11 Favored 'General case' 0 C--N 1.252 -3.652 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.84 116.05 5.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.9 t -81.87 -18.47 43.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.249 0.968 . . . . 0.0 109.846 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.9 m -144.61 156.09 43.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.42 102.02 14.7 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.25 153.75 14.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.718 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -98.1 8.33 44.95 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.387 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.62 59.77 1.87 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.678 -1.248 . . . . 0.0 111.896 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.77 143.8 16.7 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttp 65.05 29.59 12.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 108.757 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.411 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 2.4 t-20 63.14 86.97 0.11 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.28 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.58 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 31.0 tt0 -141.59 -173.6 3.82 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.257 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.647 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.2 tt -95.92 145.54 25.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 m -96.01 122.21 38.59 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 16.6 p90 -154.26 174.83 14.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 60.9 mtpt -127.33 147.79 50.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -51.98 125.68 16.13 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.669 0.605 . . . . 0.0 110.425 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.2 81.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.349 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -63.12 -30.9 71.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.504 0.668 . . . . 0.0 109.891 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 73.23 110.41 0.07 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.13 1.372 . . . . 0.0 111.298 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.518 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.4 mt -115.76 156.81 16.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 CA-C-N 113.557 -1.656 . . . . 0.0 106.671 -172.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 79.9 mt-10 -113.08 131.16 55.92 Favored 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.009 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.509 HD13 ' O ' ' A' ' 66' ' ' LEU . 6.6 tp -86.32 115.81 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.5 HD13 ' H ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -103.4 -32.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.984 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 1.078 ' HG3' HD11 ' A' ' 21' ' ' LEU . 18.1 mmt180 -134.93 112.4 10.61 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.723 HD13 ' H ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.59 -19.31 6.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.038 -1.892 . . . . 0.0 107.092 171.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.519 HG23 HG12 ' A' ' 57' ' ' ILE . 12.0 p -99.01 141.94 31.12 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.396 -177.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t0 75.67 26.06 1.12 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.058 1.343 . . . . 0.0 108.92 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.428 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 10.0 p30 -66.01 126.02 91.11 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.587 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.764 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 62.2 Cg_endo -81.23 -45.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.398 2.065 . . . . 0.0 113.3 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -99.3 -5.52 29.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.021 0.438 . . . . 0.0 111.177 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 99.46 -22.3 41.3 Favored Glycine 0 C--N 1.308 -1.004 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.1 ptmt -72.0 161.49 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.152 -1.024 . . . . 0.0 109.21 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.447 ' CG ' HG22 ' A' ' 79' ' ' THR . 32.3 m0 -99.5 176.34 5.53 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.073 0.233 . . . . 0.0 110.924 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.702 HD22 HD12 ' A' ' 21' ' ' LEU . 62.9 tp -120.36 114.33 21.68 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.08 156.18 15.81 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 73' ' ' SER . 2.1 ttp-105 -139.03 149.11 44.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 17.2 p -99.76 165.94 11.34 Favored 'General case' 0 C--N 1.266 -3.032 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.962 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.73 -30.08 42.47 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -0.07 54.92 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.34 0.866 . . . . 0.0 113.34 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.28 92.01 0.9 Allowed Glycine 0 C--N 1.319 -0.413 0 CA-C-O 121.554 0.53 . . . . 0.0 113.535 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.685 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 20.4 m -153.01 126.15 8.53 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.598 ' HB3' HD12 ' A' ' 66' ' ' LEU . 57.1 m-85 -117.81 86.68 2.57 Favored 'General case' 1 C--N 1.227 -4.727 0 CA-C-O 122.122 0.963 . . . . 0.0 108.649 -173.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.647 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.14 101.76 2.12 Favored Glycine 3 N--CA 1.359 -6.447 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.652 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -48.92 100.36 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.58 -1.31 . . . . 0.0 108.499 170.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.573 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.8 pt -80.41 148.29 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.843 0 C-N-CA 126.277 1.831 . . . . 0.0 113.074 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -77.42 119.59 21.24 Favored 'General case' 1 N--CA 1.368 -4.533 0 N-CA-C 102.647 -3.094 . . . . 0.0 102.647 163.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.461 HG21 ' HA ' ' A' ' 64' ' ' LYS . 82.0 p -36.13 -38.59 0.14 Allowed 'General case' 1 C--N 1.243 -4.051 0 C-N-CA 128.017 2.527 . . . . 0.0 113.168 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.5 t -71.71 -14.15 61.94 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.208 0.603 . . . . 0.0 112.155 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.97 -11.2 57.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.42 -0.8 . . . . 0.0 110.937 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.518 ' CG1' HD12 ' A' ' 52' ' ' ILE . 16.9 m -129.35 167.41 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.556 0.693 . . . . 0.0 111.336 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 mt-10 -131.34 110.55 11.15 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.648 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -75.77 159.5 5.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.251 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.18 102.12 14.84 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.621 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -86.12 169.39 13.16 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -101.97 86.41 2.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.4 m -96.73 -3.67 42.07 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.139 -172.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 mp 68.48 -69.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.955 0.902 . . . . 0.0 111.748 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 65.66 24.17 11.61 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.766 1.269 . . . . 0.0 110.341 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.2 tp -126.37 115.18 19.24 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.38 79.89 5.8 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -150.47 82.22 1.36 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -106.94 -175.17 2.72 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.437 -172.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.57 101.74 1.69 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.253 1.259 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.456 178.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.571 ' HB3' ' HZ3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -140.48 25.78 2.19 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.382 178.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -70.08 85.25 0.53 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.363 1.077 . . . . 0.0 111.261 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -159.89 -47.33 0.05 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.25 109.71 21.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 169.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -118.02 148.28 42.4 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.038 0.447 . . . . 0.0 111.553 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -149.28 147.21 28.09 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.568 ' HD3' ' HE2' ' A' ' 10' ' ' LYS . 87.4 tttt -137.68 129.11 28.05 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.42 ' OE1' ' HA ' ' A' ' 42' ' ' ASN . 7.7 pt-20 -79.69 102.66 9.1 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.733 0.778 . . . . 0.0 109.271 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.568 ' HE2' ' HD3' ' A' ' 8' ' ' LYS . 84.4 mttt -110.88 -78.25 0.59 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.642 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' H ' ' HB2' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -124.93 102.35 7.49 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.41 143.15 27.05 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.021 0.439 . . . . 0.0 109.981 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -90.03 -20.36 23.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 170.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.34 8.12 0.66 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.181 -1.827 . . . . 0.0 112.346 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 16' ' ' LYS . 7.7 pt -67.18 -27.87 40.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.001 0.905 . . . . 0.0 108.746 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.461 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.2 ptmt -79.55 -5.38 54.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.22 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -108.66 -19.94 13.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 2.8 tppt? -91.06 -68.0 0.82 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.031 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.671 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 3.1 t80 -89.12 -22.6 22.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 58.28 88.96 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.417 1.487 . . . . 0.0 111.206 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD11 HD23 ' A' ' 66' ' ' LEU . 1.9 mm? -95.65 -20.31 19.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.08 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p 66.28 -5.55 0.57 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.901 2.08 . . . . 0.0 114.666 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.26 -167.08 37.49 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.656 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.66 113.09 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.282 2.655 . . . . 0.0 110.86 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.404 HG23 ' HB ' ' A' ' 55' ' ' ILE . 44.5 mm -103.79 127.72 57.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.403 ' C ' HG21 ' A' ' 55' ' ' ILE . 11.7 pt20 -92.23 170.28 9.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.358 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.71 132.59 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.432 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -99.98 -30.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.171 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.495 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.5 m80 -165.41 161.92 19.14 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.27 116.61 33.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.03 154.54 17.64 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.813 0.816 . . . . 0.0 111.072 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.98 129.5 55.11 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -64.53 109.75 2.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.491 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 40.3 t -87.74 -5.96 58.42 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.619 0.723 . . . . 0.0 109.071 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.4 m -148.99 163.3 37.9 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.635 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.614 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.1 t70 -108.68 100.64 9.86 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.664 1.186 . . . . 0.0 110.734 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG12 ' CZ ' ' A' ' 46' ' ' PHE . 11.4 p -115.62 148.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.292 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.04 30.16 7.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.38 0.61 . . . . 0.0 112.461 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.92 59.85 1.55 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.236 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.81 140.97 15.07 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.53 31.0 20.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.841 0.456 . . . . 0.0 109.828 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 2.6 t-20 62.51 95.61 0.04 OUTLIER 'General case' 0 C--O 1.247 0.932 0 C-N-CA 125.001 1.32 . . . . 0.0 109.767 -176.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.5 tt0 -150.13 -173.73 4.52 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.755 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.608 HD11 ' H ' ' A' ' 75' ' ' GLY . 45.6 tp -95.45 147.83 23.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 p -100.3 115.46 29.99 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.388 0.613 . . . . 0.0 110.096 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CG ' HD12 ' A' ' 52' ' ' ILE . 32.7 p90 -151.78 168.7 24.25 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.808 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -124.44 147.63 48.18 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -176.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.418 ' N ' ' HD2' ' A' ' 47' ' ' LYS . 20.2 tt0 -51.45 121.84 6.99 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.804 0.335 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.77 29.94 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.295 -0.479 . . . . 0.0 114.147 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 27.6 mm-40 -85.61 -32.39 22.08 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.96 0.88 . . . . 0.0 113.047 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 73.95 111.83 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.524 1.154 . . . . 0.0 111.272 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD13 HD22 ' A' ' 44' ' ' LEU . 4.8 mt -118.49 173.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.782 -173.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' H ' HG21 ' A' ' 52' ' ' ILE . 24.6 mt-10 -128.94 134.05 48.07 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.539 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.7 tp -91.35 128.95 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -107.09 -53.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.749 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.671 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 20.2 ttm180 -127.62 137.78 52.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.495 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.74 -32.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 123.975 0.91 . . . . 0.0 112.07 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 p -102.81 164.1 11.83 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t70 71.45 19.57 5.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.876 1.322 . . . . 0.0 108.828 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 30.8 p-10 -80.51 118.1 70.84 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.869 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 12.1 Cg_exo -71.25 -33.29 11.56 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.737 2.958 . . . . 0.0 114.654 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -92.43 -17.07 25.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.135 0.493 . . . . 0.0 110.772 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.72 5.93 70.81 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.7 ptmt -102.88 162.59 12.81 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 77' ' ' ILE . 44.1 m0 -95.69 176.6 6.09 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 123.393 0.677 . . . . 0.0 110.676 -176.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.653 HD23 HD11 ' A' ' 21' ' ' LEU . 51.8 tp -117.04 113.58 22.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.37 147.93 18.9 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 69' ' ' THR . 43.9 ttp180 -120.9 154.33 36.02 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.038 0.447 . . . . 0.0 111.117 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.592 ' HG1' HD13 ' A' ' 44' ' ' LEU . 10.6 m -99.4 153.13 19.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.24 -34.5 32.62 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 119.242 0.928 . . . . 0.0 113.272 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -71.65 -15.37 62.23 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.503 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.33 87.67 1.17 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.9 m -153.56 122.77 6.55 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.56 ' HB3' HD11 ' A' ' 66' ' ' LEU . 77.5 m-85 -113.37 99.21 7.61 Favored 'General case' 1 C--N 1.222 -4.951 0 O-C-N 123.902 0.751 . . . . 0.0 109.828 -171.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.608 ' H ' HD11 ' A' ' 44' ' ' LEU . . . -104.19 101.69 2.01 Favored Glycine 1 N--CA 1.356 -6.633 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.71 103.19 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.884 0 CA-C-N 113.423 -1.389 . . . . 0.0 107.358 170.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.633 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.7 pt -87.71 143.89 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.97 0 C-N-CA 124.837 1.255 . . . . 0.0 113.728 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.09 117.6 18.81 Favored 'General case' 1 N--CA 1.371 -4.397 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 166.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.464 HG23 ' CG ' ' A' ' 65' ' ' TRP . 54.5 p -36.21 -39.48 0.18 Allowed 'General case' 0 C--N 1.244 -3.999 0 C-N-CA 128.868 2.867 . . . . 0.0 113.12 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -69.38 -12.61 61.8 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.255 1.022 . . . . 0.0 112.704 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.83 -12.75 41.06 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.591 -0.693 . . . . 0.0 110.997 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.473 ' CG1' HD11 ' A' ' 52' ' ' ILE . 27.7 m -130.92 164.65 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-O 121.251 0.548 . . . . 0.0 111.088 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.491 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 45.6 mt-10 -132.26 113.29 13.06 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -76.27 166.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.566 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.83 103.26 12.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -82.03 109.54 16.46 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.07 120.66 25.11 Favored 'General case' 0 C--N 1.275 -2.672 0 CA-C-O 121.645 0.735 . . . . 0.0 110.131 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.6 p -92.37 154.08 18.78 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.877 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.18 127.26 32.78 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.563 ' HG2' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -100.73 4.16 42.85 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.719 0.771 . . . . 0.0 110.363 -178.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.563 HD22 ' HG2' ' A' ' 90' ' ' LYS . 3.1 mm? -137.44 175.57 9.48 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -87.52 -51.73 5.75 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.477 ' HE2' ' HG2' ' A' ' 96' ' ' GLU . 87.2 tttt 171.83 78.73 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.97 -67.23 0.58 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.67 -1.15 . . . . 0.0 113.198 -170.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.7 tp -84.55 85.78 7.38 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-O 121.291 0.567 . . . . 0.0 111.661 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.477 ' HG2' ' HE2' ' A' ' 93' ' ' LYS . 6.3 tp10 . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 5' ' ' GLN . 42.9 mt-10 . . . . . 0 CA--C 1.494 -1.21 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -101.78 151.74 21.7 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.818 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . 10.0 mmpt? 68.17 72.67 0.3 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.235 1.014 . . . . 0.0 112.098 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 60.05 75.76 0.39 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.508 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 1' ' ' GLU . 27.9 tt0 -72.92 142.56 47.87 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.294 172.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -91.42 124.68 35.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.25 79.87 0.24 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.545 0.688 . . . . 0.0 112.15 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -94.8 7.49 45.71 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.464 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 35.2 tt0 -80.03 -22.57 42.24 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.692 175.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -74.51 92.04 2.34 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -120.19 13.89 12.09 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.782 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.98 65.84 0.77 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.262 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -90.16 -23.82 21.22 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -54.54 -31.36 56.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.36 -1.745 . . . . 0.0 111.43 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 74' ' ' TYR . 10.1 pt -68.8 -28.6 40.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.418 0.628 . . . . 0.0 110.903 -174.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . 25.7 mtpp -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.072 0.939 . . . . 0.0 108.493 -176.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.49 ' HB3' ' HZ2' ' A' ' 17' ' ' LYS . 7.4 mtpm? -114.72 9.07 16.33 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.921 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.511 ' HG2' ' CE1' ' A' ' 76' ' ' TYR . 11.9 tppt? -120.41 -60.88 1.64 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.209 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.405 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.7 t80 -91.53 -28.33 17.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.752 ' HZ2' ' HB3' ' A' ' 20' ' ' LYS . 3.1 ttpm? 65.45 90.0 0.09 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.521 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 HD12 HD21 ' A' ' 66' ' ' LEU . 1.7 mm? -98.73 -15.8 19.2 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.359 -174.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.307 80.4 p 69.83 -55.19 0.6 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.709 1.604 . . . . 0.0 113.079 -176.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.15 -147.87 5.58 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.12 173.59 11.68 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.663 2.242 . . . . 0.0 111.557 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.9 tp -160.15 130.37 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.545 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -79.52 168.61 19.19 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.7 p -80.04 134.78 26.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.508 0.671 . . . . 0.0 110.498 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.27 -38.86 11.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.987 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.6 m80 -161.65 165.01 28.87 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.57 124.76 49.4 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.617 ' HB3' HG21 ' A' ' 84' ' ' ILE . . . -99.34 158.89 15.4 Favored 'General case' 0 C--N 1.267 -2.99 0 CA-C-O 121.805 0.812 . . . . 0.0 111.831 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -106.83 125.58 51.19 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 109.88 2.15 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 41.9 t -84.69 -19.24 33.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.0 t -144.55 144.75 31.47 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.705 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.94 105.83 14.26 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.913 0.863 . . . . 0.0 111.234 174.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.31 151.35 18.12 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.425 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 66.78 1.11 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 121.896 0.855 . . . . 0.0 109.655 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 73.16 59.18 4.35 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.213 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.51 105.75 2.95 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 57.11 69.52 0.74 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.17 0.988 . . . . 0.0 110.95 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 54.49 83.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.781 0.832 . . . . 0.0 109.843 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 7.7 tt0 -149.59 -175.3 4.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.634 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.44 159.57 14.86 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.519 ' H ' HD22 ' A' ' 44' ' ' LEU . 14.8 m -101.42 118.68 37.46 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-O 121.566 0.698 . . . . 0.0 110.031 174.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.8 p90 -154.96 163.74 39.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.057 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 48.1 mtmt -117.72 156.17 28.71 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.86 116.07 1.8 Allowed 'General case' 0 CA--C 1.568 1.656 0 O-C-N 123.833 0.708 . . . . 0.0 109.325 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.99 17.58 40.24 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -80.34 -21.83 42.06 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 72.11 109.23 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.319 1.057 . . . . 0.0 110.871 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.6 mt -116.1 165.44 11.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' HB3' HG21 ' A' ' 27' ' ' VAL . 8.0 mt-10 -116.66 136.78 52.69 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 66' ' ' LEU . 7.4 tp -98.58 119.69 46.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.38 -53.24 7.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.405 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.9 tpm_? -122.43 123.96 42.53 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.901 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.536 HG23 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -113.66 -23.75 4.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.498 0.666 . . . . 0.0 110.599 174.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 p -90.85 150.33 21.59 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.718 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 60.11 55.27 3.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.234 1.014 . . . . 0.0 108.513 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -95.82 109.22 45.18 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.71 -59.95 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 124.008 3.139 . . . . 0.0 114.307 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.22 -17.52 56.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.687 0.28 . . . . 0.0 111.497 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.11 5.69 49.53 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -105.43 159.4 15.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.106 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.536 ' CD1' HG23 ' A' ' 57' ' ' ILE . 38.3 m0 -90.41 174.35 7.61 Favored 'General case' 0 C--O 1.198 -1.612 0 C-N-CA 123.459 0.703 . . . . 0.0 110.578 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.745 HD12 ' HB3' ' A' ' 74' ' ' TYR . 58.0 tp -112.74 109.36 18.81 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.987 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.08 155.13 16.52 Favored Glycine 0 N--CA 1.426 -1.986 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.8 ttp180 -133.95 147.1 51.01 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.567 HG22 ' HB2' ' A' ' 73' ' ' SER . 13.4 t -104.17 163.87 12.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.58 -28.98 15.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' NH2' ' HG2' ' A' ' 9' ' ' GLU . 1.1 tmt_? -76.36 -21.02 56.61 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.491 0.663 . . . . 0.0 110.637 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.03 1.07 Allowed Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 59.6 m -152.54 125.5 8.5 Favored 'General case' 0 N--CA 1.386 -3.67 1 N-CA-C 100.03 -4.063 . . . . 0.0 100.03 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HB3' HD12 ' A' ' 66' ' ' LEU . 35.1 m-85 -110.6 82.7 1.63 Allowed 'General case' 1 C--N 1.21 -5.482 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.28 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.634 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -98.44 97.48 1.9 Allowed Glycine 2 N--CA 1.363 -6.22 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CE1' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.84 93.68 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.883 -1.659 . . . . 0.0 110.727 172.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.67 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -70.92 139.91 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 126.9 2.08 . . . . 0.0 113.617 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 118.03 18.2 Favored 'General case' 1 N--CA 1.353 -5.31 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 166.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.524 HG21 ' CD2' ' A' ' 65' ' ' TRP . 73.7 p -35.1 -39.1 0.1 Allowed 'General case' 1 C--N 1.229 -4.67 0 C-N-CA 129.116 2.966 . . . . 0.0 112.807 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -72.02 -5.86 38.13 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.752 0.821 . . . . 0.0 112.26 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.0 -2.62 34.06 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.625 -0.672 . . . . 0.0 111.122 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 77' ' ' ILE . 19.3 m -134.38 159.86 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-O 121.784 0.802 . . . . 0.0 112.722 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.1 mt-10 -125.94 102.89 7.47 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.617 HG21 ' HB3' ' A' ' 31' ' ' ALA . 2.4 pp -69.14 149.21 11.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.63 103.78 0.72 Allowed 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 121.143 0.497 . . . . 0.0 111.162 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -71.35 115.76 10.89 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.11 104.83 0.22 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.0 m -137.58 97.67 3.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.473 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.3 tp -121.41 108.54 13.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.528 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 64.82 69.89 0.49 Allowed 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 124.098 0.959 . . . . 0.0 112.861 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.13 167.66 14.5 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.807 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 9.6 mmpt? -91.84 -60.06 1.96 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.493 0.663 . . . . 0.0 109.343 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.53 155.1 49.63 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 173.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -135.07 76.01 1.6 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.311 1.053 . . . . 0.0 109.263 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.0 tp -110.07 -32.13 7.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 N--CA 1.422 -1.829 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 174.805 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.572 0 CA-C-O 120.766 0.317 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -83.67 89.36 7.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.464 0.65 . . . . 0.0 110.515 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.772 ' HE3' ' HA ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -134.69 31.09 3.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.619 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 72.44 140.73 0.06 Allowed 'General case' 0 C--O 1.242 0.665 0 C-N-CA 125.517 1.527 . . . . 0.0 113.393 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 78.05 -49.26 0.48 Allowed 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.999 1.72 . . . . 0.0 112.779 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 68.47 103.7 0.05 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 124.276 1.03 . . . . 0.0 110.136 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.25 118.37 9.18 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.906 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 68.97 -72.58 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.736 1.615 . . . . 0.0 109.524 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 176.4 -73.37 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 125.884 1.674 . . . . 0.0 106.868 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 42.64 0.67 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.349 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 13' ' ' GLN . 88.8 tttt -65.83 118.01 9.05 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.696 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.619 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -98.0 39.18 1.24 Allowed 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 125.402 1.481 . . . . 0.0 110.706 -176.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 11.0 pt20 -58.71 -35.29 72.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 111.694 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -65.63 -23.77 66.89 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.673 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.619 HG12 ' O ' ' A' ' 12' ' ' GLU . 10.0 pt -81.31 -23.22 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.585 1.183 . . . . 0.0 109.17 -171.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' HG3' HG13 ' A' ' 15' ' ' ILE . 74.0 mttt -82.19 -9.07 59.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.32 -1.763 . . . . 0.0 110.791 -173.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 0.07 19.45 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.008 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 3.8 tppt? -114.18 -58.5 2.14 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.382 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 60' ' ' ASN . 20.1 t80 -85.94 -33.46 21.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 66.82 94.23 0.07 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.531 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.809 HD12 HD21 ' A' ' 66' ' ' LEU . 2.0 mm? -99.76 -64.85 1.0 Allowed 'General case' 0 CA--C 1.46 -2.518 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.052 -173.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 m 58.32 82.49 0.13 Allowed 'General case' 0 N--CA 1.395 -3.225 0 CA-C-N 111.678 -2.51 . . . . 0.0 111.115 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.33 116.04 2.25 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.74 137.61 42.09 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.701 2.934 . . . . 0.0 112.276 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.558 HG23 ' HB ' ' A' ' 55' ' ' ILE . 20.8 tt -127.9 150.62 33.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.248 0.546 . . . . 0.0 111.104 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.36 175.76 5.75 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.317 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -74.76 132.0 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 109.891 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.48 -33.26 5.16 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.952 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.461 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.7 m80 -166.72 165.64 16.32 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.431 HD21 ' NE2' ' A' ' 51' ' ' GLN . 5.2 mp -107.63 116.01 31.18 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.24 159.34 15.32 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.944 0.878 . . . . 0.0 112.243 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.39 127.94 54.02 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.377 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.42 ' HB3' ' HD1' ' A' ' 46' ' ' PHE . . . -64.43 107.02 1.24 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 t -75.37 -19.12 59.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.438 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.0 p -153.15 159.58 42.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.621 0.724 . . . . 0.0 109.543 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.628 HG23 ' H ' ' A' ' 39' ' ' GLY . 11.4 p -115.72 152.54 17.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.631 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.78 8.75 39.34 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.967 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.628 ' H ' HG23 ' A' ' 37' ' ' VAL . . . 84.01 60.21 1.98 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.52 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.43 80.08 1.68 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.263 -174.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 66.72 82.9 0.17 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.328 1.051 . . . . 0.0 113.309 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 89.28 26.12 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 125.516 1.526 . . . . 0.0 113.114 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.82 174.81 6.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.403 0.621 . . . . 0.0 111.668 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 46.4 tp -96.42 147.91 23.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.531 1.533 . . . . 0.0 107.315 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -96.89 121.81 39.16 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 120.907 0.385 . . . . 0.0 110.313 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.451 ' CG ' HD11 ' A' ' 52' ' ' ILE . 26.9 p90 -155.66 160.04 40.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.616 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -108.91 152.42 24.95 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.48 117.14 5.79 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.907 0.754 . . . . 0.0 109.355 -176.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.78 30.03 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.567 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.94 -25.12 16.67 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.431 ' NE2' HD21 ' A' ' 30' ' ' LEU . 42.7 tt0 72.83 134.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 O-C-N 124.8 1.313 . . . . 0.0 113.041 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.488 HD13 ' CG1' ' A' ' 82' ' ' VAL . 5.3 mt -129.64 169.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.339 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -119.07 135.5 54.61 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 65' ' ' TRP . 8.1 tp -93.16 127.04 45.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.558 ' HB ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.92 -56.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -119.09 131.9 55.97 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.921 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.498 HG23 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -116.83 -32.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.063 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 p -107.36 161.11 15.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 t70 64.79 69.16 0.5 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 125.522 1.529 . . . . 0.0 112.814 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 9.2 p30 -145.09 163.3 33.41 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.538 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -95.72 10.91 1.48 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.218 1.946 . . . . 0.0 115.416 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.558 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 8.4 tp10 -122.98 -29.91 3.86 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.985 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.05 57.61 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.6 ptmt -92.5 163.12 13.94 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 109.266 -177.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.533 ' CD2' HG21 ' A' ' 79' ' ' THR . 43.2 m0 -101.89 169.53 8.72 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.893 0.377 . . . . 0.0 110.592 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.809 HD21 HD12 ' A' ' 21' ' ' LEU . 45.7 tp -109.58 110.51 21.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.74 142.83 17.5 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.935 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 73' ' ' SER . 50.2 ttt-85 -124.32 155.02 39.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 124.319 0.658 . . . . 0.0 110.188 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.528 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 5.2 m -113.52 162.05 16.64 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.96 -28.97 7.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -172.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -69.99 -28.52 65.59 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.034 0.534 . . . . 0.0 111.577 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.485 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 96.07 69.0 1.01 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.658 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.4 m -136.62 117.09 13.75 Favored 'General case' 0 N--CA 1.383 -3.806 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.44 ' HB3' HD12 ' A' ' 66' ' ' LEU . 90.2 m-85 -116.68 105.1 12.05 Favored 'General case' 1 C--N 1.223 -4.925 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -172.027 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.84 0.75 48.42 Favored Glycine 0 C--O 1.181 -3.19 0 C-N-CA 118.372 -1.87 . . . . 0.0 116.255 -175.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.579 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.268 0.1 OUTLIER 51.2 80.44 0.08 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 123.103 1.43 . . . . 0.0 111.417 -176.976 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.588 HD13 HG22 ' A' ' 82' ' ' VAL . 2.0 pt -68.57 142.17 16.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.66 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HZ2' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -80.51 115.51 20.07 Favored 'General case' 1 N--CA 1.362 -4.831 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 165.525 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.533 HG21 ' CD2' ' A' ' 65' ' ' TRP . 73.1 p -34.95 -38.3 0.08 Allowed 'General case' 1 C--N 1.244 -4.008 0 C-N-CA 128.918 2.887 . . . . 0.0 114.422 -177.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -68.98 -7.1 32.11 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.951 0.9 . . . . 0.0 111.709 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.26 -6.86 43.59 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 121.466 -0.771 . . . . 0.0 110.657 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.588 HG22 HD13 ' A' ' 77' ' ' ILE . 26.3 m -137.52 167.88 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-O 121.618 0.723 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.628 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.8 pt -77.81 163.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.545 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -95.92 118.73 33.11 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.32 156.07 21.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.311 0.577 . . . . 0.0 110.53 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -128.96 117.62 21.26 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.9 m -85.14 142.21 29.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.985 0.421 . . . . 0.0 110.127 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 92' ' ' LYS . 3.0 mm? -94.59 84.23 4.25 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.975 0.416 . . . . 0.0 110.857 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -82.42 -16.85 47.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.6 mt -94.46 7.86 44.09 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 37.7 ttpt -126.89 98.16 5.24 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.33 73.61 0.11 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.469 1.128 . . . . 0.0 110.709 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -81.86 77.14 8.73 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.98 72.01 1.45 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.196 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 . . . . . 0 C--N 1.303 -1.425 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.305 179.062 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 . . . . . 0 CA--C 1.508 -0.635 0 CA-C-O 121.228 0.537 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 50.3 tttm -90.56 90.31 7.94 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -85.23 2.39 44.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.333 1.063 . . . . 0.0 110.486 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.407 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 13.8 pt20 -97.45 161.95 13.54 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.398 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.582 ' HG2' ' H ' ' A' ' 7' ' ' GLU . 84.8 tttt -179.32 -174.59 0.32 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 103.375 -2.824 . . . . 0.0 103.375 176.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.582 ' H ' ' HG2' ' A' ' 6' ' ' LYS . 3.3 mp0 -75.07 86.31 2.35 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 119.147 0.885 . . . . 0.0 109.73 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -83.9 83.57 7.89 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 122.977 1.37 . . . . 0.0 110.605 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.3 117.01 33.61 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.352 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -68.53 -45.13 73.04 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.319 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -152.82 165.99 33.67 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.639 0.733 . . . . 0.0 111.63 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.432 ' HG2' ' CE1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -85.53 77.57 9.84 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.388 176.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.09 -41.96 11.37 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.25 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -57.91 -32.88 68.17 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.701 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.619 HG23 ' HB2' ' A' ' 74' ' ' TYR . 7.1 pt -62.89 -33.4 60.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.068 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' N ' HG13 ' A' ' 15' ' ' ILE . 9.4 mptt -80.02 -4.34 52.22 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.174 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -112.99 -13.79 13.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -98.51 -61.76 1.33 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.074 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -87.62 -26.56 23.0 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 mttp 66.07 83.8 0.16 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.804 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.446 HD13 HD21 ' A' ' 66' ' ' LEU . 1.2 mm? -100.19 -69.76 0.76 Allowed 'General case' 0 CA--C 1.466 -2.273 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m 62.44 76.94 0.35 Allowed 'General case' 0 N--CA 1.388 -3.53 0 CA-C-N 111.881 -2.418 . . . . 0.0 112.272 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.25 161.3 11.9 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.82 108.77 2.6 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.557 2.172 . . . . 0.0 110.486 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.484 HD11 ' HB ' ' A' ' 55' ' ' ILE . 2.5 pp -113.53 171.2 4.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.59 -171.47 2.52 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.803 HG23 ' HB3' ' A' ' 53' ' ' GLU . 12.1 p -94.05 145.3 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 HG13 HD12 ' A' ' 57' ' ' ILE . 45.5 mm -100.9 -38.9 6.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.446 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.5 m80 -160.64 168.57 24.65 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.19 118.38 36.86 Favored 'General case' 0 C--O 1.191 -1.998 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.0 155.75 16.96 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-O 122.14 0.971 . . . . 0.0 110.659 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -103.65 129.88 51.03 Favored 'General case' 1 C--N 1.243 -4.05 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -67.67 110.76 3.87 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.541 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 20.7 t -80.46 -18.29 49.15 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.629 0.728 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.6 m -144.33 155.09 43.65 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -93.97 105.01 17.04 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -114.74 163.46 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.445 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.501 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -107.8 10.17 28.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 100.26 61.08 0.82 Allowed Glycine 0 CA--C 1.491 -1.459 0 C-N-CA 118.262 -1.923 . . . . 0.0 109.459 -173.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.05 99.66 1.42 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -172.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.649 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 6.5 ttpm? 61.91 76.88 0.35 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.387 1.475 . . . . 0.0 110.741 -177.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 t30 57.7 70.49 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.002 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.647 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 39.8 tt0 -145.67 -175.07 4.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.876 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.552 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.52 153.73 17.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -102.27 128.06 48.98 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 120.962 0.411 . . . . 0.0 109.96 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -158.82 171.33 20.26 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.051 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 98.7 mttt -120.44 142.8 48.9 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.2 pt20 -54.99 124.48 16.9 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.53 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.61 10.34 55.6 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.717 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 6.9 tp10 -69.66 -37.87 76.87 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.883 0.849 . . . . 0.0 110.103 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 70.51 102.14 0.06 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 126.205 1.802 . . . . 0.0 108.851 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD13 ' CG1' ' A' ' 82' ' ' VAL . 13.1 mt -104.23 156.02 5.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.803 ' HB3' HG23 ' A' ' 27' ' ' VAL . 34.3 mt-10 -116.06 126.55 53.92 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -85.4 118.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.535 HG23 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -104.15 -38.35 4.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.67 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -132.73 130.51 40.1 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.811 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.606 HG23 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -125.81 -32.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.683 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -85.06 143.66 28.75 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.08 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 t70 66.99 53.41 0.82 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.818 1.295 . . . . 0.0 109.752 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -94.51 114.89 64.52 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.452 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.46 -53.67 0.28 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.917 1.745 . . . . 0.0 111.137 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.975 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 7.0 tp10 -66.56 -40.56 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.43 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.31 -18.11 18.48 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.975 ' HD2' ' HG2' ' A' ' 62' ' ' GLU . 14.0 ptmt -76.11 163.32 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.529 1.132 . . . . 0.0 109.299 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG23 ' A' ' 57' ' ' ILE . 27.6 m0 -95.31 164.84 12.66 Favored 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 122.862 0.465 . . . . 0.0 112.157 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -111.79 113.76 26.31 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -126.56 160.3 20.89 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' A' ' 73' ' ' SER . 54.5 ttp180 -131.47 152.72 50.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 24.7 m -112.76 164.59 13.19 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.04 -18.31 9.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.486 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 2.3 tmm_? -82.93 -24.98 32.81 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 83.9 1.66 Allowed Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.674 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.6 m -151.69 117.58 5.49 Favored 'General case' 0 N--CA 1.383 -3.824 0 N-CA-C 101.041 -3.689 . . . . 0.0 101.041 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.741 ' HB3' HD13 ' A' ' 66' ' ' LEU . 22.2 m-85 -109.97 83.23 1.72 Allowed 'General case' 1 C--N 1.219 -5.085 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -99.84 97.35 1.76 Allowed Glycine 2 N--CA 1.369 -5.808 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.596 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -40.82 100.75 0.02 OUTLIER 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 112.555 -1.822 . . . . 0.0 109.163 171.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -81.42 147.99 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.512 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.371 -177.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 9.6 ptpp? -76.35 118.45 19.06 Favored 'General case' 1 N--CA 1.358 -5.06 0 N-CA-C 102.915 -2.995 . . . . 0.0 102.915 163.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.497 HG21 ' CD2' ' A' ' 65' ' ' TRP . 69.6 p -36.46 -39.36 0.19 Allowed 'General case' 1 C--N 1.241 -4.151 0 C-N-CA 128.193 2.597 . . . . 0.0 113.026 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.1 -10.0 55.46 Favored 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 123.882 0.873 . . . . 0.0 112.25 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.77 -9.84 36.19 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.426 -0.796 . . . . 0.0 111.028 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.499 ' CG1' HD13 ' A' ' 52' ' ' ILE . 13.3 m -126.58 167.23 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.129 0.49 . . . . 0.0 111.482 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.98 113.02 9.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.9 pt -75.46 159.39 5.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.116 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.28 117.18 30.28 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -78.28 165.32 24.02 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.671 -175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.09 -41.95 97.12 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.298 0.571 . . . . 0.0 109.767 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 p -107.16 142.39 36.93 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.484 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.78 101.56 13.26 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.496 0.665 . . . . 0.0 110.625 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.16 -165.77 1.51 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 173.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.63 155.21 21.76 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 6.1 tmtm? -118.92 20.97 12.63 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 123.727 1.727 . . . . 0.0 106.695 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -155.28 149.97 26.4 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 80.08 -41.64 0.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.0 0.92 . . . . 0.0 111.708 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.409 ' HG ' ' HG3' ' A' ' 96' ' ' GLU . 66.8 tp -68.52 -69.53 0.32 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HG3' ' HG ' ' A' ' 95' ' ' LEU . 36.7 mt-10 . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 . . . . . 0 CA--C 1.499 -0.992 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -124.77 169.59 11.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.87 152.03 19.17 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.72 12.17 1.41 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 122.949 0.5 . . . . 0.0 111.77 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.567 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -72.86 88.52 1.34 Allowed 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.708 0.766 . . . . 0.0 109.064 178.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.602 ' HD2' ' HG3' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -108.03 -15.28 14.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.434 178.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.602 ' HG3' ' HD2' ' A' ' 6' ' ' LYS . 46.9 mt-10 -92.42 77.49 5.09 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.608 0.718 . . . . 0.0 109.783 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.452 ' HE3' ' O ' ' A' ' 5' ' ' GLN . 97.0 mttt -109.44 -60.78 1.72 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -109.07 -173.66 2.32 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -89.06 39.92 0.96 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.683 0.754 . . . . 0.0 109.82 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.0 pttt 47.79 30.16 1.79 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.146 1.778 . . . . 0.0 113.375 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.804 ' HG2' ' HD1' ' A' ' 74' ' ' TYR . 4.4 mp0 55.17 42.02 31.01 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.662 1.185 . . . . 0.0 111.705 176.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -80.03 -30.79 39.57 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.715 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 13.1 pt-20 -61.83 -38.16 87.12 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.396 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 12' ' ' GLU . 2.1 pp -64.52 -24.07 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 C-N-CA 124.785 1.234 . . . . 0.0 113.119 -169.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HA ' HD23 ' A' ' 21' ' ' LEU . 12.4 mptt -54.48 -58.82 5.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 124.125 0.891 . . . . 0.0 113.139 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -83.78 8.89 13.3 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 121.058 0.456 . . . . 0.0 111.783 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 30.5 mmmt -92.16 -61.34 1.64 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.663 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.4 t80 -86.58 -21.63 26.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 tttm 71.55 83.46 0.14 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.077 0.941 . . . . 0.0 110.134 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.6 -65.0 0.99 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.393 -177.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 5.1 t 36.93 75.42 0.06 Allowed 'General case' 0 C--O 1.251 1.17 0 C-N-CA 126.136 1.775 . . . . 0.0 114.047 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.03 170.3 19.16 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.099 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.21 132.68 28.42 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.464 2.776 . . . . 0.0 111.545 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.8 tp -148.65 145.28 18.31 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.423 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -129.09 174.81 9.22 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.04 131.8 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 109.744 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -96.57 -33.51 4.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.95 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.48 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.8 m80 -165.13 174.03 10.78 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.87 116.55 30.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.288 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 84' ' ' ILE . . . -97.09 156.02 16.56 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-O 121.703 0.763 . . . . 0.0 111.688 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -107.12 123.95 48.98 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.52 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.36 106.16 1.31 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.9 t -87.25 -8.41 56.83 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.344 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -144.6 130.71 19.49 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . 7.2 p-10 -77.13 99.49 5.41 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.45 1.119 . . . . 0.0 108.339 172.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.78 163.25 11.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.566 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.51 25.37 7.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.787 0.327 . . . . 0.0 111.063 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 99.96 60.13 0.84 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.827 -1.178 . . . . 0.0 111.113 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 91.67 0.66 Allowed Glycine 0 C--N 1.316 -0.545 0 O-C-N 123.808 0.357 . . . . 0.0 112.948 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt 61.92 72.11 0.52 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.996 1.319 . . . . 0.0 109.797 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 58.48 80.15 0.19 Allowed 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.227 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 10.3 tt0 -145.1 -175.92 4.89 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.311 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 45' ' ' SER . 2.3 tt -96.44 149.59 21.55 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.431 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.2 m -98.21 115.3 28.05 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.342 0.591 . . . . 0.0 110.052 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.52 ' HD1' ' HB1' ' A' ' 33' ' ' ALA . 22.3 p90 -144.52 161.63 38.61 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.295 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mmpt? -114.92 154.74 28.16 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -53.49 126.16 20.54 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.075 0.859 . . . . 0.0 110.873 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.39 20.77 74.27 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.753 -0.658 . . . . 0.0 114.451 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 30.4 mm-40 -74.83 -30.37 61.36 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.725 0.762 . . . . 0.0 112.844 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.61 116.99 0.06 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.906 1.379 . . . . 0.0 109.032 -176.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.525 HD12 ' CG1' ' A' ' 82' ' ' VAL . 12.8 mt -118.26 154.52 20.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.83 139.13 47.56 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.809 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.0 tp -94.77 126.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -47.55 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.959 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.663 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 22.9 ttt180 -130.47 133.58 46.41 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -125.0 -33.95 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.781 -178.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -100.01 150.12 22.77 Favored 'General case' 0 C--O 1.25 1.106 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.896 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.617 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.7 t70 62.32 69.27 0.62 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.566 1.166 . . . . 0.0 108.264 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 7.2 p30 -112.75 139.37 22.73 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.379 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 11.9 Cg_exo -73.61 -58.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.893 2.395 . . . . 0.0 114.345 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.93 -42.74 38.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.647 0.737 . . . . 0.0 111.07 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.532 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 121.13 17.86 3.97 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.673 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 16.2 ptmt -117.24 162.56 17.68 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.588 ' CD2' HG22 ' A' ' 79' ' ' THR . 35.8 m0 -97.21 171.37 8.49 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.103 0.561 . . . . 0.0 111.63 -173.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 21' ' ' LEU . 50.4 tp -112.11 105.88 14.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.44 161.02 12.83 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 73' ' ' SER . 53.8 ttp180 -138.81 153.64 48.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.204 0.525 . . . . 0.0 110.491 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.58 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 11.5 m -100.02 154.68 18.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.7 -33.25 60.7 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.91 0.777 . . . . 0.0 112.803 -173.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -2.77 41.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.19 96.76 0.79 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.431 0.462 . . . . 0.0 112.752 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 24.5 m -154.78 120.69 5.19 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.804 ' HD1' ' HG2' ' A' ' 12' ' ' GLU . 70.2 m-85 -117.43 94.32 4.5 Favored 'General case' 1 C--N 1.221 -5.019 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -177.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -109.52 11.92 33.07 Favored Glycine 1 CA--C 1.437 -4.836 0 C-N-CA 117.283 -2.389 . . . . 0.0 115.679 -173.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.673 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.275 0.1 OUTLIER 47.28 89.73 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.341 0 CA-C-O 122.764 1.269 . . . . 0.0 111.754 -178.413 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.666 HD12 HG23 ' A' ' 82' ' ' VAL . 2.3 pt -70.5 140.39 18.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.573 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 64' ' ' LYS . 7.5 ptpp? -80.1 118.55 21.91 Favored 'General case' 1 N--CA 1.372 -4.343 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.588 HG22 ' CD2' ' A' ' 65' ' ' TRP . 70.7 p -34.96 -33.05 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.939 0 C-N-CA 128.905 2.882 . . . . 0.0 114.435 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -77.02 -11.81 59.85 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 123.293 0.637 . . . . 0.0 112.229 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.24 -3.76 53.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.213 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.666 HG23 HD12 ' A' ' 77' ' ' ILE . 16.4 m -133.23 170.21 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 121.538 0.685 . . . . 0.0 110.93 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.45 107.56 7.18 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 31' ' ' ALA . 18.5 pt -80.81 165.62 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.508 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.428 ' OD2' ' HA ' ' A' ' 88' ' ' SER . 19.4 t70 -79.0 103.28 8.84 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.933 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -88.42 -55.59 3.66 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.93 93.95 9.46 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.518 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.428 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 55.3 m -68.28 131.29 45.1 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.318 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.0 mt 61.59 75.75 0.39 Allowed 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 124.919 1.387 . . . . 0.0 109.688 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.91 103.72 0.61 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.122 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.2 mt -77.68 -31.69 52.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.266 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 141.66 29.18 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -122.96 90.23 3.26 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.875 0.845 . . . . 0.0 110.722 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -160.49 104.7 1.43 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.7 tp 69.37 96.89 0.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.619 1.199 . . . . 0.0 109.302 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.847 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 . . . . . 0 C--O 1.234 0.24 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -81.4 168.45 18.34 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.004 0.522 . . . . 0.0 111.577 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HG2' ' HD2' ' A' ' 17' ' ' LYS . 12.5 mptt -80.88 142.39 33.64 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' HG2' ' HB2' ' A' ' 9' ' ' GLU . 8.6 tp10 -82.91 107.89 15.84 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -126.86 -21.95 3.94 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.307 -174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.576 ' HD3' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -85.64 -8.94 57.94 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 121.93 0.872 . . . . 0.0 109.899 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.745 ' HG3' ' H ' ' A' ' 9' ' ' GLU . 9.5 tp10 -146.36 167.45 23.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -97.64 -12.84 21.97 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.801 0.728 . . . . 0.0 109.903 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.745 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 37.5 tt0 72.56 -65.89 0.33 Allowed 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.215 1.406 . . . . 0.0 110.047 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 88.2 tttt -169.38 141.65 2.51 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HG3' ' HG2' ' A' ' 10' ' ' LYS . 86.5 mttt 67.32 -161.37 0.23 Allowed 'General case' 0 C--O 1.242 0.698 0 O-C-N 124.517 1.136 . . . . 0.0 108.716 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -94.01 155.24 17.23 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.653 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -71.43 -63.44 1.12 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.8 mt-10 -58.72 -27.8 65.23 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -172.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.579 ' HA ' ' HE1' ' A' ' 76' ' ' TYR . 1.9 pp -65.85 -29.66 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.386 0.612 . . . . 0.0 110.413 -173.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 55.4 mtpt -71.49 -34.86 70.52 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.062 -1.427 . . . . 0.0 112.011 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HD2' ' HG2' ' A' ' 3' ' ' LYS . 60.7 tttm -102.45 -12.82 17.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.959 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 7.4 tppt? -82.32 -54.26 5.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.594 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 9.9 t80 -86.36 -28.09 23.85 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 25.7 ttpt 71.33 89.99 0.1 Allowed 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.565 1.146 . . . . 0.0 110.328 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.66 -56.47 2.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.316 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 p 56.83 82.42 0.12 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 124.701 1.2 . . . . 0.0 112.439 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.68 139.18 5.47 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 -176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.97 112.52 1.18 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.75 2.3 . . . . 0.0 111.797 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.49 HD11 ' HB ' ' A' ' 55' ' ' ILE . 41.3 pt -94.35 -176.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.349 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.34 169.91 16.72 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.623 -175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.601 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.4 p -83.81 123.5 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.266 1.032 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.8 mm -85.71 -34.51 8.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -167.19 166.2 15.03 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp -105.01 116.21 31.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -90.18 154.06 20.04 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 122.087 0.946 . . . . 0.0 110.914 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -106.95 119.29 38.97 Favored 'General case' 0 C--N 1.254 -3.546 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -66.06 103.7 1.01 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -87.65 -10.98 49.79 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.3 m -136.12 130.55 33.49 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.765 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' HB2' ' H ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -76.7 102.89 6.39 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.69 0.757 . . . . 0.0 110.402 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.34 155.68 15.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.623 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 55.85 1.65 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.513 0.673 . . . . 0.0 111.413 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 86.35 60.5 1.73 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.694 177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.42 78.42 1.62 Allowed Glycine 0 C--N 1.309 -0.964 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttm 67.32 81.21 0.2 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.857 1.263 . . . . 0.0 110.362 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 56.15 74.51 0.39 Allowed 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.604 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.412 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 7.4 tt0 -144.3 -175.52 4.66 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.142 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.535 ' HB3' ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -98.42 157.86 15.94 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -102.86 115.93 31.56 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.535 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 25.2 p90 -148.06 153.97 39.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.172 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 68.0 mttm -105.75 151.3 24.62 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.298 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.464 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -55.6 113.66 1.54 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.145 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.71 21.14 22.33 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.106 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.4 tp10 -73.05 -44.27 60.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.224 0.61 . . . . 0.0 111.638 -176.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 74.71 107.3 0.07 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.96 1.412 . . . . 0.0 109.218 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.584 HD11 ' CG1' ' A' ' 82' ' ' VAL . 7.6 mt -116.61 164.07 13.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 107.721 -172.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.601 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 21.9 mt-10 -116.68 133.38 56.08 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.7 tp -92.21 124.58 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.601 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.22 -37.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.592 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 31.7 ttm180 -136.77 133.56 36.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.619 175.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.614 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -127.27 -19.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 124.789 1.235 . . . . 0.0 111.832 -176.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -99.94 143.93 29.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 59.32 67.37 0.91 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.877 1.36 . . . . 0.0 110.296 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.518 HD22 ' HD1' ' A' ' 65' ' ' TRP . 8.4 m120 -86.68 130.94 47.02 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.331 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.594 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -55.61 -66.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.734 2.289 . . . . 0.0 112.219 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.681 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 42.4 mt-10 -94.43 -3.76 49.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.26 0.553 . . . . 0.0 110.932 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.99 -17.12 35.57 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.681 ' HD2' ' HB2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.31 152.48 34.52 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.693 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.535 ' HB2' HG13 ' A' ' 77' ' ' ILE . 34.6 m0 -87.08 177.06 7.32 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 124.282 1.033 . . . . 0.0 110.344 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 21' ' ' LEU . 52.5 tp -113.89 113.78 25.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.48 154.01 16.74 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 73' ' ' SER . 59.4 ttp180 -137.25 152.02 49.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.237 0.542 . . . . 0.0 110.786 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.576 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 21.6 m -100.71 157.15 16.9 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 175.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.43 14.94 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -73.6 -12.18 60.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 84.14 87.01 0.86 Allowed Glycine 0 N--CA 1.433 -1.546 0 CA-C-O 121.718 0.621 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.638 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.2 m -151.12 121.43 7.3 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 100.229 -3.989 . . . . 0.0 100.229 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' HE2' HG13 ' A' ' 55' ' ' ILE . 52.8 m-85 -115.84 90.21 3.28 Favored 'General case' 1 C--N 1.232 -4.501 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -171.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.531 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -106.56 96.84 1.16 Allowed Glycine 3 N--CA 1.375 -5.385 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.579 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -43.23 94.88 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 O-C-N 125.597 1.41 . . . . 0.0 110.869 174.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.635 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.6 pt -70.64 143.24 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.222 0 C-N-CA 127.2 2.2 . . . . 0.0 114.824 -174.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -78.46 116.63 18.99 Favored 'General case' 1 N--CA 1.351 -5.38 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 166.976 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.502 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.5 p -36.13 -29.86 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.955 0 C-N-CA 128.411 2.684 . . . . 0.0 113.83 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 t -84.14 -0.74 53.17 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 123.206 0.603 . . . . 0.0 111.649 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.53 -12.49 21.18 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 120.78 -1.2 . . . . 0.0 110.286 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.617 HG21 HD12 ' A' ' 77' ' ' ILE . 35.3 m -135.16 166.82 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.471 0.653 . . . . 0.0 110.757 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -140.24 123.03 16.43 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 171.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 pt -70.64 161.26 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.225 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.96 115.86 28.17 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -74.35 162.61 28.71 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.81 99.93 0.37 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.356 0.598 . . . . 0.0 110.443 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 m -84.42 97.25 9.4 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.474 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.6 tp -91.13 -34.43 15.05 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -84.93 147.49 26.71 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -90.36 164.36 14.36 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.586 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 68.56 171.45 0.29 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.061 0.944 . . . . 0.0 110.384 -175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 93' ' ' LYS . 30.6 mmtp -120.06 63.81 0.83 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -111.21 -30.46 7.44 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.0 tp 71.87 -75.03 0.08 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.849 1.66 . . . . 0.0 112.006 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 N--CA 1.423 -1.778 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -175.771 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 CA--C 1.5 -0.974 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -78.52 117.27 19.55 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 168.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -64.67 141.18 58.86 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.392 0.432 . . . . 0.0 110.788 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 2.6 mp0 -50.26 108.29 0.21 Allowed 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.792 1.237 . . . . 0.0 110.812 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.694 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 27.3 pt20 -126.74 5.2 6.7 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.776 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -76.29 -52.41 10.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -96.04 -48.31 5.73 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 5' ' ' GLN . 62.2 tttp 61.48 109.59 0.02 OUTLIER 'General case' 0 C--O 1.245 0.847 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 74.17 -70.88 0.14 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.795 1.638 . . . . 0.0 112.589 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 50.49 86.11 0.03 OUTLIER 'General case' 0 C--O 1.247 0.955 0 O-C-N 124.416 1.072 . . . . 0.0 110.109 -176.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -113.79 -176.75 2.97 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.044 -173.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.16 22.41 2.8 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 56.2 tp60 -90.2 -41.94 11.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.052 -174.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 31.0 mm-40 -76.54 20.16 0.24 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.414 -174.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.578 HG22 ' HH ' ' A' ' 76' ' ' TYR . 2.4 pp -92.73 -28.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 20.8 ptmt -66.57 -41.96 87.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.008 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -94.18 -0.35 55.26 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.899 0.857 . . . . 0.0 109.77 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 76' ' ' TYR . 10.7 tppt? -85.53 -65.22 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 11.4 t80 -78.85 -25.94 44.06 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 32.2 mtmm 68.18 88.23 0.11 Allowed 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.497 1.119 . . . . 0.0 110.32 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.725 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -97.17 -25.65 15.23 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.318 -175.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 74.9 p 70.63 -32.26 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.525 1.93 . . . . 0.0 113.896 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.49 178.55 20.91 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.92 169.58 21.78 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.285 1.99 . . . . 0.0 110.325 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.9 tp -155.48 133.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 120.663 0.268 . . . . 0.0 111.016 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.417 ' O ' HG21 ' A' ' 55' ' ' ILE . 11.7 pt20 -80.59 172.32 13.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.3 p -81.77 133.01 30.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.172 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.55 -38.25 10.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.709 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 24.3 m80 -161.3 171.35 18.49 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.35 132.59 54.91 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.681 ' HB1' HG21 ' A' ' 84' ' ' ILE . . . -104.76 161.64 13.99 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.984 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -106.88 129.26 54.74 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.37 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 52' ' ' ILE . . . -74.05 102.41 4.18 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.421 ' SG ' ' HG3' ' A' ' 83' ' ' GLU . 69.2 m -86.29 -5.06 59.26 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.82 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -133.99 140.37 46.68 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.23 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -91.07 99.09 12.18 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.327 1.061 . . . . 0.0 108.994 173.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.85 150.05 16.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.5 33.94 5.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.733 0.778 . . . . 0.0 110.202 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 95.83 58.86 1.09 Allowed Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.823 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.13 117.27 4.76 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 65.46 37.12 6.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.353 1.061 . . . . 0.0 110.858 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 t30 63.71 89.21 0.09 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.313 1.054 . . . . 0.0 109.794 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.552 ' HG3' ' H ' ' A' ' 44' ' ' LEU . 2.1 tp10 -136.95 -172.98 3.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.045 -168.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.67 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.7 tt -95.08 148.15 22.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.415 ' H ' HD22 ' A' ' 44' ' ' LEU . 16.1 m -96.71 115.76 27.98 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.827 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 22.6 p90 -147.01 158.99 44.1 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.268 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 9.3 mtmp? -108.39 156.7 19.13 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.44 118.77 6.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.85 25.78 28.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 11.5 tp10 -74.56 -36.85 63.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 122.844 0.458 . . . . 0.0 110.66 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 72.41 109.17 0.07 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 125.448 1.499 . . . . 0.0 108.849 -172.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.565 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.7 mt -115.29 162.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.596 ' HB3' HG21 ' A' ' 27' ' ' VAL . 11.9 mt-10 -116.76 140.59 49.25 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.523 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.9 tp -101.77 125.01 55.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.417 HG21 ' O ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -111.02 -46.25 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.672 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.79 HH21 ' HB3' ' A' ' 59' ' ' ASP . 47.6 ttt180 -130.61 138.51 50.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.95 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 HD11 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.6 -37.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 123.805 0.842 . . . . 0.0 111.16 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 p -98.4 156.04 16.94 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.79 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.9 t70 67.3 71.59 0.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.439 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.713 HD22 ' HG2' ' A' ' 64' ' ' LYS . 32.0 t30 -154.16 117.44 2.61 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.218 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.31 -23.0 67.99 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.649 2.9 . . . . 0.0 114.073 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.89 -16.67 61.1 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.128 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.41 27.76 70.88 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.713 ' HG2' HD22 ' A' ' 60' ' ' ASN . 7.1 ptmt -118.79 161.4 20.2 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.534 ' HB2' HG13 ' A' ' 77' ' ' ILE . 42.5 m0 -99.86 176.46 5.43 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 -178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.725 HD22 HD11 ' A' ' 21' ' ' LEU . 62.8 tp -117.13 110.52 18.29 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.59 158.19 14.45 Favored Glycine 0 N--CA 1.419 -2.449 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.89 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.7 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.5 ttp180 -139.16 151.68 46.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -106.34 165.6 11.14 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.7 62.91 0.82 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.352 1.073 . . . . 0.0 111.664 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 71' ' ' ARG . 8.9 ptp180 -170.29 -27.4 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.911 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.29 88.52 1.96 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.7 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 26.3 m -152.72 117.91 5.2 Favored 'General case' 0 N--CA 1.381 -3.877 0 N-CA-C 100.805 -3.776 . . . . 0.0 100.805 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.544 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 64.5 m-85 -110.78 81.87 1.5 Allowed 'General case' 1 C--N 1.216 -5.221 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -173.125 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.67 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -101.57 99.09 1.87 Allowed Glycine 2 N--CA 1.347 -7.276 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -44.39 101.17 0.02 OUTLIER 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 112.185 -2.007 . . . . 0.0 108.215 169.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.592 HD11 HG22 ' A' ' 82' ' ' VAL . 2.0 pt -82.41 147.27 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.98 0 C-N-CA 126.822 2.049 . . . . 0.0 113.478 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HZ2' ' CD ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -80.93 118.83 22.76 Favored 'General case' 1 N--CA 1.354 -5.268 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 166.38 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.49 HG23 ' CG ' ' A' ' 65' ' ' TRP . 55.0 p -35.96 -39.81 0.18 Allowed 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 128.113 2.565 . . . . 0.0 112.984 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -72.09 -10.52 59.89 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.348 1.059 . . . . 0.0 112.891 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.04 -12.94 39.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.578 0.704 . . . . 0.0 110.159 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.592 HG22 HD11 ' A' ' 77' ' ' ILE . 30.7 m -130.97 173.48 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.785 0.802 . . . . 0.0 111.412 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 44.1 mt-10 -137.95 122.64 18.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.681 HG21 ' HB1' ' A' ' 31' ' ' ALA . 12.4 pt -86.48 158.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.935 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -88.88 131.03 35.29 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 90.4 m-85 -81.6 -34.59 30.85 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 2.9 t70 162.78 140.69 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 126.463 1.905 . . . . 0.0 106.872 166.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -131.06 1.65 4.27 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.02 -44.5 2.7 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.425 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -122.78 84.95 2.34 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.904 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.0 mt -88.65 74.95 8.33 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.125 0.964 . . . . 0.0 108.459 173.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -65.0 -36.89 85.85 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.995 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -126.34 121.58 32.96 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.31 -82.33 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 O-C-N 124.111 0.882 . . . . 0.0 112.216 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.0 mt -147.21 22.99 1.19 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.716 177.411 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 C--O 1.243 0.722 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -153.08 134.49 14.32 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.429 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' HZ1' ' HB2' ' A' ' 3' ' ' LYS . 10.1 mtmp? -123.12 114.21 20.02 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 173.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 37.3 mt-10 -68.56 -11.66 60.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.479 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -70.31 93.33 0.85 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 32.7 mtmm -84.57 129.42 34.85 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.622 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -87.02 106.61 17.96 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -124.57 115.97 21.69 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.56 0.695 . . . . 0.0 110.877 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' A' ' 11' ' ' LYS . 3.5 mp0 -87.79 -158.32 0.45 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.71 10.67 36.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG2' ' HG2' ' A' ' 14' ' ' GLU . 44.0 tttp 67.96 87.49 0.12 Allowed 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 127.828 2.451 . . . . 0.0 109.277 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -81.25 -9.76 59.72 Favored 'General case' 0 C--O 1.202 -1.415 0 CA-C-O 122.634 1.206 . . . . 0.0 108.809 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -70.42 -17.98 63.01 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.173 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 17.1 mm-40 -73.97 -15.42 61.11 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.441 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 pp -78.55 -27.04 14.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.4 0.619 . . . . 0.0 109.52 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -55.5 -55.43 31.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.213 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -87.6 4.43 43.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.539 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.9 tppt? -94.46 -53.06 4.05 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.846 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t80 -90.25 -24.81 20.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp 70.71 86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.105 1.362 . . . . 0.0 110.616 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.749 HD12 HD21 ' A' ' 66' ' ' LEU . 1.4 mm? -99.05 -53.21 3.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.37 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p 54.71 91.62 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.267 1.427 . . . . 0.0 113.66 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.31 137.69 9.09 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.616 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.93 132.89 25.69 Favored 'Trans proline' 0 C--O 1.25 1.098 0 C-N-CA 122.235 1.956 . . . . 0.0 111.323 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 28' ' ' ILE . 15.4 tt -125.8 152.44 32.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.221 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -86.89 171.73 10.6 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.63 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -71.78 130.14 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.885 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.472 HD13 HD12 ' A' ' 25' ' ' ILE . 50.6 mm -83.47 -40.32 15.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.754 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.533 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.0 m80 -160.72 167.79 26.15 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.04 120.48 41.89 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.659 ' HB3' HG23 ' A' ' 84' ' ' ILE . . . -98.24 151.35 20.55 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.495 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -107.61 135.38 49.15 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.83 112.78 3.42 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 49.5 t -86.07 -12.47 50.06 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.616 0.722 . . . . 0.0 109.925 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -149.34 155.93 41.27 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.831 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 4.5 p-10 -99.42 112.89 25.01 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.738 0.78 . . . . 0.0 109.088 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.48 163.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.085 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.61 21.43 7.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.895 0.379 . . . . 0.0 111.604 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.37 59.69 1.9 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.72 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.03 138.52 13.96 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm 66.91 33.65 5.79 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.92 0.867 . . . . 0.0 108.903 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 61.49 84.81 0.13 Allowed 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.235 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 19.4 tt0 -138.04 -175.22 4.02 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 73' ' ' SER . 0.7 OUTLIER -96.64 153.19 18.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.481 ' H ' HD23 ' A' ' 44' ' ' LEU . 8.6 p -105.89 124.87 50.27 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -157.9 166.92 31.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.398 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.831 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 66.9 mmtt -112.63 147.03 37.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 19.2 tt0 -52.24 124.27 12.75 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.295 0.638 . . . . 0.0 110.292 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 13.63 75.14 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.911 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 30.9 tt0 -70.89 -39.83 72.56 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 26.8 tt0 92.52 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.247 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.55 HD13 ' CG1' ' A' ' 82' ' ' VAL . 11.1 mt -120.27 160.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.375 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.63 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 17.4 mt-10 -116.22 142.59 46.63 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.533 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.3 tp -102.42 127.65 55.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.77 -49.2 6.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.846 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 10.8 ttm180 -126.48 140.49 52.42 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.112 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.566 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -128.85 -37.27 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 123.833 0.853 . . . . 0.0 111.016 -177.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 p -117.21 168.85 9.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.0 t70 60.43 65.5 1.06 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.466 1.127 . . . . 0.0 110.137 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -140.84 172.45 6.15 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.632 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -94.45 13.04 1.52 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.011 1.807 . . . . 0.0 114.272 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.71 ' HG3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 tm-20 -135.12 -72.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.56 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -25.76 2.14 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.71 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 13.7 ptmt -61.87 162.76 8.45 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.862 1.265 . . . . 0.0 110.779 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.554 ' CD1' HG22 ' A' ' 57' ' ' ILE . 49.0 m0 -102.31 166.6 10.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.98 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.749 HD21 HD12 ' A' ' 21' ' ' LEU . 51.6 tp -112.7 108.11 17.02 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -113.28 160.73 12.97 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.735 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.683 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.3 ttp180 -135.29 141.2 45.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.646 0.736 . . . . 0.0 111.801 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 p -101.37 167.25 10.29 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.421 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.28 37.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.162 0.985 . . . . 0.0 113.292 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.74 -19.29 55.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.029 0.443 . . . . 0.0 110.188 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.94 86.25 0.87 Allowed Glycine 0 CA--C 1.489 -1.561 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.683 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.6 m -151.22 125.16 9.18 Favored 'General case' 0 N--CA 1.381 -3.884 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.554 ' HB3' HD12 ' A' ' 66' ' ' LEU . 50.0 m-85 -108.5 73.84 0.89 Allowed 'General case' 1 C--N 1.213 -5.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -176.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -92.44 97.64 2.3 Favored Glycine 2 N--CA 1.375 -5.429 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -178.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' HB3' ' HD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -44.04 96.38 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 125.408 1.299 . . . . 0.0 110.253 172.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.639 HD12 HG22 ' A' ' 82' ' ' VAL . 1.6 pt -77.38 144.82 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.436 -3.414 0 C-N-CA 126.625 1.97 . . . . 0.0 113.232 -175.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -79.95 118.4 21.66 Favored 'General case' 1 N--CA 1.359 -5.008 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 165.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 64' ' ' LYS . 69.3 p -35.8 -39.09 0.14 Allowed 'General case' 1 C--N 1.241 -4.12 0 C-N-CA 128.369 2.668 . . . . 0.0 112.815 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -69.85 -1.4 9.33 Favored 'General case' 0 CA--C 1.564 1.5 0 C-N-CA 124.085 0.954 . . . . 0.0 112.213 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.23 -8.47 21.26 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.737 -0.602 . . . . 0.0 111.213 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.639 HG22 HD12 ' A' ' 77' ' ' ILE . 22.3 m -137.05 165.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 CA-C-O 121.312 0.577 . . . . 0.0 112.221 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.557 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 50.4 mt-10 -129.47 119.59 24.01 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 31' ' ' ALA . 8.6 pt -89.55 162.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.173 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.72 138.98 30.99 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.588 ' HB2' ' HB2' ' A' ' 89' ' ' LEU . 88.6 m-85 -105.53 170.26 7.99 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.42 -35.05 6.16 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.817 0.847 . . . . 0.0 109.793 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.4 m -102.88 36.36 2.23 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.002 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 86' ' ' TYR . 19.6 tp -87.37 18.95 3.48 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.367 0.603 . . . . 0.0 110.22 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -61.77 -29.73 70.33 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.309 1.044 . . . . 0.0 109.942 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.3 121.55 29.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -80.11 112.13 17.13 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.106 0.479 . . . . 0.0 111.43 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.39 155.58 13.27 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -123.51 -71.21 0.73 Allowed 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.58 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 tp -159.5 119.36 3.0 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.421 -1.875 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.498 -1.049 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -76.19 130.19 37.87 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 123.429 0.456 . . . . 0.0 110.026 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -109.34 84.13 1.87 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 170.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -119.25 148.25 43.34 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.542 0.687 . . . . 0.0 112.411 -171.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -103.31 126.66 50.58 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -71.38 -38.08 71.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.565 ' HB3' ' HG2' ' A' ' 9' ' ' GLU . 49.3 mt-10 -78.13 158.09 29.22 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.737 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -107.54 12.18 27.99 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.565 ' HG2' ' HB3' ' A' ' 7' ' ' GLU . 16.7 mm-40 -66.41 128.24 35.4 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 113.877 -1.511 . . . . 0.0 108.694 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -103.41 91.64 4.14 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -112.33 166.63 11.12 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.433 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.733 ' HB2' ' HA ' ' A' ' 73' ' ' SER . 7.2 tp10 -80.06 111.6 16.57 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -51.62 5.3 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.647 -171.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.38 23.71 0.11 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -169.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.698 HG23 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -85.79 -26.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 122.33 -0.231 . . . . 0.0 111.326 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -54.86 -45.13 74.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 124.234 0.959 . . . . 0.0 112.818 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.28 -9.35 27.77 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.243 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -78.28 -63.84 1.3 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.648 -173.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.647 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.2 t80 -81.09 -24.46 37.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 38.1 ttpt 66.86 87.79 0.12 Allowed 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.384 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.534 HD11 ' HD2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -98.3 -65.54 0.96 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p 50.25 80.81 0.07 Allowed 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 125.025 1.33 . . . . 0.0 113.745 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.81 -165.57 33.64 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.97 101.11 0.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.266 2.644 . . . . 0.0 111.363 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 tt -113.34 156.21 14.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -150.94 178.01 9.58 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.87 134.05 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.746 0.784 . . . . 0.0 109.271 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.41 ' HB ' HG22 ' A' ' 54' ' ' ILE . 36.2 mm -97.24 -35.2 5.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.435 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 28.3 m80 -168.38 169.98 10.22 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.53 119.49 39.33 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.06 158.17 15.92 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.025 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -106.99 127.82 53.8 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.644 ' HA ' HG13 ' A' ' 82' ' ' VAL . . . -67.65 106.76 2.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.0 m -83.58 -5.08 59.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.8 t -158.75 143.15 15.72 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.611 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -80.21 107.94 13.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.721 175.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.67 163.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.919 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.81 23.32 12.03 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.933 -0.48 . . . . 0.0 110.814 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.31 60.16 1.58 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.035 -1.555 . . . . 0.0 111.291 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.82 120.07 5.11 Favored Glycine 0 C--N 1.306 -1.113 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.086 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HE3' ' N ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER 63.65 45.71 4.47 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.287 0.635 . . . . 0.0 110.48 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.3 t30 63.49 85.95 0.13 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.041 0.936 . . . . 0.0 109.616 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.6 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 5.4 tt0 -145.67 -173.92 4.26 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.082 -174.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.658 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -95.72 155.67 16.65 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.454 ' H ' HD21 ' A' ' 44' ' ' LEU . 7.2 m -101.56 116.03 31.84 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.486 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 26.6 p90 -149.73 159.34 44.42 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.611 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 49.3 mttm -112.93 156.45 22.97 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -59.09 127.34 31.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.891 0.377 . . . . 0.0 110.078 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.89 21.14 61.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.088 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.5 mm-40 -88.57 -23.99 22.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 70.78 129.91 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.57 1.169 . . . . 0.0 111.363 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.783 HD13 HG11 ' A' ' 82' ' ' VAL . 7.8 mt -127.51 162.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -112.28 136.08 52.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 66' ' ' LEU . 9.7 tp -94.35 123.33 46.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.491 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.69 -36.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.647 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -135.5 130.13 34.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.713 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.611 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -130.85 2.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 124.578 1.151 . . . . 0.0 109.725 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -117.47 154.15 31.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.655 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 64.58 18.89 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.98 1.312 . . . . 0.0 111.337 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 21.4 p-10 -77.55 111.46 17.56 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.284 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 22.1 Cg_exo -66.56 -58.41 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.783 2.989 . . . . 0.0 113.134 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.5 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 23.8 tt0 -66.54 -30.58 70.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.984 0.421 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.62 12.24 25.08 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.325 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 12.9 ptmt -101.9 162.13 13.14 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.597 ' CD1' HG23 ' A' ' 57' ' ' ILE . 42.6 m0 -95.82 176.13 6.25 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 123.255 0.622 . . . . 0.0 110.577 -175.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.696 HD12 ' HB3' ' A' ' 74' ' ' TYR . 61.2 tp -119.21 113.7 21.28 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.92 157.32 15.12 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.652 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.7 ttt-85 -135.56 153.3 51.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.558 0.694 . . . . 0.0 111.61 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 35.2 m -105.61 154.37 20.51 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.23 -33.96 13.85 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -53.97 -43.02 69.57 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.207 1.004 . . . . 0.0 110.663 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.29 83.26 1.7 Allowed Glycine 0 N--CA 1.413 -2.834 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.196 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.733 ' HA ' ' HB2' ' A' ' 12' ' ' GLU . 49.6 m -151.53 123.3 8.01 Favored 'General case' 1 N--CA 1.376 -4.138 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB2' HG23 ' A' ' 15' ' ' ILE . 57.9 m-85 -113.87 92.67 4.06 Favored 'General case' 1 C--N 1.216 -5.221 0 O-C-N 125.108 1.505 . . . . 0.0 107.07 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.658 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -102.02 103.14 2.44 Favored Glycine 3 N--CA 1.359 -6.499 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.84 98.09 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 112.946 -1.627 . . . . 0.0 108.213 170.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.6 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.1 pt -85.15 143.46 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.814 0 C-N-CA 126.283 1.833 . . . . 0.0 114.127 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 18.4 pttm -77.62 118.34 19.92 Favored 'General case' 1 N--CA 1.372 -4.345 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 164.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.486 HG23 ' CG ' ' A' ' 65' ' ' TRP . 48.4 p -35.26 -38.49 0.1 Allowed 'General case' 1 C--N 1.236 -4.333 0 C-N-CA 129.253 3.021 . . . . 0.0 113.588 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.1 -15.49 63.75 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 0.0 112.698 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.99 48.81 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.954 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.783 HG11 HD13 ' A' ' 52' ' ' ILE . 30.3 m -137.11 172.07 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 CA-C-O 121.779 0.8 . . . . 0.0 111.411 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.79 122.81 17.89 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 pt -77.55 171.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.001 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -79.11 103.78 9.28 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.78 91.72 7.59 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.788 0.804 . . . . 0.0 109.866 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.02 92.39 7.36 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.055 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 t -177.6 138.86 0.23 Allowed 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.1 mt -114.94 6.33 15.32 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.673 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -145.42 136.21 24.48 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.12 132.94 51.95 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -70.82 99.93 1.82 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.643 0.735 . . . . 0.0 112.53 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -121.11 14.62 11.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.44 -10.09 59.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.152 -1.386 . . . . 0.0 109.484 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 pp -96.97 154.04 17.54 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.884 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.411 177.451 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.24 0.561 0 CA-C-O 120.893 0.378 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -135.41 143.05 45.78 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -68.12 -66.57 0.55 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -86.52 71.49 10.41 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -69.88 -41.65 74.49 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.62 96.86 5.05 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 171.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.9 159.09 33.3 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.916 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -77.74 131.68 37.78 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.601 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 90.1 7.95 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -90.34 157.97 17.37 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.035 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -116.65 88.51 2.91 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.933 0.873 . . . . 0.0 109.714 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.68 34.46 3.67 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.302 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -84.91 -52.77 5.77 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.602 0.715 . . . . 0.0 110.627 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.55 -14.88 63.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.39 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.462 HG13 ' HD2' ' A' ' 16' ' ' LYS . 1.4 pp -66.04 -31.08 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.4 mptt -69.28 -23.37 63.82 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.667 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.15 -29.91 11.86 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.243 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 6.9 tppt? -73.12 -61.15 1.92 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.845 0.355 . . . . 0.0 111.13 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -79.1 -34.17 43.76 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.622 ' HZ1' ' HB3' ' A' ' 20' ' ' LYS . 0.0 OUTLIER 68.7 99.23 0.06 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.947 -178.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 1.008 HD11 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.79 -57.34 2.2 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.633 0.73 . . . . 0.0 110.15 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 29.2 p 56.13 78.42 0.2 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 125.399 1.48 . . . . 0.0 113.098 -176.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.91 146.0 5.07 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.845 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.34 141.9 26.24 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.557 2.171 . . . . 0.0 111.222 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 tt -151.4 155.55 6.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.419 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.7 pt20 -121.38 174.21 6.88 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -176.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.572 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -59.37 126.34 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 122.056 0.932 . . . . 0.0 111.174 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.2 -31.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.467 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 27.1 m80 -163.22 157.33 20.25 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.51 118.1 34.44 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.641 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -96.1 156.12 16.47 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-O 122.014 0.911 . . . . 0.0 111.202 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 35.1 ttpt -106.68 128.27 54.05 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.745 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.96 105.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.72 -18.33 61.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.674 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -160.53 156.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.41 119.25 20.02 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.02 163.72 10.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.601 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -102.06 -4.94 25.15 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.98 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 77.64 60.58 2.76 Favored Glycine 0 C--O 1.241 0.568 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.092 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.67 131.33 10.6 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 115.084 -0.558 . . . . 0.0 113.035 -172.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.8 69.97 0.68 Allowed 'General case' 0 C--O 1.249 1.041 0 C-N-CA 125.301 1.44 . . . . 0.0 109.743 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.05 68.62 0.83 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.223 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.555 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 31.9 tt0 -136.42 172.98 12.21 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.537 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 1.7 tt -97.9 141.29 31.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 p -98.78 118.24 35.07 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.864 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.443 ' HE2' HG21 ' A' ' 77' ' ' ILE . 22.5 p90 -142.35 170.11 16.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.708 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 98.3 mttt -119.55 161.44 20.6 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -63.62 129.29 39.56 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.43 46.53 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.345 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.426 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 31.6 mm-40 -89.42 -26.14 21.16 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 70.3 120.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.933 1.396 . . . . 0.0 111.307 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.598 HD13 ' CG1' ' A' ' 82' ' ' VAL . 8.9 mt -119.31 158.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.86 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.572 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 14.7 mt-10 -116.67 132.68 56.62 Favored 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.607 HG12 HG22 ' A' ' 57' ' ' ILE . 8.6 tp -93.08 125.7 45.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -110.13 -47.88 6.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.442 176.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 1.008 ' HG3' HD11 ' A' ' 21' ' ' LEU . 18.2 mmt180 -120.06 107.8 13.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.844 ' H ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -104.53 -30.16 2.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 113.252 -1.795 . . . . 0.0 107.192 172.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.497 HG21 HG12 ' A' ' 57' ' ' ILE . 15.6 p -86.68 142.05 28.49 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.565 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 71.55 31.09 2.32 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.451 1.12 . . . . 0.0 110.957 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 8.8 p30 -72.87 126.24 90.69 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.941 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 2.1 Cg_endo -80.58 -61.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.618 2.212 . . . . 0.0 113.256 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.4 tt0 -79.21 -2.96 43.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.302 0.572 . . . . 0.0 111.268 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 87.51 21.17 49.13 Favored Glycine 0 CA--C 1.497 -1.087 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.513 -176.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.678 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.3 ptmt -118.21 156.88 28.01 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.513 ' CD1' ' HA ' ' A' ' 57' ' ' ILE . 25.6 m0 -98.12 171.9 7.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.145 0.278 . . . . 0.0 110.94 -174.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.678 HD21 HD12 ' A' ' 21' ' ' LEU . 65.4 tp -111.1 107.33 16.66 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.46 158.57 14.23 Favored Glycine 0 N--CA 1.416 -2.664 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 73' ' ' SER . 45.8 ttp180 -135.17 144.73 47.19 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.694 0.797 . . . . 0.0 109.888 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -101.4 165.14 11.42 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.89 -29.78 65.34 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -74.83 -9.62 58.72 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.03 89.82 0.49 Allowed Glycine 0 N--CA 1.434 -1.454 0 CA-C-O 121.908 0.727 . . . . 0.0 111.754 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.1 m -153.16 117.46 4.9 Favored 'General case' 0 N--CA 1.389 -3.514 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 64.8 m-85 -110.76 96.67 6.31 Favored 'General case' 1 C--N 1.221 -4.999 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.471 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -110.98 11.85 29.36 Favored Glycine 1 CA--C 1.445 -4.313 0 C-N-CA 117.77 -2.157 . . . . 0.0 115.516 -174.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.678 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 48.13 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.853 1.311 . . . . 0.0 111.651 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.584 HD11 HG22 ' A' ' 82' ' ' VAL . 2.1 pt -67.8 145.92 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.1 0 C-N-CA 126.029 1.731 . . . . 0.0 113.584 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 8.7 ptpp? -81.36 112.99 19.15 Favored 'General case' 1 N--CA 1.379 -4.01 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 165.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.471 HG22 ' CG ' ' A' ' 65' ' ' TRP . 43.2 p -36.3 -36.75 0.1 Allowed 'General case' 0 C--N 1.251 -3.685 0 C-N-CA 128.006 2.522 . . . . 0.0 113.757 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.82 -9.88 56.36 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.802 0.841 . . . . 0.0 112.318 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.51 -6.38 49.84 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.652 -0.655 . . . . 0.0 109.979 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.598 ' CG1' HD13 ' A' ' 52' ' ' ILE . 31.3 m -131.17 162.77 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.94 111.36 11.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 14.3 pt -76.71 171.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.047 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.98 103.75 1.92 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -86.02 -48.47 8.63 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -175.85 109.65 0.1 Allowed 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.657 178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.9 m -111.84 175.32 5.48 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.184 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp 59.85 71.67 0.56 Allowed 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.371 1.044 . . . . 0.0 111.038 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 14.7 ptmt -147.29 165.55 29.77 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.293 -174.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.8 mt -101.3 -37.87 8.31 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.954 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.722 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 9.9 mmpt? -101.64 134.03 45.42 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.158 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp 67.17 30.31 7.32 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.724 1.21 . . . . 0.0 113.473 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.76 98.02 11.53 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.072 0.463 . . . . 0.0 109.825 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 61.0 tp 61.31 78.02 0.3 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.735 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.307 -1.28 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.802 178.01 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.24 0.603 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -158.93 130.2 6.28 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.3 tttm 74.2 -46.15 0.61 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.378 1.471 . . . . 0.0 112.111 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.94 129.39 36.29 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 77.99 138.2 0.07 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.454 1.101 . . . . 0.0 112.127 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -118.93 177.08 4.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -118.81 87.44 2.73 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.036 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -176.04 -68.6 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.15 177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -77.23 81.19 3.74 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.608 0.718 . . . . 0.0 110.979 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -84.2 -56.75 3.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -170.02 82.43 0.11 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' NZ ' ' A' ' 16' ' ' LYS . 7.0 pt-20 -147.02 33.51 0.91 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.775 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.568 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 8.5 tp-100 -78.75 -20.22 50.45 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.962 -177.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.7 mp0 -61.89 -26.65 68.28 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.451 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.776 HG21 ' HH ' ' A' ' 76' ' ' TYR . 1.4 pp -90.22 -20.56 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.568 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 37.9 mmtm -66.96 -54.8 18.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.808 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -79.99 1.92 25.67 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.847 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 9.3 tppt? -98.79 -53.41 3.3 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.873 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.558 ' HE2' ' HG2' ' A' ' 56' ' ' ARG . 38.2 t80 -91.2 -27.98 18.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.939 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 42.2 tttt 77.59 90.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.686 1.195 . . . . 0.0 109.934 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.808 HD13 HD21 ' A' ' 66' ' ' LEU . 1.3 mm? -100.96 -41.66 6.72 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.607 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p 64.32 16.21 9.98 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.656 1.982 . . . . 0.0 112.543 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.98 173.24 37.94 Favored Glycine 0 N--CA 1.417 -2.611 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.49 92.69 0.84 Allowed 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.736 2.29 . . . . 0.0 111.412 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 21' ' ' LEU . 46.3 mm -78.66 130.31 36.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.402 ' C ' HG23 ' A' ' 55' ' ' ILE . 13.6 pt20 -104.69 175.87 5.35 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.526 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.17 134.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.322 1.058 . . . . 0.0 112.294 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.2 mm -102.19 -36.64 4.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.133 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.4 m80 -168.12 -178.19 3.59 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.75 139.6 45.89 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -112.46 158.32 20.01 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -107.01 130.42 54.65 Favored 'General case' 0 C--N 1.263 -3.154 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.585 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.88 112.61 3.35 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 39.9 t -82.35 -19.09 39.97 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 124.185 0.928 . . . . 0.0 109.635 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.13 156.73 46.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.862 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -96.39 107.85 20.29 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 173.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG13 ' CE1' ' A' ' 46' ' ' PHE . 10.4 p -113.19 145.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.66 12.42 21.2 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.775 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 78.84 46.85 8.16 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.714 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -96.9 151.52 19.86 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp 68.27 31.87 4.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.299 1.047 . . . . 0.0 108.833 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.456 ' ND2' ' HE2' ' A' ' 76' ' ' TYR . 0.2 OUTLIER 68.31 46.3 1.1 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.678 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -103.55 -175.16 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.615 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 tt -95.74 147.47 23.59 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.475 ' H ' HD21 ' A' ' 44' ' ' LEU . 5.7 m -96.05 115.48 27.5 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.777 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CE1' HG13 ' A' ' 37' ' ' VAL . 17.9 p90 -150.37 177.62 9.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.196 0.522 . . . . 0.0 111.006 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.862 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.5 mmtt -124.83 149.61 47.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.73 122.43 11.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 124.145 0.903 . . . . 0.0 108.737 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.42 23.88 52.69 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.759 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.5 mm-40 -78.64 -26.67 45.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 74.63 104.43 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.414 1.578 . . . . 0.0 110.33 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.425 ' HB ' ' HB1' ' A' ' 31' ' ' ALA . 7.9 mm -101.96 158.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.196 0 CA-C-N 111.697 -2.501 . . . . 0.0 105.659 -174.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -112.49 134.21 54.15 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.502 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 7.0 tp -99.75 121.04 49.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.402 HG23 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -106.1 -54.13 6.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.213 -178.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.558 ' HG2' ' HE2' ' A' ' 19' ' ' PHE . 53.9 ttt180 -121.43 138.39 54.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.729 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.37 -43.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.578 -176.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 p -117.8 158.66 24.38 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.112 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.51 68.73 0.16 Allowed 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.928 1.691 . . . . 0.0 111.302 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -148.42 144.43 18.59 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.93 12.52 2.22 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 122.848 2.365 . . . . 0.0 114.469 -175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.655 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -109.23 -64.7 1.22 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.6 -6.03 7.52 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.655 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -90.04 165.05 14.26 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.636 0.775 . . . . 0.0 110.535 177.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.55 ' CG ' HG23 ' A' ' 79' ' ' THR . 40.2 m0 -97.84 169.89 9.35 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.768 0.827 . . . . 0.0 110.741 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.808 HD21 HD13 ' A' ' 21' ' ' LEU . 54.6 tp -113.99 110.25 19.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.02 155.87 15.99 Favored Glycine 0 N--CA 1.419 -2.497 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.299 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.1 ttp180 -137.96 156.66 47.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.567 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 6.8 m -111.63 156.07 22.39 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.6 33.13 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.476 1.035 . . . . 0.0 113.05 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -69.8 -3.09 14.05 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.91 86.81 0.16 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 121.728 0.627 . . . . 0.0 112.134 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.69 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.0 m -151.78 117.67 5.48 Favored 'General case' 0 N--CA 1.391 -3.388 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.503 ' HB2' HG22 ' A' ' 15' ' ' ILE . 65.3 m-85 -113.37 90.06 3.25 Favored 'General case' 1 C--N 1.228 -4.701 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.186 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.615 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -104.72 102.19 2.04 Favored Glycine 3 N--CA 1.36 -6.416 0 N-CA-C 106.906 -2.478 . . . . 0.0 106.906 176.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.776 ' HH ' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -50.22 98.94 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.867 0 CA-C-N 113.195 -1.503 . . . . 0.0 107.247 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.707 HD12 HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -82.25 140.25 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.431 -3.611 0 C-N-CA 125.542 1.537 . . . . 0.0 114.713 -172.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -74.88 114.3 13.18 Favored 'General case' 1 N--CA 1.365 -4.705 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 167.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.55 HG23 ' CG ' ' A' ' 65' ' ' TRP . 72.9 p -36.28 -34.82 0.07 Allowed 'General case' 1 C--N 1.234 -4.428 0 C-N-CA 128.523 2.729 . . . . 0.0 114.299 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -66.0 -24.32 66.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.2 59.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.097 -0.377 . . . . 0.0 111.57 -174.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.707 HG23 HD12 ' A' ' 77' ' ' ILE . 30.0 m -136.39 165.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.512 0.672 . . . . 0.0 111.321 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.561 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.83 118.86 15.35 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.458 -2.052 . . . . 0.0 105.458 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.3 pp -72.46 146.97 10.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.647 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.77 133.36 34.74 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -87.17 135.37 33.33 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -61.38 139.77 58.14 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 t -72.81 77.51 1.14 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -166.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -179.58 166.16 1.38 Allowed 'General case' 0 C--O 1.247 0.947 0 C-N-CA 126.812 2.045 . . . . 0.0 105.672 171.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -126.57 -63.75 1.06 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.677 ' HB3' ' HG2' ' A' ' 93' ' ' LYS . 94.8 mt -90.25 147.05 23.78 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.588 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -97.92 12.68 33.3 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 122.692 1.234 . . . . 0.0 108.12 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.677 ' HG2' ' HB3' ' A' ' 91' ' ' LEU . 72.4 mmtt -70.42 -47.35 61.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.557 177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -166.34 156.28 11.97 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.637 HD21 ' H ' ' A' ' 95' ' ' LEU . 1.6 pt? -85.88 75.34 10.02 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 . . . . . 0 C--N 1.31 -1.121 0 C-N-CA 124.469 1.108 . . . . 0.0 109.145 174.958 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--O 1.246 0.896 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -135.13 157.66 46.34 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -69.96 150.91 46.2 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.431 ' HB3' ' HG3' ' A' ' 6' ' ' LYS . 48.5 mt-10 -89.03 -51.84 5.39 Favored 'General case' 0 C--N 1.285 -2.212 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.57 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.308 0.6 OUTLIER 33.59 70.15 0.12 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.471 1.108 . . . . 0.0 111.022 -172.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' HG3' ' HB3' ' A' ' 4' ' ' GLU . 55.9 mtpt -87.26 109.21 19.34 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.556 -169.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.23 92.6 3.98 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.703 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -125.4 -1.29 7.55 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.037 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.764 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 9.8 tp10 -138.69 154.88 48.62 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -121.72 24.36 9.77 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.764 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 61.0 mttp 72.55 129.59 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.3 -175.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -104.1 18.57 21.79 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.399 -176.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -62.31 -30.21 70.99 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.55 0.69 . . . . 0.0 110.127 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.3 mm-40 -51.52 -34.71 37.36 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.758 173.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.636 ' HA ' ' HH ' ' A' ' 76' ' ' TYR . 1.4 pp -71.85 -34.05 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 CA-C-O 120.889 0.376 . . . . 0.0 110.115 -173.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HA ' HD22 ' A' ' 21' ' ' LEU . 4.7 mptt -74.91 -30.97 61.43 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -90.5 -19.53 23.72 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.011 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.2 tppt? -77.26 -58.77 3.09 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.074 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.571 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.3 t80 -81.18 -22.79 38.65 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 0.3 OUTLIER 70.25 90.92 0.09 Allowed 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 125.548 1.539 . . . . 0.0 109.911 -179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.693 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -99.51 -67.48 0.85 Allowed 'General case' 0 CA--C 1.453 -2.765 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.939 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 m 61.46 57.47 2.33 Favored 'General case' 0 N--CA 1.404 -2.763 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.658 171.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.37 176.58 26.83 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.432 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.47 108.43 2.68 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.824 2.35 . . . . 0.0 111.764 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.71 HD12 ' HB ' ' A' ' 55' ' ' ILE . 45.0 pt -102.42 -176.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.92 170.6 18.43 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.6 t -79.35 127.32 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -90.35 -37.21 9.22 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.637 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.869 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 37.6 m80 -168.88 170.64 8.98 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -172.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.32 127.32 55.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 172.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -100.46 159.63 14.99 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-O 121.739 0.781 . . . . 0.0 110.928 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.88 131.39 54.02 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.65 106.94 1.28 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.8 t -91.37 -5.8 53.92 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.194 0.997 . . . . 0.0 108.335 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.8 m -147.2 147.41 30.45 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.775 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -93.14 103.53 15.8 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.48 HG22 ' OE2' ' A' ' 43' ' ' GLU . 8.6 p -114.66 156.71 15.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.103 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.52 34.04 5.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.989 0.423 . . . . 0.0 110.51 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 99.9 60.65 0.84 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.131 -1.509 . . . . 0.0 113.251 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.79 95.66 1.14 Allowed Glycine 0 C--N 1.313 -0.721 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 57.24 78.44 0.23 Allowed 'General case' 0 C--O 1.252 1.215 0 C-N-CA 124.707 1.203 . . . . 0.0 111.041 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.49 71.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.407 1.067 . . . . 0.0 109.768 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.511 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 15.9 tt0 -132.72 -173.78 3.28 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.464 -172.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.629 ' HG ' ' N ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.15 151.07 20.17 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.9 m -97.95 124.68 42.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.411 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -159.64 160.99 34.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.722 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -117.56 151.37 37.29 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -53.39 123.26 11.48 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.17 0.919 . . . . 0.0 110.657 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.84 17.22 52.62 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.087 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -87.92 -30.69 19.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.954 0.877 . . . . 0.0 113.171 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 2.1 mp0 75.45 128.98 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.535 1.159 . . . . 0.0 112.386 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.579 HD11 ' CG1' ' A' ' 82' ' ' VAL . 10.9 mt -129.08 165.11 29.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -114.66 142.23 46.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.5 tp -100.69 124.24 54.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -110.51 -40.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.662 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.571 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 48.2 ttt180 -134.8 136.96 42.94 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.136 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.549 ' N ' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.1 -36.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 124.439 1.096 . . . . 0.0 111.778 -177.243 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -96.64 154.84 17.05 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.93 67.86 0.72 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.907 1.283 . . . . 0.0 107.963 -174.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -134.39 115.4 12.7 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.626 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.91 -28.71 29.16 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.393 2.729 . . . . 0.0 115.394 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.11 -15.49 23.33 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.799 0.809 . . . . 0.0 110.146 -177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.01 0.19 83.5 Favored Glycine 0 C--N 1.308 -0.992 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.152 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 17.8 ptmt -95.06 161.68 14.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.545 ' CD2' HG21 ' A' ' 79' ' ' THR . 43.2 m0 -97.8 176.03 5.95 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.947 0.899 . . . . 0.0 111.478 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.693 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -115.52 108.72 16.82 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -111.43 156.57 15.48 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.563 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.773 ' HA ' ' O ' ' A' ' 73' ' ' SER . 62.5 ttt-85 -134.62 147.55 50.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.515 0.674 . . . . 0.0 111.593 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 27.0 m -100.75 162.13 13.12 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.0 18.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -89.16 3.15 52.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.66 87.86 0.33 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.773 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.8 m -152.48 117.75 5.25 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 79.9 m-85 -115.21 91.35 3.58 Favored 'General case' 1 C--N 1.224 -4.882 0 O-C-N 124.25 0.969 . . . . 0.0 108.459 -173.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.629 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -107.45 102.52 1.82 Allowed Glycine 2 N--CA 1.366 -5.992 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.636 ' HH ' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -42.16 101.14 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 112.959 -1.621 . . . . 0.0 108.52 171.078 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.642 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.2 pt -85.39 145.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.948 0 C-N-CA 126.248 1.819 . . . . 0.0 113.312 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -80.92 122.79 27.68 Favored 'General case' 1 N--CA 1.348 -5.538 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 164.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.545 HG21 ' CD2' ' A' ' 65' ' ' TRP . 47.7 p -36.47 -30.71 0.02 OUTLIER 'General case' 1 C--N 1.243 -4.039 0 C-N-CA 128.341 2.656 . . . . 0.0 112.653 176.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -32.47 73.98 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.892 1.277 . . . . 0.0 110.835 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.49 -4.9 59.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.778 -172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 77' ' ' ILE . 28.9 m -133.97 159.35 42.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.46 0.648 . . . . 0.0 111.813 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.4 mt-10 -128.03 117.5 21.79 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 171.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.5 pt -78.38 160.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.388 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.77 123.64 30.08 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 172.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -58.8 -36.9 75.21 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -167.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.426 ' O ' ' HD2' ' A' ' 29' ' ' HIS . 23.9 t70 -138.24 -87.19 0.26 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 19.9 t 166.07 126.38 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.12 173.53 9.62 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 120.807 0.337 . . . . 0.0 110.384 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -102.77 -34.61 8.95 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.552 ' HG ' ' HB3' ' A' ' 93' ' ' LYS . 47.0 tp -90.91 106.19 18.35 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -80.84 6.33 13.41 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.727 1.251 . . . . 0.0 110.421 -173.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.552 ' HB3' ' HG ' ' A' ' 91' ' ' LEU . 1.5 tmtp? -77.37 -20.18 55.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.393 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 64.74 86.34 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.125 0.97 . . . . 0.0 111.356 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' HG ' ' HG3' ' A' ' 96' ' ' GLU . 51.9 tp -160.77 -64.69 0.06 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.444 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.542 ' HG3' ' HG ' ' A' ' 95' ' ' LEU . 43.9 mt-10 . . . . . 0 N--CA 1.432 -1.334 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.513 -0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -137.34 160.89 37.77 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -110.66 136.92 49.01 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.549 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.51 142.66 31.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.436 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -77.25 0.06 Allowed 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 125.121 1.369 . . . . 0.0 108.752 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.5 tptm 52.66 -84.2 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.252 1.821 . . . . 0.0 113.524 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -70.08 126.09 28.67 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -57.01 -47.51 80.69 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 123.491 0.494 . . . . 0.0 112.225 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 55.42 43.33 28.9 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -80.48 -9.38 59.76 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.668 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.603 ' HG3' ' HB2' ' A' ' 13' ' ' GLN . 47.2 tptt -108.77 103.42 12.49 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.101 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.03 75.86 1.89 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.468 1.127 . . . . 0.0 108.036 172.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.603 ' HB2' ' HG3' ' A' ' 11' ' ' LYS . 64.2 tt0 -91.16 -12.25 35.99 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.904 -170.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.63 -38.07 88.81 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.5 HG22 ' HH ' ' A' ' 76' ' ' TYR . 6.9 pt -67.33 -28.99 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.987 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.446 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -78.08 -7.37 56.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.223 0.535 . . . . 0.0 110.535 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -99.39 -30.1 12.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.23 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 4.3 tppt? -84.16 -65.55 1.0 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.065 -174.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.554 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 1.8 t80 -86.59 -28.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.0 ttmt 63.08 86.05 0.12 Allowed 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.613 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD12 HD23 ' A' ' 66' ' ' LEU . 1.3 mm? -93.69 -58.61 2.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.236 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p 54.5 83.47 0.08 Allowed 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 124.679 1.192 . . . . 0.0 114.165 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.68 161.9 8.89 Favored Glycine 0 C--N 1.297 -1.634 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.2 109.15 1.09 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.439 2.093 . . . . 0.0 109.429 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.555 HG13 ' HB ' ' A' ' 55' ' ' ILE . 7.8 tp -95.89 119.43 43.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.071 0.462 . . . . 0.0 110.546 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -86.61 166.03 15.71 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.904 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.595 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.7 p -79.59 139.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.88 -40.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.508 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.519 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.0 m80 -159.89 166.45 30.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.05 116.51 32.1 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.65 ' HB3' HG21 ' A' ' 84' ' ' ILE . . . -89.51 157.92 17.9 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 122.281 1.038 . . . . 0.0 112.196 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -107.74 126.18 52.3 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.329 -1.305 . . . . 0.0 107.918 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 52' ' ' ILE . . . -67.68 109.79 3.46 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 171.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.3 m -83.86 -5.72 59.27 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.474 0.484 . . . . 0.0 111.852 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.9 p -155.59 154.72 32.11 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -82.83 110.65 18.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.52 160.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -112.91 0.55 15.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.569 -169.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 76.77 61.19 2.77 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.706 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.42 122.47 7.22 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.767 -0.716 . . . . 0.0 111.469 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 62.6 71.9 0.51 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.421 1.088 . . . . 0.0 110.592 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.554 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . 96.6 m-20 53.04 73.01 0.38 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.336 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.558 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 41.8 tt0 -145.66 171.02 15.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.562 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -98.95 152.74 19.45 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.445 ' H ' HD21 ' A' ' 44' ' ' LEU . 3.6 m -101.61 127.64 48.25 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -156.78 170.82 21.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 99.2 mttt -119.78 153.87 35.07 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 123.93 15.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.42 13.21 65.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.685 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.6 tp10 -63.59 -37.54 87.73 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.46 0.704 . . . . 0.0 111.682 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 71.56 107.49 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.267 1.427 . . . . 0.0 108.637 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.565 HD11 ' CG1' ' A' ' 82' ' ' VAL . 15.8 mt -113.34 159.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.595 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 16.2 mt-10 -111.8 132.36 54.72 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -93.34 122.85 45.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.577 HG23 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -108.27 -36.57 3.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.554 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 32.4 ttm180 -140.79 137.87 33.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.723 175.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.549 ' N ' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.86 -28.92 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 124.005 0.922 . . . . 0.0 111.816 -176.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.0 p -106.27 162.75 13.39 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.6 t70 58.29 71.2 0.6 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.795 1.283 . . . . 0.0 110.54 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 16.3 p30 -125.67 136.46 28.39 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.255 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 17.7 Cg_exo -69.4 -32.11 20.74 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.063 2.509 . . . . 0.0 113.851 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -101.8 -51.88 3.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.04 -2.47 5.14 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 16.4 ptpt -80.8 162.41 24.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.689 -0.756 . . . . 0.0 109.059 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 77' ' ' ILE . 41.3 m0 -99.25 176.75 5.43 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.76 0.824 . . . . 0.0 109.789 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.569 HD23 HD12 ' A' ' 21' ' ' LEU . 56.7 tp -117.47 112.12 20.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.21 157.11 15.22 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.121 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.724 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.6 ttp180 -135.82 156.91 48.06 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.0 110.805 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.9 m -111.95 155.72 23.25 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 68.34 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.286 1.041 . . . . 0.0 111.977 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -167.62 -35.29 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.011 -1.904 . . . . 0.0 107.66 175.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.03 90.18 1.98 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.724 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 2.5 m -151.92 116.76 5.15 Favored 'General case' 0 N--CA 1.386 -3.634 1 N-CA-C 100.097 -4.038 . . . . 0.0 100.097 -178.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.553 ' HB3' HD13 ' A' ' 66' ' ' LEU . 48.2 m-85 -116.75 89.41 3.1 Favored 'General case' 1 C--N 1.216 -5.214 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -175.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.02 104.13 2.5 Favored Glycine 3 N--CA 1.352 -6.957 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -51.31 97.51 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 O-C-N 125.305 1.238 . . . . 0.0 108.129 172.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.658 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.9 pt -76.17 137.49 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.437 -3.397 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.406 -173.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 22.5 pttm -79.16 112.51 16.44 Favored 'General case' 1 N--CA 1.369 -4.495 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 167.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.49 HG23 ' CD2' ' A' ' 65' ' ' TRP . 64.6 p -35.65 -34.16 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.437 0 C-N-CA 129.327 3.051 . . . . 0.0 114.818 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -62.93 -16.24 58.44 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.8 -17.11 39.17 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.698 -0.626 . . . . 0.0 111.723 -177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.565 ' CG1' HD11 ' A' ' 52' ' ' ILE . 30.4 m -135.96 168.18 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.752 0.786 . . . . 0.0 112.616 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -135.27 126.19 27.59 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.65 HG21 ' HB3' ' A' ' 31' ' ' ALA . 25.9 pt -84.77 164.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.137 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.91 111.4 20.77 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.85 -21.13 55.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 123.699 0.624 . . . . 0.0 110.804 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 64.96 -94.14 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 O-C-N 124.382 1.051 . . . . 0.0 109.935 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 m 42.47 78.98 0.04 OUTLIER 'General case' 0 C--O 1.251 1.181 0 C-N-CA 124.888 1.275 . . . . 0.0 112.941 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.583 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 81.9 mt -81.37 105.04 12.24 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 121.765 0.793 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -78.68 -8.6 58.84 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.436 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.9 tt -58.52 -34.44 70.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.203 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.583 ' HE3' ' HB2' ' A' ' 89' ' ' LEU . 85.7 mttt -74.86 114.17 13.01 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 174.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.718 ' NZ ' ' HA ' ' A' ' 93' ' ' LYS . 2.4 tpmp? -116.04 163.87 15.29 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 118.427 -1.309 . . . . 0.0 112.061 -174.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.498 ' H ' ' HG3' ' A' ' 93' ' ' LYS . 4.7 m-20 -110.97 -66.1 1.11 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.569 -172.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.1 -56.48 2.17 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.732 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 118.23 -0.89 . . . . 0.0 108.909 -177.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 38.5 mm-40 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.53 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 1.3 pp -77.62 -28.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.849 0.833 . . . . 0.0 108.842 -174.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' HD23 ' A' ' 21' ' ' LEU . 15.4 mtpp -70.0 -41.49 74.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.352 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -85.04 -22.52 28.98 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.153 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.5 tppt? -76.36 -48.61 19.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.546 -175.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 13.8 t80 -94.45 -26.49 16.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.889 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? 70.91 90.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.518 1.127 . . . . 0.0 108.882 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.47 -44.96 5.71 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.28 80.2 p . . . . . 0 CA--C 1.552 1.048 0 C-N-CA 125.699 1.599 . . . . 0.0 112.384 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 C--O 1.246 0.874 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.648 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -57.18 134.04 21.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 123.714 0.634 . . . . 0.0 111.81 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.1 mm -89.2 -38.22 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.621 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 54' ' ' ILE . 32.8 m80 -162.02 156.66 22.49 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -100.57 117.1 34.02 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -92.43 155.83 17.6 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.7 0.762 . . . . 0.0 110.293 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -107.11 131.17 54.42 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.56 115.72 5.46 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.8 t -79.34 -12.05 59.93 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.946 0.779 . . . . 0.0 110.025 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -158.35 171.7 19.7 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.702 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 5.5 p-10 -105.67 104.86 14.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.698 0.761 . . . . 0.0 110.653 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.02 158.98 15.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 17.4 19.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.827 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 83.22 59.88 2.1 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.204 -0.998 . . . . 0.0 114.476 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.04 145.91 17.55 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 63.65 34.22 12.5 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.362 0.665 . . . . 0.0 109.635 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.6 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 83.3 m-20 64.77 82.6 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.387 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 15.9 tt0 -140.86 -176.87 4.83 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.575 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 54.7 tp -95.65 145.17 25.47 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.4 m -94.98 119.58 33.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 52' ' ' ILE . 28.3 p90 -153.28 157.85 40.74 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.702 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 42.7 mmtm -107.97 146.78 31.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.062 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.75 118.59 2.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.912 0.885 . . . . 0.0 110.001 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 15.8 76.85 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.919 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 28.9 tt0 -69.01 -33.08 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.402 0.601 . . . . 0.0 111.58 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 80.07 122.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 110.214 -174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.468 HD13 HD23 ' A' ' 44' ' ' LEU . 4.7 mt -125.76 162.19 29.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.648 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 35.5 mt-10 -116.49 134.82 54.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 119.211 0.914 . . . . 0.0 109.093 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 65' ' ' TRP . 9.0 tp -93.05 127.15 45.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -56.61 4.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.528 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.3 tpm_? -116.18 121.97 43.67 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.524 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.603 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -118.74 -26.86 2.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.026 174.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.6 p -85.39 136.34 33.5 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.412 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t0 67.3 33.58 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.66 1.184 . . . . 0.0 110.918 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.23 128.58 93.78 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.296 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.44 -27.59 1.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.049 1.832 . . . . 0.0 114.147 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.505 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 17.5 mm-40 -109.14 -6.09 15.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.28 -18.7 56.14 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.762 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -86.3 161.39 18.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.603 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.1 m0 -98.44 163.45 12.68 Favored 'General case' 0 C--O 1.199 -1.58 0 C-N-CA 123.565 0.746 . . . . 0.0 109.633 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD11 ' HB3' ' A' ' 74' ' ' TYR . 55.7 tp -104.06 108.84 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.032 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.34 144.86 18.44 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 73' ' ' SER . 22.1 ttp180 -115.74 149.32 38.65 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.248 0.547 . . . . 0.0 110.419 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.529 ' OG1' HD11 ' A' ' 44' ' ' LEU . 89.7 m -98.17 156.52 16.64 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.84 -33.73 17.75 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -79.67 -1.81 39.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 77.14 86.14 0.42 Allowed Glycine 0 C--O 1.221 -0.695 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.8 m -152.7 127.19 9.34 Favored 'General case' 0 N--CA 1.394 -3.229 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.736 ' HB3' HD11 ' A' ' 66' ' ' LEU . 83.7 m-85 -115.59 100.08 7.8 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -174.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.575 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.29 5.09 52.04 Favored Glycine 0 C--O 1.188 -2.737 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.616 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.6 ' HE1' ' HB3' ' A' ' 42' ' ' ASN 0.314 0.3 OUTLIER 46.01 75.18 0.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 123.068 1.414 . . . . 0.0 112.844 -179.874 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 82' ' ' VAL . 1.6 pt -61.94 141.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.038 0 CA-C-N 112.199 -2.273 . . . . 0.0 113.125 -174.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -77.71 114.78 16.9 Favored 'General case' 1 N--CA 1.365 -4.711 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 166.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.507 HG22 ' CG ' ' A' ' 65' ' ' TRP . 34.0 p -35.53 -38.78 0.12 Allowed 'General case' 0 C--N 1.244 -3.99 0 C-N-CA 127.91 2.484 . . . . 0.0 113.628 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -66.67 -19.84 65.85 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.41 0.684 . . . . 0.0 111.675 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.5 -5.87 59.04 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 121.835 -0.54 . . . . 0.0 111.357 -175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.62 HG21 HD12 ' A' ' 77' ' ' ILE . 30.1 m -135.79 167.84 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.377 0.608 . . . . 0.0 110.992 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -133.96 116.17 15.24 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.781 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.3 pp -81.53 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.315 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.306 -1.299 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.554 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 46.4 mt-10 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.738 0.78 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.604 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.5 pt -88.69 -32.35 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.858 -170.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.0 ptmt -91.22 -9.44 45.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.591 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 13.4 tmtt? -92.89 -23.96 18.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 169.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.3 tppt? -82.56 -58.44 2.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.035 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 9.8 t80 -92.52 -33.98 14.25 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.4 tttm 75.11 93.48 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.34 1.025 . . . . 0.0 110.656 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.654 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.09 -28.82 12.85 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.864 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.268 69.0 p . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 126.663 1.985 . . . . 0.0 115.964 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.41 133.55 31.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.86 0.838 . . . . 0.0 111.612 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.502 HD11 HH21 ' A' ' 56' ' ' ARG . 62.6 mt -98.46 -32.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.7 m80 -162.58 165.83 25.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.87 116.39 31.87 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.691 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -95.64 150.52 20.26 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-O 121.771 0.796 . . . . 0.0 111.047 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -107.31 133.61 51.59 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -64.41 117.03 6.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 31.3 t -79.8 -18.08 51.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 124.294 0.996 . . . . 0.0 110.321 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.6 t -152.93 161.0 43.08 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.99 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 1.8 p-10 -94.51 109.57 21.45 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.016 0.912 . . . . 0.0 108.769 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.26 152.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 9.04 39.01 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.064 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.87 58.24 8.57 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.801 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.31 162.23 14.48 Favored Glycine 0 C--O 1.2 -1.982 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.864 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 6.4 mmpt? 57.71 34.28 24.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.843 1.321 . . . . 0.0 111.691 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 76' ' ' TYR . 42.6 m-80 66.01 51.81 1.28 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.89 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' OE1' ' HE3' ' A' ' 78' ' ' LYS . 1.2 mp0 -110.04 179.45 4.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.831 171.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 1.1 tt -97.75 151.26 20.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -94.87 126.57 40.28 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.189 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 14.2 p90 -158.57 163.27 37.17 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.952 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.99 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.2 mmtt -110.7 148.27 32.62 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 18.8 tm0? -52.06 119.79 4.71 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.748 0.655 . . . . 0.0 109.548 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.58 13.69 69.71 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.742 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 12.9 tp10 -63.12 -32.01 73.29 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.95 0.5 . . . . 0.0 110.901 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 77.63 99.32 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.018 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.555 HD12 HG12 ' A' ' 82' ' ' VAL . 12.1 mt -106.69 165.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 113.399 -1.728 . . . . 0.0 106.742 -173.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -127.63 136.48 51.69 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.7 tp -93.24 130.68 41.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.11 -37.84 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.369 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -137.86 134.71 35.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.911 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.69 -13.32 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 123.954 0.902 . . . . 0.0 110.39 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -117.16 159.04 23.23 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.11 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.14 70.78 0.59 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.219 1.408 . . . . 0.0 110.089 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 15.3 p30 -127.75 139.3 34.91 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.671 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 23.6 Cg_exo -68.66 -49.2 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.938 2.426 . . . . 0.0 113.105 177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.91 -23.45 25.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 111.681 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.18 8.53 58.79 Favored Glycine 0 C--N 1.312 -0.772 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.73 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 12.7 ptmt -89.32 162.26 15.92 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.584 ' HB2' HG13 ' A' ' 77' ' ' ILE . 46.6 m0 -93.79 176.41 6.36 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.654 HD22 HD11 ' A' ' 21' ' ' LEU . 59.7 tp -121.2 112.57 18.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.73 14.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 73' ' ' SER . 48.5 ttp180 -133.56 153.69 51.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.322 0.582 . . . . 0.0 110.285 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.2 m -100.0 153.82 18.89 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -30.04 12.62 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -81.68 -12.06 58.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.812 0.339 . . . . 0.0 111.855 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.59 92.59 1.56 Allowed Glycine 0 C--N 1.315 -0.591 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.7 m -153.73 118.05 4.87 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 66' ' ' LEU . 48.2 m-85 -114.59 94.95 5.01 Favored 'General case' 1 C--N 1.222 -4.972 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -173.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.577 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -111.18 103.41 1.58 Allowed Glycine 3 N--CA 1.359 -6.434 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -45.52 100.55 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 113.133 -1.534 . . . . 0.0 108.293 173.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.584 HG13 ' HB2' ' A' ' 65' ' ' TRP . 2.0 pt -81.4 142.0 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.249 0 C-N-CA 124.341 1.057 . . . . 0.0 113.482 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 18.7 ptpt -79.28 119.01 21.74 Favored 'General case' 1 N--CA 1.361 -4.911 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 165.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.464 HG22 ' CD2' ' A' ' 65' ' ' TRP . 50.5 p -36.11 -39.46 0.17 Allowed 'General case' 1 C--N 1.242 -4.1 0 C-N-CA 127.732 2.413 . . . . 0.0 112.894 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.84 -13.35 62.06 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 123.274 0.63 . . . . 0.0 112.341 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.78 -9.08 50.59 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.359 -0.838 . . . . 0.0 111.112 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.555 HG12 HD12 ' A' ' 52' ' ' ILE . 31.5 m -133.91 167.22 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 122.152 0.977 . . . . 0.0 111.974 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.4 mt-10 -132.89 111.62 11.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.1 pt -75.36 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.686 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--N 1.288 -2.086 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.208 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 121.013 0.435 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.724 HG21 ' HB2' ' A' ' 74' ' ' TYR . 4.3 pt -79.72 -31.45 13.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.419 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 2.7 mptp? -68.62 -23.8 64.49 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 121.357 0.599 . . . . 0.0 110.768 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -103.6 6.49 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.997 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 8.8 ttmm -121.62 -43.42 2.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.098 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.574 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 2.9 t80 -94.6 -33.8 12.87 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 87.4 tttt 68.13 88.51 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.653 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 HD22 ' A' ' 66' ' ' LEU . 1.2 mm? -98.09 -29.98 12.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.675 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 124.985 1.314 . . . . 0.0 113.379 -179.287 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.425 ' O ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.55 136.21 25.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.2 0.524 . . . . 0.0 109.636 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 54' ' ' ILE . 49.9 mm -91.29 -35.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.79 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.799 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.403 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.2 m80 -168.64 162.56 11.91 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.26 121.14 41.33 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.715 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -96.14 155.79 16.61 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-O 121.758 0.789 . . . . 0.0 110.027 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -107.04 128.08 54.04 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -68.36 109.39 3.63 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.52 -22.5 32.44 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.23 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.4 m -133.19 144.01 49.56 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.848 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.43 104.55 16.56 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.321 1.058 . . . . 0.0 109.281 172.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 39' ' ' GLY . 8.5 p -114.47 151.49 16.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.682 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.388 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -97.97 7.24 46.65 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.201 0.6 . . . . 0.0 111.942 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 75.25 59.04 3.73 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.609 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.11 151.14 17.01 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 tttm 62.0 32.87 17.58 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.934 0.873 . . . . 0.0 108.687 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 90.6 m-20 66.55 86.64 0.13 Allowed 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.385 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.601 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 22.4 tt0 -147.09 -175.73 4.94 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.565 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.67 154.53 17.89 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.48 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 m -101.89 120.19 40.0 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 18.5 p90 -151.06 161.77 42.12 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.731 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 73.2 mmtt -107.2 151.19 25.76 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.118 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -55.59 111.65 0.95 Allowed 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.57 24.96 14.49 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.406 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -75.91 -39.96 55.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.144 0.577 . . . . 0.0 111.162 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 76.34 108.08 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.915 1.686 . . . . 0.0 109.04 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.582 HD12 ' CG1' ' A' ' 82' ' ' VAL . 8.1 mt -116.87 162.71 14.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -173.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.47 135.24 54.85 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.0 tp -93.48 128.54 44.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -113.33 -42.24 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.574 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 1.8 tpm_? -128.52 128.23 43.92 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -126.07 -6.74 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 123.612 0.765 . . . . 0.0 109.637 177.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -112.13 150.84 30.21 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.521 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 t70 56.24 56.53 5.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.743 1.258 . . . . 0.0 109.535 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 17.7 p-10 -105.83 106.31 56.19 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.535 -1.666 . . . . 0.0 112.486 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 16.6 Cg_exo -66.76 -23.52 48.3 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.814 3.009 . . . . 0.0 115.072 -173.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -111.08 0.17 16.81 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.915 0.864 . . . . 0.0 109.852 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 17.49 80.19 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.688 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.0 ptmt -110.33 161.68 15.39 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.522 ' CD2' HG22 ' A' ' 79' ' ' THR . 40.4 m0 -96.63 176.18 6.11 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 122.383 0.273 . . . . 0.0 110.367 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' A' ' 74' ' ' TYR . 64.5 tp -117.37 111.77 19.79 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.74 155.43 16.32 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.184 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.1 ttp180 -136.45 148.26 47.63 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.562 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.7 m -101.41 157.96 16.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.79 30.36 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 119.243 0.928 . . . . 0.0 113.174 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmt_? -64.01 -26.0 68.37 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.071 0.948 . . . . 0.0 110.2 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.67 89.05 1.44 Allowed Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.4 m -153.56 122.31 6.37 Favored 'General case' 0 N--CA 1.387 -3.582 0 N-CA-C 100.422 -3.918 . . . . 0.0 100.422 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.724 ' HB2' HG21 ' A' ' 15' ' ' ILE . 67.4 m-85 -114.61 96.52 5.79 Favored 'General case' 1 C--N 1.225 -4.806 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -175.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -111.04 105.31 1.86 Allowed Glycine 3 N--CA 1.357 -6.567 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 177.382 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -49.38 96.49 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.291 -1.455 . . . . 0.0 108.88 169.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.601 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.7 pt -76.09 143.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.276 0 C-N-CA 125.631 1.572 . . . . 0.0 113.518 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -78.93 115.88 18.89 Favored 'General case' 1 N--CA 1.371 -4.411 0 N-CA-C 102.811 -3.033 . . . . 0.0 102.811 166.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 64' ' ' LYS . 68.9 p -36.02 -35.96 0.08 Allowed 'General case' 0 C--N 1.244 -3.995 0 C-N-CA 128.167 2.587 . . . . 0.0 113.962 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -70.16 -15.13 62.91 Favored 'General case' 0 CA--C 1.567 1.625 0 C-N-CA 123.361 0.665 . . . . 0.0 112.636 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.92 -13.84 38.11 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.582 ' CG1' HD12 ' A' ' 52' ' ' ILE . 28.4 m -127.89 165.5 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-O 121.297 0.57 . . . . 0.0 110.888 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -133.8 117.3 16.72 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.715 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.1 pp -77.96 134.1 29.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 119.504 -0.879 . . . . 0.0 109.936 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--N 1.301 -1.515 0 CA-C-O 121.365 0.602 . . . . 0.0 110.416 179.626 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 122.493 1.139 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -87.15 -25.18 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.417 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.658 ' HB3' ' HD3' ' A' ' 17' ' ' LYS . 10.5 tptm -64.3 -41.65 96.76 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.286 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.658 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 3.4 mppt? -98.02 12.46 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.699 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 8.2 tppt? -105.67 -57.04 2.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.695 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 1.8 t80 -80.11 -25.07 40.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 49.5 mtpt 70.09 89.4 0.1 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.989 1.316 . . . . 0.0 110.6 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.542 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -98.74 -18.63 17.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.804 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 70.7 p . . . . . 0 C--N 1.306 -1.299 0 C-N-CA 126.061 1.744 . . . . 0.0 114.32 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 . . . . . 0 C--O 1.22 -0.484 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.12 136.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.379 0.609 . . . . 0.0 109.464 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.88 -33.66 3.53 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.057 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.564 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.6 m80 -161.82 168.65 22.73 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -173.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.72 115.67 30.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -98.12 155.12 17.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-O 122.281 1.038 . . . . 0.0 111.352 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 34.1 ttpt -107.91 128.83 54.97 Favored 'General case' 0 C--N 1.256 -3.465 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -64.84 116.03 5.92 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.87 -17.4 35.7 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.451 0.643 . . . . 0.0 109.658 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.1 t -144.33 156.07 44.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 8.2 p-10 -94.43 101.92 13.86 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.16 0.981 . . . . 0.0 110.169 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG12 ' CE1' ' A' ' 46' ' ' PHE . 7.3 p -112.42 153.35 14.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.35 42.94 3.13 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 111.406 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 74.39 58.84 4.08 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.14 176.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.06 126.6 8.02 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 64.4 34.79 10.12 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.598 0.713 . . . . 0.0 109.79 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 71.52 87.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.702 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 20.2 tt0 -151.85 -172.45 4.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.102 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.1 tt -94.96 151.5 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.515 ' H ' HD23 ' A' ' 44' ' ' LEU . 50.1 m -102.77 118.58 37.14 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CE1' HG12 ' A' ' 37' ' ' VAL . 20.3 p90 -154.89 177.22 11.54 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.618 0.767 . . . . 0.0 109.619 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 99.1 mttt -133.69 151.18 51.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 1.4 tm0? -47.74 119.3 2.71 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 124.322 1.014 . . . . 0.0 110.9 176.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.44 12.7 59.41 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.937 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -79.23 -15.54 57.87 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 66.34 113.93 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 O-C-N 124.394 1.059 . . . . 0.0 111.208 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.5 mt -120.69 156.25 23.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.39 138.26 51.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 65' ' ' TRP . 7.8 tp -95.16 117.43 39.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.436 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -105.53 -27.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.404 -176.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 tpp180 -141.88 125.81 17.18 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.052 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -118.78 -38.95 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.738 -177.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -106.68 154.91 20.26 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.199 -172.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 82.82 10.91 0.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.894 1.677 . . . . 0.0 109.798 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 6.5 p30 -54.57 123.95 46.73 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.213 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 21.3 Cg_exo -68.4 -40.69 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.088 2.526 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -99.74 -49.84 4.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 145.18 -2.59 1.15 Allowed Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.288 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 14.8 ptpt -100.69 163.67 12.23 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 122.572 0.349 . . . . 0.0 110.314 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.678 ' HB3' HD11 ' A' ' 54' ' ' ILE . 35.9 m0 -98.03 174.33 6.6 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 124.263 0.977 . . . . 0.0 111.103 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 74' ' ' TYR . 41.4 tp -115.05 108.31 16.5 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.06 157.97 14.62 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.2 ttp180 -136.09 147.11 47.69 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.171 0.51 . . . . 0.0 111.389 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.495 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.6 p -100.83 165.31 11.42 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.052 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.55 24.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.385 1.074 . . . . 0.0 113.641 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -78.04 -18.96 55.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.301 0.572 . . . . 0.0 111.384 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.69 92.09 1.38 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.1 m -151.96 129.11 11.14 Favored 'General case' 0 N--CA 1.392 -3.36 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 66' ' ' LEU . 41.9 m-85 -119.73 61.31 0.84 Allowed 'General case' 1 C--N 1.226 -4.788 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -172.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.627 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -87.11 93.38 1.88 Allowed Glycine 1 N--CA 1.384 -4.82 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -176.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.54 ' O ' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -34.29 101.05 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 125.809 1.535 . . . . 0.0 110.324 174.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -78.07 137.01 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.342 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.661 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -73.67 114.05 11.49 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 103.576 -2.749 . . . . 0.0 103.576 166.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.536 HG22 ' CD2' ' A' ' 65' ' ' TRP . 81.4 p -36.11 -35.9 0.08 Allowed 'General case' 1 C--N 1.24 -4.189 0 C-N-CA 128.428 2.691 . . . . 0.0 113.471 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.6 t -69.04 -14.24 62.92 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.068 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.32 -7.14 51.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.443 -0.785 . . . . 0.0 111.137 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 HD12 ' A' ' 77' ' ' ILE . 26.8 m -133.96 157.46 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.93 0.871 . . . . 0.0 112.365 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -120.3 110.69 16.86 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.711 HG22 ' HB2' ' A' ' 31' ' ' ALA . 18.8 pt -79.82 163.03 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 C--N 1.282 -2.34 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.365 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 3.6 mp0 . . . . . 0 N--CA 1.442 -0.838 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.3 pp -87.98 -23.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 120.922 0.391 . . . . 0.0 110.125 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -48.1 -61.68 1.86 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.845 1.658 . . . . 0.0 112.711 -171.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -104.82 11.66 33.53 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.553 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 12.6 tppt? -84.87 -50.74 7.28 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 26.2 t80 -89.99 -28.99 18.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.626 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 8.0 mtmp? 75.0 88.25 0.09 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 125.577 1.551 . . . . 0.0 110.066 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 HD11 HD22 ' A' ' 66' ' ' LEU . 1.7 mm? -99.94 -69.9 0.75 Allowed 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.411 -2.41 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.131 173.679 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.732 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.9 p -76.85 134.67 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.349 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.77 -34.77 4.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.861 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 35.6 m80 -159.15 163.03 36.43 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.39 116.39 32.34 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.89 155.31 17.24 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 122.345 1.069 . . . . 0.0 111.67 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -106.85 126.47 52.35 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.06 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.53 109.4 2.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.6 t -80.94 -18.7 46.17 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.884 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -147.32 151.48 36.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -89.06 105.4 17.76 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.847 0.832 . . . . 0.0 109.662 173.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.32 162.28 12.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.905 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -125.18 31.52 5.58 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.537 0.684 . . . . 0.0 111.411 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 81.26 59.2 2.45 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.169 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.19 116.12 4.52 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 tttm 57.43 71.11 0.6 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.984 1.313 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.577 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 18.8 m120 51.47 79.47 0.1 Allowed 'General case' 0 C--O 1.245 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 111.493 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.3 tt0 -146.81 -175.45 4.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.649 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -97.59 155.24 17.06 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.559 ' H ' HD23 ' A' ' 44' ' ' LEU . 28.0 m -100.65 115.44 30.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.171 0.51 . . . . 0.0 109.69 174.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.5 p90 -149.48 158.22 43.98 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.819 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HG2' ' OD1' ' A' ' 36' ' ' ASP . 59.4 mttm -110.84 152.93 26.11 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 123.695 0.622 . . . . 0.0 109.922 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 110.22 0.66 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.33 27.23 10.15 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.103 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.7 tp10 -80.11 -37.05 34.43 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.086 0.555 . . . . 0.0 111.117 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 72.21 112.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.182 1.793 . . . . 0.0 110.505 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.559 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.0 mt -119.88 160.68 20.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.117 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.732 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 44.8 mt-10 -117.83 134.36 55.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.6 tp -90.14 126.53 42.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.407 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -110.22 -39.55 3.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.63 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -134.89 130.15 35.48 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 118.549 -1.261 . . . . 0.0 110.906 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.45 -1.93 5.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 123.934 0.894 . . . . 0.0 110.233 176.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.8 p -112.38 147.43 36.42 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.916 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 t70 67.08 28.59 8.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 122.75 1.262 . . . . 0.0 109.428 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 23.3 p-10 -77.98 115.05 47.28 Favored Pre-proline 0 C--N 1.302 -1.464 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.203 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 30.9 Cg_exo -62.63 -62.4 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.711 2.941 . . . . 0.0 113.877 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.35 -8.41 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.819 0.818 . . . . 0.0 110.874 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 7.88 68.05 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.0 ptmt -95.96 162.91 13.36 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 57' ' ' ILE . 46.0 m0 -97.71 175.94 6.0 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 122.365 0.266 . . . . 0.0 110.529 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 74' ' ' TYR . 60.1 tp -120.54 114.18 21.38 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -120.24 159.81 15.03 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.4 ttp180 -134.68 152.81 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.0 m -111.82 165.44 12.06 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.23 -31.96 15.36 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -89.29 -6.86 56.42 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 118.372 -1.331 . . . . 0.0 111.091 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.24 97.2 1.25 Allowed Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.874 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.4 m -153.89 124.31 7.04 Favored 'General case' 0 N--CA 1.394 -3.27 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.578 ' HB2' HG21 ' A' ' 15' ' ' ILE . 39.9 m-85 -113.85 80.56 1.4 Allowed 'General case' 1 C--N 1.223 -4.908 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -175.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.649 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -97.46 101.97 2.64 Favored Glycine 3 N--CA 1.346 -7.334 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.577 ' HE1' ' HB3' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.92 100.34 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 113.198 -1.501 . . . . 0.0 108.121 168.21 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.6 pt -80.44 145.68 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.442 -3.204 0 C-N-CA 126.645 1.978 . . . . 0.0 113.515 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 117.58 22.25 Favored 'General case' 1 N--CA 1.359 -5.007 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 166.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.472 HG22 ' CG ' ' A' ' 65' ' ' TRP . 62.1 p -35.34 -38.2 0.09 Allowed 'General case' 0 C--N 1.251 -3.696 0 C-N-CA 129.05 2.94 . . . . 0.0 114.014 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 t -70.27 -9.89 57.32 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.308 1.043 . . . . 0.0 112.248 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.32 -10.18 36.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.427 -0.796 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.604 HG21 HD12 ' A' ' 77' ' ' ILE . 19.0 m -129.08 152.28 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-O 121.808 0.813 . . . . 0.0 112.29 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.5 mt-10 -119.14 107.05 12.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 10.2 pt -72.82 159.3 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.198 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--N 1.287 -2.13 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.095 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 35.0 mm-40 . . . . . 0 CA--C 1.501 -0.912 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.586 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 2.4 pp -72.3 -28.3 28.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.316 -172.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HA ' HD23 ' A' ' 21' ' ' LEU . 48.7 mtpt -67.91 -36.19 79.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.015 -172.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -107.53 -16.74 14.29 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.298 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 5.8 tppt? -71.32 -45.73 62.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 31.3 t80 -90.68 -30.61 17.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . 0.254 15.2 tptp 74.61 85.58 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.695 1.236 . . . . 0.0 111.392 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.605 HD11 HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -98.99 -59.84 1.65 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.304 36.2 p . . . . . 0 C--N 1.318 -0.768 0 C-N-CA 125.792 1.637 . . . . 0.0 112.634 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.4 p -81.64 137.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.442 0.639 . . . . 0.0 111.159 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.42 -40.36 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.748 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.4 m80 -161.15 171.75 17.95 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.86 126.33 52.54 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -102.68 156.6 17.52 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.418 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -107.1 133.51 51.6 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -65.99 103.22 0.9 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.9 t -71.2 -28.93 64.57 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.3 m -132.09 156.43 46.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.708 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.7 p-10 -81.38 112.03 18.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 171.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 81' ' ' ALA . 30.8 t -112.62 140.89 30.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.789 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.34 -168.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -86.7 -14.61 42.01 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.341 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 37' ' ' VAL . . . 75.78 60.49 3.16 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.983 -1.58 . . . . 0.0 110.432 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.17 131.89 10.85 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.83 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp 58.88 71.58 0.58 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.405 1.082 . . . . 0.0 110.658 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 56.29 61.45 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.114 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 46.5 mt-10 -134.16 -179.22 5.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.548 0.339 . . . . 0.0 111.133 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -98.46 140.96 31.93 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 p -94.6 115.73 27.92 Favored 'General case' 0 C--N 1.28 -2.443 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.161 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 29.1 p90 -145.47 177.12 9.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.478 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 9.3 mtmp? -134.81 142.53 46.69 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.6 tm0? -35.79 111.97 0.15 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 125.131 1.519 . . . . 0.0 110.376 173.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.09 19.97 40.77 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.648 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.553 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -73.33 -26.0 60.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.003 0.901 . . . . 0.0 113.227 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 70.84 104.2 0.06 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.882 1.364 . . . . 0.0 108.813 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.552 HD12 HG12 ' A' ' 82' ' ' VAL . 14.8 mt -110.74 165.95 5.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 24.9 mt-10 -122.65 141.11 52.1 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.8 tp -98.75 116.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.49 -41.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.387 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.592 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -133.7 136.54 44.74 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 117.782 -1.567 . . . . 0.0 111.497 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.02 -37.84 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.376 -1.283 . . . . 0.0 109.675 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -88.45 158.09 18.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t70 54.82 66.36 1.25 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 125.032 1.333 . . . . 0.0 109.192 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 31.5 p30 -112.11 136.93 21.3 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.166 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.6 Cg_exo -76.76 -32.3 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.431 2.087 . . . . 0.0 112.872 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.79 -34.89 6.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.74 -7.04 15.63 Favored Glycine 0 C--N 1.305 -1.142 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HA ' HG23 ' A' ' 79' ' ' THR . 11.4 ptmt -80.52 162.33 24.38 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.557 ' CD1' HG22 ' A' ' 57' ' ' ILE . 37.7 m0 -99.08 176.65 5.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.608 0.186 . . . . 0.0 110.801 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.605 HD22 HD11 ' A' ' 21' ' ' LEU . 61.4 tp -116.39 110.93 19.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.83 158.84 14.07 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 73' ' ' SER . 66.4 ttt-85 -140.53 147.8 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.769 0.427 . . . . 0.0 109.88 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 7.1 p -101.03 165.54 11.27 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.12 65.2 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.087 0.47 . . . . 0.0 112.254 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -71.55 -14.97 62.26 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.338 0.655 . . . . 0.0 111.749 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 81.77 88.37 0.65 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.181 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.7 m -151.99 120.82 6.57 Favored 'General case' 0 N--CA 1.394 -3.269 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.568 ' HB2' HG21 ' A' ' 15' ' ' ILE . 61.0 m-85 -108.91 90.74 3.38 Favored 'General case' 1 C--N 1.219 -5.076 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.16 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.601 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -107.05 104.81 2.21 Favored Glycine 3 N--CA 1.355 -6.748 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.586 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -46.0 96.99 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.351 -1.424 . . . . 0.0 108.29 169.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 82' ' ' VAL . 1.5 pt -78.22 147.18 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.898 0 C-N-CA 125.713 1.605 . . . . 0.0 114.398 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -76.64 113.82 14.7 Favored 'General case' 1 N--CA 1.376 -4.143 0 N-CA-C 101.712 -3.44 . . . . 0.0 101.712 165.77 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 64' ' ' LYS . 79.4 p -36.64 -41.92 0.33 Allowed 'General case' 0 C--N 1.246 -3.92 0 C-N-CA 127.769 2.427 . . . . 0.0 113.594 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -63.53 -20.42 65.61 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.258 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -82.97 -12.54 57.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.835 -0.54 . . . . 0.0 111.279 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 77' ' ' ILE . 29.1 m -127.06 166.82 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.343 0.592 . . . . 0.0 111.847 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 58.3 mt-10 -133.26 107.91 8.43 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.742 HG22 ' HB2' ' A' ' 31' ' ' ALA . 8.6 pt -75.53 155.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.391 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 C--N 1.291 -1.974 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.706 178.499 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 121.003 0.43 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.704 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.9 pp -67.54 -30.77 49.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-O 121.454 0.645 . . . . 0.0 111.422 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -76.48 -27.32 56.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.805 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -93.65 -8.93 39.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.019 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 12.6 tppt? -99.58 -67.01 0.87 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.073 0.463 . . . . 0.0 110.96 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.786 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 21.1 t80 -79.07 -32.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 -172.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 7.9 mtmp? 75.72 91.84 0.07 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.834 1.253 . . . . 0.0 109.692 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.058 HD12 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.35 -46.33 5.83 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.318 0.58 . . . . 0.0 109.772 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p . . . . . 0 CA--C 1.546 0.826 0 C-N-CA 125.507 1.523 . . . . 0.0 114.877 174.871 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.438 ' C ' HG22 ' A' ' 55' ' ' ILE . 12.9 pt20 . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -53.95 133.7 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.64 -31.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.066 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.1 m80 -161.05 157.03 25.49 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.27 116.04 28.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.669 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -94.63 150.81 19.85 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 122.072 0.939 . . . . 0.0 111.127 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.81 128.27 54.11 Favored 'General case' 0 C--N 1.252 -3.652 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -63.84 116.05 5.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.553 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.9 t -81.87 -18.47 43.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.249 0.968 . . . . 0.0 109.846 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.9 m -144.61 156.09 43.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 6.3 p-10 -91.42 102.02 14.7 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.402 HG12 ' CE1' ' A' ' 46' ' ' PHE . 9.9 p -113.25 153.75 14.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.795 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -98.1 8.33 44.95 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.387 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.62 59.77 1.87 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.678 -1.248 . . . . 0.0 111.896 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.77 143.8 16.7 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttp 65.05 29.59 12.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 108.757 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.414 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 2.4 t-20 63.14 86.97 0.11 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.28 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 31.0 tt0 -141.59 -173.6 3.82 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.257 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.646 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.2 tt -95.92 145.54 25.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 m -96.01 122.21 38.59 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 16.6 p90 -154.26 174.83 14.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 60.9 mtpt -127.33 147.79 50.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.3 tm0? -51.98 125.68 16.13 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.669 0.605 . . . . 0.0 110.425 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.2 81.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.349 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -63.12 -30.9 71.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.504 0.668 . . . . 0.0 109.891 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 73.23 110.41 0.07 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.13 1.372 . . . . 0.0 111.298 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.528 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.4 mt -115.76 156.81 16.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 CA-C-N 113.557 -1.656 . . . . 0.0 106.671 -172.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 79.9 mt-10 -113.08 131.16 55.92 Favored 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.009 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.6 tp -86.32 115.81 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.523 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -103.4 -32.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.984 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 1.058 ' HG3' HD12 ' A' ' 21' ' ' LEU . 18.1 mmt180 -134.93 112.4 10.61 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.721 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.59 -19.31 6.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.038 -1.892 . . . . 0.0 107.092 171.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 57' ' ' ILE . 12.0 p -99.01 141.94 31.12 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.396 -177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t0 75.67 26.06 1.12 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.058 1.343 . . . . 0.0 108.92 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 10.0 p30 -66.01 126.02 91.11 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.587 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.786 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 62.2 Cg_endo -81.23 -45.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.398 2.065 . . . . 0.0 113.3 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -99.3 -5.52 29.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.021 0.438 . . . . 0.0 111.177 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 99.46 -22.3 41.3 Favored Glycine 0 C--N 1.308 -1.004 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.1 ptmt -72.0 161.49 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.152 -1.024 . . . . 0.0 109.21 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.456 ' CG ' HG22 ' A' ' 79' ' ' THR . 32.3 m0 -99.5 176.34 5.53 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.073 0.233 . . . . 0.0 110.924 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 74' ' ' TYR . 62.9 tp -120.36 114.33 21.68 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.08 156.18 15.81 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 73' ' ' SER . 2.1 ttp-105 -139.03 149.11 44.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 17.2 p -99.76 165.94 11.34 Favored 'General case' 0 C--N 1.266 -3.032 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.962 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.73 -30.08 42.47 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -0.07 54.92 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.34 0.866 . . . . 0.0 113.34 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.28 92.01 0.9 Allowed Glycine 0 C--N 1.319 -0.413 0 CA-C-O 121.554 0.53 . . . . 0.0 113.535 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 20.4 m -153.01 126.15 8.53 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.73 ' HB3' HD11 ' A' ' 66' ' ' LEU . 57.1 m-85 -117.81 86.68 2.57 Favored 'General case' 1 C--N 1.227 -4.727 0 CA-C-O 122.122 0.963 . . . . 0.0 108.649 -173.036 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.646 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.14 101.76 2.12 Favored Glycine 3 N--CA 1.359 -6.447 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.678 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -48.92 100.36 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.58 -1.31 . . . . 0.0 108.499 170.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.602 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.8 pt -80.41 148.29 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.843 0 C-N-CA 126.277 1.831 . . . . 0.0 113.074 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -77.42 119.59 21.24 Favored 'General case' 1 N--CA 1.368 -4.533 0 N-CA-C 102.647 -3.094 . . . . 0.0 102.647 163.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 64' ' ' LYS . 82.0 p -36.13 -38.59 0.14 Allowed 'General case' 1 C--N 1.243 -4.051 0 C-N-CA 128.017 2.527 . . . . 0.0 113.168 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.5 t -71.71 -14.15 61.94 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.208 0.603 . . . . 0.0 112.155 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.97 -11.2 57.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.42 -0.8 . . . . 0.0 110.937 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.528 ' CG1' HD12 ' A' ' 52' ' ' ILE . 16.9 m -129.35 167.41 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.556 0.693 . . . . 0.0 111.336 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 mt-10 -131.34 110.55 11.15 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -75.77 159.5 5.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.251 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 C--N 1.283 -2.32 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.621 -178.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 74' ' ' TYR . 7.7 pt -67.18 -27.87 40.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.001 0.905 . . . . 0.0 108.746 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.2 ptmt -79.55 -5.38 54.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.22 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -108.66 -19.94 13.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tppt? -91.06 -68.0 0.82 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.031 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.618 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 3.1 t80 -89.12 -22.6 22.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 58.28 88.96 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.417 1.487 . . . . 0.0 111.206 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.673 HD11 HD22 ' A' ' 66' ' ' LEU . 1.9 mm? -95.65 -20.31 19.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.08 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 C--N 1.315 -0.917 0 C-N-CA 126.901 2.08 . . . . 0.0 114.666 179.263 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' C ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 . . . . . 0 N--CA 1.439 -0.995 0 CA-C-O 121.007 0.432 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.71 132.59 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.432 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -99.98 -30.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.171 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.5 m80 -165.41 161.92 19.14 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.27 116.61 33.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.681 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.03 154.54 17.64 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.813 0.816 . . . . 0.0 111.072 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.98 129.5 55.11 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.53 109.75 2.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 40.3 t -87.74 -5.96 58.42 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.619 0.723 . . . . 0.0 109.071 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.4 m -148.99 163.3 37.9 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.635 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.1 t70 -108.68 100.64 9.86 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.664 1.186 . . . . 0.0 110.734 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 46' ' ' PHE . 11.4 p -115.62 148.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.292 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.04 30.16 7.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.38 0.61 . . . . 0.0 112.461 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.92 59.85 1.55 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.236 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.81 140.97 15.07 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.53 31.0 20.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.841 0.456 . . . . 0.0 109.828 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.51 95.61 0.04 OUTLIER 'General case' 0 C--O 1.247 0.932 0 C-N-CA 125.001 1.32 . . . . 0.0 109.767 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.5 tt0 -150.13 -173.73 4.52 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.755 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.672 HD13 ' H ' ' A' ' 75' ' ' GLY . 45.6 tp -95.45 147.83 23.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 p -100.3 115.46 29.99 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.388 0.613 . . . . 0.0 110.096 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 37' ' ' VAL . 32.7 p90 -151.78 168.7 24.25 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.808 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.594 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -124.44 147.63 48.18 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -176.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 20.2 tt0 -51.45 121.84 6.99 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.804 0.335 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.77 29.94 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.295 -0.479 . . . . 0.0 114.147 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 27.6 mm-40 -85.61 -32.39 22.08 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.96 0.88 . . . . 0.0 113.047 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 73.95 111.83 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.524 1.154 . . . . 0.0 111.272 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.52 HD13 HD23 ' A' ' 44' ' ' LEU . 4.8 mt -118.49 173.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.782 -173.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' H ' HG22 ' A' ' 52' ' ' ILE . 24.6 mt-10 -128.94 134.05 48.07 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.7 tp -91.35 128.95 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.415 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -107.09 -53.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.749 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.618 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 20.2 ttm180 -127.62 137.78 52.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.495 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.74 -32.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 123.975 0.91 . . . . 0.0 112.07 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 p -102.81 164.1 11.83 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t70 71.45 19.57 5.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.876 1.322 . . . . 0.0 108.828 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.519 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 30.8 p-10 -80.51 118.1 70.84 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.869 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 12.1 Cg_exo -71.25 -33.29 11.56 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.737 2.958 . . . . 0.0 114.654 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 64' ' ' LYS . 1.5 mp0 -92.43 -17.07 25.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.135 0.493 . . . . 0.0 110.772 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.72 5.93 70.81 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.7 ptmt -102.88 162.59 12.81 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.52 ' HB2' HG13 ' A' ' 77' ' ' ILE . 44.1 m0 -95.69 176.6 6.09 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 123.393 0.677 . . . . 0.0 110.676 -176.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 21' ' ' LEU . 51.8 tp -117.04 113.58 22.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.37 147.93 18.9 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' THR . 43.9 ttp180 -120.9 154.33 36.02 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.038 0.447 . . . . 0.0 111.117 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.586 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m -99.4 153.13 19.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.24 -34.5 32.62 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 119.242 0.928 . . . . 0.0 113.272 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -71.65 -15.37 62.23 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.503 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.33 87.67 1.17 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.9 m -153.56 122.77 6.55 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' A' ' 66' ' ' LEU . 77.5 m-85 -113.37 99.21 7.61 Favored 'General case' 1 C--N 1.222 -4.951 0 O-C-N 123.902 0.751 . . . . 0.0 109.828 -171.21 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.672 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -104.19 101.69 2.01 Favored Glycine 1 N--CA 1.356 -6.633 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.71 103.19 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.884 0 CA-C-N 113.423 -1.389 . . . . 0.0 107.358 170.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.7 pt -87.71 143.89 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.97 0 C-N-CA 124.837 1.255 . . . . 0.0 113.728 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.09 117.6 18.81 Favored 'General case' 1 N--CA 1.371 -4.397 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 166.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.472 HG22 ' CG ' ' A' ' 65' ' ' TRP . 54.5 p -36.21 -39.48 0.18 Allowed 'General case' 0 C--N 1.244 -3.999 0 C-N-CA 128.868 2.867 . . . . 0.0 113.12 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -69.38 -12.61 61.8 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.255 1.022 . . . . 0.0 112.704 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.83 -12.75 41.06 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.591 -0.693 . . . . 0.0 110.997 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 52' ' ' ILE . 27.7 m -130.92 164.65 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-O 121.251 0.548 . . . . 0.0 111.088 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 45.6 mt-10 -132.26 113.29 13.06 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -76.27 166.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.566 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 C--N 1.304 -1.41 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.004 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 C--O 1.222 -0.366 0 CA-C-O 120.902 0.382 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.737 HG21 ' HB2' ' A' ' 74' ' ' TYR . 10.1 pt -68.8 -28.6 40.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.418 0.628 . . . . 0.0 110.903 -174.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.481 ' N ' HG13 ' A' ' 15' ' ' ILE . 25.7 mtpp -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.072 0.939 . . . . 0.0 108.493 -176.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HB3' ' NZ ' ' A' ' 17' ' ' LYS . 7.4 mtpm? -114.72 9.07 16.33 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.921 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 76' ' ' TYR . 11.9 tppt? -120.41 -60.88 1.64 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.209 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.7 t80 -91.53 -28.33 17.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 3.1 ttpm? 65.45 90.0 0.09 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.521 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 66' ' ' LEU . 1.7 mm? -98.73 -15.8 19.2 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.359 -174.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.307 80.4 p . . . . . 0 C--N 1.311 -1.075 0 C-N-CA 125.709 1.604 . . . . 0.0 113.079 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.7 p -80.04 134.78 26.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.508 0.671 . . . . 0.0 110.498 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.27 -38.86 11.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.987 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.6 m80 -161.65 165.01 28.87 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.57 124.76 49.4 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -99.34 158.89 15.4 Favored 'General case' 0 C--N 1.267 -2.99 0 CA-C-O 121.805 0.812 . . . . 0.0 111.831 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -106.83 125.58 51.19 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 109.88 2.15 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.448 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 41.9 t -84.69 -19.24 33.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.0 t -144.55 144.75 31.47 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.94 105.83 14.26 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.913 0.863 . . . . 0.0 111.234 174.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.31 151.35 18.12 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.425 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 66.78 1.11 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 121.896 0.855 . . . . 0.0 109.655 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 73.16 59.18 4.35 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.213 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.51 105.75 2.95 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 57.11 69.52 0.74 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.17 0.988 . . . . 0.0 110.95 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 54.49 83.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.781 0.832 . . . . 0.0 109.843 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 7.7 tt0 -149.59 -175.3 4.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.625 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.44 159.57 14.86 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.555 ' H ' HD23 ' A' ' 44' ' ' LEU . 14.8 m -101.42 118.68 37.46 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-O 121.566 0.698 . . . . 0.0 110.031 174.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.8 p90 -154.96 163.74 39.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.057 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.575 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 48.1 mtmt -117.72 156.17 28.71 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.86 116.07 1.8 Allowed 'General case' 0 CA--C 1.568 1.656 0 O-C-N 123.833 0.708 . . . . 0.0 109.325 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.99 17.58 40.24 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.575 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -80.34 -21.83 42.06 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 72.11 109.23 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.319 1.057 . . . . 0.0 110.871 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.6 mt -116.1 165.44 11.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' HG21 ' A' ' 27' ' ' VAL . 8.0 mt-10 -116.66 136.78 52.69 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 65' ' ' TRP . 7.4 tp -98.58 119.69 46.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.38 -53.24 7.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.9 tpm_? -122.43 123.96 42.53 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.901 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -113.66 -23.75 4.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.498 0.666 . . . . 0.0 110.599 174.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 p -90.85 150.33 21.59 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.718 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 60.11 55.27 3.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.234 1.014 . . . . 0.0 108.513 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -95.82 109.22 45.18 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.71 -59.95 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 124.008 3.139 . . . . 0.0 114.307 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.22 -17.52 56.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.687 0.28 . . . . 0.0 111.497 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.11 5.69 49.53 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -105.43 159.4 15.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.106 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.542 ' CD1' HG22 ' A' ' 57' ' ' ILE . 38.3 m0 -90.41 174.35 7.61 Favored 'General case' 0 C--O 1.198 -1.612 0 C-N-CA 123.459 0.703 . . . . 0.0 110.578 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 74' ' ' TYR . 58.0 tp -112.74 109.36 18.81 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.987 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 53' ' ' GLU . . . -114.08 155.13 16.52 Favored Glycine 0 N--CA 1.426 -1.986 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.8 ttp180 -133.95 147.1 51.01 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 73' ' ' SER . 13.4 t -104.17 163.87 12.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.58 -28.98 15.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.36 -21.02 56.61 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.491 0.663 . . . . 0.0 110.637 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.03 1.07 Allowed Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 59.6 m -152.54 125.5 8.5 Favored 'General case' 0 N--CA 1.386 -3.67 1 N-CA-C 100.03 -4.063 . . . . 0.0 100.03 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.83 ' HB3' HD11 ' A' ' 66' ' ' LEU . 35.1 m-85 -110.6 82.7 1.63 Allowed 'General case' 1 C--N 1.21 -5.482 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.28 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.625 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -98.44 97.48 1.9 Allowed Glycine 2 N--CA 1.363 -6.22 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.519 ' CE1' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.84 93.68 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.883 -1.659 . . . . 0.0 110.727 172.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -70.92 139.91 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 126.9 2.08 . . . . 0.0 113.617 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 118.03 18.2 Favored 'General case' 1 N--CA 1.353 -5.31 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 166.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CD2' ' A' ' 65' ' ' TRP . 73.7 p -35.1 -39.1 0.1 Allowed 'General case' 1 C--N 1.229 -4.67 0 C-N-CA 129.116 2.966 . . . . 0.0 112.807 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -72.02 -5.86 38.13 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.752 0.821 . . . . 0.0 112.26 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.0 -2.62 34.06 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.625 -0.672 . . . . 0.0 111.122 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 77' ' ' ILE . 19.3 m -134.38 159.86 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-O 121.784 0.802 . . . . 0.0 112.722 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.1 mt-10 -125.94 102.89 7.47 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.4 pp -69.14 149.21 11.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 CA--C 1.487 -1.454 0 CA-C-O 121.143 0.497 . . . . 0.0 111.162 176.877 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.241 0.643 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.629 HG21 ' HB2' ' A' ' 74' ' ' TYR . 10.0 pt -81.31 -23.22 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.585 1.183 . . . . 0.0 109.17 -171.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HG3' HG13 ' A' ' 15' ' ' ILE . 74.0 mttt -82.19 -9.07 59.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.32 -1.763 . . . . 0.0 110.791 -173.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 0.07 19.45 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.008 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 3.8 tppt? -114.18 -58.5 2.14 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.382 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 60' ' ' ASN . 20.1 t80 -85.94 -33.46 21.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 66.82 94.23 0.07 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.531 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.85 HD11 HD22 ' A' ' 66' ' ' LEU . 2.0 mm? -99.76 -64.85 1.0 Allowed 'General case' 0 CA--C 1.46 -2.518 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.052 -173.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.395 -3.225 0 CA-C-N 111.678 -2.51 . . . . 0.0 111.115 178.817 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -74.76 132.0 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 109.891 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.48 -33.26 5.16 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.952 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.7 m80 -166.72 165.64 16.32 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.63 116.01 31.18 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.24 159.34 15.32 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.944 0.878 . . . . 0.0 112.243 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.39 127.94 54.02 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.377 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -64.43 107.02 1.24 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 t -75.37 -19.12 59.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.438 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.0 p -153.15 159.58 42.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 48' ' ' GLN . 4.5 p30 -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.621 0.724 . . . . 0.0 109.543 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.686 HG22 ' H ' ' A' ' 39' ' ' GLY . 11.4 p -115.72 152.54 17.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.631 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.78 8.75 39.34 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.967 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 37' ' ' VAL . . . 84.01 60.21 1.98 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.52 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.43 80.08 1.68 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.263 -174.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 66.72 82.9 0.17 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.328 1.051 . . . . 0.0 113.309 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 89.28 26.12 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 125.516 1.526 . . . . 0.0 113.114 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.82 174.81 6.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.403 0.621 . . . . 0.0 111.668 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 46.4 tp -96.42 147.91 23.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.531 1.533 . . . . 0.0 107.315 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -96.89 121.81 39.16 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 120.907 0.385 . . . . 0.0 110.313 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CG ' HD11 ' A' ' 52' ' ' ILE . 26.9 p90 -155.66 160.04 40.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.616 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -108.91 152.42 24.95 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -62.48 117.14 5.79 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.907 0.754 . . . . 0.0 109.355 -176.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.78 30.03 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.567 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.94 -25.12 16.67 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 72.83 134.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 O-C-N 124.8 1.313 . . . . 0.0 113.041 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 82' ' ' VAL . 5.3 mt -129.64 169.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.339 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -119.07 135.5 54.61 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.1 tp -93.16 127.04 45.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -110.92 -56.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HD2' HD12 ' A' ' 21' ' ' LEU . 12.6 ttt180 -119.09 131.9 55.97 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.921 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.507 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -116.83 -32.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.063 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 p -107.36 161.11 15.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 t70 64.79 69.16 0.5 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 125.522 1.529 . . . . 0.0 112.814 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 9.2 p30 -145.09 163.3 33.41 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.538 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -95.72 10.91 1.48 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.218 1.946 . . . . 0.0 115.416 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 8.4 tp10 -122.98 -29.91 3.86 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.985 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.05 57.61 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.6 ptmt -92.5 163.12 13.94 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 109.266 -177.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.542 ' CD2' HG22 ' A' ' 79' ' ' THR . 43.2 m0 -101.89 169.53 8.72 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.893 0.377 . . . . 0.0 110.592 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.85 HD22 HD11 ' A' ' 21' ' ' LEU . 45.7 tp -109.58 110.51 21.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -112.74 142.83 17.5 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 73' ' ' SER . 50.2 ttt-85 -124.32 155.02 39.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 124.319 0.658 . . . . 0.0 110.188 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.551 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 5.2 m -113.52 162.05 16.64 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.96 -28.97 7.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -172.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -69.99 -28.52 65.59 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.034 0.534 . . . . 0.0 111.577 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 96.07 69.0 1.01 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.665 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.4 m -136.62 117.09 13.75 Favored 'General case' 0 N--CA 1.383 -3.806 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.629 ' HB2' HG21 ' A' ' 15' ' ' ILE . 90.2 m-85 -116.68 105.1 12.05 Favored 'General case' 1 C--N 1.223 -4.925 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -172.027 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.84 0.75 48.42 Favored Glycine 0 C--O 1.181 -3.19 0 C-N-CA 118.372 -1.87 . . . . 0.0 116.255 -175.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.584 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.268 0.1 OUTLIER 51.2 80.44 0.08 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 123.103 1.43 . . . . 0.0 111.417 -176.976 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 82' ' ' VAL . 2.0 pt -68.57 142.17 16.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.66 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.51 115.51 20.07 Favored 'General case' 1 N--CA 1.362 -4.831 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 165.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 64' ' ' LYS . 73.1 p -34.95 -38.3 0.08 Allowed 'General case' 1 C--N 1.244 -4.008 0 C-N-CA 128.918 2.887 . . . . 0.0 114.422 -177.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -68.98 -7.1 32.11 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.951 0.9 . . . . 0.0 111.709 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.26 -6.86 43.59 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 121.466 -0.771 . . . . 0.0 110.657 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 HD12 ' A' ' 77' ' ' ILE . 26.3 m -137.52 167.88 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-O 121.618 0.723 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.8 pt -77.81 163.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.545 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.793 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 CA--C 1.494 -1.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.785 HG21 ' HB2' ' A' ' 74' ' ' TYR . 7.1 pt -62.89 -33.4 60.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.068 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' N ' HG13 ' A' ' 15' ' ' ILE . 9.4 mptt -80.02 -4.34 52.22 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.174 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 42.7 tptt -112.99 -13.79 13.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -98.51 -61.76 1.33 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.074 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -87.62 -26.56 23.0 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 mttp 66.07 83.8 0.16 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.804 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 66' ' ' LEU . 1.2 mm? -100.19 -69.76 0.76 Allowed 'General case' 0 CA--C 1.466 -2.273 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.457 ' H ' ' HB2' ' A' ' 21' ' ' LEU . 3.0 m . . . . . 0 N--CA 1.388 -3.53 0 CA-C-N 111.881 -2.418 . . . . 0.0 112.272 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.1 p -94.05 145.3 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -100.9 -38.9 6.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.5 m80 -160.64 168.57 24.65 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.19 118.38 36.86 Favored 'General case' 0 C--O 1.191 -1.998 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.0 155.75 16.96 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-O 122.14 0.971 . . . . 0.0 110.659 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -103.65 129.88 51.03 Favored 'General case' 1 C--N 1.243 -4.05 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -67.67 110.76 3.87 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 20.7 t -80.46 -18.29 49.15 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.629 0.728 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.6 m -144.33 155.09 43.65 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -93.97 105.01 17.04 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -114.74 163.46 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.445 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 10.17 28.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 100.26 61.08 0.82 Allowed Glycine 0 CA--C 1.491 -1.459 0 C-N-CA 118.262 -1.923 . . . . 0.0 109.459 -173.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.05 99.66 1.42 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -172.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? 61.91 76.88 0.35 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.387 1.475 . . . . 0.0 110.741 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 t30 57.7 70.49 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.002 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 39.8 tt0 -145.67 -175.07 4.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.876 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.539 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.52 153.73 17.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -102.27 128.06 48.98 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 120.962 0.411 . . . . 0.0 109.96 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -158.82 171.33 20.26 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.051 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 98.7 mttt -120.44 142.8 48.9 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.2 pt20 -54.99 124.48 16.9 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.53 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.61 10.34 55.6 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.717 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 6.9 tp10 -69.66 -37.87 76.87 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.883 0.849 . . . . 0.0 110.103 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 5.7 tp60 70.51 102.14 0.06 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 126.205 1.802 . . . . 0.0 108.851 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.508 HD12 ' CG1' ' A' ' 82' ' ' VAL . 13.1 mt -104.23 156.02 5.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.83 ' HB3' HG21 ' A' ' 27' ' ' VAL . 34.3 mt-10 -116.06 126.55 53.92 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -85.4 118.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -104.15 -38.35 4.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.723 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -132.73 130.51 40.1 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.811 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.616 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -125.81 -32.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.683 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -85.06 143.66 28.75 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.08 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 t70 66.99 53.41 0.82 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.818 1.295 . . . . 0.0 109.752 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.51 114.89 64.52 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.452 177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.46 -53.67 0.28 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.917 1.745 . . . . 0.0 111.137 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 1.012 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 7.0 tp10 -66.56 -40.56 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.43 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.31 -18.11 18.48 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 1.012 ' HD2' ' HG2' ' A' ' 62' ' ' GLU . 14.0 ptmt -76.11 163.32 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.529 1.132 . . . . 0.0 109.299 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.616 ' CD1' HG22 ' A' ' 57' ' ' ILE . 27.6 m0 -95.31 164.84 12.66 Favored 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 122.862 0.465 . . . . 0.0 112.157 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -111.79 113.76 26.31 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -126.56 160.3 20.89 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.676 ' HA ' ' O ' ' A' ' 73' ' ' SER . 54.5 ttp180 -131.47 152.72 50.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 24.7 m -112.76 164.59 13.19 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.04 -18.31 9.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmm_? -82.93 -24.98 32.81 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 83.9 1.66 Allowed Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.6 m -151.69 117.58 5.49 Favored 'General case' 0 N--CA 1.383 -3.824 0 N-CA-C 101.041 -3.689 . . . . 0.0 101.041 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.785 ' HB2' HG21 ' A' ' 15' ' ' ILE . 22.2 m-85 -109.97 83.23 1.72 Allowed 'General case' 1 C--N 1.219 -5.085 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -99.84 97.35 1.76 Allowed Glycine 2 N--CA 1.369 -5.808 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.597 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -40.82 100.75 0.02 OUTLIER 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 112.555 -1.822 . . . . 0.0 109.163 171.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.725 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -81.42 147.99 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.512 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.371 -177.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 9.6 ptpp? -76.35 118.45 19.06 Favored 'General case' 1 N--CA 1.358 -5.06 0 N-CA-C 102.915 -2.995 . . . . 0.0 102.915 163.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.6 p -36.46 -39.36 0.19 Allowed 'General case' 1 C--N 1.241 -4.151 0 C-N-CA 128.193 2.597 . . . . 0.0 113.026 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.1 -10.0 55.46 Favored 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 123.882 0.873 . . . . 0.0 112.25 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.77 -9.84 36.19 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.426 -0.796 . . . . 0.0 111.028 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 52' ' ' ILE . 13.3 m -126.58 167.23 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.129 0.49 . . . . 0.0 111.482 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.98 113.02 9.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.9 pt -75.46 159.39 5.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.116 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.825 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 13.1 pt-20 . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 120.58 0.229 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.52 -24.07 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 C-N-CA 124.785 1.234 . . . . 0.0 113.119 -169.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HA ' HD23 ' A' ' 21' ' ' LEU . 12.4 mptt -54.48 -58.82 5.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 124.125 0.891 . . . . 0.0 113.139 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -83.78 8.89 13.3 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 121.058 0.456 . . . . 0.0 111.783 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 30.5 mmmt -92.16 -61.34 1.64 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.596 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.4 t80 -86.58 -21.63 26.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 tttm 71.55 83.46 0.14 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.077 0.941 . . . . 0.0 110.134 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.734 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.6 -65.0 0.99 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.393 -177.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 5.1 t . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.136 1.775 . . . . 0.0 114.047 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.04 131.8 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 109.744 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -96.57 -33.51 4.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.95 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.476 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.8 m80 -165.13 174.03 10.78 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.87 116.55 30.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.288 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.717 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -97.09 156.02 16.56 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-O 121.703 0.763 . . . . 0.0 111.688 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -107.12 123.95 48.98 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.36 106.16 1.31 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.9 t -87.25 -8.41 56.83 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.344 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -144.6 130.71 19.49 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . 7.2 p-10 -77.13 99.49 5.41 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.45 1.119 . . . . 0.0 108.339 172.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.78 163.25 11.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.566 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.51 25.37 7.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.787 0.327 . . . . 0.0 111.063 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.96 60.13 0.84 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.827 -1.178 . . . . 0.0 111.113 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 91.67 0.66 Allowed Glycine 0 C--N 1.316 -0.545 0 O-C-N 123.808 0.357 . . . . 0.0 112.948 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt 61.92 72.11 0.52 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.996 1.319 . . . . 0.0 109.797 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 58.48 80.15 0.19 Allowed 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.227 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 10.3 tt0 -145.1 -175.92 4.89 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.311 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 45' ' ' SER . 2.3 tt -96.44 149.59 21.55 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.443 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.2 m -98.21 115.3 28.05 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.342 0.591 . . . . 0.0 110.052 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.537 ' HD1' ' HB1' ' A' ' 33' ' ' ALA . 22.3 p90 -144.52 161.63 38.61 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.295 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.558 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mmpt? -114.92 154.74 28.16 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 98.8 mt-30 -53.49 126.16 20.54 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.075 0.859 . . . . 0.0 110.873 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.39 20.77 74.27 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.753 -0.658 . . . . 0.0 114.451 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 30.4 mm-40 -74.83 -30.37 61.36 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.725 0.762 . . . . 0.0 112.844 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? 75.61 116.99 0.06 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.906 1.379 . . . . 0.0 109.032 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.536 HD12 ' CG1' ' A' ' 82' ' ' VAL . 12.8 mt -118.26 154.52 20.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.83 139.13 47.56 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.809 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.0 tp -94.77 126.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -47.55 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.959 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.64 HH21 ' HB3' ' A' ' 59' ' ' ASP . 22.9 ttt180 -130.47 133.58 46.41 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -125.0 -33.95 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.781 -178.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -100.01 150.12 22.77 Favored 'General case' 0 C--O 1.25 1.106 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.896 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.64 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.7 t70 62.32 69.27 0.62 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.566 1.166 . . . . 0.0 108.264 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.53 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 7.2 p30 -112.75 139.37 22.73 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.379 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 11.9 Cg_exo -73.61 -58.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.893 2.395 . . . . 0.0 114.345 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.93 -42.74 38.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.647 0.737 . . . . 0.0 111.07 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.53 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 121.13 17.86 3.97 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.671 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 16.2 ptmt -117.24 162.56 17.68 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.598 ' CD2' HG22 ' A' ' 79' ' ' THR . 35.8 m0 -97.21 171.37 8.49 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.103 0.561 . . . . 0.0 111.63 -173.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.734 HD22 HD11 ' A' ' 21' ' ' LEU . 50.4 tp -112.11 105.88 14.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.44 161.02 12.83 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' A' ' 73' ' ' SER . 53.8 ttp180 -138.81 153.64 48.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.204 0.525 . . . . 0.0 110.491 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 11.5 m -100.02 154.68 18.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.7 -33.25 60.7 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.91 0.777 . . . . 0.0 112.803 -173.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -2.77 41.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.19 96.76 0.79 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.431 0.462 . . . . 0.0 112.752 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 24.5 m -154.78 120.69 5.19 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.58 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 70.2 m-85 -117.43 94.32 4.5 Favored 'General case' 1 C--N 1.221 -5.019 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -177.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -109.52 11.92 33.07 Favored Glycine 1 CA--C 1.437 -4.836 0 C-N-CA 117.283 -2.389 . . . . 0.0 115.679 -173.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.671 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.275 0.1 OUTLIER 47.28 89.73 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.341 0 CA-C-O 122.764 1.269 . . . . 0.0 111.754 -178.413 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.696 HD12 HG21 ' A' ' 82' ' ' VAL . 2.3 pt -70.5 140.39 18.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.573 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 64' ' ' LYS . 7.5 ptpp? -80.1 118.55 21.91 Favored 'General case' 1 N--CA 1.372 -4.343 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.598 HG22 ' CD2' ' A' ' 65' ' ' TRP . 70.7 p -34.96 -33.05 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.939 0 C-N-CA 128.905 2.882 . . . . 0.0 114.435 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -77.02 -11.81 59.85 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 123.293 0.637 . . . . 0.0 112.229 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.24 -3.76 53.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.213 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.696 HG21 HD12 ' A' ' 77' ' ' ILE . 16.4 m -133.23 170.21 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 121.538 0.685 . . . . 0.0 110.93 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.45 107.56 7.18 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.717 HG22 ' HB2' ' A' ' 31' ' ' ALA . 18.5 pt -80.81 165.62 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.508 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--N 1.287 -2.126 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.933 175.604 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.8 mt-10 . . . . . 0 CA--C 1.491 -1.311 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.607 ' HA ' ' HE1' ' A' ' 76' ' ' TYR . 1.9 pp -65.85 -29.66 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.386 0.612 . . . . 0.0 110.413 -173.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 55.4 mtpt -71.49 -34.86 70.52 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.062 -1.427 . . . . 0.0 112.011 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -102.45 -12.82 17.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.959 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 7.4 tppt? -82.32 -54.26 5.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.593 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 9.9 t80 -86.36 -28.09 23.85 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 25.7 ttpt 71.33 89.99 0.1 Allowed 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.565 1.146 . . . . 0.0 110.328 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.726 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.66 -56.47 2.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.316 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 C--N 1.312 -1.052 0 C-N-CA 124.701 1.2 . . . . 0.0 112.439 179.071 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.626 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.4 p -83.81 123.5 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.266 1.032 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.8 mm -85.71 -34.51 8.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -167.19 166.2 15.03 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp -105.01 116.21 31.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -90.18 154.06 20.04 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 122.087 0.946 . . . . 0.0 110.914 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -106.95 119.29 38.97 Favored 'General case' 0 C--N 1.254 -3.546 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.06 103.7 1.01 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -87.65 -10.98 49.79 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.3 m -136.12 130.55 33.49 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.765 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -76.7 102.89 6.39 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.69 0.757 . . . . 0.0 110.402 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.34 155.68 15.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.623 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 55.85 1.65 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.513 0.673 . . . . 0.0 111.413 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 60.5 1.73 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.694 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.42 78.42 1.62 Allowed Glycine 0 C--N 1.309 -0.964 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttm 67.32 81.21 0.2 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.857 1.263 . . . . 0.0 110.362 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 56.15 74.51 0.39 Allowed 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.604 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 7.4 tt0 -144.3 -175.52 4.66 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.142 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -98.42 157.86 15.94 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -102.86 115.93 31.56 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.548 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 25.2 p90 -148.06 153.97 39.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.172 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 68.0 mttm -105.75 151.3 24.62 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.298 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.533 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -55.6 113.66 1.54 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.145 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.71 21.14 22.33 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.106 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.4 tp10 -73.05 -44.27 60.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.224 0.61 . . . . 0.0 111.638 -176.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 74.71 107.3 0.07 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.96 1.412 . . . . 0.0 109.218 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.594 HD12 ' CG1' ' A' ' 82' ' ' VAL . 7.6 mt -116.61 164.07 13.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 107.721 -172.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.626 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 21.9 mt-10 -116.68 133.38 56.08 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.7 tp -92.21 124.58 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.609 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.22 -37.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.536 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 31.7 ttm180 -136.77 133.56 36.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.619 175.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -127.27 -19.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 124.789 1.235 . . . . 0.0 111.832 -176.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -99.94 143.93 29.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 59.32 67.37 0.91 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.877 1.36 . . . . 0.0 110.296 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -86.68 130.94 47.02 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.331 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.593 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -55.61 -66.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.734 2.289 . . . . 0.0 112.219 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.721 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 42.4 mt-10 -94.43 -3.76 49.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.26 0.553 . . . . 0.0 110.932 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.99 -17.12 35.57 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.721 ' HD2' ' HB2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.31 152.48 34.52 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.693 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.554 ' HB2' HG13 ' A' ' 77' ' ' ILE . 34.6 m0 -87.08 177.06 7.32 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 124.282 1.033 . . . . 0.0 110.344 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD22 HD11 ' A' ' 21' ' ' LEU . 52.5 tp -113.89 113.78 25.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.48 154.01 16.74 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 73' ' ' SER . 59.4 ttp180 -137.25 152.02 49.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.237 0.542 . . . . 0.0 110.786 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.587 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 21.6 m -100.71 157.15 16.9 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 175.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.43 14.94 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -73.6 -12.18 60.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.449 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 84.14 87.01 0.86 Allowed Glycine 0 N--CA 1.433 -1.546 0 CA-C-O 121.718 0.621 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.2 m -151.12 121.43 7.3 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 100.229 -3.989 . . . . 0.0 100.229 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.609 ' HE2' HG13 ' A' ' 55' ' ' ILE . 52.8 m-85 -115.84 90.21 3.28 Favored 'General case' 1 C--N 1.232 -4.501 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -171.146 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -106.56 96.84 1.16 Allowed Glycine 3 N--CA 1.375 -5.385 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.607 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -43.23 94.88 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 O-C-N 125.597 1.41 . . . . 0.0 110.869 174.664 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 82' ' ' VAL . 2.6 pt -70.64 143.24 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.222 0 C-N-CA 127.2 2.2 . . . . 0.0 114.824 -174.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' NZ ' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -78.46 116.63 18.99 Favored 'General case' 1 N--CA 1.351 -5.38 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 166.976 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.5 p -36.13 -29.86 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.955 0 C-N-CA 128.411 2.684 . . . . 0.0 113.83 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 t -84.14 -0.74 53.17 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 123.206 0.603 . . . . 0.0 111.649 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.53 -12.49 21.18 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 120.78 -1.2 . . . . 0.0 110.286 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.634 HG21 HD12 ' A' ' 77' ' ' ILE . 35.3 m -135.16 166.82 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.471 0.653 . . . . 0.0 110.757 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -140.24 123.03 16.43 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 171.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 pt -70.64 161.26 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.225 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--N 1.29 -2.014 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.591 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 31.0 mm-40 . . . . . 0 C--O 1.222 -0.364 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -92.73 -28.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 20.8 ptmt -66.57 -41.96 87.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.008 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -94.18 -0.35 55.26 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.899 0.857 . . . . 0.0 109.77 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 76' ' ' TYR . 10.7 tppt? -85.53 -65.22 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 11.4 t80 -78.85 -25.94 44.06 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 32.2 mtmm 68.18 88.23 0.11 Allowed 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.497 1.119 . . . . 0.0 110.32 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.746 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -97.17 -25.65 15.23 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.318 -175.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 74.9 p . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 126.525 1.93 . . . . 0.0 113.896 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 . . . . . 0 CA--C 1.526 0.021 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.3 p -81.77 133.01 30.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.172 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.55 -38.25 10.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.709 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 24.3 m80 -161.3 171.35 18.49 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.35 132.59 54.91 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -104.76 161.64 13.99 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.984 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -106.88 129.26 54.74 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.37 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -74.05 102.41 4.18 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.404 ' SG ' ' HG3' ' A' ' 83' ' ' GLU . 69.2 m -86.29 -5.06 59.26 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.82 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -133.99 140.37 46.68 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.23 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 48' ' ' GLN . 15.1 p-10 -91.07 99.09 12.18 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.327 1.061 . . . . 0.0 108.994 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.85 150.05 16.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -119.5 33.94 5.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.733 0.778 . . . . 0.0 110.202 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 95.83 58.86 1.09 Allowed Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.823 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.13 117.27 4.76 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 65.46 37.12 6.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.353 1.061 . . . . 0.0 110.858 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 t30 63.71 89.21 0.09 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.313 1.054 . . . . 0.0 109.794 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.572 ' HG3' ' H ' ' A' ' 44' ' ' LEU . 2.1 tp10 -136.95 -172.98 3.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.045 -168.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.669 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.7 tt -95.08 148.15 22.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.426 ' H ' HD23 ' A' ' 44' ' ' LEU . 16.1 m -96.71 115.76 27.98 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.827 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 22.6 p90 -147.01 158.99 44.1 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.268 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 9.3 mtmp? -108.39 156.7 19.13 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.433 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -59.44 118.77 6.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.04 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.85 25.78 28.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 11.5 tp10 -74.56 -36.85 63.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 122.844 0.458 . . . . 0.0 110.66 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 72.41 109.17 0.07 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 125.448 1.499 . . . . 0.0 108.849 -172.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.576 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.7 mt -115.29 162.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.618 ' HB3' HG21 ' A' ' 27' ' ' VAL . 11.9 mt-10 -116.76 140.59 49.25 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.527 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.9 tp -101.77 125.01 55.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -111.02 -46.25 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.672 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.807 HH21 ' HB3' ' A' ' 59' ' ' ASP . 47.6 ttt180 -130.61 138.51 50.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.95 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.502 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.6 -37.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 123.805 0.842 . . . . 0.0 111.16 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 p -98.4 156.04 16.94 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.807 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.9 t70 67.3 71.59 0.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.439 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.779 HD21 ' HG2' ' A' ' 64' ' ' LYS . 32.0 t30 -154.16 117.44 2.61 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.218 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 60' ' ' ASN . 18.0 Cg_endo -59.31 -23.0 67.99 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.649 2.9 . . . . 0.0 114.073 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.89 -16.67 61.1 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.128 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.41 27.76 70.88 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.779 ' HG2' HD21 ' A' ' 60' ' ' ASN . 7.1 ptmt -118.79 161.4 20.2 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.56 ' HB2' HG13 ' A' ' 77' ' ' ILE . 42.5 m0 -99.86 176.46 5.43 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 -178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.746 HD22 HD11 ' A' ' 21' ' ' LEU . 62.8 tp -117.13 110.52 18.29 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.59 158.19 14.45 Favored Glycine 0 N--CA 1.419 -2.449 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.89 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.5 ttp180 -139.16 151.68 46.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -106.34 165.6 11.14 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.7 62.91 0.82 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.352 1.073 . . . . 0.0 111.664 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -170.29 -27.4 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.911 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.29 88.52 1.96 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 26.3 m -152.72 117.91 5.2 Favored 'General case' 0 N--CA 1.381 -3.877 0 N-CA-C 100.805 -3.776 . . . . 0.0 100.805 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.604 ' HB3' HD11 ' A' ' 66' ' ' LEU . 64.5 m-85 -110.78 81.87 1.5 Allowed 'General case' 1 C--N 1.216 -5.221 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -173.125 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.669 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -101.57 99.09 1.87 Allowed Glycine 2 N--CA 1.347 -7.276 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -44.39 101.17 0.02 OUTLIER 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 112.185 -2.007 . . . . 0.0 108.215 169.722 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.608 HD12 HG21 ' A' ' 82' ' ' VAL . 2.0 pt -82.41 147.27 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.98 0 C-N-CA 126.822 2.049 . . . . 0.0 113.478 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HZ3' ' CD ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -80.93 118.83 22.76 Favored 'General case' 1 N--CA 1.354 -5.268 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 166.38 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.503 HG22 ' CG ' ' A' ' 65' ' ' TRP . 55.0 p -35.96 -39.81 0.18 Allowed 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 128.113 2.565 . . . . 0.0 112.984 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -72.09 -10.52 59.89 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.348 1.059 . . . . 0.0 112.891 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.04 -12.94 39.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.578 0.704 . . . . 0.0 110.159 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 HD12 ' A' ' 77' ' ' ILE . 30.7 m -130.97 173.48 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.785 0.802 . . . . 0.0 111.412 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 44.1 mt-10 -137.95 122.64 18.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 31' ' ' ALA . 12.4 pt -86.48 158.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.935 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.616 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 pp -78.55 -27.04 14.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.4 0.619 . . . . 0.0 109.52 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -55.5 -55.43 31.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.213 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -87.6 4.43 43.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.539 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 9.9 tppt? -94.46 -53.06 4.05 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.798 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t80 -90.25 -24.81 20.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp 70.71 86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.105 1.362 . . . . 0.0 110.616 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 66' ' ' LEU . 1.4 mm? -99.05 -53.21 3.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.37 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--N 1.314 -0.962 0 C-N-CA 125.267 1.427 . . . . 0.0 113.66 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.644 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -71.78 130.14 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.885 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.6 mm -83.47 -40.32 15.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.754 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.0 m80 -160.72 167.79 26.15 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.04 120.48 41.89 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.694 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -98.24 151.35 20.55 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.495 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -107.61 135.38 49.15 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.83 112.78 3.42 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 49.5 t -86.07 -12.47 50.06 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.616 0.722 . . . . 0.0 109.925 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -149.34 155.93 41.27 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.854 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 4.5 p-10 -99.42 112.89 25.01 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.738 0.78 . . . . 0.0 109.088 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.48 163.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.085 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.61 21.43 7.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.895 0.379 . . . . 0.0 111.604 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.37 59.69 1.9 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.72 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.03 138.52 13.96 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm 66.91 33.65 5.79 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.92 0.867 . . . . 0.0 108.903 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 61.49 84.81 0.13 Allowed 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.235 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.528 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 19.4 tt0 -138.04 -175.22 4.02 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 73' ' ' SER . 0.7 OUTLIER -96.64 153.19 18.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.507 ' H ' HD23 ' A' ' 44' ' ' LEU . 8.6 p -105.89 124.87 50.27 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -157.9 166.92 31.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.398 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.854 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 66.9 mmtt -112.63 147.03 37.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 19.2 tt0 -52.24 124.27 12.75 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.295 0.638 . . . . 0.0 110.292 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 13.63 75.14 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.911 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 30.9 tt0 -70.89 -39.83 72.56 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 26.8 tt0 92.52 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.247 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.1 mt -120.27 160.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.375 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.644 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 17.4 mt-10 -116.22 142.59 46.63 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.3 tp -102.42 127.65 55.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.77 -49.2 6.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.798 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 10.8 ttm180 -126.48 140.49 52.42 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.112 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.56 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -128.85 -37.27 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 123.833 0.853 . . . . 0.0 111.016 -177.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 p -117.21 168.85 9.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.0 t70 60.43 65.5 1.06 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.466 1.127 . . . . 0.0 110.137 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -140.84 172.45 6.15 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.632 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -94.45 13.04 1.52 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.011 1.807 . . . . 0.0 114.272 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.725 ' HG3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 tm-20 -135.12 -72.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.56 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -25.76 2.14 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.725 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 13.7 ptmt -61.87 162.76 8.45 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.862 1.265 . . . . 0.0 110.779 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.56 ' CD1' HG22 ' A' ' 57' ' ' ILE . 49.0 m0 -102.31 166.6 10.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.98 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -112.7 108.11 17.02 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -113.28 160.73 12.97 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.735 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.3 ttp180 -135.29 141.2 45.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.646 0.736 . . . . 0.0 111.801 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 p -101.37 167.25 10.29 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.421 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.28 37.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.162 0.985 . . . . 0.0 113.292 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.74 -19.29 55.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.029 0.443 . . . . 0.0 110.188 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.94 86.25 0.87 Allowed Glycine 0 CA--C 1.489 -1.561 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.6 m -151.22 125.16 9.18 Favored 'General case' 0 N--CA 1.381 -3.884 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.643 ' HB3' HD11 ' A' ' 66' ' ' LEU . 50.0 m-85 -108.5 73.84 0.89 Allowed 'General case' 1 C--N 1.213 -5.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -176.412 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -92.44 97.64 2.3 Favored Glycine 2 N--CA 1.375 -5.429 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -178.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -44.04 96.38 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 125.408 1.299 . . . . 0.0 110.253 172.144 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.647 HD12 HG21 ' A' ' 82' ' ' VAL . 1.6 pt -77.38 144.82 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.436 -3.414 0 C-N-CA 126.625 1.97 . . . . 0.0 113.232 -175.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -79.95 118.4 21.66 Favored 'General case' 1 N--CA 1.359 -5.008 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 165.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.544 HG23 ' HA ' ' A' ' 64' ' ' LYS . 69.3 p -35.8 -39.09 0.14 Allowed 'General case' 1 C--N 1.241 -4.12 0 C-N-CA 128.369 2.668 . . . . 0.0 112.815 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -69.85 -1.4 9.33 Favored 'General case' 0 CA--C 1.564 1.5 0 C-N-CA 124.085 0.954 . . . . 0.0 112.213 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.23 -8.47 21.26 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.737 -0.602 . . . . 0.0 111.213 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 77' ' ' ILE . 22.3 m -137.05 165.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 CA-C-O 121.312 0.577 . . . . 0.0 112.221 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 50.4 mt-10 -129.47 119.59 24.01 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.694 HG22 ' HB2' ' A' ' 31' ' ' ALA . 8.6 pt -89.55 162.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.173 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 C--N 1.297 -1.691 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.603 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.886 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -85.79 -26.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 122.33 -0.231 . . . . 0.0 111.326 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -54.86 -45.13 74.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 124.234 0.959 . . . . 0.0 112.818 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.28 -9.35 27.77 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.243 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 13.4 tppt? -78.28 -63.84 1.3 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.648 -173.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.668 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.2 t80 -81.09 -24.46 37.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 38.1 ttpt 66.86 87.79 0.12 Allowed 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.384 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.551 HD12 ' HD2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -98.3 -65.54 0.96 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 C--N 1.317 -0.841 0 C-N-CA 125.025 1.33 . . . . 0.0 113.745 175.83 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.87 134.05 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.746 0.784 . . . . 0.0 109.271 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.434 ' HB ' HG23 ' A' ' 54' ' ' ILE . 36.2 mm -97.24 -35.2 5.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.435 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 28.3 m80 -168.38 169.98 10.22 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.53 119.49 39.33 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.06 158.17 15.92 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.025 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -106.99 127.82 53.8 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.654 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.65 106.76 2.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.0 m -83.58 -5.08 59.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.8 t -158.75 143.15 15.72 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -80.21 107.94 13.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.721 175.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.67 163.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.919 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.81 23.32 12.03 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.933 -0.48 . . . . 0.0 110.814 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.31 60.16 1.58 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.035 -1.555 . . . . 0.0 111.291 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.82 120.07 5.11 Favored Glycine 0 C--N 1.306 -1.113 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.086 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.599 ' N ' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER 63.65 45.71 4.47 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.287 0.635 . . . . 0.0 110.48 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.3 t30 63.49 85.95 0.13 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.041 0.936 . . . . 0.0 109.616 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.673 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 5.4 tt0 -145.67 -173.92 4.26 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.082 -174.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.656 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -95.72 155.67 16.65 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.439 ' H ' HD23 ' A' ' 44' ' ' LEU . 7.2 m -101.56 116.03 31.84 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.493 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 26.6 p90 -149.73 159.34 44.42 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 49.3 mttm -112.93 156.45 22.97 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -59.09 127.34 31.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.891 0.377 . . . . 0.0 110.078 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.89 21.14 61.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.088 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.5 mm-40 -88.57 -23.99 22.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 70.78 129.91 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.57 1.169 . . . . 0.0 111.363 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 82' ' ' VAL . 7.8 mt -127.51 162.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -112.28 136.08 52.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 66' ' ' LEU . 9.7 tp -94.35 123.33 46.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.69 -36.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.103 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.668 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -135.5 130.13 34.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.713 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -130.85 2.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 124.578 1.151 . . . . 0.0 109.725 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -117.47 154.15 31.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.655 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 64.58 18.89 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.98 1.312 . . . . 0.0 111.337 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 21.4 p-10 -77.55 111.46 17.56 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.284 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 22.1 Cg_exo -66.56 -58.41 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.783 2.989 . . . . 0.0 113.134 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 23.8 tt0 -66.54 -30.58 70.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.984 0.421 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.62 12.24 25.08 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.325 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 12.9 ptmt -101.9 162.13 13.14 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 57' ' ' ILE . 42.6 m0 -95.82 176.13 6.25 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 123.255 0.622 . . . . 0.0 110.577 -175.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 74' ' ' TYR . 61.2 tp -119.21 113.7 21.28 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.92 157.32 15.12 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.7 ttt-85 -135.56 153.3 51.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.558 0.694 . . . . 0.0 111.61 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 35.2 m -105.61 154.37 20.51 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.23 -33.96 13.85 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -53.97 -43.02 69.57 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.207 1.004 . . . . 0.0 110.663 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.29 83.26 1.7 Allowed Glycine 0 N--CA 1.413 -2.834 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.196 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 49.6 m -151.53 123.3 8.01 Favored 'General case' 1 N--CA 1.376 -4.138 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.886 ' HB2' HG21 ' A' ' 15' ' ' ILE . 57.9 m-85 -113.87 92.67 4.06 Favored 'General case' 1 C--N 1.216 -5.221 0 O-C-N 125.108 1.505 . . . . 0.0 107.07 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.656 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -102.02 103.14 2.44 Favored Glycine 3 N--CA 1.359 -6.499 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.84 98.09 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 112.946 -1.627 . . . . 0.0 108.213 170.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.673 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.1 pt -85.15 143.46 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.814 0 C-N-CA 126.283 1.833 . . . . 0.0 114.127 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -77.62 118.34 19.92 Favored 'General case' 1 N--CA 1.372 -4.345 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 164.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.494 HG22 ' CG ' ' A' ' 65' ' ' TRP . 48.4 p -35.26 -38.49 0.1 Allowed 'General case' 1 C--N 1.236 -4.333 0 C-N-CA 129.253 3.021 . . . . 0.0 113.588 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.1 -15.49 63.75 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 0.0 112.698 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.99 48.81 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.954 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 52' ' ' ILE . 30.3 m -137.11 172.07 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 CA-C-O 121.779 0.8 . . . . 0.0 111.411 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.79 122.81 17.89 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.651 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 pt -77.55 171.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.001 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.317 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.509 -0.623 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.4 pp -66.04 -31.08 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.4 mptt -69.28 -23.37 63.82 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.667 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.15 -29.91 11.86 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.243 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.52 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 6.9 tppt? -73.12 -61.15 1.92 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.845 0.355 . . . . 0.0 111.13 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -79.1 -34.17 43.76 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 68.7 99.23 0.06 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.947 -178.24 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.014 HD12 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.79 -57.34 2.2 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.633 0.73 . . . . 0.0 110.15 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 29.2 p . . . . . 0 C--N 1.308 -1.205 0 C-N-CA 125.399 1.48 . . . . 0.0 113.098 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.431 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.7 pt20 . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -59.37 126.34 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 122.056 0.932 . . . . 0.0 111.174 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.2 -31.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.475 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 27.1 m80 -163.22 157.33 20.25 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.51 118.1 34.44 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -96.1 156.12 16.47 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-O 122.014 0.911 . . . . 0.0 111.202 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 35.1 ttpt -106.68 128.27 54.05 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.745 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.96 105.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.72 -18.33 61.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.674 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -160.53 156.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.41 119.25 20.02 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.02 163.72 10.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.666 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -102.06 -4.94 25.15 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.98 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 77.64 60.58 2.76 Favored Glycine 0 C--O 1.241 0.568 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.092 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.409 ' N ' ' HB3' ' A' ' 43' ' ' GLU . . . -104.67 131.33 10.6 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 115.084 -0.558 . . . . 0.0 113.035 -172.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.8 69.97 0.68 Allowed 'General case' 0 C--O 1.249 1.041 0 C-N-CA 125.301 1.44 . . . . 0.0 109.743 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.05 68.62 0.83 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.223 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 31.9 tt0 -136.42 172.98 12.21 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.537 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 73' ' ' SER . 1.7 tt -97.9 141.29 31.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 p -98.78 118.24 35.07 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.864 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.464 ' HE2' HG22 ' A' ' 77' ' ' ILE . 22.5 p90 -142.35 170.11 16.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.708 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 98.3 mttt -119.55 161.44 20.6 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -63.62 129.29 39.56 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.43 46.53 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.345 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 31.6 mm-40 -89.42 -26.14 21.16 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 70.3 120.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.933 1.396 . . . . 0.0 111.307 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.61 HD12 ' CG1' ' A' ' 82' ' ' VAL . 8.9 mt -119.31 158.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.86 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 14.7 mt-10 -116.67 132.68 56.62 Favored 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 57' ' ' ILE . 8.6 tp -93.08 125.7 45.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.431 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -110.13 -47.88 6.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.442 176.606 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 1.014 ' HG3' HD12 ' A' ' 21' ' ' LEU . 18.2 mmt180 -120.06 107.8 13.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.822 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -104.53 -30.16 2.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 113.252 -1.795 . . . . 0.0 107.192 172.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 57' ' ' ILE . 15.6 p -86.68 142.05 28.49 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.565 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 71.55 31.09 2.32 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.451 1.12 . . . . 0.0 110.957 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 8.8 p30 -72.87 126.24 90.69 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.941 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 2.1 Cg_endo -80.58 -61.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.618 2.212 . . . . 0.0 113.256 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.4 tt0 -79.21 -2.96 43.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.302 0.572 . . . . 0.0 111.268 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 87.51 21.17 49.13 Favored Glycine 0 CA--C 1.497 -1.087 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.513 -176.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.688 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.3 ptmt -118.21 156.88 28.01 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 57' ' ' ILE . 25.6 m0 -98.12 171.9 7.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.145 0.278 . . . . 0.0 110.94 -174.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 21' ' ' LEU . 65.4 tp -111.1 107.33 16.66 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.46 158.57 14.23 Favored Glycine 0 N--CA 1.416 -2.664 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 73' ' ' SER . 45.8 ttp180 -135.17 144.73 47.19 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.694 0.797 . . . . 0.0 109.888 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -101.4 165.14 11.42 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.89 -29.78 65.34 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -74.83 -9.62 58.72 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.03 89.82 0.49 Allowed Glycine 0 N--CA 1.434 -1.454 0 CA-C-O 121.908 0.727 . . . . 0.0 111.754 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.705 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.1 m -153.16 117.46 4.9 Favored 'General case' 0 N--CA 1.389 -3.514 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.596 ' HB2' HG21 ' A' ' 15' ' ' ILE . 64.8 m-85 -110.76 96.67 6.31 Favored 'General case' 1 C--N 1.221 -4.999 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.501 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -110.98 11.85 29.36 Favored Glycine 1 CA--C 1.445 -4.313 0 C-N-CA 117.77 -2.157 . . . . 0.0 115.516 -174.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.688 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 48.13 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.853 1.311 . . . . 0.0 111.651 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.601 HD12 HG21 ' A' ' 82' ' ' VAL . 2.1 pt -67.8 145.92 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.1 0 C-N-CA 126.029 1.731 . . . . 0.0 113.584 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 8.7 ptpp? -81.36 112.99 19.15 Favored 'General case' 1 N--CA 1.379 -4.01 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 165.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.477 HG22 ' CG ' ' A' ' 65' ' ' TRP . 43.2 p -36.3 -36.75 0.1 Allowed 'General case' 0 C--N 1.251 -3.685 0 C-N-CA 128.006 2.522 . . . . 0.0 113.757 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.82 -9.88 56.36 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.802 0.841 . . . . 0.0 112.318 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.51 -6.38 49.84 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.652 -0.655 . . . . 0.0 109.979 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.61 ' CG1' HD12 ' A' ' 52' ' ' ILE . 31.3 m -131.17 162.77 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.94 111.36 11.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 14.3 pt -76.71 171.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.047 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 . . . . . 0 C--N 1.301 -1.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 171.278 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.7 mp0 . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 120.869 0.366 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.697 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.4 pp -90.22 -20.56 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HA ' HD23 ' A' ' 21' ' ' LEU . 37.9 mmtm -66.96 -54.8 18.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.808 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -79.99 1.92 25.67 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.847 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 9.3 tppt? -98.79 -53.41 3.3 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.873 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.429 ' HE2' ' HG2' ' A' ' 56' ' ' ARG . 38.2 t80 -91.2 -27.98 18.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.939 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 42.2 tttt 77.59 90.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.686 1.195 . . . . 0.0 109.934 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.851 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -100.96 -41.66 6.72 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.607 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 126.656 1.982 . . . . 0.0 112.543 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.408 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.6 pt20 . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.763 0.316 . . . . 0.0 110.526 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.17 134.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.322 1.058 . . . . 0.0 112.294 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.2 mm -102.19 -36.64 4.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.133 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.4 m80 -168.12 -178.19 3.59 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.75 139.6 45.89 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -112.46 158.32 20.01 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -107.01 130.42 54.65 Favored 'General case' 0 C--N 1.263 -3.154 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.88 112.61 3.35 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 39.9 t -82.35 -19.09 39.97 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 124.185 0.928 . . . . 0.0 109.635 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.13 156.73 46.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.887 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -96.39 107.85 20.29 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 173.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.441 HG12 ' CE1' ' A' ' 46' ' ' PHE . 10.4 p -113.19 145.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.66 12.42 21.2 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.775 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 78.84 46.85 8.16 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.714 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -96.9 151.52 19.86 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp 68.27 31.87 4.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.299 1.047 . . . . 0.0 108.833 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 68.31 46.3 1.1 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.678 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -103.55 -175.16 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.606 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 tt -95.74 147.47 23.59 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.47 ' H ' HD23 ' A' ' 44' ' ' LEU . 5.7 m -96.05 115.48 27.5 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.777 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.441 ' CE1' HG12 ' A' ' 37' ' ' VAL . 17.9 p90 -150.37 177.62 9.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.196 0.522 . . . . 0.0 111.006 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.887 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.5 mmtt -124.83 149.61 47.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.73 122.43 11.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 124.145 0.903 . . . . 0.0 108.737 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.42 23.88 52.69 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.759 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.5 mm-40 -78.64 -26.67 45.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 74.63 104.43 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.414 1.578 . . . . 0.0 110.33 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 31' ' ' ALA . 7.9 mm -101.96 158.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.196 0 CA-C-N 111.697 -2.501 . . . . 0.0 105.659 -174.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -112.49 134.21 54.15 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 7.0 tp -99.75 121.04 49.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.408 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -106.1 -54.13 6.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.213 -178.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG2' ' HE2' ' A' ' 19' ' ' PHE . 53.9 ttt180 -121.43 138.39 54.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.729 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.37 -43.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.578 -176.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 p -117.8 158.66 24.38 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.112 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.51 68.73 0.16 Allowed 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.928 1.691 . . . . 0.0 111.302 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 8.8 p30 -148.42 144.43 18.59 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.0 Cg_exo -78.93 12.52 2.22 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 122.848 2.365 . . . . 0.0 114.469 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.679 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -109.23 -64.7 1.22 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.6 -6.03 7.52 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -90.04 165.05 14.26 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.636 0.775 . . . . 0.0 110.535 177.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.559 ' CG ' HG22 ' A' ' 79' ' ' THR . 40.2 m0 -97.84 169.89 9.35 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.768 0.827 . . . . 0.0 110.741 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.851 HD22 HD11 ' A' ' 21' ' ' LEU . 54.6 tp -113.99 110.25 19.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.02 155.87 15.99 Favored Glycine 0 N--CA 1.419 -2.497 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.299 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.697 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.1 ttp180 -137.96 156.66 47.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.589 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 6.8 m -111.63 156.07 22.39 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.6 33.13 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.476 1.035 . . . . 0.0 113.05 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -69.8 -3.09 14.05 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.91 86.81 0.16 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 121.728 0.627 . . . . 0.0 112.134 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.697 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.0 m -151.78 117.67 5.48 Favored 'General case' 0 N--CA 1.391 -3.388 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.697 ' HB2' HG21 ' A' ' 15' ' ' ILE . 65.3 m-85 -113.37 90.06 3.25 Favored 'General case' 1 C--N 1.228 -4.701 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.186 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.606 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -104.72 102.19 2.04 Favored Glycine 3 N--CA 1.36 -6.416 0 N-CA-C 106.906 -2.478 . . . . 0.0 106.906 176.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -50.22 98.94 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.867 0 CA-C-N 113.195 -1.503 . . . . 0.0 107.247 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.727 HD12 HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -82.25 140.25 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.431 -3.611 0 C-N-CA 125.542 1.537 . . . . 0.0 114.713 -172.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -74.88 114.3 13.18 Favored 'General case' 1 N--CA 1.365 -4.705 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 167.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.559 HG22 ' CG ' ' A' ' 65' ' ' TRP . 72.9 p -36.28 -34.82 0.07 Allowed 'General case' 1 C--N 1.234 -4.428 0 C-N-CA 128.523 2.729 . . . . 0.0 114.299 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -66.0 -24.32 66.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.2 59.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.097 -0.377 . . . . 0.0 111.57 -174.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.727 HG21 HD12 ' A' ' 77' ' ' ILE . 30.0 m -136.39 165.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.512 0.672 . . . . 0.0 111.321 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.83 118.86 15.35 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.458 -2.052 . . . . 0.0 105.458 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.3 pp -72.46 146.97 10.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.647 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--N 1.282 -2.355 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.151 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.3 mm-40 . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.541 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 1.4 pp -71.85 -34.05 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 CA-C-O 120.889 0.376 . . . . 0.0 110.115 -173.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.655 ' HA ' HD23 ' A' ' 21' ' ' LEU . 4.7 mptt -74.91 -30.97 61.43 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -90.5 -19.53 23.72 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.011 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.2 tppt? -77.26 -58.77 3.09 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.074 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.3 t80 -81.18 -22.79 38.65 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.25 90.92 0.09 Allowed 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 125.548 1.539 . . . . 0.0 109.911 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -99.51 -67.48 0.85 Allowed 'General case' 0 CA--C 1.453 -2.765 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.939 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.404 -2.763 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.658 171.903 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 . . . . . 0 N--CA 1.438 -1.038 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.6 t -79.35 127.32 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -90.35 -37.21 9.22 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.637 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.869 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 37.6 m80 -168.88 170.64 8.98 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -172.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.32 127.32 55.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 172.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -100.46 159.63 14.99 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-O 121.739 0.781 . . . . 0.0 110.928 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.88 131.39 54.02 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.65 106.94 1.28 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.8 t -91.37 -5.8 53.92 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.194 0.997 . . . . 0.0 108.335 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 81' ' ' ALA . 82.8 m -147.2 147.41 30.45 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.775 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 7.2 p-10 -93.14 103.53 15.8 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.486 HG21 ' OE2' ' A' ' 43' ' ' GLU . 8.6 p -114.66 156.71 15.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.103 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.52 34.04 5.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.989 0.423 . . . . 0.0 110.51 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 99.9 60.65 0.84 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.131 -1.509 . . . . 0.0 113.251 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.79 95.66 1.14 Allowed Glycine 0 C--N 1.313 -0.721 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 57.24 78.44 0.23 Allowed 'General case' 0 C--O 1.252 1.215 0 C-N-CA 124.707 1.203 . . . . 0.0 111.041 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.49 71.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.407 1.067 . . . . 0.0 109.768 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.632 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 15.9 tt0 -132.72 -173.78 3.28 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.464 -172.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' N ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.15 151.07 20.17 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.9 m -97.95 124.68 42.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.411 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 25.5 p90 -159.64 160.99 34.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.722 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 57.0 mtmt -117.56 151.37 37.29 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -53.39 123.26 11.48 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.17 0.919 . . . . 0.0 110.657 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.84 17.22 52.62 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.087 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -87.92 -30.69 19.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.954 0.877 . . . . 0.0 113.171 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 2.1 mp0 75.45 128.98 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.535 1.159 . . . . 0.0 112.386 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.589 HD12 ' CG1' ' A' ' 82' ' ' VAL . 10.9 mt -129.08 165.11 29.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -114.66 142.23 46.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.5 tp -100.69 124.24 54.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -110.51 -40.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.662 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 48.2 ttt180 -134.8 136.96 42.94 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.136 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.1 -36.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 124.439 1.096 . . . . 0.0 111.778 -177.243 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -96.64 154.84 17.05 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.93 67.86 0.72 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.907 1.283 . . . . 0.0 107.963 -174.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -134.39 115.4 12.7 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.626 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.91 -28.71 29.16 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.393 2.729 . . . . 0.0 115.394 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.11 -15.49 23.33 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.799 0.809 . . . . 0.0 110.146 -177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.01 0.19 83.5 Favored Glycine 0 C--N 1.308 -0.992 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.152 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.639 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 17.8 ptmt -95.06 161.68 14.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.546 ' CD2' HG22 ' A' ' 79' ' ' THR . 43.2 m0 -97.8 176.03 5.95 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.947 0.899 . . . . 0.0 111.478 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -115.52 108.72 16.82 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -111.43 156.57 15.48 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.563 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 73' ' ' SER . 62.5 ttt-85 -134.62 147.55 50.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.515 0.674 . . . . 0.0 111.593 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 27.0 m -100.75 162.13 13.12 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.0 18.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -89.16 3.15 52.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 76.66 87.86 0.33 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.764 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.8 m -152.48 117.75 5.25 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 79.9 m-85 -115.21 91.35 3.58 Favored 'General case' 1 C--N 1.224 -4.882 0 O-C-N 124.25 0.969 . . . . 0.0 108.459 -173.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.613 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -107.45 102.52 1.82 Allowed Glycine 2 N--CA 1.366 -5.992 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.639 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -42.16 101.14 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 112.959 -1.621 . . . . 0.0 108.52 171.078 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.632 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.2 pt -85.39 145.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.948 0 C-N-CA 126.248 1.819 . . . . 0.0 113.312 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -80.92 122.79 27.68 Favored 'General case' 1 N--CA 1.348 -5.538 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 164.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' CD2' ' A' ' 65' ' ' TRP . 47.7 p -36.47 -30.71 0.02 OUTLIER 'General case' 1 C--N 1.243 -4.039 0 C-N-CA 128.341 2.656 . . . . 0.0 112.653 176.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -63.72 -32.47 73.98 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.892 1.277 . . . . 0.0 110.835 -177.534 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -86.49 -4.9 59.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.778 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.632 HG21 HD12 ' A' ' 77' ' ' ILE . 28.9 m -133.97 159.35 42.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.46 0.648 . . . . 0.0 111.813 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.4 mt-10 -128.03 117.5 21.79 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 171.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.5 pt -78.38 160.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.388 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--N 1.289 -2.054 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 172.512 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 74' ' ' TYR . 6.9 pt -67.33 -28.99 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.987 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -78.08 -7.37 56.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.223 0.535 . . . . 0.0 110.535 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -99.39 -30.1 12.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.23 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 4.3 tppt? -84.16 -65.55 1.0 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.065 -174.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.515 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 1.8 t80 -86.59 -28.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.0 ttmt 63.08 86.05 0.12 Allowed 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.613 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.588 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -93.69 -58.61 2.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.236 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 C--N 1.313 -1.013 0 C-N-CA 124.679 1.192 . . . . 0.0 114.165 -179.823 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.611 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.7 p -79.59 139.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.88 -40.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.508 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.519 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.0 m80 -159.89 166.45 30.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.05 116.51 32.1 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.695 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -89.51 157.92 17.9 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 122.281 1.038 . . . . 0.0 112.196 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -107.74 126.18 52.3 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.329 -1.305 . . . . 0.0 107.918 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -67.68 109.79 3.46 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 171.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.3 m -83.86 -5.72 59.27 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.474 0.484 . . . . 0.0 111.852 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 81' ' ' ALA . 19.9 p -155.59 154.72 32.11 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 7.6 p-10 -82.83 110.65 18.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 173.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.52 160.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -112.91 0.55 15.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.569 -169.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 76.77 61.19 2.77 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.706 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.42 122.47 7.22 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.767 -0.716 . . . . 0.0 111.469 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 62.6 71.9 0.51 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.421 1.088 . . . . 0.0 110.592 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.561 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . 96.6 m-20 53.04 73.01 0.38 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.336 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 41.8 tt0 -145.66 171.02 15.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.551 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -98.95 152.74 19.45 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.455 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 m -101.61 127.64 48.25 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -156.78 170.82 21.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 99.2 mttt -119.78 153.87 35.07 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 123.93 15.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.42 13.21 65.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.685 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.6 tp10 -63.59 -37.54 87.73 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.46 0.704 . . . . 0.0 111.682 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 71.56 107.49 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.267 1.427 . . . . 0.0 108.637 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.572 HD12 ' CG1' ' A' ' 82' ' ' VAL . 15.8 mt -113.34 159.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 16.2 mt-10 -111.8 132.36 54.72 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -93.34 122.85 45.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -108.27 -36.57 3.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 32.4 ttm180 -140.79 137.87 33.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.723 175.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.514 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.86 -28.92 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 124.005 0.922 . . . . 0.0 111.816 -176.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.0 p -106.27 162.75 13.39 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.6 t70 58.29 71.2 0.6 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.795 1.283 . . . . 0.0 110.54 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 16.3 p30 -125.67 136.46 28.39 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.255 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 17.7 Cg_exo -69.4 -32.11 20.74 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.063 2.509 . . . . 0.0 113.851 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -101.8 -51.88 3.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.04 -2.47 5.14 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 16.4 ptpt -80.8 162.41 24.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.689 -0.756 . . . . 0.0 109.059 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.51 ' HB2' HG13 ' A' ' 77' ' ' ILE . 41.3 m0 -99.25 176.75 5.43 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.76 0.824 . . . . 0.0 109.789 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -117.47 112.12 20.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.21 157.11 15.22 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.121 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.734 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.6 ttp180 -135.82 156.91 48.06 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.0 110.805 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.9 m -111.95 155.72 23.25 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 68.34 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.286 1.041 . . . . 0.0 111.977 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -167.62 -35.29 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.011 -1.904 . . . . 0.0 107.66 175.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.03 90.18 1.98 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.734 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 2.5 m -151.92 116.76 5.15 Favored 'General case' 0 N--CA 1.386 -3.634 1 N-CA-C 100.097 -4.038 . . . . 0.0 100.097 -178.234 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 66' ' ' LEU . 48.2 m-85 -116.75 89.41 3.1 Favored 'General case' 1 C--N 1.216 -5.214 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -175.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.02 104.13 2.5 Favored Glycine 3 N--CA 1.352 -6.957 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.054 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CD2' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -51.31 97.51 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 O-C-N 125.305 1.238 . . . . 0.0 108.129 172.059 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.9 pt -76.17 137.49 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.437 -3.397 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.406 -173.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 22.5 pttm -79.16 112.51 16.44 Favored 'General case' 1 N--CA 1.369 -4.495 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 167.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' CD2' ' A' ' 65' ' ' TRP . 64.6 p -35.65 -34.16 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.437 0 C-N-CA 129.327 3.051 . . . . 0.0 114.818 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -62.93 -16.24 58.44 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -84.8 -17.11 39.17 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.698 -0.626 . . . . 0.0 111.723 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.572 ' CG1' HD12 ' A' ' 52' ' ' ILE . 30.4 m -135.96 168.18 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.752 0.786 . . . . 0.0 112.616 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -135.27 126.19 27.59 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.695 HG22 ' HB2' ' A' ' 31' ' ' ALA . 25.9 pt -84.77 164.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.137 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--N 1.291 -1.94 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 174.505 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.64 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -91.97 106.34 18.39 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -106.03 27.68 8.36 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 122.023 0.916 . . . . 0.0 108.815 -172.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -94.4 63.62 3.03 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.083 -174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -163.93 135.49 4.7 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -115.2 -33.65 5.27 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 9' ' ' GLU . 7.2 mm-40 -143.69 179.35 7.2 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.614 1.565 . . . . 0.0 107.551 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.09 -0.47 41.72 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 170.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' H ' ' HB3' ' A' ' 7' ' ' GLU . 43.0 mt-10 67.82 84.96 0.15 Allowed 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.907 -1.951 . . . . 0.0 113.123 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 10' ' ' LYS . 33.6 ttpt -113.44 26.06 10.74 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -91.77 4.81 51.96 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.385 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.529 ' HB2' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -83.72 46.58 1.18 Allowed 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 124.645 1.178 . . . . 0.0 110.595 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -60.71 -29.73 69.53 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.073 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 38.5 mm-40 -68.58 -29.1 67.57 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.53 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 1.3 pp -77.62 -28.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.849 0.833 . . . . 0.0 108.842 -174.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' HD23 ' A' ' 21' ' ' LEU . 15.4 mtpp -70.0 -41.49 74.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.352 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -85.04 -22.52 28.98 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.153 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.5 tppt? -76.36 -48.61 19.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.546 -175.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 13.8 t80 -94.45 -26.49 16.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.889 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? 70.91 90.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.518 1.127 . . . . 0.0 108.882 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.47 -44.96 5.71 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.28 80.2 p 68.81 -72.38 0.1 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.699 1.599 . . . . 0.0 112.384 -173.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.36 108.8 2.17 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.22 139.77 47.07 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.277 1.985 . . . . 0.0 111.877 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.45 HD12 HD11 ' A' ' 28' ' ' ILE . 42.4 pt -115.83 -171.23 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.311 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -96.01 169.65 9.83 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.648 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -57.18 134.04 21.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 123.714 0.634 . . . . 0.0 111.81 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 25' ' ' ILE . 49.1 mm -89.2 -38.22 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.621 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 54' ' ' ILE . 32.8 m80 -162.02 156.66 22.49 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -100.57 117.1 34.02 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -92.43 155.83 17.6 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.7 0.762 . . . . 0.0 110.293 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -107.11 131.17 54.42 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.56 115.72 5.46 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.8 t -79.34 -12.05 59.93 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.946 0.779 . . . . 0.0 110.025 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -158.35 171.7 19.7 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.702 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 5.5 p-10 -105.67 104.86 14.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.698 0.761 . . . . 0.0 110.653 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.02 158.98 15.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 17.4 19.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.827 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 83.22 59.88 2.1 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.204 -0.998 . . . . 0.0 114.476 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.04 145.91 17.55 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 63.65 34.22 12.5 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.362 0.665 . . . . 0.0 109.635 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.6 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 83.3 m-20 64.77 82.6 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.387 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 15.9 tt0 -140.86 -176.87 4.83 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.575 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 54.7 tp -95.65 145.17 25.47 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.4 m -94.98 119.58 33.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 52' ' ' ILE . 28.3 p90 -153.28 157.85 40.74 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.702 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 42.7 mmtm -107.97 146.78 31.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.062 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.75 118.59 2.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.912 0.885 . . . . 0.0 110.001 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 15.8 76.85 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.919 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 28.9 tt0 -69.01 -33.08 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.402 0.601 . . . . 0.0 111.58 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 80.07 122.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 110.214 -174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.468 HD13 HD23 ' A' ' 44' ' ' LEU . 4.7 mt -125.76 162.19 29.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.648 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 35.5 mt-10 -116.49 134.82 54.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 119.211 0.914 . . . . 0.0 109.093 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 65' ' ' TRP . 9.0 tp -93.05 127.15 45.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -56.61 4.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.528 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.3 tpm_? -116.18 121.97 43.67 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.524 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.603 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -118.74 -26.86 2.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.026 174.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.6 p -85.39 136.34 33.5 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.412 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t0 67.3 33.58 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.66 1.184 . . . . 0.0 110.918 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.23 128.58 93.78 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.296 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.44 -27.59 1.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.049 1.832 . . . . 0.0 114.147 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.505 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 17.5 mm-40 -109.14 -6.09 15.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.28 -18.7 56.14 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.762 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -86.3 161.39 18.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.603 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.1 m0 -98.44 163.45 12.68 Favored 'General case' 0 C--O 1.199 -1.58 0 C-N-CA 123.565 0.746 . . . . 0.0 109.633 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD11 ' HB3' ' A' ' 74' ' ' TYR . 55.7 tp -104.06 108.84 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.032 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.34 144.86 18.44 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 73' ' ' SER . 22.1 ttp180 -115.74 149.32 38.65 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.248 0.547 . . . . 0.0 110.419 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.529 ' OG1' HD11 ' A' ' 44' ' ' LEU . 89.7 m -98.17 156.52 16.64 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.84 -33.73 17.75 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -79.67 -1.81 39.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 77.14 86.14 0.42 Allowed Glycine 0 C--O 1.221 -0.695 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.8 m -152.7 127.19 9.34 Favored 'General case' 0 N--CA 1.394 -3.229 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.736 ' HB3' HD11 ' A' ' 66' ' ' LEU . 83.7 m-85 -115.59 100.08 7.8 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -174.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.575 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.29 5.09 52.04 Favored Glycine 0 C--O 1.188 -2.737 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.616 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.6 ' HE1' ' HB3' ' A' ' 42' ' ' ASN 0.314 0.3 OUTLIER 46.01 75.18 0.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 123.068 1.414 . . . . 0.0 112.844 -179.874 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 82' ' ' VAL . 1.6 pt -61.94 141.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.038 0 CA-C-N 112.199 -2.273 . . . . 0.0 113.125 -174.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -77.71 114.78 16.9 Favored 'General case' 1 N--CA 1.365 -4.711 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 166.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.507 HG22 ' CG ' ' A' ' 65' ' ' TRP . 34.0 p -35.53 -38.78 0.12 Allowed 'General case' 0 C--N 1.244 -3.99 0 C-N-CA 127.91 2.484 . . . . 0.0 113.628 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -66.67 -19.84 65.85 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.41 0.684 . . . . 0.0 111.675 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.5 -5.87 59.04 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 121.835 -0.54 . . . . 0.0 111.357 -175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.62 HG21 HD12 ' A' ' 77' ' ' ILE . 30.1 m -135.79 167.84 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.377 0.608 . . . . 0.0 110.992 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -133.96 116.17 15.24 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.781 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.3 pp -81.53 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.315 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.62 117.46 12.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -77.35 153.64 33.56 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.114 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 88' ' ' SER . 17.7 t70 89.23 -92.77 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.156 1.782 . . . . 0.0 110.529 -178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 39.2 t 168.16 -82.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.982 0.913 . . . . 0.0 108.773 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.9 mt -153.09 -54.95 0.12 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 103.439 -2.8 . . . . 0.0 103.439 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -148.4 77.3 1.39 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.404 -1.725 . . . . 0.0 108.4 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 45.5 tp -70.53 -28.42 64.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -100.32 102.71 14.03 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 170.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -124.4 89.53 3.09 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.3 1.048 . . . . 0.0 111.902 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.23 29.55 1.4 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.467 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 69.74 27.15 4.72 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.211 1.404 . . . . 0.0 111.607 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 . . . . . 0 C--N 1.307 -1.265 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.697 178.229 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--O 1.235 0.332 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -88.28 0.45 56.12 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 118.159 0.436 . . . . 0.0 112.009 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -145.62 158.46 43.84 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -93.4 171.32 8.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -119.36 159.08 24.86 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 43.8 mmtm -89.76 94.24 9.76 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -98.88 -63.08 1.15 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.888 -173.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -178.48 -47.61 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 72.18 -68.92 0.2 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.565 1.546 . . . . 0.0 109.752 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.2 127.2 45.31 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -77.03 126.08 30.39 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 122.958 0.503 . . . . 0.0 111.224 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -107.23 -172.62 2.11 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.605 ' HB3' HG23 ' A' ' 15' ' ' ILE . 64.6 tt0 -80.04 -2.0 42.3 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 46.4 mt-10 83.72 29.45 0.08 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 127.038 2.135 . . . . 0.0 109.39 -175.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 13' ' ' GLN . 2.5 pt -88.69 -32.35 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.858 -170.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.0 ptmt -91.22 -9.44 45.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.591 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 13.4 tmtt? -92.89 -23.96 18.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 169.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.3 tppt? -82.56 -58.44 2.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.035 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 9.8 t80 -92.52 -33.98 14.25 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.4 tttm 75.11 93.48 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.34 1.025 . . . . 0.0 110.656 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.654 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.09 -28.82 12.85 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.864 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.268 69.0 p 64.97 -38.3 0.24 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.663 1.985 . . . . 0.0 115.964 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.08 162.31 24.24 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.41 117.43 4.47 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 122.68 2.253 . . . . 0.0 110.349 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.418 HG23 ' HB ' ' A' ' 55' ' ' ILE . 9.4 tp -109.95 140.71 27.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.979 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -98.05 175.99 5.92 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.248 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.41 133.55 31.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.86 0.838 . . . . 0.0 111.612 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.502 HD11 HH21 ' A' ' 56' ' ' ARG . 62.6 mt -98.46 -32.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.7 m80 -162.58 165.83 25.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.87 116.39 31.87 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.691 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -95.64 150.52 20.26 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-O 121.771 0.796 . . . . 0.0 111.047 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -107.31 133.61 51.59 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -64.41 117.03 6.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 31.3 t -79.8 -18.08 51.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 124.294 0.996 . . . . 0.0 110.321 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.6 t -152.93 161.0 43.08 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.99 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 1.8 p-10 -94.51 109.57 21.45 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.016 0.912 . . . . 0.0 108.769 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.26 152.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 9.04 39.01 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.064 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.87 58.24 8.57 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.801 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.31 162.23 14.48 Favored Glycine 0 C--O 1.2 -1.982 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.864 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 6.4 mmpt? 57.71 34.28 24.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.843 1.321 . . . . 0.0 111.691 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 76' ' ' TYR . 42.6 m-80 66.01 51.81 1.28 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.89 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.532 ' OE1' ' HE3' ' A' ' 78' ' ' LYS . 1.2 mp0 -110.04 179.45 4.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.831 171.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 1.1 tt -97.75 151.26 20.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -94.87 126.57 40.28 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.189 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 14.2 p90 -158.57 163.27 37.17 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.952 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.99 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.2 mmtt -110.7 148.27 32.62 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 18.8 tm0? -52.06 119.79 4.71 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.748 0.655 . . . . 0.0 109.548 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.58 13.69 69.71 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.742 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 12.9 tp10 -63.12 -32.01 73.29 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.95 0.5 . . . . 0.0 110.901 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 77.63 99.32 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.018 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.555 HD12 HG12 ' A' ' 82' ' ' VAL . 12.1 mt -106.69 165.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 113.399 -1.728 . . . . 0.0 106.742 -173.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -127.63 136.48 51.69 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.7 tp -93.24 130.68 41.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.418 ' HB ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -115.11 -37.84 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.369 177.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -137.86 134.71 35.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.911 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.69 -13.32 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 123.954 0.902 . . . . 0.0 110.39 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -117.16 159.04 23.23 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.11 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.14 70.78 0.59 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.219 1.408 . . . . 0.0 110.089 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 15.3 p30 -127.75 139.3 34.91 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.671 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 23.6 Cg_exo -68.66 -49.2 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.938 2.426 . . . . 0.0 113.105 177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.91 -23.45 25.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 111.681 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.18 8.53 58.79 Favored Glycine 0 C--N 1.312 -0.772 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.73 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 12.7 ptmt -89.32 162.26 15.92 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.584 ' HB2' HG13 ' A' ' 77' ' ' ILE . 46.6 m0 -93.79 176.41 6.36 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.654 HD22 HD11 ' A' ' 21' ' ' LEU . 59.7 tp -121.2 112.57 18.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.73 14.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 73' ' ' SER . 48.5 ttp180 -133.56 153.69 51.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.322 0.582 . . . . 0.0 110.285 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.2 m -100.0 153.82 18.89 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -30.04 12.62 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -81.68 -12.06 58.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.812 0.339 . . . . 0.0 111.855 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.59 92.59 1.56 Allowed Glycine 0 C--N 1.315 -0.591 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.7 m -153.73 118.05 4.87 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 66' ' ' LEU . 48.2 m-85 -114.59 94.95 5.01 Favored 'General case' 1 C--N 1.222 -4.972 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -173.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.577 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -111.18 103.41 1.58 Allowed Glycine 3 N--CA 1.359 -6.434 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -45.52 100.55 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 113.133 -1.534 . . . . 0.0 108.293 173.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.584 HG13 ' HB2' ' A' ' 65' ' ' TRP . 2.0 pt -81.4 142.0 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.249 0 C-N-CA 124.341 1.057 . . . . 0.0 113.482 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 18.7 ptpt -79.28 119.01 21.74 Favored 'General case' 1 N--CA 1.361 -4.911 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 165.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.464 HG22 ' CD2' ' A' ' 65' ' ' TRP . 50.5 p -36.11 -39.46 0.17 Allowed 'General case' 1 C--N 1.242 -4.1 0 C-N-CA 127.732 2.413 . . . . 0.0 112.894 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.84 -13.35 62.06 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 123.274 0.63 . . . . 0.0 112.341 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.78 -9.08 50.59 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.359 -0.838 . . . . 0.0 111.112 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.555 HG12 HD12 ' A' ' 52' ' ' ILE . 31.5 m -133.91 167.22 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 122.152 0.977 . . . . 0.0 111.974 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.4 mt-10 -132.89 111.62 11.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.1 pt -75.36 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.686 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.28 98.79 5.28 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -87.23 149.25 24.72 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.041 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -126.89 87.7 2.7 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -111.52 -20.23 12.26 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.62 -172.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.493 HD23 ' HG2' ' A' ' 92' ' ' LYS . 53.2 tp -145.92 107.17 4.19 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 90' ' ' LYS . 14.3 tppt? -71.31 -38.26 71.75 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.055 0.455 . . . . 0.0 110.396 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.52 97.15 6.54 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.15 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HG2' HD23 ' A' ' 89' ' ' LEU . 98.1 mttt -85.45 127.55 34.43 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.06 102.16 14.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.239 0.542 . . . . 0.0 112.022 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -139.92 7.34 2.26 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.993 0.901 . . . . 0.0 108.947 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 62.0 tp -104.64 130.21 52.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.803 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--N 1.299 -1.615 0 CA-C-O 118.197 -0.906 . . . . 0.0 108.581 177.87 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.4 tptt 64.66 77.18 0.32 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.891 0.876 . . . . 0.0 110.832 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -111.27 90.02 3.22 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.54 113.56 26.29 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -124.84 15.4 8.63 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -171.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 6' ' ' LYS . 54.8 mtpt -118.4 -37.51 3.32 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -92.48 114.51 27.08 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.595 0.712 . . . . 0.0 110.81 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 68.8 1.26 Allowed 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 171.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.648 ' HG3' ' HG3' ' A' ' 10' ' ' LYS . 9.9 pt-20 -57.44 -32.37 66.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.732 -1.576 . . . . 0.0 113.485 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.648 ' HG3' ' HG3' ' A' ' 9' ' ' GLU . 62.5 mttp -104.03 176.07 5.28 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.439 -176.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 70.42 93.17 0.08 Allowed 'General case' 0 C--N 1.322 -0.59 0 O-C-N 124.65 1.219 . . . . 0.0 109.574 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 15' ' ' ILE . 5.5 mp0 -80.18 79.36 6.75 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.323 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 6.7 tp60 -72.4 -23.83 61.15 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.88 0.848 . . . . 0.0 110.046 -175.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -60.91 -30.0 69.93 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.24 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.724 HG21 ' HB2' ' A' ' 74' ' ' TYR . 4.3 pt -79.72 -31.45 13.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.419 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 2.7 mptp? -68.62 -23.8 64.49 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 121.357 0.599 . . . . 0.0 110.768 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -103.6 6.49 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.997 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 8.8 ttmm -121.62 -43.42 2.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.098 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.574 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 2.9 t80 -94.6 -33.8 12.87 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 87.4 tttt 68.13 88.51 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.653 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 HD22 ' A' ' 66' ' ' LEU . 1.2 mm? -98.09 -29.98 12.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.675 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p 60.24 23.89 13.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.985 1.314 . . . . 0.0 113.379 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.78 172.94 32.86 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -87.39 170.07 6.89 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.879 2.386 . . . . 0.0 111.167 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG23 ' HB ' ' A' ' 55' ' ' ILE . 14.9 tt -163.62 154.98 2.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.309 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.425 ' O ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 -83.63 178.41 7.98 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.255 0.622 . . . . 0.0 109.398 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.55 136.21 25.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.2 0.524 . . . . 0.0 109.636 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 54' ' ' ILE . 49.9 mm -91.29 -35.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.79 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.799 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.403 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.2 m80 -168.64 162.56 11.91 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.26 121.14 41.33 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.715 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -96.14 155.79 16.61 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-O 121.758 0.789 . . . . 0.0 110.027 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -107.04 128.08 54.04 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -68.36 109.39 3.63 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.52 -22.5 32.44 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.23 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.4 m -133.19 144.01 49.56 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.848 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.43 104.55 16.56 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.321 1.058 . . . . 0.0 109.281 172.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 39' ' ' GLY . 8.5 p -114.47 151.49 16.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.682 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.388 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -97.97 7.24 46.65 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.201 0.6 . . . . 0.0 111.942 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 75.25 59.04 3.73 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.609 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.11 151.14 17.01 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 tttm 62.0 32.87 17.58 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.934 0.873 . . . . 0.0 108.687 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 90.6 m-20 66.55 86.64 0.13 Allowed 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.385 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.601 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 22.4 tt0 -147.09 -175.73 4.94 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.565 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.67 154.53 17.89 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.48 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 m -101.89 120.19 40.0 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 18.5 p90 -151.06 161.77 42.12 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.731 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 73.2 mmtt -107.2 151.19 25.76 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.118 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -55.59 111.65 0.95 Allowed 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.57 24.96 14.49 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.406 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -75.91 -39.96 55.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.144 0.577 . . . . 0.0 111.162 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 76.34 108.08 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.915 1.686 . . . . 0.0 109.04 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.582 HD12 ' CG1' ' A' ' 82' ' ' VAL . 8.1 mt -116.87 162.71 14.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -173.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.47 135.24 54.85 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.0 tp -93.48 128.54 44.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -113.33 -42.24 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.574 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 1.8 tpm_? -128.52 128.23 43.92 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -126.07 -6.74 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 123.612 0.765 . . . . 0.0 109.637 177.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -112.13 150.84 30.21 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.521 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 t70 56.24 56.53 5.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.743 1.258 . . . . 0.0 109.535 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 17.7 p-10 -105.83 106.31 56.19 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.535 -1.666 . . . . 0.0 112.486 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 16.6 Cg_exo -66.76 -23.52 48.3 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.814 3.009 . . . . 0.0 115.072 -173.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -111.08 0.17 16.81 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.915 0.864 . . . . 0.0 109.852 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 17.49 80.19 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.688 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.0 ptmt -110.33 161.68 15.39 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.522 ' CD2' HG22 ' A' ' 79' ' ' THR . 40.4 m0 -96.63 176.18 6.11 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 122.383 0.273 . . . . 0.0 110.367 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' A' ' 74' ' ' TYR . 64.5 tp -117.37 111.77 19.79 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.74 155.43 16.32 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.184 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.1 ttp180 -136.45 148.26 47.63 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.562 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.7 m -101.41 157.96 16.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.79 30.36 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 119.243 0.928 . . . . 0.0 113.174 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmt_? -64.01 -26.0 68.37 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.071 0.948 . . . . 0.0 110.2 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.67 89.05 1.44 Allowed Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.4 m -153.56 122.31 6.37 Favored 'General case' 0 N--CA 1.387 -3.582 0 N-CA-C 100.422 -3.918 . . . . 0.0 100.422 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.724 ' HB2' HG21 ' A' ' 15' ' ' ILE . 67.4 m-85 -114.61 96.52 5.79 Favored 'General case' 1 C--N 1.225 -4.806 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -175.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -111.04 105.31 1.86 Allowed Glycine 3 N--CA 1.357 -6.567 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 177.382 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -49.38 96.49 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.291 -1.455 . . . . 0.0 108.88 169.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.601 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.7 pt -76.09 143.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.276 0 C-N-CA 125.631 1.572 . . . . 0.0 113.518 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -78.93 115.88 18.89 Favored 'General case' 1 N--CA 1.371 -4.411 0 N-CA-C 102.811 -3.033 . . . . 0.0 102.811 166.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 64' ' ' LYS . 68.9 p -36.02 -35.96 0.08 Allowed 'General case' 0 C--N 1.244 -3.995 0 C-N-CA 128.167 2.587 . . . . 0.0 113.962 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -70.16 -15.13 62.91 Favored 'General case' 0 CA--C 1.567 1.625 0 C-N-CA 123.361 0.665 . . . . 0.0 112.636 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.92 -13.84 38.11 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.582 ' CG1' HD12 ' A' ' 52' ' ' ILE . 28.4 m -127.89 165.5 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-O 121.297 0.57 . . . . 0.0 110.888 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -133.8 117.3 16.72 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.715 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.1 pp -77.96 134.1 29.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 119.504 -0.879 . . . . 0.0 109.936 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.88 123.71 23.95 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.365 0.602 . . . . 0.0 110.416 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -85.54 146.06 27.08 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.815 -171.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -103.72 6.13 36.68 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 123.141 1.448 . . . . 0.0 107.275 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 t -122.22 176.24 5.95 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 113.743 -1.571 . . . . 0.0 107.082 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 mp 63.95 27.51 14.36 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.975 0.91 . . . . 0.0 110.679 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -83.93 100.18 10.85 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.153 0.501 . . . . 0.0 110.088 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.33 109.48 6.84 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -127.84 95.26 4.16 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.99 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.846 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 1.0 OUTLIER 57.63 95.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 125.1 1.36 . . . . 0.0 112.526 177.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.99 169.66 10.25 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.145 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.8 tp -154.14 109.78 3.19 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 C--N 1.296 -1.748 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.692 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 120.823 0.344 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -98.51 93.93 6.42 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 120.844 0.354 . . . . 0.0 110.152 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 3' ' ' LYS . 71.5 mmtt -132.59 102.0 5.53 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.493 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -93.18 17.97 10.17 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.861 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -80.71 104.09 10.99 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.464 0.649 . . . . 0.0 110.789 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -121.97 -149.48 0.43 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 61.36 65.95 0.92 Allowed 'General case' 0 C--O 1.248 0.998 0 C-N-CA 124.1 0.96 . . . . 0.0 111.439 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' O ' ' HD2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.19 132.07 44.01 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.981 178.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.57 107.44 15.8 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -173.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -88.89 106.56 18.48 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 171.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -142.44 146.53 34.91 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.177 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -178.77 4.79 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.148 0.499 . . . . 0.0 112.233 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 14.9 mm-40 -70.83 -3.01 16.75 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 -174.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 30.0 mm-40 85.29 21.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 125.21 1.404 . . . . 0.0 108.879 -173.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -87.15 -25.18 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.417 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.658 ' HB3' ' HD3' ' A' ' 17' ' ' LYS . 10.5 tptm -64.3 -41.65 96.76 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.286 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.658 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 3.4 mppt? -98.02 12.46 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.699 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 8.2 tppt? -105.67 -57.04 2.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.695 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 1.8 t80 -80.11 -25.07 40.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 49.5 mtpt 70.09 89.4 0.1 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.989 1.316 . . . . 0.0 110.6 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.542 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -98.74 -18.63 17.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.804 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 70.7 p 69.88 -69.6 0.16 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 126.061 1.744 . . . . 0.0 114.32 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.12 -130.81 5.55 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.324 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.59 163.23 39.11 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.808 2.338 . . . . 0.0 111.984 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.525 HG13 ' HB ' ' A' ' 55' ' ' ILE . 8.9 tp -134.88 126.02 46.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -123.35 166.61 15.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.12 136.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.379 0.609 . . . . 0.0 109.464 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.88 -33.66 3.53 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.057 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.564 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.6 m80 -161.82 168.65 22.73 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -173.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.72 115.67 30.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -98.12 155.12 17.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-O 122.281 1.038 . . . . 0.0 111.352 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 34.1 ttpt -107.91 128.83 54.97 Favored 'General case' 0 C--N 1.256 -3.465 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -64.84 116.03 5.92 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.87 -17.4 35.7 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.451 0.643 . . . . 0.0 109.658 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.1 t -144.33 156.07 44.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 8.2 p-10 -94.43 101.92 13.86 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.16 0.981 . . . . 0.0 110.169 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG12 ' CE1' ' A' ' 46' ' ' PHE . 7.3 p -112.42 153.35 14.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.35 42.94 3.13 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 111.406 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 74.39 58.84 4.08 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.14 176.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.06 126.6 8.02 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 64.4 34.79 10.12 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.598 0.713 . . . . 0.0 109.79 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 71.52 87.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.702 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 20.2 tt0 -151.85 -172.45 4.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.102 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.1 tt -94.96 151.5 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.515 ' H ' HD23 ' A' ' 44' ' ' LEU . 50.1 m -102.77 118.58 37.14 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CE1' HG12 ' A' ' 37' ' ' VAL . 20.3 p90 -154.89 177.22 11.54 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.618 0.767 . . . . 0.0 109.619 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 99.1 mttt -133.69 151.18 51.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 1.4 tm0? -47.74 119.3 2.71 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 124.322 1.014 . . . . 0.0 110.9 176.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.44 12.7 59.41 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.937 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -79.23 -15.54 57.87 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 66.34 113.93 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 O-C-N 124.394 1.059 . . . . 0.0 111.208 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.5 mt -120.69 156.25 23.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.39 138.26 51.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 65' ' ' TRP . 7.8 tp -95.16 117.43 39.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.525 ' HB ' HG13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.53 -27.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.404 -176.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 tpp180 -141.88 125.81 17.18 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.052 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -118.78 -38.95 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.738 -177.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -106.68 154.91 20.26 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.199 -172.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 82.82 10.91 0.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.894 1.677 . . . . 0.0 109.798 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 6.5 p30 -54.57 123.95 46.73 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.213 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 21.3 Cg_exo -68.4 -40.69 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.088 2.526 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -99.74 -49.84 4.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 145.18 -2.59 1.15 Allowed Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.288 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 14.8 ptpt -100.69 163.67 12.23 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 122.572 0.349 . . . . 0.0 110.314 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.678 ' HB3' HD11 ' A' ' 54' ' ' ILE . 35.9 m0 -98.03 174.33 6.6 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 124.263 0.977 . . . . 0.0 111.103 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 74' ' ' TYR . 41.4 tp -115.05 108.31 16.5 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.06 157.97 14.62 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.2 ttp180 -136.09 147.11 47.69 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.171 0.51 . . . . 0.0 111.389 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.495 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.6 p -100.83 165.31 11.42 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.052 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.55 24.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.385 1.074 . . . . 0.0 113.641 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -78.04 -18.96 55.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.301 0.572 . . . . 0.0 111.384 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.69 92.09 1.38 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.1 m -151.96 129.11 11.14 Favored 'General case' 0 N--CA 1.392 -3.36 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 66' ' ' LEU . 41.9 m-85 -119.73 61.31 0.84 Allowed 'General case' 1 C--N 1.226 -4.788 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -172.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.627 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -87.11 93.38 1.88 Allowed Glycine 1 N--CA 1.384 -4.82 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -176.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.54 ' O ' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -34.29 101.05 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 125.809 1.535 . . . . 0.0 110.324 174.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -78.07 137.01 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.342 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.661 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -73.67 114.05 11.49 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 103.576 -2.749 . . . . 0.0 103.576 166.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.536 HG22 ' CD2' ' A' ' 65' ' ' TRP . 81.4 p -36.11 -35.9 0.08 Allowed 'General case' 1 C--N 1.24 -4.189 0 C-N-CA 128.428 2.691 . . . . 0.0 113.471 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.6 t -69.04 -14.24 62.92 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.068 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.32 -7.14 51.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.443 -0.785 . . . . 0.0 111.137 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 HD12 ' A' ' 77' ' ' ILE . 26.8 m -133.96 157.46 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.93 0.871 . . . . 0.0 112.365 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -120.3 110.69 16.86 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.711 HG22 ' HB2' ' A' ' 31' ' ' ALA . 18.8 pt -79.82 163.03 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -86.67 109.87 19.49 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -80.83 -52.58 7.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -167.17 61.45 0.08 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 m -95.7 -62.11 1.35 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.727 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.33 28.94 2.75 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 90' ' ' LYS . 4.4 tmtm? -71.97 -38.31 69.76 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 91' ' ' LEU . 3.3 pp -71.24 109.51 5.32 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.292 1.044 . . . . 0.0 111.167 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -119.94 146.7 45.56 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? 60.55 79.06 0.25 Allowed 'General case' 0 C--N 1.312 -1.053 0 O-C-N 124.409 1.068 . . . . 0.0 110.81 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -106.64 109.78 21.79 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.1 mt -71.42 106.51 3.95 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.542 0.686 . . . . 0.0 112.279 -172.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.41 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.712 0.292 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -91.39 -33.47 15.25 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.404 0.282 . . . . 0.0 111.689 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt 69.31 86.99 0.12 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -170.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.17 109.41 17.71 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.073 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . 45.0 mt-30 -115.69 128.82 56.18 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -96.22 -29.85 13.8 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.945 -173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -88.23 24.47 1.86 Allowed 'General case' 0 C--O 1.242 0.678 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 5' ' ' GLN . 47.8 mtmt -80.62 -75.47 0.27 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.844 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -115.86 100.54 8.07 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.59 0.709 . . . . 0.0 109.865 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 11' ' ' LYS . 17.8 ptmt -146.19 -19.83 0.44 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.775 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 10' ' ' LYS . 41.4 ttmt 74.49 150.88 0.11 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.767 1.227 . . . . 0.0 110.796 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' HB3' HG12 ' A' ' 15' ' ' ILE . 6.1 mm-40 -74.34 91.85 2.24 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.319 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 15.4 mm100 -91.09 -34.73 14.96 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.395 1.093 . . . . 0.0 109.19 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 3.6 mp0 -70.56 -12.06 61.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.438 -174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.3 pp -87.98 -23.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 120.922 0.391 . . . . 0.0 110.125 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 24.9 tptt -48.1 -61.68 1.86 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.845 1.658 . . . . 0.0 112.711 -171.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -104.82 11.66 33.53 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.553 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 12.6 tppt? -84.87 -50.74 7.28 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 26.2 t80 -89.99 -28.99 18.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.626 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 8.0 mtmp? 75.0 88.25 0.09 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 125.577 1.551 . . . . 0.0 110.066 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 HD11 HD22 ' A' ' 66' ' ' LEU . 1.7 mm? -99.94 -69.9 0.75 Allowed 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 m 54.02 84.37 0.06 Allowed 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.131 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.55 -143.47 15.15 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.232 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.76 127.82 16.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.518 2.812 . . . . 0.0 111.386 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.598 HD11 ' HB ' ' A' ' 55' ' ' ILE . 10.4 tp -136.35 127.14 42.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.92 162.27 39.63 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.732 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.9 p -76.85 134.67 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.349 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.77 -34.77 4.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.861 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 35.6 m80 -159.15 163.03 36.43 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.39 116.39 32.34 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.89 155.31 17.24 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 122.345 1.069 . . . . 0.0 111.67 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -106.85 126.47 52.35 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.06 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.53 109.4 2.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.6 t -80.94 -18.7 46.17 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.884 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -147.32 151.48 36.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -89.06 105.4 17.76 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.847 0.832 . . . . 0.0 109.662 173.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.32 162.28 12.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.905 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -125.18 31.52 5.58 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.537 0.684 . . . . 0.0 111.411 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 81.26 59.2 2.45 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.169 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.19 116.12 4.52 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 tttm 57.43 71.11 0.6 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.984 1.313 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.577 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 18.8 m120 51.47 79.47 0.1 Allowed 'General case' 0 C--O 1.245 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 111.493 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.3 tt0 -146.81 -175.45 4.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.649 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -97.59 155.24 17.06 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.559 ' H ' HD23 ' A' ' 44' ' ' LEU . 28.0 m -100.65 115.44 30.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.171 0.51 . . . . 0.0 109.69 174.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.5 p90 -149.48 158.22 43.98 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.819 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HG2' ' OD1' ' A' ' 36' ' ' ASP . 59.4 mttm -110.84 152.93 26.11 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 123.695 0.622 . . . . 0.0 109.922 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 110.22 0.66 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.33 27.23 10.15 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.103 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.7 tp10 -80.11 -37.05 34.43 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.086 0.555 . . . . 0.0 111.117 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 72.21 112.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.182 1.793 . . . . 0.0 110.505 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.559 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.0 mt -119.88 160.68 20.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.117 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.732 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 44.8 mt-10 -117.83 134.36 55.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.6 tp -90.14 126.53 42.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.598 ' HB ' HD11 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.22 -39.55 3.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.63 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -134.89 130.15 35.48 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 118.549 -1.261 . . . . 0.0 110.906 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.45 -1.93 5.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 123.934 0.894 . . . . 0.0 110.233 176.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.8 p -112.38 147.43 36.42 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.916 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 t70 67.08 28.59 8.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 122.75 1.262 . . . . 0.0 109.428 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 23.3 p-10 -77.98 115.05 47.28 Favored Pre-proline 0 C--N 1.302 -1.464 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.203 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 30.9 Cg_exo -62.63 -62.4 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.711 2.941 . . . . 0.0 113.877 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.35 -8.41 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.819 0.818 . . . . 0.0 110.874 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 7.88 68.05 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.0 ptmt -95.96 162.91 13.36 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 57' ' ' ILE . 46.0 m0 -97.71 175.94 6.0 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 122.365 0.266 . . . . 0.0 110.529 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 74' ' ' TYR . 60.1 tp -120.54 114.18 21.38 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -120.24 159.81 15.03 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.4 ttp180 -134.68 152.81 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.0 m -111.82 165.44 12.06 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.23 -31.96 15.36 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -89.29 -6.86 56.42 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 118.372 -1.331 . . . . 0.0 111.091 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.24 97.2 1.25 Allowed Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.874 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.4 m -153.89 124.31 7.04 Favored 'General case' 0 N--CA 1.394 -3.27 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.578 ' HB2' HG21 ' A' ' 15' ' ' ILE . 39.9 m-85 -113.85 80.56 1.4 Allowed 'General case' 1 C--N 1.223 -4.908 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -175.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.649 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -97.46 101.97 2.64 Favored Glycine 3 N--CA 1.346 -7.334 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.577 ' HE1' ' HB3' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.92 100.34 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 113.198 -1.501 . . . . 0.0 108.121 168.21 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.6 pt -80.44 145.68 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.442 -3.204 0 C-N-CA 126.645 1.978 . . . . 0.0 113.515 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 117.58 22.25 Favored 'General case' 1 N--CA 1.359 -5.007 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 166.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.472 HG22 ' CG ' ' A' ' 65' ' ' TRP . 62.1 p -35.34 -38.2 0.09 Allowed 'General case' 0 C--N 1.251 -3.696 0 C-N-CA 129.05 2.94 . . . . 0.0 114.014 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 t -70.27 -9.89 57.32 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.308 1.043 . . . . 0.0 112.248 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.32 -10.18 36.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.427 -0.796 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.604 HG21 HD12 ' A' ' 77' ' ' ILE . 19.0 m -129.08 152.28 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-O 121.808 0.813 . . . . 0.0 112.29 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.5 mt-10 -119.14 107.05 12.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 10.2 pt -72.82 159.3 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.198 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.529 ' OD2' ' HA ' ' A' ' 88' ' ' SER . 28.4 t70 -94.11 101.64 13.66 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -51.94 -45.3 64.26 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 124.785 1.234 . . . . 0.0 112.23 -172.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 2.1 m-20 -116.0 88.7 2.94 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.529 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 50.8 m -74.26 104.94 5.22 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.0 tp 79.2 -39.4 0.22 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.916 1.686 . . . . 0.0 110.277 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . 46.8 tttm 70.11 79.94 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.607 1.163 . . . . 0.0 109.411 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.17 155.18 51.12 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.759 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -157.37 96.73 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 123.773 0.829 . . . . 0.0 109.275 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 76.3 174.77 0.22 Allowed 'General case' 0 C--O 1.245 0.831 0 C-N-CA 125.105 1.362 . . . . 0.0 110.623 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -113.86 28.51 8.7 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.719 0.771 . . . . 0.0 109.944 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.8 tp -69.23 -31.74 70.52 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.033 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 C--N 1.303 -1.417 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.216 -178.942 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 120.942 0.401 . . . . 0.0 112.016 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -120.82 114.54 21.76 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -93.73 118.93 32.07 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -140.51 73.66 1.43 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 168.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 67.29 166.99 0.23 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.194 -175.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.58 89.1 2.89 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.708 0.765 . . . . 0.0 111.209 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.76 109.11 20.6 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -133.03 94.83 3.43 Favored 'General case' 0 C--O 1.255 1.354 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.38 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 74.1 -59.64 0.55 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.197 1.399 . . . . 0.0 112.488 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 75.86 103.6 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.623 1.569 . . . . 0.0 112.011 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -97.33 12.15 34.06 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 83.09 140.31 0.06 Allowed 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 126.444 1.897 . . . . 0.0 111.079 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.2 -32.22 16.7 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.315 0.579 . . . . 0.0 111.175 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 35.0 mm-40 -59.63 -34.59 72.98 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.182 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.586 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 2.4 pp -72.3 -28.3 28.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.316 -172.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HA ' HD23 ' A' ' 21' ' ' LEU . 48.7 mtpt -67.91 -36.19 79.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.015 -172.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -107.53 -16.74 14.29 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.298 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 5.8 tppt? -71.32 -45.73 62.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.444 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 31.3 t80 -90.68 -30.61 17.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . 0.254 15.2 tptp 74.61 85.58 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.695 1.236 . . . . 0.0 111.392 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.605 HD11 HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -98.99 -59.84 1.65 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.304 36.2 p 62.75 100.23 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.792 1.637 . . . . 0.0 112.634 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.08 144.3 10.19 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -173.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.97 125.97 20.86 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 123.311 2.674 . . . . 0.0 111.599 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.3 tp -107.97 136.33 43.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.33 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -103.59 167.49 9.76 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.4 p -81.64 137.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.442 0.639 . . . . 0.0 111.159 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.42 -40.36 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.748 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.4 m80 -161.15 171.75 17.95 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.86 126.33 52.54 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -102.68 156.6 17.52 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.418 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -107.1 133.51 51.6 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -65.99 103.22 0.9 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.9 t -71.2 -28.93 64.57 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.3 m -132.09 156.43 46.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.708 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.7 p-10 -81.38 112.03 18.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 171.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 81' ' ' ALA . 30.8 t -112.62 140.89 30.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.789 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.34 -168.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -86.7 -14.61 42.01 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.341 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 37' ' ' VAL . . . 75.78 60.49 3.16 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.983 -1.58 . . . . 0.0 110.432 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.17 131.89 10.85 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.83 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp 58.88 71.58 0.58 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.405 1.082 . . . . 0.0 110.658 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 56.29 61.45 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.114 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 46.5 mt-10 -134.16 -179.22 5.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.548 0.339 . . . . 0.0 111.133 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -98.46 140.96 31.93 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 p -94.6 115.73 27.92 Favored 'General case' 0 C--N 1.28 -2.443 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.161 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 29.1 p90 -145.47 177.12 9.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.478 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 9.3 mtmp? -134.81 142.53 46.69 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.6 tm0? -35.79 111.97 0.15 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 125.131 1.519 . . . . 0.0 110.376 173.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.09 19.97 40.77 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.648 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.553 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -73.33 -26.0 60.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.003 0.901 . . . . 0.0 113.227 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 70.84 104.2 0.06 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.882 1.364 . . . . 0.0 108.813 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.552 HD12 HG12 ' A' ' 82' ' ' VAL . 14.8 mt -110.74 165.95 5.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 24.9 mt-10 -122.65 141.11 52.1 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.8 tp -98.75 116.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.49 -41.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.387 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.592 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -133.7 136.54 44.74 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 117.782 -1.567 . . . . 0.0 111.497 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.02 -37.84 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.376 -1.283 . . . . 0.0 109.675 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -88.45 158.09 18.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t70 54.82 66.36 1.25 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 125.032 1.333 . . . . 0.0 109.192 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 31.5 p30 -112.11 136.93 21.3 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.166 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.6 Cg_exo -76.76 -32.3 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.431 2.087 . . . . 0.0 112.872 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.79 -34.89 6.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.74 -7.04 15.63 Favored Glycine 0 C--N 1.305 -1.142 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HA ' HG23 ' A' ' 79' ' ' THR . 11.4 ptmt -80.52 162.33 24.38 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.557 ' CD1' HG22 ' A' ' 57' ' ' ILE . 37.7 m0 -99.08 176.65 5.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.608 0.186 . . . . 0.0 110.801 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.605 HD22 HD11 ' A' ' 21' ' ' LEU . 61.4 tp -116.39 110.93 19.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.83 158.84 14.07 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 73' ' ' SER . 66.4 ttt-85 -140.53 147.8 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.769 0.427 . . . . 0.0 109.88 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 7.1 p -101.03 165.54 11.27 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.12 65.2 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.087 0.47 . . . . 0.0 112.254 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -71.55 -14.97 62.26 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.338 0.655 . . . . 0.0 111.749 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 81.77 88.37 0.65 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.181 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.7 m -151.99 120.82 6.57 Favored 'General case' 0 N--CA 1.394 -3.269 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' HB2' HG21 ' A' ' 15' ' ' ILE . 61.0 m-85 -108.91 90.74 3.38 Favored 'General case' 1 C--N 1.219 -5.076 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.16 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.601 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -107.05 104.81 2.21 Favored Glycine 3 N--CA 1.355 -6.748 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.586 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -46.0 96.99 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.351 -1.424 . . . . 0.0 108.29 169.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 82' ' ' VAL . 1.5 pt -78.22 147.18 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.898 0 C-N-CA 125.713 1.605 . . . . 0.0 114.398 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -76.64 113.82 14.7 Favored 'General case' 1 N--CA 1.376 -4.143 0 N-CA-C 101.712 -3.44 . . . . 0.0 101.712 165.77 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 64' ' ' LYS . 79.4 p -36.64 -41.92 0.33 Allowed 'General case' 0 C--N 1.246 -3.92 0 C-N-CA 127.769 2.427 . . . . 0.0 113.594 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -63.53 -20.42 65.61 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.258 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -82.97 -12.54 57.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.835 -0.54 . . . . 0.0 111.279 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 77' ' ' ILE . 29.1 m -127.06 166.82 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.343 0.592 . . . . 0.0 111.847 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 58.3 mt-10 -133.26 107.91 8.43 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.742 HG22 ' HB2' ' A' ' 31' ' ' ALA . 8.6 pt -75.53 155.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.391 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -97.25 108.86 21.68 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.706 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.46 -5.5 0.84 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.135 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 t70 48.9 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.166 1.787 . . . . 0.0 114.445 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.1 m -96.94 39.41 1.18 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.819 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.2 mt -71.28 -53.23 15.02 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.157 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 54.56 72.98 0.43 Allowed 'General case' 0 C--O 1.245 0.848 0 O-C-N 124.788 1.305 . . . . 0.0 110.07 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.56 123.93 18.44 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.091 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -77.11 125.87 30.03 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.138 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.16 174.98 10.11 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.424 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -114.64 -160.94 0.75 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.6 mt -75.88 106.42 7.45 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 119.005 0.82 . . . . 0.0 110.892 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.416 -2.132 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -179.613 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -92.26 95.93 9.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' HG2' ' HG2' ' A' ' 4' ' ' GLU . 64.5 tttp -112.03 -63.31 1.44 Allowed 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 12.2 pt-20 170.35 151.69 0.04 OUTLIER 'General case' 0 C--O 1.246 0.876 0 C-N-CA 125.957 1.703 . . . . 0.0 107.43 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.53 134.98 57.19 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -48.16 -38.22 17.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.87 103.36 3.36 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -107.72 -82.55 0.55 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 50.39 30.82 4.82 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.699 1.2 . . . . 0.0 111.667 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -130.87 80.22 1.93 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -86.14 122.72 30.54 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.897 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' A' ' 15' ' ' ILE . 14.1 tt0 -133.02 56.87 1.83 Allowed 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.587 ' HG3' ' HD3' ' A' ' 16' ' ' LYS . 28.5 tt0 -74.96 -13.48 60.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.705 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -59.4 -29.92 68.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.827 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.704 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.9 pp -67.54 -30.77 49.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-O 121.454 0.645 . . . . 0.0 111.422 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HD3' ' HG3' ' A' ' 13' ' ' GLN . 21.8 mtpp -76.48 -27.32 56.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.805 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -93.65 -8.93 39.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.019 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 12.6 tppt? -99.58 -67.01 0.87 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.073 0.463 . . . . 0.0 110.96 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.786 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 21.1 t80 -79.07 -32.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 -172.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 7.9 mtmp? 75.72 91.84 0.07 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.834 1.253 . . . . 0.0 109.692 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.058 HD12 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.35 -46.33 5.83 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.318 0.58 . . . . 0.0 109.772 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p 56.88 21.41 6.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.507 1.523 . . . . 0.0 114.877 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.86 143.67 7.19 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.48 97.0 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.747 2.298 . . . . 0.0 111.109 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.454 HD13 ' HB ' ' A' ' 55' ' ' ILE . 2.3 pp -114.54 163.73 11.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.305 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.438 ' C ' HG22 ' A' ' 55' ' ' ILE . 12.9 pt20 -124.53 -172.69 2.61 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -53.95 133.7 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.64 -31.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.066 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.1 m80 -161.05 157.03 25.49 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.27 116.04 28.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.669 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -94.63 150.81 19.85 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 122.072 0.939 . . . . 0.0 111.127 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.81 128.27 54.11 Favored 'General case' 0 C--N 1.252 -3.652 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -63.84 116.05 5.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.553 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.9 t -81.87 -18.47 43.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.249 0.968 . . . . 0.0 109.846 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.9 m -144.61 156.09 43.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 6.3 p-10 -91.42 102.02 14.7 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.402 HG12 ' CE1' ' A' ' 46' ' ' PHE . 9.9 p -113.25 153.75 14.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.795 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -98.1 8.33 44.95 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.387 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.62 59.77 1.87 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.678 -1.248 . . . . 0.0 111.896 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.77 143.8 16.7 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttp 65.05 29.59 12.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 108.757 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.414 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 2.4 t-20 63.14 86.97 0.11 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.28 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 31.0 tt0 -141.59 -173.6 3.82 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.257 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.646 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.2 tt -95.92 145.54 25.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 m -96.01 122.21 38.59 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 16.6 p90 -154.26 174.83 14.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 60.9 mtpt -127.33 147.79 50.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.3 tm0? -51.98 125.68 16.13 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.669 0.605 . . . . 0.0 110.425 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.2 81.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.349 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -63.12 -30.9 71.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.504 0.668 . . . . 0.0 109.891 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 73.23 110.41 0.07 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.13 1.372 . . . . 0.0 111.298 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.528 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.4 mt -115.76 156.81 16.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 CA-C-N 113.557 -1.656 . . . . 0.0 106.671 -172.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 79.9 mt-10 -113.08 131.16 55.92 Favored 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.009 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.6 tp -86.32 115.81 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.523 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -103.4 -32.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.984 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 1.058 ' HG3' HD12 ' A' ' 21' ' ' LEU . 18.1 mmt180 -134.93 112.4 10.61 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.721 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.59 -19.31 6.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.038 -1.892 . . . . 0.0 107.092 171.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 57' ' ' ILE . 12.0 p -99.01 141.94 31.12 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.396 -177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t0 75.67 26.06 1.12 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.058 1.343 . . . . 0.0 108.92 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 10.0 p30 -66.01 126.02 91.11 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.587 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.786 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 62.2 Cg_endo -81.23 -45.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.398 2.065 . . . . 0.0 113.3 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -99.3 -5.52 29.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.021 0.438 . . . . 0.0 111.177 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 99.46 -22.3 41.3 Favored Glycine 0 C--N 1.308 -1.004 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.1 ptmt -72.0 161.49 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.152 -1.024 . . . . 0.0 109.21 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.456 ' CG ' HG22 ' A' ' 79' ' ' THR . 32.3 m0 -99.5 176.34 5.53 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.073 0.233 . . . . 0.0 110.924 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 74' ' ' TYR . 62.9 tp -120.36 114.33 21.68 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.08 156.18 15.81 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 73' ' ' SER . 2.1 ttp-105 -139.03 149.11 44.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 17.2 p -99.76 165.94 11.34 Favored 'General case' 0 C--N 1.266 -3.032 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.962 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.73 -30.08 42.47 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -0.07 54.92 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.34 0.866 . . . . 0.0 113.34 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.28 92.01 0.9 Allowed Glycine 0 C--N 1.319 -0.413 0 CA-C-O 121.554 0.53 . . . . 0.0 113.535 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 20.4 m -153.01 126.15 8.53 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.73 ' HB3' HD11 ' A' ' 66' ' ' LEU . 57.1 m-85 -117.81 86.68 2.57 Favored 'General case' 1 C--N 1.227 -4.727 0 CA-C-O 122.122 0.963 . . . . 0.0 108.649 -173.036 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.646 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.14 101.76 2.12 Favored Glycine 3 N--CA 1.359 -6.447 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.678 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -48.92 100.36 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.58 -1.31 . . . . 0.0 108.499 170.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.602 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.8 pt -80.41 148.29 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.843 0 C-N-CA 126.277 1.831 . . . . 0.0 113.074 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -77.42 119.59 21.24 Favored 'General case' 1 N--CA 1.368 -4.533 0 N-CA-C 102.647 -3.094 . . . . 0.0 102.647 163.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 64' ' ' LYS . 82.0 p -36.13 -38.59 0.14 Allowed 'General case' 1 C--N 1.243 -4.051 0 C-N-CA 128.017 2.527 . . . . 0.0 113.168 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.5 t -71.71 -14.15 61.94 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.208 0.603 . . . . 0.0 112.155 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.97 -11.2 57.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.42 -0.8 . . . . 0.0 110.937 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.528 ' CG1' HD12 ' A' ' 52' ' ' ILE . 16.9 m -129.35 167.41 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.556 0.693 . . . . 0.0 111.336 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 mt-10 -131.34 110.55 11.15 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -75.77 159.5 5.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.251 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.18 102.12 14.84 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.621 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -86.12 169.39 13.16 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -101.97 86.41 2.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.4 m -96.73 -3.67 42.07 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.139 -172.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 mp 68.48 -69.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.955 0.902 . . . . 0.0 111.748 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 65.66 24.17 11.61 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.766 1.269 . . . . 0.0 110.341 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.2 tp -126.37 115.18 19.24 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.38 79.89 5.8 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -150.47 82.22 1.36 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -106.94 -175.17 2.72 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.437 -172.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.57 101.74 1.69 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.253 1.259 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.456 178.989 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.48 25.78 2.19 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.382 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 3' ' ' LYS . 73.3 mmtt -70.08 85.25 0.53 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.363 1.077 . . . . 0.0 111.261 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -159.89 -47.33 0.05 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.25 109.71 21.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 169.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -118.02 148.28 42.4 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.038 0.447 . . . . 0.0 111.553 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -149.28 147.21 28.09 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.597 ' HD3' ' HE2' ' A' ' 10' ' ' LYS . 87.4 tttt -137.68 129.11 28.05 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 42' ' ' ASN . 7.7 pt-20 -79.69 102.66 9.1 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.733 0.778 . . . . 0.0 109.271 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.597 ' HE2' ' HD3' ' A' ' 8' ' ' LYS . 84.4 mttt -110.88 -78.25 0.59 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.642 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.93 102.35 7.49 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.41 143.15 27.05 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.021 0.439 . . . . 0.0 109.981 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -90.03 -20.36 23.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 170.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.34 8.12 0.66 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.181 -1.827 . . . . 0.0 112.346 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 74' ' ' TYR . 7.7 pt -67.18 -27.87 40.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.001 0.905 . . . . 0.0 108.746 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.2 ptmt -79.55 -5.38 54.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.22 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -108.66 -19.94 13.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tppt? -91.06 -68.0 0.82 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.031 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.618 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 3.1 t80 -89.12 -22.6 22.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 58.28 88.96 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.417 1.487 . . . . 0.0 111.206 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.673 HD11 HD22 ' A' ' 66' ' ' LEU . 1.9 mm? -95.65 -20.31 19.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.08 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p 66.28 -5.55 0.57 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.901 2.08 . . . . 0.0 114.666 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.26 -167.08 37.49 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.656 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.66 113.09 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.282 2.655 . . . . 0.0 110.86 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.408 HG22 ' HB ' ' A' ' 55' ' ' ILE . 44.5 mm -103.79 127.72 57.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' C ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 -92.23 170.28 9.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.358 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.71 132.59 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.432 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -99.98 -30.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.171 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.5 m80 -165.41 161.92 19.14 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.27 116.61 33.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.681 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.03 154.54 17.64 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.813 0.816 . . . . 0.0 111.072 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.98 129.5 55.11 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.53 109.75 2.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 40.3 t -87.74 -5.96 58.42 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.619 0.723 . . . . 0.0 109.071 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.4 m -148.99 163.3 37.9 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.635 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.1 t70 -108.68 100.64 9.86 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.664 1.186 . . . . 0.0 110.734 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 46' ' ' PHE . 11.4 p -115.62 148.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.292 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.04 30.16 7.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.38 0.61 . . . . 0.0 112.461 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.92 59.85 1.55 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.236 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.81 140.97 15.07 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.53 31.0 20.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.841 0.456 . . . . 0.0 109.828 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 2.6 t-20 62.51 95.61 0.04 OUTLIER 'General case' 0 C--O 1.247 0.932 0 C-N-CA 125.001 1.32 . . . . 0.0 109.767 -176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.5 tt0 -150.13 -173.73 4.52 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.755 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.672 HD13 ' H ' ' A' ' 75' ' ' GLY . 45.6 tp -95.45 147.83 23.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 p -100.3 115.46 29.99 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.388 0.613 . . . . 0.0 110.096 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 37' ' ' VAL . 32.7 p90 -151.78 168.7 24.25 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.808 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.594 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -124.44 147.63 48.18 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -176.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 20.2 tt0 -51.45 121.84 6.99 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.804 0.335 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.77 29.94 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.295 -0.479 . . . . 0.0 114.147 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 27.6 mm-40 -85.61 -32.39 22.08 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.96 0.88 . . . . 0.0 113.047 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 73.95 111.83 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.524 1.154 . . . . 0.0 111.272 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.52 HD13 HD23 ' A' ' 44' ' ' LEU . 4.8 mt -118.49 173.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.782 -173.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' H ' HG22 ' A' ' 52' ' ' ILE . 24.6 mt-10 -128.94 134.05 48.07 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.7 tp -91.35 128.95 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.415 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -107.09 -53.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.749 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.618 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 20.2 ttm180 -127.62 137.78 52.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.495 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.74 -32.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 123.975 0.91 . . . . 0.0 112.07 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 p -102.81 164.1 11.83 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t70 71.45 19.57 5.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.876 1.322 . . . . 0.0 108.828 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.519 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 30.8 p-10 -80.51 118.1 70.84 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.869 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 12.1 Cg_exo -71.25 -33.29 11.56 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.737 2.958 . . . . 0.0 114.654 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 64' ' ' LYS . 1.5 mp0 -92.43 -17.07 25.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.135 0.493 . . . . 0.0 110.772 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.72 5.93 70.81 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.7 ptmt -102.88 162.59 12.81 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.52 ' HB2' HG13 ' A' ' 77' ' ' ILE . 44.1 m0 -95.69 176.6 6.09 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 123.393 0.677 . . . . 0.0 110.676 -176.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 21' ' ' LEU . 51.8 tp -117.04 113.58 22.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.37 147.93 18.9 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' THR . 43.9 ttp180 -120.9 154.33 36.02 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.038 0.447 . . . . 0.0 111.117 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.586 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m -99.4 153.13 19.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.24 -34.5 32.62 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 119.242 0.928 . . . . 0.0 113.272 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -71.65 -15.37 62.23 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.503 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.33 87.67 1.17 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.9 m -153.56 122.77 6.55 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' A' ' 66' ' ' LEU . 77.5 m-85 -113.37 99.21 7.61 Favored 'General case' 1 C--N 1.222 -4.951 0 O-C-N 123.902 0.751 . . . . 0.0 109.828 -171.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.672 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -104.19 101.69 2.01 Favored Glycine 1 N--CA 1.356 -6.633 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.71 103.19 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.884 0 CA-C-N 113.423 -1.389 . . . . 0.0 107.358 170.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.7 pt -87.71 143.89 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.97 0 C-N-CA 124.837 1.255 . . . . 0.0 113.728 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.09 117.6 18.81 Favored 'General case' 1 N--CA 1.371 -4.397 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 166.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.472 HG22 ' CG ' ' A' ' 65' ' ' TRP . 54.5 p -36.21 -39.48 0.18 Allowed 'General case' 0 C--N 1.244 -3.999 0 C-N-CA 128.868 2.867 . . . . 0.0 113.12 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -69.38 -12.61 61.8 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.255 1.022 . . . . 0.0 112.704 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.83 -12.75 41.06 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.591 -0.693 . . . . 0.0 110.997 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 52' ' ' ILE . 27.7 m -130.92 164.65 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-O 121.251 0.548 . . . . 0.0 111.088 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 45.6 mt-10 -132.26 113.29 13.06 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -76.27 166.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.566 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.83 103.26 12.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -82.03 109.54 16.46 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.07 120.66 25.11 Favored 'General case' 0 C--N 1.275 -2.672 0 CA-C-O 121.645 0.735 . . . . 0.0 110.131 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.6 p -92.37 154.08 18.78 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.877 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.18 127.26 32.78 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.629 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -100.73 4.16 42.85 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.719 0.771 . . . . 0.0 110.363 -178.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.579 HD22 ' HG2' ' A' ' 90' ' ' LYS . 3.1 mm? -137.44 175.57 9.48 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -87.52 -51.73 5.75 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.49 ' HE2' ' HG2' ' A' ' 96' ' ' GLU . 87.2 tttt 171.83 78.73 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.97 -67.23 0.58 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.67 -1.15 . . . . 0.0 113.198 -170.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.7 tp -84.55 85.78 7.38 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-O 121.291 0.567 . . . . 0.0 111.661 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG2' ' HE2' ' A' ' 93' ' ' LYS . 6.3 tp10 . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 5' ' ' GLN . 42.9 mt-10 . . . . . 0 CA--C 1.494 -1.21 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -101.78 151.74 21.7 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.863 ' HE2' ' HA ' ' A' ' 3' ' ' LYS . 10.0 mmpt? 68.17 72.67 0.3 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.235 1.014 . . . . 0.0 112.098 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 60.05 75.76 0.39 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.508 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.55 ' HB2' ' HB2' ' A' ' 1' ' ' GLU . 27.9 tt0 -72.92 142.56 47.87 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.294 172.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -91.42 124.68 35.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.25 79.87 0.24 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.545 0.688 . . . . 0.0 112.15 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -94.8 7.49 45.71 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.479 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 35.2 tt0 -80.03 -22.57 42.24 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.692 175.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -74.51 92.04 2.34 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -120.19 13.89 12.09 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.782 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.98 65.84 0.77 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.262 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -90.16 -23.82 21.22 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -54.54 -31.36 56.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.36 -1.745 . . . . 0.0 111.43 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.737 HG21 ' HB2' ' A' ' 74' ' ' TYR . 10.1 pt -68.8 -28.6 40.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.418 0.628 . . . . 0.0 110.903 -174.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.481 ' N ' HG13 ' A' ' 15' ' ' ILE . 25.7 mtpp -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.072 0.939 . . . . 0.0 108.493 -176.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HB3' ' NZ ' ' A' ' 17' ' ' LYS . 7.4 mtpm? -114.72 9.07 16.33 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.921 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 76' ' ' TYR . 11.9 tppt? -120.41 -60.88 1.64 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.209 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.7 t80 -91.53 -28.33 17.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 3.1 ttpm? 65.45 90.0 0.09 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.521 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 66' ' ' LEU . 1.7 mm? -98.73 -15.8 19.2 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.359 -174.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.307 80.4 p 69.83 -55.19 0.6 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.709 1.604 . . . . 0.0 113.079 -176.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.15 -147.87 5.58 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.12 173.59 11.68 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.663 2.242 . . . . 0.0 111.557 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.9 tp -160.15 130.37 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.545 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -79.52 168.61 19.19 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.7 p -80.04 134.78 26.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.508 0.671 . . . . 0.0 110.498 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.27 -38.86 11.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.987 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.6 m80 -161.65 165.01 28.87 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.57 124.76 49.4 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -99.34 158.89 15.4 Favored 'General case' 0 C--N 1.267 -2.99 0 CA-C-O 121.805 0.812 . . . . 0.0 111.831 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -106.83 125.58 51.19 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 109.88 2.15 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.448 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 41.9 t -84.69 -19.24 33.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.0 t -144.55 144.75 31.47 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.94 105.83 14.26 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.913 0.863 . . . . 0.0 111.234 174.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.31 151.35 18.12 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.425 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 66.78 1.11 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 121.896 0.855 . . . . 0.0 109.655 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 73.16 59.18 4.35 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.213 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.51 105.75 2.95 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 57.11 69.52 0.74 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.17 0.988 . . . . 0.0 110.95 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 54.49 83.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.781 0.832 . . . . 0.0 109.843 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 7.7 tt0 -149.59 -175.3 4.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.625 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.44 159.57 14.86 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.555 ' H ' HD23 ' A' ' 44' ' ' LEU . 14.8 m -101.42 118.68 37.46 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-O 121.566 0.698 . . . . 0.0 110.031 174.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.8 p90 -154.96 163.74 39.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.057 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.575 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 48.1 mtmt -117.72 156.17 28.71 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.86 116.07 1.8 Allowed 'General case' 0 CA--C 1.568 1.656 0 O-C-N 123.833 0.708 . . . . 0.0 109.325 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.99 17.58 40.24 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.575 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -80.34 -21.83 42.06 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 72.11 109.23 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.319 1.057 . . . . 0.0 110.871 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.6 mt -116.1 165.44 11.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' HG21 ' A' ' 27' ' ' VAL . 8.0 mt-10 -116.66 136.78 52.69 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 65' ' ' TRP . 7.4 tp -98.58 119.69 46.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.38 -53.24 7.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.9 tpm_? -122.43 123.96 42.53 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.901 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -113.66 -23.75 4.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.498 0.666 . . . . 0.0 110.599 174.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 p -90.85 150.33 21.59 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.718 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 60.11 55.27 3.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.234 1.014 . . . . 0.0 108.513 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -95.82 109.22 45.18 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.71 -59.95 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 124.008 3.139 . . . . 0.0 114.307 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.22 -17.52 56.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.687 0.28 . . . . 0.0 111.497 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.11 5.69 49.53 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -105.43 159.4 15.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.106 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.542 ' CD1' HG22 ' A' ' 57' ' ' ILE . 38.3 m0 -90.41 174.35 7.61 Favored 'General case' 0 C--O 1.198 -1.612 0 C-N-CA 123.459 0.703 . . . . 0.0 110.578 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 74' ' ' TYR . 58.0 tp -112.74 109.36 18.81 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.987 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 53' ' ' GLU . . . -114.08 155.13 16.52 Favored Glycine 0 N--CA 1.426 -1.986 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.8 ttp180 -133.95 147.1 51.01 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 73' ' ' SER . 13.4 t -104.17 163.87 12.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.58 -28.98 15.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.479 ' NH2' ' HG2' ' A' ' 9' ' ' GLU . 1.1 tmt_? -76.36 -21.02 56.61 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.491 0.663 . . . . 0.0 110.637 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.03 1.07 Allowed Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 59.6 m -152.54 125.5 8.5 Favored 'General case' 0 N--CA 1.386 -3.67 1 N-CA-C 100.03 -4.063 . . . . 0.0 100.03 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.83 ' HB3' HD11 ' A' ' 66' ' ' LEU . 35.1 m-85 -110.6 82.7 1.63 Allowed 'General case' 1 C--N 1.21 -5.482 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.28 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.625 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -98.44 97.48 1.9 Allowed Glycine 2 N--CA 1.363 -6.22 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.519 ' CE1' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.84 93.68 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.883 -1.659 . . . . 0.0 110.727 172.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -70.92 139.91 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 126.9 2.08 . . . . 0.0 113.617 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 118.03 18.2 Favored 'General case' 1 N--CA 1.353 -5.31 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 166.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CD2' ' A' ' 65' ' ' TRP . 73.7 p -35.1 -39.1 0.1 Allowed 'General case' 1 C--N 1.229 -4.67 0 C-N-CA 129.116 2.966 . . . . 0.0 112.807 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -72.02 -5.86 38.13 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.752 0.821 . . . . 0.0 112.26 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.0 -2.62 34.06 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.625 -0.672 . . . . 0.0 111.122 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 77' ' ' ILE . 19.3 m -134.38 159.86 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-O 121.784 0.802 . . . . 0.0 112.722 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.1 mt-10 -125.94 102.89 7.47 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.4 pp -69.14 149.21 11.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.63 103.78 0.72 Allowed 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 121.143 0.497 . . . . 0.0 111.162 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -71.35 115.76 10.89 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.11 104.83 0.22 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.0 m -137.58 97.67 3.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.473 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.3 tp -121.41 108.54 13.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.528 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 64.82 69.89 0.49 Allowed 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 124.098 0.959 . . . . 0.0 112.861 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.13 167.66 14.5 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.825 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 9.6 mmpt? -91.84 -60.06 1.96 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.493 0.663 . . . . 0.0 109.343 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.53 155.1 49.63 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 173.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -135.07 76.01 1.6 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.311 1.053 . . . . 0.0 109.263 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.0 tp -110.07 -32.13 7.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 N--CA 1.422 -1.829 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 174.805 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.572 0 CA-C-O 120.766 0.317 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -83.67 89.36 7.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.464 0.65 . . . . 0.0 110.515 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.799 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -134.69 31.09 3.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.619 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 72.44 140.73 0.06 Allowed 'General case' 0 C--O 1.242 0.665 0 C-N-CA 125.517 1.527 . . . . 0.0 113.393 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 78.05 -49.26 0.48 Allowed 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.999 1.72 . . . . 0.0 112.779 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 68.47 103.7 0.05 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 124.276 1.03 . . . . 0.0 110.136 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.25 118.37 9.18 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.906 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 68.97 -72.58 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.736 1.615 . . . . 0.0 109.524 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 176.4 -73.37 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 125.884 1.674 . . . . 0.0 106.868 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 42.64 0.67 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.349 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 13' ' ' GLN . 88.8 tttt -65.83 118.01 9.05 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.696 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.651 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -98.0 39.18 1.24 Allowed 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 125.402 1.481 . . . . 0.0 110.706 -176.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 11.0 pt20 -58.71 -35.29 72.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 111.694 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -65.63 -23.77 66.89 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.673 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 12' ' ' GLU . 10.0 pt -81.31 -23.22 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.585 1.183 . . . . 0.0 109.17 -171.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HG3' HG13 ' A' ' 15' ' ' ILE . 74.0 mttt -82.19 -9.07 59.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.32 -1.763 . . . . 0.0 110.791 -173.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 0.07 19.45 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.008 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 3.8 tppt? -114.18 -58.5 2.14 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.382 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 60' ' ' ASN . 20.1 t80 -85.94 -33.46 21.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 66.82 94.23 0.07 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.531 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.85 HD11 HD22 ' A' ' 66' ' ' LEU . 2.0 mm? -99.76 -64.85 1.0 Allowed 'General case' 0 CA--C 1.46 -2.518 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.052 -173.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 m 58.32 82.49 0.13 Allowed 'General case' 0 N--CA 1.395 -3.225 0 CA-C-N 111.678 -2.51 . . . . 0.0 111.115 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.33 116.04 2.25 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.74 137.61 42.09 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.701 2.934 . . . . 0.0 112.276 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.571 HG23 ' HB ' ' A' ' 55' ' ' ILE . 20.8 tt -127.9 150.62 33.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.248 0.546 . . . . 0.0 111.104 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.36 175.76 5.75 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.317 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -74.76 132.0 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 109.891 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.48 -33.26 5.16 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.952 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.7 m80 -166.72 165.64 16.32 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.63 116.01 31.18 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.24 159.34 15.32 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.944 0.878 . . . . 0.0 112.243 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.39 127.94 54.02 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.377 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -64.43 107.02 1.24 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 t -75.37 -19.12 59.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.438 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.0 p -153.15 159.58 42.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 48' ' ' GLN . 4.5 p30 -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.621 0.724 . . . . 0.0 109.543 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.686 HG22 ' H ' ' A' ' 39' ' ' GLY . 11.4 p -115.72 152.54 17.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.631 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.78 8.75 39.34 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.967 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 37' ' ' VAL . . . 84.01 60.21 1.98 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.52 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.43 80.08 1.68 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.263 -174.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 66.72 82.9 0.17 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.328 1.051 . . . . 0.0 113.309 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 89.28 26.12 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 125.516 1.526 . . . . 0.0 113.114 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.82 174.81 6.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.403 0.621 . . . . 0.0 111.668 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 46.4 tp -96.42 147.91 23.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.531 1.533 . . . . 0.0 107.315 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -96.89 121.81 39.16 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 120.907 0.385 . . . . 0.0 110.313 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CG ' HD11 ' A' ' 52' ' ' ILE . 26.9 p90 -155.66 160.04 40.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.616 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -108.91 152.42 24.95 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -62.48 117.14 5.79 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.907 0.754 . . . . 0.0 109.355 -176.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.78 30.03 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.567 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.94 -25.12 16.67 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 72.83 134.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 O-C-N 124.8 1.313 . . . . 0.0 113.041 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 82' ' ' VAL . 5.3 mt -129.64 169.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.339 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -119.07 135.5 54.61 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.1 tp -93.16 127.04 45.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.571 ' HB ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.92 -56.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HD2' HD12 ' A' ' 21' ' ' LEU . 12.6 ttt180 -119.09 131.9 55.97 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.921 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.507 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -116.83 -32.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.063 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 p -107.36 161.11 15.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 t70 64.79 69.16 0.5 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 125.522 1.529 . . . . 0.0 112.814 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 9.2 p30 -145.09 163.3 33.41 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.538 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -95.72 10.91 1.48 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.218 1.946 . . . . 0.0 115.416 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 8.4 tp10 -122.98 -29.91 3.86 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.985 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.05 57.61 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.6 ptmt -92.5 163.12 13.94 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 109.266 -177.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.542 ' CD2' HG22 ' A' ' 79' ' ' THR . 43.2 m0 -101.89 169.53 8.72 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.893 0.377 . . . . 0.0 110.592 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.85 HD22 HD11 ' A' ' 21' ' ' LEU . 45.7 tp -109.58 110.51 21.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -112.74 142.83 17.5 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 73' ' ' SER . 50.2 ttt-85 -124.32 155.02 39.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 124.319 0.658 . . . . 0.0 110.188 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.551 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 5.2 m -113.52 162.05 16.64 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.96 -28.97 7.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -172.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -69.99 -28.52 65.59 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.034 0.534 . . . . 0.0 111.577 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 96.07 69.0 1.01 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.665 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.4 m -136.62 117.09 13.75 Favored 'General case' 0 N--CA 1.383 -3.806 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.629 ' HB2' HG21 ' A' ' 15' ' ' ILE . 90.2 m-85 -116.68 105.1 12.05 Favored 'General case' 1 C--N 1.223 -4.925 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -172.027 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.84 0.75 48.42 Favored Glycine 0 C--O 1.181 -3.19 0 C-N-CA 118.372 -1.87 . . . . 0.0 116.255 -175.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.584 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.268 0.1 OUTLIER 51.2 80.44 0.08 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 123.103 1.43 . . . . 0.0 111.417 -176.976 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 82' ' ' VAL . 2.0 pt -68.57 142.17 16.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.66 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.51 115.51 20.07 Favored 'General case' 1 N--CA 1.362 -4.831 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 165.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 64' ' ' LYS . 73.1 p -34.95 -38.3 0.08 Allowed 'General case' 1 C--N 1.244 -4.008 0 C-N-CA 128.918 2.887 . . . . 0.0 114.422 -177.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -68.98 -7.1 32.11 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.951 0.9 . . . . 0.0 111.709 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.26 -6.86 43.59 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 121.466 -0.771 . . . . 0.0 110.657 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 HD12 ' A' ' 77' ' ' ILE . 26.3 m -137.52 167.88 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-O 121.618 0.723 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.8 pt -77.81 163.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.545 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -95.92 118.73 33.11 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.32 156.07 21.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.311 0.577 . . . . 0.0 110.53 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -128.96 117.62 21.26 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.9 m -85.14 142.21 29.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.985 0.421 . . . . 0.0 110.127 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 92' ' ' LYS . 3.0 mm? -94.59 84.23 4.25 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.975 0.416 . . . . 0.0 110.857 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -82.42 -16.85 47.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.6 mt -94.46 7.86 44.09 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 37.7 ttpt -126.89 98.16 5.24 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.33 73.61 0.11 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.469 1.128 . . . . 0.0 110.709 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -81.86 77.14 8.73 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.98 72.01 1.45 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.196 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 . . . . . 0 C--N 1.303 -1.425 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.305 179.062 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 . . . . . 0 CA--C 1.508 -0.635 0 CA-C-O 121.228 0.537 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 50.3 tttm -90.56 90.31 7.94 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -85.23 2.39 44.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.333 1.063 . . . . 0.0 110.486 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.407 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 13.8 pt20 -97.45 161.95 13.54 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.398 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.602 ' HG2' ' H ' ' A' ' 7' ' ' GLU . 84.8 tttt -179.32 -174.59 0.32 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 103.375 -2.824 . . . . 0.0 103.375 176.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.602 ' H ' ' HG2' ' A' ' 6' ' ' LYS . 3.3 mp0 -75.07 86.31 2.35 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 119.147 0.885 . . . . 0.0 109.73 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -83.9 83.57 7.89 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 122.977 1.37 . . . . 0.0 110.605 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.3 117.01 33.61 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.352 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -68.53 -45.13 73.04 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.319 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -152.82 165.99 33.67 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.639 0.733 . . . . 0.0 111.63 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HG2' ' CE1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -85.53 77.57 9.84 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.388 176.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.09 -41.96 11.37 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.25 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -57.91 -32.88 68.17 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.701 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.785 HG21 ' HB2' ' A' ' 74' ' ' TYR . 7.1 pt -62.89 -33.4 60.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.068 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' N ' HG13 ' A' ' 15' ' ' ILE . 9.4 mptt -80.02 -4.34 52.22 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.174 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 42.7 tptt -112.99 -13.79 13.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -98.51 -61.76 1.33 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.074 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -87.62 -26.56 23.0 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 mttp 66.07 83.8 0.16 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.804 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 66' ' ' LEU . 1.2 mm? -100.19 -69.76 0.76 Allowed 'General case' 0 CA--C 1.466 -2.273 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.457 ' H ' ' HB2' ' A' ' 21' ' ' LEU . 3.0 m 62.44 76.94 0.35 Allowed 'General case' 0 N--CA 1.388 -3.53 0 CA-C-N 111.881 -2.418 . . . . 0.0 112.272 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.25 161.3 11.9 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.82 108.77 2.6 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.557 2.172 . . . . 0.0 110.486 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.502 HD13 ' HB ' ' A' ' 55' ' ' ILE . 2.5 pp -113.53 171.2 4.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.59 -171.47 2.52 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.1 p -94.05 145.3 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -100.9 -38.9 6.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.5 m80 -160.64 168.57 24.65 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.19 118.38 36.86 Favored 'General case' 0 C--O 1.191 -1.998 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.0 155.75 16.96 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-O 122.14 0.971 . . . . 0.0 110.659 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -103.65 129.88 51.03 Favored 'General case' 1 C--N 1.243 -4.05 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -67.67 110.76 3.87 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 20.7 t -80.46 -18.29 49.15 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.629 0.728 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.6 m -144.33 155.09 43.65 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -93.97 105.01 17.04 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -114.74 163.46 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.445 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 10.17 28.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 100.26 61.08 0.82 Allowed Glycine 0 CA--C 1.491 -1.459 0 C-N-CA 118.262 -1.923 . . . . 0.0 109.459 -173.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.05 99.66 1.42 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -172.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? 61.91 76.88 0.35 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.387 1.475 . . . . 0.0 110.741 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 t30 57.7 70.49 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.002 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 39.8 tt0 -145.67 -175.07 4.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.876 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.539 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.52 153.73 17.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -102.27 128.06 48.98 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 120.962 0.411 . . . . 0.0 109.96 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -158.82 171.33 20.26 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.051 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 98.7 mttt -120.44 142.8 48.9 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.2 pt20 -54.99 124.48 16.9 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.53 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.61 10.34 55.6 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.717 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 6.9 tp10 -69.66 -37.87 76.87 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.883 0.849 . . . . 0.0 110.103 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 5.7 tp60 70.51 102.14 0.06 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 126.205 1.802 . . . . 0.0 108.851 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.508 HD12 ' CG1' ' A' ' 82' ' ' VAL . 13.1 mt -104.23 156.02 5.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.83 ' HB3' HG21 ' A' ' 27' ' ' VAL . 34.3 mt-10 -116.06 126.55 53.92 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -85.4 118.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -104.15 -38.35 4.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.723 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -132.73 130.51 40.1 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.811 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.616 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -125.81 -32.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.683 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -85.06 143.66 28.75 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.08 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 t70 66.99 53.41 0.82 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.818 1.295 . . . . 0.0 109.752 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.51 114.89 64.52 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.452 177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.46 -53.67 0.28 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.917 1.745 . . . . 0.0 111.137 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 1.012 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 7.0 tp10 -66.56 -40.56 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.43 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.31 -18.11 18.48 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 1.012 ' HD2' ' HG2' ' A' ' 62' ' ' GLU . 14.0 ptmt -76.11 163.32 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.529 1.132 . . . . 0.0 109.299 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.616 ' CD1' HG22 ' A' ' 57' ' ' ILE . 27.6 m0 -95.31 164.84 12.66 Favored 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 122.862 0.465 . . . . 0.0 112.157 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -111.79 113.76 26.31 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -126.56 160.3 20.89 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.676 ' HA ' ' O ' ' A' ' 73' ' ' SER . 54.5 ttp180 -131.47 152.72 50.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 24.7 m -112.76 164.59 13.19 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.04 -18.31 9.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmm_? -82.93 -24.98 32.81 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 83.9 1.66 Allowed Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.6 m -151.69 117.58 5.49 Favored 'General case' 0 N--CA 1.383 -3.824 0 N-CA-C 101.041 -3.689 . . . . 0.0 101.041 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.785 ' HB2' HG21 ' A' ' 15' ' ' ILE . 22.2 m-85 -109.97 83.23 1.72 Allowed 'General case' 1 C--N 1.219 -5.085 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -99.84 97.35 1.76 Allowed Glycine 2 N--CA 1.369 -5.808 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.597 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -40.82 100.75 0.02 OUTLIER 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 112.555 -1.822 . . . . 0.0 109.163 171.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.725 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -81.42 147.99 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.512 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.371 -177.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 9.6 ptpp? -76.35 118.45 19.06 Favored 'General case' 1 N--CA 1.358 -5.06 0 N-CA-C 102.915 -2.995 . . . . 0.0 102.915 163.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.6 p -36.46 -39.36 0.19 Allowed 'General case' 1 C--N 1.241 -4.151 0 C-N-CA 128.193 2.597 . . . . 0.0 113.026 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.1 -10.0 55.46 Favored 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 123.882 0.873 . . . . 0.0 112.25 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.77 -9.84 36.19 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.426 -0.796 . . . . 0.0 111.028 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 52' ' ' ILE . 13.3 m -126.58 167.23 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.129 0.49 . . . . 0.0 111.482 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.98 113.02 9.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.9 pt -75.46 159.39 5.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.116 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.28 117.18 30.28 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -78.28 165.32 24.02 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.671 -175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.09 -41.95 97.12 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.298 0.571 . . . . 0.0 109.767 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 p -107.16 142.39 36.93 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.484 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.78 101.56 13.26 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.496 0.665 . . . . 0.0 110.625 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.16 -165.77 1.51 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 173.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.63 155.21 21.76 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 6.1 tmtm? -118.92 20.97 12.63 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 123.727 1.727 . . . . 0.0 106.695 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -155.28 149.97 26.4 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 80.08 -41.64 0.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.0 0.92 . . . . 0.0 111.708 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.435 ' HG ' ' HG3' ' A' ' 96' ' ' GLU . 66.8 tp -68.52 -69.53 0.32 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HG3' ' HG ' ' A' ' 95' ' ' LEU . 36.7 mt-10 . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 . . . . . 0 CA--C 1.499 -0.992 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -124.77 169.59 11.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.87 152.03 19.17 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.72 12.17 1.41 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 122.949 0.5 . . . . 0.0 111.77 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.465 ' O ' ' HE3' ' A' ' 8' ' ' LYS . 9.1 tp60 -72.86 88.52 1.34 Allowed 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.708 0.766 . . . . 0.0 109.064 178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.632 ' HD2' ' HG3' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -108.03 -15.28 14.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.434 178.112 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.632 ' HG3' ' HD2' ' A' ' 6' ' ' LYS . 46.9 mt-10 -92.42 77.49 5.09 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.608 0.718 . . . . 0.0 109.783 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 5' ' ' GLN . 97.0 mttt -109.44 -60.78 1.72 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -109.07 -173.66 2.32 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -89.06 39.92 0.96 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.683 0.754 . . . . 0.0 109.82 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.0 pttt 47.79 30.16 1.79 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.146 1.778 . . . . 0.0 113.375 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.826 ' HG2' ' HD1' ' A' ' 74' ' ' TYR . 4.4 mp0 55.17 42.02 31.01 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.662 1.185 . . . . 0.0 111.705 176.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -80.03 -30.79 39.57 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.715 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 13.1 pt-20 -61.83 -38.16 87.12 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.396 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 12' ' ' GLU . 2.1 pp -64.52 -24.07 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 C-N-CA 124.785 1.234 . . . . 0.0 113.119 -169.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HA ' HD23 ' A' ' 21' ' ' LEU . 12.4 mptt -54.48 -58.82 5.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 124.125 0.891 . . . . 0.0 113.139 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -83.78 8.89 13.3 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 121.058 0.456 . . . . 0.0 111.783 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 30.5 mmmt -92.16 -61.34 1.64 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.596 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.4 t80 -86.58 -21.63 26.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 tttm 71.55 83.46 0.14 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.077 0.941 . . . . 0.0 110.134 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.734 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.6 -65.0 0.99 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.393 -177.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 5.1 t 36.93 75.42 0.06 Allowed 'General case' 0 C--O 1.251 1.17 0 C-N-CA 126.136 1.775 . . . . 0.0 114.047 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.03 170.3 19.16 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.099 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.21 132.68 28.42 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.464 2.776 . . . . 0.0 111.545 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.8 tp -148.65 145.28 18.31 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.423 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -129.09 174.81 9.22 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.04 131.8 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 109.744 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -96.57 -33.51 4.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.95 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.476 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.8 m80 -165.13 174.03 10.78 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.87 116.55 30.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.288 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.717 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -97.09 156.02 16.56 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-O 121.703 0.763 . . . . 0.0 111.688 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -107.12 123.95 48.98 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.36 106.16 1.31 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.9 t -87.25 -8.41 56.83 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.344 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -144.6 130.71 19.49 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . 7.2 p-10 -77.13 99.49 5.41 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.45 1.119 . . . . 0.0 108.339 172.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.78 163.25 11.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.566 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.51 25.37 7.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.787 0.327 . . . . 0.0 111.063 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.96 60.13 0.84 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.827 -1.178 . . . . 0.0 111.113 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 91.67 0.66 Allowed Glycine 0 C--N 1.316 -0.545 0 O-C-N 123.808 0.357 . . . . 0.0 112.948 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt 61.92 72.11 0.52 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.996 1.319 . . . . 0.0 109.797 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 58.48 80.15 0.19 Allowed 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.227 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 10.3 tt0 -145.1 -175.92 4.89 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.311 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 45' ' ' SER . 2.3 tt -96.44 149.59 21.55 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.443 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.2 m -98.21 115.3 28.05 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.342 0.591 . . . . 0.0 110.052 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.537 ' HD1' ' HB1' ' A' ' 33' ' ' ALA . 22.3 p90 -144.52 161.63 38.61 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.295 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.558 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mmpt? -114.92 154.74 28.16 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 98.8 mt-30 -53.49 126.16 20.54 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.075 0.859 . . . . 0.0 110.873 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.39 20.77 74.27 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.753 -0.658 . . . . 0.0 114.451 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 30.4 mm-40 -74.83 -30.37 61.36 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.725 0.762 . . . . 0.0 112.844 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? 75.61 116.99 0.06 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.906 1.379 . . . . 0.0 109.032 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.536 HD12 ' CG1' ' A' ' 82' ' ' VAL . 12.8 mt -118.26 154.52 20.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.83 139.13 47.56 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.809 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.0 tp -94.77 126.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -47.55 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.959 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.64 HH21 ' HB3' ' A' ' 59' ' ' ASP . 22.9 ttt180 -130.47 133.58 46.41 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -125.0 -33.95 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.781 -178.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -100.01 150.12 22.77 Favored 'General case' 0 C--O 1.25 1.106 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.896 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.64 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.7 t70 62.32 69.27 0.62 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.566 1.166 . . . . 0.0 108.264 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.53 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 7.2 p30 -112.75 139.37 22.73 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.379 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 11.9 Cg_exo -73.61 -58.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.893 2.395 . . . . 0.0 114.345 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.93 -42.74 38.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.647 0.737 . . . . 0.0 111.07 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.53 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 121.13 17.86 3.97 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.671 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 16.2 ptmt -117.24 162.56 17.68 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.598 ' CD2' HG22 ' A' ' 79' ' ' THR . 35.8 m0 -97.21 171.37 8.49 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.103 0.561 . . . . 0.0 111.63 -173.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.734 HD22 HD11 ' A' ' 21' ' ' LEU . 50.4 tp -112.11 105.88 14.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.44 161.02 12.83 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' A' ' 73' ' ' SER . 53.8 ttp180 -138.81 153.64 48.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.204 0.525 . . . . 0.0 110.491 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 11.5 m -100.02 154.68 18.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.7 -33.25 60.7 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.91 0.777 . . . . 0.0 112.803 -173.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -2.77 41.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.19 96.76 0.79 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.431 0.462 . . . . 0.0 112.752 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 24.5 m -154.78 120.69 5.19 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.826 ' HD1' ' HG2' ' A' ' 12' ' ' GLU . 70.2 m-85 -117.43 94.32 4.5 Favored 'General case' 1 C--N 1.221 -5.019 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -177.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -109.52 11.92 33.07 Favored Glycine 1 CA--C 1.437 -4.836 0 C-N-CA 117.283 -2.389 . . . . 0.0 115.679 -173.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.671 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.275 0.1 OUTLIER 47.28 89.73 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.341 0 CA-C-O 122.764 1.269 . . . . 0.0 111.754 -178.413 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.696 HD12 HG21 ' A' ' 82' ' ' VAL . 2.3 pt -70.5 140.39 18.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.573 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 64' ' ' LYS . 7.5 ptpp? -80.1 118.55 21.91 Favored 'General case' 1 N--CA 1.372 -4.343 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.598 HG22 ' CD2' ' A' ' 65' ' ' TRP . 70.7 p -34.96 -33.05 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.939 0 C-N-CA 128.905 2.882 . . . . 0.0 114.435 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -77.02 -11.81 59.85 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 123.293 0.637 . . . . 0.0 112.229 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.24 -3.76 53.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.213 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.696 HG21 HD12 ' A' ' 77' ' ' ILE . 16.4 m -133.23 170.21 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 121.538 0.685 . . . . 0.0 110.93 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.45 107.56 7.18 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.717 HG22 ' HB2' ' A' ' 31' ' ' ALA . 18.5 pt -80.81 165.62 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.508 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 88' ' ' SER . 19.4 t70 -79.0 103.28 8.84 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.933 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -88.42 -55.59 3.66 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.93 93.95 9.46 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.518 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.421 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 55.3 m -68.28 131.29 45.1 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.318 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.0 mt 61.59 75.75 0.39 Allowed 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 124.919 1.387 . . . . 0.0 109.688 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.91 103.72 0.61 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.122 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.2 mt -77.68 -31.69 52.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.266 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 141.66 29.18 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -122.96 90.23 3.26 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.875 0.845 . . . . 0.0 110.722 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -160.49 104.7 1.43 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.7 tp 69.37 96.89 0.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.619 1.199 . . . . 0.0 109.302 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.847 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 . . . . . 0 C--O 1.234 0.24 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -81.4 168.45 18.34 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.004 0.522 . . . . 0.0 111.577 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 17' ' ' LYS . 12.5 mptt -80.88 142.39 33.64 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.625 ' HG2' ' HB2' ' A' ' 9' ' ' GLU . 8.6 tp10 -82.91 107.89 15.84 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -126.86 -21.95 3.94 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.307 -174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.58 ' HD3' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -85.64 -8.94 57.94 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 121.93 0.872 . . . . 0.0 109.899 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.82 ' HG3' ' H ' ' A' ' 9' ' ' GLU . 9.5 tp10 -146.36 167.45 23.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -97.64 -12.84 21.97 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.801 0.728 . . . . 0.0 109.903 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.82 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 37.5 tt0 72.56 -65.89 0.33 Allowed 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.215 1.406 . . . . 0.0 110.047 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 88.2 tttt -169.38 141.65 2.51 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 10' ' ' LYS . 86.5 mttt 67.32 -161.37 0.23 Allowed 'General case' 0 C--O 1.242 0.698 0 O-C-N 124.517 1.136 . . . . 0.0 108.716 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -94.01 155.24 17.23 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.653 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -71.43 -63.44 1.12 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.8 mt-10 -58.72 -27.8 65.23 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -172.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.607 ' HA ' ' HE1' ' A' ' 76' ' ' TYR . 1.9 pp -65.85 -29.66 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.386 0.612 . . . . 0.0 110.413 -173.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 55.4 mtpt -71.49 -34.86 70.52 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.062 -1.427 . . . . 0.0 112.011 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.484 ' HD2' ' HG2' ' A' ' 3' ' ' LYS . 60.7 tttm -102.45 -12.82 17.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.959 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 7.4 tppt? -82.32 -54.26 5.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.593 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 9.9 t80 -86.36 -28.09 23.85 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 25.7 ttpt 71.33 89.99 0.1 Allowed 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.565 1.146 . . . . 0.0 110.328 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.726 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.66 -56.47 2.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.316 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 p 56.83 82.42 0.12 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 124.701 1.2 . . . . 0.0 112.439 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.68 139.18 5.47 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 -176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.97 112.52 1.18 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.75 2.3 . . . . 0.0 111.797 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.524 HD12 ' HB ' ' A' ' 55' ' ' ILE . 41.3 pt -94.35 -176.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.349 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.34 169.91 16.72 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.623 -175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.626 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.4 p -83.81 123.5 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.266 1.032 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.8 mm -85.71 -34.51 8.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -167.19 166.2 15.03 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp -105.01 116.21 31.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -90.18 154.06 20.04 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 122.087 0.946 . . . . 0.0 110.914 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -106.95 119.29 38.97 Favored 'General case' 0 C--N 1.254 -3.546 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.06 103.7 1.01 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -87.65 -10.98 49.79 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.3 m -136.12 130.55 33.49 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.765 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -76.7 102.89 6.39 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.69 0.757 . . . . 0.0 110.402 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.34 155.68 15.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.623 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 55.85 1.65 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.513 0.673 . . . . 0.0 111.413 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 60.5 1.73 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.694 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.42 78.42 1.62 Allowed Glycine 0 C--N 1.309 -0.964 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttm 67.32 81.21 0.2 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.857 1.263 . . . . 0.0 110.362 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 56.15 74.51 0.39 Allowed 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.604 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 7.4 tt0 -144.3 -175.52 4.66 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.142 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -98.42 157.86 15.94 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -102.86 115.93 31.56 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.548 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 25.2 p90 -148.06 153.97 39.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.172 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 68.0 mttm -105.75 151.3 24.62 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.298 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.533 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -55.6 113.66 1.54 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.145 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.71 21.14 22.33 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.106 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.4 tp10 -73.05 -44.27 60.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.224 0.61 . . . . 0.0 111.638 -176.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 74.71 107.3 0.07 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.96 1.412 . . . . 0.0 109.218 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.594 HD12 ' CG1' ' A' ' 82' ' ' VAL . 7.6 mt -116.61 164.07 13.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 107.721 -172.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.626 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 21.9 mt-10 -116.68 133.38 56.08 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.7 tp -92.21 124.58 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.609 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.22 -37.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.536 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 31.7 ttm180 -136.77 133.56 36.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.619 175.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -127.27 -19.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 124.789 1.235 . . . . 0.0 111.832 -176.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -99.94 143.93 29.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 59.32 67.37 0.91 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.877 1.36 . . . . 0.0 110.296 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -86.68 130.94 47.02 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.331 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.593 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -55.61 -66.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.734 2.289 . . . . 0.0 112.219 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.721 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 42.4 mt-10 -94.43 -3.76 49.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.26 0.553 . . . . 0.0 110.932 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.99 -17.12 35.57 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.721 ' HD2' ' HB2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.31 152.48 34.52 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.693 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.554 ' HB2' HG13 ' A' ' 77' ' ' ILE . 34.6 m0 -87.08 177.06 7.32 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 124.282 1.033 . . . . 0.0 110.344 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD22 HD11 ' A' ' 21' ' ' LEU . 52.5 tp -113.89 113.78 25.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.48 154.01 16.74 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 73' ' ' SER . 59.4 ttp180 -137.25 152.02 49.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.237 0.542 . . . . 0.0 110.786 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.587 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 21.6 m -100.71 157.15 16.9 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 175.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.43 14.94 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -73.6 -12.18 60.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 84.14 87.01 0.86 Allowed Glycine 0 N--CA 1.433 -1.546 0 CA-C-O 121.718 0.621 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.2 m -151.12 121.43 7.3 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 100.229 -3.989 . . . . 0.0 100.229 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.609 ' HE2' HG13 ' A' ' 55' ' ' ILE . 52.8 m-85 -115.84 90.21 3.28 Favored 'General case' 1 C--N 1.232 -4.501 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -171.146 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -106.56 96.84 1.16 Allowed Glycine 3 N--CA 1.375 -5.385 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.607 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -43.23 94.88 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 O-C-N 125.597 1.41 . . . . 0.0 110.869 174.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 82' ' ' VAL . 2.6 pt -70.64 143.24 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.222 0 C-N-CA 127.2 2.2 . . . . 0.0 114.824 -174.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' NZ ' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -78.46 116.63 18.99 Favored 'General case' 1 N--CA 1.351 -5.38 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 166.976 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.5 p -36.13 -29.86 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.955 0 C-N-CA 128.411 2.684 . . . . 0.0 113.83 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 t -84.14 -0.74 53.17 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 123.206 0.603 . . . . 0.0 111.649 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.53 -12.49 21.18 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 120.78 -1.2 . . . . 0.0 110.286 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.634 HG21 HD12 ' A' ' 77' ' ' ILE . 35.3 m -135.16 166.82 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.471 0.653 . . . . 0.0 110.757 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -140.24 123.03 16.43 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 171.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 pt -70.64 161.26 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.225 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.96 115.86 28.17 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -74.35 162.61 28.71 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.81 99.93 0.37 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.356 0.598 . . . . 0.0 110.443 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 m -84.42 97.25 9.4 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.474 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.6 tp -91.13 -34.43 15.05 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -84.93 147.49 26.71 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -90.36 164.36 14.36 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.586 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 68.56 171.45 0.29 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.061 0.944 . . . . 0.0 110.384 -175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 93' ' ' LYS . 30.6 mmtp -120.06 63.81 0.83 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -111.21 -30.46 7.44 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.0 tp 71.87 -75.03 0.08 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.849 1.66 . . . . 0.0 112.006 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 N--CA 1.423 -1.778 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -175.771 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 CA--C 1.5 -0.974 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -78.52 117.27 19.55 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 168.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -64.67 141.18 58.86 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.392 0.432 . . . . 0.0 110.788 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 2.6 mp0 -50.26 108.29 0.21 Allowed 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.792 1.237 . . . . 0.0 110.812 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.707 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 27.3 pt20 -126.74 5.2 6.7 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.776 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -76.29 -52.41 10.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -96.04 -48.31 5.73 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 5' ' ' GLN . 62.2 tttp 61.48 109.59 0.02 OUTLIER 'General case' 0 C--O 1.245 0.847 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 74.17 -70.88 0.14 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.795 1.638 . . . . 0.0 112.589 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 50.49 86.11 0.03 OUTLIER 'General case' 0 C--O 1.247 0.955 0 O-C-N 124.416 1.072 . . . . 0.0 110.109 -176.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -113.79 -176.75 2.97 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.044 -173.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.16 22.41 2.8 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 56.2 tp60 -90.2 -41.94 11.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.052 -174.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 31.0 mm-40 -76.54 20.16 0.24 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.414 -174.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -92.73 -28.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 13' ' ' GLN . 20.8 ptmt -66.57 -41.96 87.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.008 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -94.18 -0.35 55.26 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.899 0.857 . . . . 0.0 109.77 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 76' ' ' TYR . 10.7 tppt? -85.53 -65.22 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 11.4 t80 -78.85 -25.94 44.06 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 32.2 mtmm 68.18 88.23 0.11 Allowed 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.497 1.119 . . . . 0.0 110.32 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.746 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -97.17 -25.65 15.23 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.318 -175.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 74.9 p 70.63 -32.26 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.525 1.93 . . . . 0.0 113.896 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.49 178.55 20.91 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.92 169.58 21.78 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.285 1.99 . . . . 0.0 110.325 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.9 tp -155.48 133.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 120.663 0.268 . . . . 0.0 111.016 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 -80.59 172.32 13.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.3 p -81.77 133.01 30.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.172 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.55 -38.25 10.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.709 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 24.3 m80 -161.3 171.35 18.49 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.35 132.59 54.91 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -104.76 161.64 13.99 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.984 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -106.88 129.26 54.74 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.37 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -74.05 102.41 4.18 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.404 ' SG ' ' HG3' ' A' ' 83' ' ' GLU . 69.2 m -86.29 -5.06 59.26 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.82 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -133.99 140.37 46.68 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.23 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 48' ' ' GLN . 15.1 p-10 -91.07 99.09 12.18 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.327 1.061 . . . . 0.0 108.994 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.85 150.05 16.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -119.5 33.94 5.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.733 0.778 . . . . 0.0 110.202 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 95.83 58.86 1.09 Allowed Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.823 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.13 117.27 4.76 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 65.46 37.12 6.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.353 1.061 . . . . 0.0 110.858 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 t30 63.71 89.21 0.09 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.313 1.054 . . . . 0.0 109.794 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.572 ' HG3' ' H ' ' A' ' 44' ' ' LEU . 2.1 tp10 -136.95 -172.98 3.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.045 -168.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.669 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.7 tt -95.08 148.15 22.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.426 ' H ' HD23 ' A' ' 44' ' ' LEU . 16.1 m -96.71 115.76 27.98 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.827 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 22.6 p90 -147.01 158.99 44.1 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.268 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 9.3 mtmp? -108.39 156.7 19.13 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.433 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -59.44 118.77 6.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.04 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.85 25.78 28.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 11.5 tp10 -74.56 -36.85 63.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 122.844 0.458 . . . . 0.0 110.66 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 72.41 109.17 0.07 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 125.448 1.499 . . . . 0.0 108.849 -172.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.576 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.7 mt -115.29 162.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.618 ' HB3' HG21 ' A' ' 27' ' ' VAL . 11.9 mt-10 -116.76 140.59 49.25 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.527 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.9 tp -101.77 125.01 55.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -111.02 -46.25 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.672 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.807 HH21 ' HB3' ' A' ' 59' ' ' ASP . 47.6 ttt180 -130.61 138.51 50.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.95 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.502 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.6 -37.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 123.805 0.842 . . . . 0.0 111.16 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 p -98.4 156.04 16.94 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.807 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.9 t70 67.3 71.59 0.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.439 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.779 HD21 ' HG2' ' A' ' 64' ' ' LYS . 32.0 t30 -154.16 117.44 2.61 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.218 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 60' ' ' ASN . 18.0 Cg_endo -59.31 -23.0 67.99 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.649 2.9 . . . . 0.0 114.073 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.89 -16.67 61.1 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.128 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.41 27.76 70.88 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.779 ' HG2' HD21 ' A' ' 60' ' ' ASN . 7.1 ptmt -118.79 161.4 20.2 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.56 ' HB2' HG13 ' A' ' 77' ' ' ILE . 42.5 m0 -99.86 176.46 5.43 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 -178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.746 HD22 HD11 ' A' ' 21' ' ' LEU . 62.8 tp -117.13 110.52 18.29 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.59 158.19 14.45 Favored Glycine 0 N--CA 1.419 -2.449 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.89 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.5 ttp180 -139.16 151.68 46.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -106.34 165.6 11.14 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.7 62.91 0.82 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.352 1.073 . . . . 0.0 111.664 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -170.29 -27.4 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.911 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.29 88.52 1.96 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 26.3 m -152.72 117.91 5.2 Favored 'General case' 0 N--CA 1.381 -3.877 0 N-CA-C 100.805 -3.776 . . . . 0.0 100.805 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.604 ' HB3' HD11 ' A' ' 66' ' ' LEU . 64.5 m-85 -110.78 81.87 1.5 Allowed 'General case' 1 C--N 1.216 -5.221 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -173.125 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.669 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -101.57 99.09 1.87 Allowed Glycine 2 N--CA 1.347 -7.276 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -44.39 101.17 0.02 OUTLIER 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 112.185 -2.007 . . . . 0.0 108.215 169.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.608 HD12 HG21 ' A' ' 82' ' ' VAL . 2.0 pt -82.41 147.27 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.98 0 C-N-CA 126.822 2.049 . . . . 0.0 113.478 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HZ3' ' CD ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -80.93 118.83 22.76 Favored 'General case' 1 N--CA 1.354 -5.268 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 166.38 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.503 HG22 ' CG ' ' A' ' 65' ' ' TRP . 55.0 p -35.96 -39.81 0.18 Allowed 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 128.113 2.565 . . . . 0.0 112.984 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -72.09 -10.52 59.89 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.348 1.059 . . . . 0.0 112.891 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.04 -12.94 39.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.578 0.704 . . . . 0.0 110.159 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 HD12 ' A' ' 77' ' ' ILE . 30.7 m -130.97 173.48 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.785 0.802 . . . . 0.0 111.412 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 44.1 mt-10 -137.95 122.64 18.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 31' ' ' ALA . 12.4 pt -86.48 158.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.935 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -88.88 131.03 35.29 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 90.4 m-85 -81.6 -34.59 30.85 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 2.9 t70 162.78 140.69 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 126.463 1.905 . . . . 0.0 106.872 166.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -131.06 1.65 4.27 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.02 -44.5 2.7 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.425 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -122.78 84.95 2.34 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.904 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.0 mt -88.65 74.95 8.33 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.125 0.964 . . . . 0.0 108.459 173.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -65.0 -36.89 85.85 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.995 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 28.8 ttpp -126.34 121.58 32.96 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.31 -82.33 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 O-C-N 124.111 0.882 . . . . 0.0 112.216 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.0 mt -147.21 22.99 1.19 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' HG3' ' HD2' ' A' ' 93' ' ' LYS . 16.1 pt-20 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.716 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 C--O 1.243 0.722 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -153.08 134.49 14.32 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.429 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -123.12 114.21 20.02 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 37.3 mt-10 -68.56 -11.66 60.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.479 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -70.31 93.33 0.85 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 32.7 mtmm -84.57 129.42 34.85 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.622 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -87.02 106.61 17.96 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -124.57 115.97 21.69 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.56 0.695 . . . . 0.0 110.877 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' A' ' 11' ' ' LYS . 3.5 mp0 -87.79 -158.32 0.45 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.71 10.67 36.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.55 ' H ' ' HB2' ' A' ' 9' ' ' GLU . 44.0 tttp 67.96 87.49 0.12 Allowed 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 127.828 2.451 . . . . 0.0 109.277 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -81.25 -9.76 59.72 Favored 'General case' 0 C--O 1.202 -1.415 0 CA-C-O 122.634 1.206 . . . . 0.0 108.809 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -70.42 -17.98 63.01 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.173 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 17.1 mm-40 -73.97 -15.42 61.11 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.441 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 pp -78.55 -27.04 14.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.4 0.619 . . . . 0.0 109.52 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -55.5 -55.43 31.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.213 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -87.6 4.43 43.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.539 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 9.9 tppt? -94.46 -53.06 4.05 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.798 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t80 -90.25 -24.81 20.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp 70.71 86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.105 1.362 . . . . 0.0 110.616 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 66' ' ' LEU . 1.4 mm? -99.05 -53.21 3.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.37 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p 54.71 91.62 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.267 1.427 . . . . 0.0 113.66 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.31 137.69 9.09 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.616 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.93 132.89 25.69 Favored 'Trans proline' 0 C--O 1.25 1.098 0 C-N-CA 122.235 1.956 . . . . 0.0 111.323 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 28' ' ' ILE . 15.4 tt -125.8 152.44 32.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.221 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -86.89 171.73 10.6 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.644 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -71.78 130.14 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.885 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 25' ' ' ILE . 50.6 mm -83.47 -40.32 15.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.754 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.0 m80 -160.72 167.79 26.15 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.04 120.48 41.89 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.694 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -98.24 151.35 20.55 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.495 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -107.61 135.38 49.15 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.83 112.78 3.42 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 49.5 t -86.07 -12.47 50.06 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.616 0.722 . . . . 0.0 109.925 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -149.34 155.93 41.27 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.854 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 4.5 p-10 -99.42 112.89 25.01 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.738 0.78 . . . . 0.0 109.088 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.48 163.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.085 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.61 21.43 7.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.895 0.379 . . . . 0.0 111.604 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.37 59.69 1.9 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.72 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.03 138.52 13.96 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm 66.91 33.65 5.79 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.92 0.867 . . . . 0.0 108.903 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 61.49 84.81 0.13 Allowed 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.235 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.528 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 19.4 tt0 -138.04 -175.22 4.02 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 73' ' ' SER . 0.7 OUTLIER -96.64 153.19 18.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.507 ' H ' HD23 ' A' ' 44' ' ' LEU . 8.6 p -105.89 124.87 50.27 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -157.9 166.92 31.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.398 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.854 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 66.9 mmtt -112.63 147.03 37.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 19.2 tt0 -52.24 124.27 12.75 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.295 0.638 . . . . 0.0 110.292 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 13.63 75.14 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.911 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 30.9 tt0 -70.89 -39.83 72.56 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 26.8 tt0 92.52 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.247 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.1 mt -120.27 160.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.375 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.644 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 17.4 mt-10 -116.22 142.59 46.63 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.3 tp -102.42 127.65 55.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.77 -49.2 6.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.798 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 10.8 ttm180 -126.48 140.49 52.42 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.112 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.56 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -128.85 -37.27 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 123.833 0.853 . . . . 0.0 111.016 -177.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 p -117.21 168.85 9.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.0 t70 60.43 65.5 1.06 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.466 1.127 . . . . 0.0 110.137 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -140.84 172.45 6.15 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.632 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -94.45 13.04 1.52 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.011 1.807 . . . . 0.0 114.272 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.725 ' HG3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 tm-20 -135.12 -72.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.56 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -25.76 2.14 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.725 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 13.7 ptmt -61.87 162.76 8.45 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.862 1.265 . . . . 0.0 110.779 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.56 ' CD1' HG22 ' A' ' 57' ' ' ILE . 49.0 m0 -102.31 166.6 10.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.98 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -112.7 108.11 17.02 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -113.28 160.73 12.97 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.735 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.3 ttp180 -135.29 141.2 45.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.646 0.736 . . . . 0.0 111.801 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 p -101.37 167.25 10.29 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.421 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.28 37.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.162 0.985 . . . . 0.0 113.292 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.74 -19.29 55.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.029 0.443 . . . . 0.0 110.188 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.94 86.25 0.87 Allowed Glycine 0 CA--C 1.489 -1.561 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.6 m -151.22 125.16 9.18 Favored 'General case' 0 N--CA 1.381 -3.884 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.643 ' HB3' HD11 ' A' ' 66' ' ' LEU . 50.0 m-85 -108.5 73.84 0.89 Allowed 'General case' 1 C--N 1.213 -5.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -176.412 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -92.44 97.64 2.3 Favored Glycine 2 N--CA 1.375 -5.429 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -178.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -44.04 96.38 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 125.408 1.299 . . . . 0.0 110.253 172.144 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.647 HD12 HG21 ' A' ' 82' ' ' VAL . 1.6 pt -77.38 144.82 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.436 -3.414 0 C-N-CA 126.625 1.97 . . . . 0.0 113.232 -175.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -79.95 118.4 21.66 Favored 'General case' 1 N--CA 1.359 -5.008 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 165.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.544 HG23 ' HA ' ' A' ' 64' ' ' LYS . 69.3 p -35.8 -39.09 0.14 Allowed 'General case' 1 C--N 1.241 -4.12 0 C-N-CA 128.369 2.668 . . . . 0.0 112.815 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -69.85 -1.4 9.33 Favored 'General case' 0 CA--C 1.564 1.5 0 C-N-CA 124.085 0.954 . . . . 0.0 112.213 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.23 -8.47 21.26 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.737 -0.602 . . . . 0.0 111.213 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 77' ' ' ILE . 22.3 m -137.05 165.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 CA-C-O 121.312 0.577 . . . . 0.0 112.221 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 50.4 mt-10 -129.47 119.59 24.01 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.694 HG22 ' HB2' ' A' ' 31' ' ' ALA . 8.6 pt -89.55 162.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.173 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.72 138.98 30.99 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.615 ' HB2' ' HB2' ' A' ' 89' ' ' LEU . 88.6 m-85 -105.53 170.26 7.99 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.42 -35.05 6.16 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.817 0.847 . . . . 0.0 109.793 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.4 m -102.88 36.36 2.23 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.002 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 86' ' ' TYR . 19.6 tp -87.37 18.95 3.48 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.367 0.603 . . . . 0.0 110.22 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -61.77 -29.73 70.33 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.309 1.044 . . . . 0.0 109.942 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.3 121.55 29.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -80.11 112.13 17.13 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.106 0.479 . . . . 0.0 111.43 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.39 155.58 13.27 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -123.51 -71.21 0.73 Allowed 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.58 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 tp -159.5 119.36 3.0 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.421 -1.875 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.498 -1.049 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -76.19 130.19 37.87 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 123.429 0.456 . . . . 0.0 110.026 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -109.34 84.13 1.87 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 170.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -119.25 148.25 43.34 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.542 0.687 . . . . 0.0 112.411 -171.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -103.31 126.66 50.58 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -71.38 -38.08 71.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.6 ' HB3' ' HG2' ' A' ' 9' ' ' GLU . 49.3 mt-10 -78.13 158.09 29.22 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.737 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -107.54 12.18 27.99 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.6 ' HG2' ' HB3' ' A' ' 7' ' ' GLU . 16.7 mm-40 -66.41 128.24 35.4 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 113.877 -1.511 . . . . 0.0 108.694 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -103.41 91.64 4.14 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -112.33 166.63 11.12 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.433 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.79 ' HB2' ' HA ' ' A' ' 73' ' ' SER . 7.2 tp10 -80.06 111.6 16.57 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -51.62 5.3 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.647 -171.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.38 23.71 0.11 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -169.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.886 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -85.79 -26.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 122.33 -0.231 . . . . 0.0 111.326 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -54.86 -45.13 74.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 124.234 0.959 . . . . 0.0 112.818 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.28 -9.35 27.77 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.243 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 13.4 tppt? -78.28 -63.84 1.3 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.648 -173.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.668 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.2 t80 -81.09 -24.46 37.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 38.1 ttpt 66.86 87.79 0.12 Allowed 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.384 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.551 HD12 ' HD2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -98.3 -65.54 0.96 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p 50.25 80.81 0.07 Allowed 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 125.025 1.33 . . . . 0.0 113.745 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.81 -165.57 33.64 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.97 101.11 0.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.266 2.644 . . . . 0.0 111.363 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 tt -113.34 156.21 14.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -150.94 178.01 9.58 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.87 134.05 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.746 0.784 . . . . 0.0 109.271 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.434 ' HB ' HG23 ' A' ' 54' ' ' ILE . 36.2 mm -97.24 -35.2 5.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.435 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 28.3 m80 -168.38 169.98 10.22 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.53 119.49 39.33 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.06 158.17 15.92 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.025 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -106.99 127.82 53.8 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.654 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.65 106.76 2.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.0 m -83.58 -5.08 59.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.8 t -158.75 143.15 15.72 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -80.21 107.94 13.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.721 175.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.67 163.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.919 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.81 23.32 12.03 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.933 -0.48 . . . . 0.0 110.814 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.31 60.16 1.58 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.035 -1.555 . . . . 0.0 111.291 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.82 120.07 5.11 Favored Glycine 0 C--N 1.306 -1.113 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.086 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.599 ' N ' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER 63.65 45.71 4.47 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.287 0.635 . . . . 0.0 110.48 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.3 t30 63.49 85.95 0.13 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.041 0.936 . . . . 0.0 109.616 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.673 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 5.4 tt0 -145.67 -173.92 4.26 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.082 -174.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.656 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -95.72 155.67 16.65 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.439 ' H ' HD23 ' A' ' 44' ' ' LEU . 7.2 m -101.56 116.03 31.84 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.493 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 26.6 p90 -149.73 159.34 44.42 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 49.3 mttm -112.93 156.45 22.97 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -59.09 127.34 31.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.891 0.377 . . . . 0.0 110.078 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.89 21.14 61.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.088 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.5 mm-40 -88.57 -23.99 22.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 70.78 129.91 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.57 1.169 . . . . 0.0 111.363 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 82' ' ' VAL . 7.8 mt -127.51 162.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -112.28 136.08 52.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 66' ' ' LEU . 9.7 tp -94.35 123.33 46.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.69 -36.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.103 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.668 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -135.5 130.13 34.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.713 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -130.85 2.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 124.578 1.151 . . . . 0.0 109.725 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -117.47 154.15 31.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.655 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 64.58 18.89 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.98 1.312 . . . . 0.0 111.337 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 21.4 p-10 -77.55 111.46 17.56 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.284 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 22.1 Cg_exo -66.56 -58.41 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.783 2.989 . . . . 0.0 113.134 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 23.8 tt0 -66.54 -30.58 70.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.984 0.421 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.62 12.24 25.08 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.325 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 12.9 ptmt -101.9 162.13 13.14 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 57' ' ' ILE . 42.6 m0 -95.82 176.13 6.25 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 123.255 0.622 . . . . 0.0 110.577 -175.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 74' ' ' TYR . 61.2 tp -119.21 113.7 21.28 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.92 157.32 15.12 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.7 ttt-85 -135.56 153.3 51.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.558 0.694 . . . . 0.0 111.61 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 35.2 m -105.61 154.37 20.51 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.23 -33.96 13.85 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -53.97 -43.02 69.57 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.207 1.004 . . . . 0.0 110.663 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.29 83.26 1.7 Allowed Glycine 0 N--CA 1.413 -2.834 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.196 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.79 ' HA ' ' HB2' ' A' ' 12' ' ' GLU . 49.6 m -151.53 123.3 8.01 Favored 'General case' 1 N--CA 1.376 -4.138 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.886 ' HB2' HG21 ' A' ' 15' ' ' ILE . 57.9 m-85 -113.87 92.67 4.06 Favored 'General case' 1 C--N 1.216 -5.221 0 O-C-N 125.108 1.505 . . . . 0.0 107.07 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.656 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -102.02 103.14 2.44 Favored Glycine 3 N--CA 1.359 -6.499 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.84 98.09 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 112.946 -1.627 . . . . 0.0 108.213 170.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.673 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.1 pt -85.15 143.46 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.814 0 C-N-CA 126.283 1.833 . . . . 0.0 114.127 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -77.62 118.34 19.92 Favored 'General case' 1 N--CA 1.372 -4.345 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 164.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.494 HG22 ' CG ' ' A' ' 65' ' ' TRP . 48.4 p -35.26 -38.49 0.1 Allowed 'General case' 1 C--N 1.236 -4.333 0 C-N-CA 129.253 3.021 . . . . 0.0 113.588 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.1 -15.49 63.75 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 0.0 112.698 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.99 48.81 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.954 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 52' ' ' ILE . 30.3 m -137.11 172.07 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 CA-C-O 121.779 0.8 . . . . 0.0 111.411 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.79 122.81 17.89 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.651 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 pt -77.55 171.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.001 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -79.11 103.78 9.28 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.78 91.72 7.59 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.788 0.804 . . . . 0.0 109.866 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.02 92.39 7.36 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.055 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 t -177.6 138.86 0.23 Allowed 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.1 mt -114.94 6.33 15.32 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.673 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -145.42 136.21 24.48 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.12 132.94 51.95 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -70.82 99.93 1.82 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.643 0.735 . . . . 0.0 112.53 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -121.11 14.62 11.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.44 -10.09 59.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.152 -1.386 . . . . 0.0 109.484 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 pp -96.97 154.04 17.54 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.884 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.411 177.451 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.24 0.561 0 CA-C-O 120.893 0.378 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -135.41 143.05 45.78 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -68.12 -66.57 0.55 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -86.52 71.49 10.41 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -69.88 -41.65 74.49 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.62 96.86 5.05 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 171.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.9 159.09 33.3 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.916 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -77.74 131.68 37.78 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.601 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 90.1 7.95 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -90.34 157.97 17.37 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.035 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -116.65 88.51 2.91 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.933 0.873 . . . . 0.0 109.714 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.68 34.46 3.67 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.302 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -84.91 -52.77 5.77 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.602 0.715 . . . . 0.0 110.627 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.55 -14.88 63.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.39 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.4 pp -66.04 -31.08 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.4 mptt -69.28 -23.37 63.82 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.667 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.15 -29.91 11.86 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.243 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.52 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 6.9 tppt? -73.12 -61.15 1.92 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.845 0.355 . . . . 0.0 111.13 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -79.1 -34.17 43.76 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 68.7 99.23 0.06 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.947 -178.24 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.014 HD12 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.79 -57.34 2.2 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.633 0.73 . . . . 0.0 110.15 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 29.2 p 56.13 78.42 0.2 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 125.399 1.48 . . . . 0.0 113.098 -176.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.91 146.0 5.07 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.845 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.34 141.9 26.24 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.557 2.171 . . . . 0.0 111.222 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 tt -151.4 155.55 6.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.431 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.7 pt20 -121.38 174.21 6.88 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -176.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -59.37 126.34 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 122.056 0.932 . . . . 0.0 111.174 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.2 -31.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.475 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 27.1 m80 -163.22 157.33 20.25 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.51 118.1 34.44 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -96.1 156.12 16.47 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-O 122.014 0.911 . . . . 0.0 111.202 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 35.1 ttpt -106.68 128.27 54.05 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.745 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.96 105.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.72 -18.33 61.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.674 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -160.53 156.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.41 119.25 20.02 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.02 163.72 10.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.666 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -102.06 -4.94 25.15 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.98 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 77.64 60.58 2.76 Favored Glycine 0 C--O 1.241 0.568 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.092 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.409 ' N ' ' HB3' ' A' ' 43' ' ' GLU . . . -104.67 131.33 10.6 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 115.084 -0.558 . . . . 0.0 113.035 -172.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.8 69.97 0.68 Allowed 'General case' 0 C--O 1.249 1.041 0 C-N-CA 125.301 1.44 . . . . 0.0 109.743 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.05 68.62 0.83 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.223 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 31.9 tt0 -136.42 172.98 12.21 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.537 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 73' ' ' SER . 1.7 tt -97.9 141.29 31.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 p -98.78 118.24 35.07 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.864 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.464 ' HE2' HG22 ' A' ' 77' ' ' ILE . 22.5 p90 -142.35 170.11 16.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.708 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 98.3 mttt -119.55 161.44 20.6 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -63.62 129.29 39.56 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.43 46.53 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.345 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 31.6 mm-40 -89.42 -26.14 21.16 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 70.3 120.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.933 1.396 . . . . 0.0 111.307 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.61 HD12 ' CG1' ' A' ' 82' ' ' VAL . 8.9 mt -119.31 158.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.86 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 14.7 mt-10 -116.67 132.68 56.62 Favored 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 57' ' ' ILE . 8.6 tp -93.08 125.7 45.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.431 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -110.13 -47.88 6.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.442 176.606 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 1.014 ' HG3' HD12 ' A' ' 21' ' ' LEU . 18.2 mmt180 -120.06 107.8 13.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.822 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -104.53 -30.16 2.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 113.252 -1.795 . . . . 0.0 107.192 172.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 57' ' ' ILE . 15.6 p -86.68 142.05 28.49 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.565 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 71.55 31.09 2.32 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.451 1.12 . . . . 0.0 110.957 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 8.8 p30 -72.87 126.24 90.69 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.941 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 2.1 Cg_endo -80.58 -61.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.618 2.212 . . . . 0.0 113.256 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.4 tt0 -79.21 -2.96 43.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.302 0.572 . . . . 0.0 111.268 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 87.51 21.17 49.13 Favored Glycine 0 CA--C 1.497 -1.087 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.513 -176.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.688 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.3 ptmt -118.21 156.88 28.01 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 57' ' ' ILE . 25.6 m0 -98.12 171.9 7.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.145 0.278 . . . . 0.0 110.94 -174.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 21' ' ' LEU . 65.4 tp -111.1 107.33 16.66 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.46 158.57 14.23 Favored Glycine 0 N--CA 1.416 -2.664 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 73' ' ' SER . 45.8 ttp180 -135.17 144.73 47.19 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.694 0.797 . . . . 0.0 109.888 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -101.4 165.14 11.42 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.89 -29.78 65.34 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -74.83 -9.62 58.72 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.03 89.82 0.49 Allowed Glycine 0 N--CA 1.434 -1.454 0 CA-C-O 121.908 0.727 . . . . 0.0 111.754 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.705 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.1 m -153.16 117.46 4.9 Favored 'General case' 0 N--CA 1.389 -3.514 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.596 ' HB2' HG21 ' A' ' 15' ' ' ILE . 64.8 m-85 -110.76 96.67 6.31 Favored 'General case' 1 C--N 1.221 -4.999 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.501 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -110.98 11.85 29.36 Favored Glycine 1 CA--C 1.445 -4.313 0 C-N-CA 117.77 -2.157 . . . . 0.0 115.516 -174.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.688 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 48.13 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.853 1.311 . . . . 0.0 111.651 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.601 HD12 HG21 ' A' ' 82' ' ' VAL . 2.1 pt -67.8 145.92 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.1 0 C-N-CA 126.029 1.731 . . . . 0.0 113.584 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 8.7 ptpp? -81.36 112.99 19.15 Favored 'General case' 1 N--CA 1.379 -4.01 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 165.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.477 HG22 ' CG ' ' A' ' 65' ' ' TRP . 43.2 p -36.3 -36.75 0.1 Allowed 'General case' 0 C--N 1.251 -3.685 0 C-N-CA 128.006 2.522 . . . . 0.0 113.757 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.82 -9.88 56.36 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.802 0.841 . . . . 0.0 112.318 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.51 -6.38 49.84 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.652 -0.655 . . . . 0.0 109.979 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.61 ' CG1' HD12 ' A' ' 52' ' ' ILE . 31.3 m -131.17 162.77 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.94 111.36 11.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 14.3 pt -76.71 171.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.047 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.98 103.75 1.92 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -86.02 -48.47 8.63 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -175.85 109.65 0.1 Allowed 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.657 178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.9 m -111.84 175.32 5.48 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.184 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp 59.85 71.67 0.56 Allowed 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.371 1.044 . . . . 0.0 111.038 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 14.7 ptmt -147.29 165.55 29.77 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.293 -174.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.8 mt -101.3 -37.87 8.31 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.954 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.732 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 9.9 mmpt? -101.64 134.03 45.42 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.158 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp 67.17 30.31 7.32 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.724 1.21 . . . . 0.0 113.473 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 34.8 t70 -89.76 98.02 11.53 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.072 0.463 . . . . 0.0 109.825 176.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 61.0 tp 61.31 78.02 0.3 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.735 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.307 -1.28 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.802 178.01 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.24 0.603 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -158.93 130.2 6.28 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.3 tttm 74.2 -46.15 0.61 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.378 1.471 . . . . 0.0 112.111 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.94 129.39 36.29 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 77.99 138.2 0.07 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.454 1.101 . . . . 0.0 112.127 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -118.93 177.08 4.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -118.81 87.44 2.73 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.036 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 8' ' ' LYS . 25.7 tptp -176.04 -68.6 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.15 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -77.23 81.19 3.74 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.608 0.718 . . . . 0.0 110.979 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -84.2 -56.75 3.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -170.02 82.43 0.11 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' NZ ' ' A' ' 16' ' ' LYS . 7.0 pt-20 -147.02 33.51 0.91 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.775 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 56.6 tp60 -78.75 -20.22 50.45 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.962 -177.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 1.7 mp0 -61.89 -26.65 68.28 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.451 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.697 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.4 pp -90.22 -20.56 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 37.9 mmtm -66.96 -54.8 18.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.808 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -79.99 1.92 25.67 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.847 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 9.3 tppt? -98.79 -53.41 3.3 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.873 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.429 ' HE2' ' HG2' ' A' ' 56' ' ' ARG . 38.2 t80 -91.2 -27.98 18.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.939 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 42.2 tttt 77.59 90.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.686 1.195 . . . . 0.0 109.934 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.851 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -100.96 -41.66 6.72 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.607 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p 64.32 16.21 9.98 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.656 1.982 . . . . 0.0 112.543 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.98 173.24 37.94 Favored Glycine 0 N--CA 1.417 -2.611 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.49 92.69 0.84 Allowed 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.736 2.29 . . . . 0.0 111.412 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 21' ' ' LEU . 46.3 mm -78.66 130.31 36.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.6 pt20 -104.69 175.87 5.35 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.526 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.17 134.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.322 1.058 . . . . 0.0 112.294 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.2 mm -102.19 -36.64 4.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.133 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.4 m80 -168.12 -178.19 3.59 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.75 139.6 45.89 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -112.46 158.32 20.01 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -107.01 130.42 54.65 Favored 'General case' 0 C--N 1.263 -3.154 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.88 112.61 3.35 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 39.9 t -82.35 -19.09 39.97 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 124.185 0.928 . . . . 0.0 109.635 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.13 156.73 46.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.887 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -96.39 107.85 20.29 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 173.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.441 HG12 ' CE1' ' A' ' 46' ' ' PHE . 10.4 p -113.19 145.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.66 12.42 21.2 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.775 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 78.84 46.85 8.16 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.714 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -96.9 151.52 19.86 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp 68.27 31.87 4.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.299 1.047 . . . . 0.0 108.833 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 68.31 46.3 1.1 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.678 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -103.55 -175.16 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.606 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 tt -95.74 147.47 23.59 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.47 ' H ' HD23 ' A' ' 44' ' ' LEU . 5.7 m -96.05 115.48 27.5 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.777 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.441 ' CE1' HG12 ' A' ' 37' ' ' VAL . 17.9 p90 -150.37 177.62 9.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.196 0.522 . . . . 0.0 111.006 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.887 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.5 mmtt -124.83 149.61 47.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.73 122.43 11.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 124.145 0.903 . . . . 0.0 108.737 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.42 23.88 52.69 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.759 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.5 mm-40 -78.64 -26.67 45.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 74.63 104.43 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.414 1.578 . . . . 0.0 110.33 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 31' ' ' ALA . 7.9 mm -101.96 158.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.196 0 CA-C-N 111.697 -2.501 . . . . 0.0 105.659 -174.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -112.49 134.21 54.15 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 7.0 tp -99.75 121.04 49.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.408 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -106.1 -54.13 6.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.213 -178.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG2' ' HE2' ' A' ' 19' ' ' PHE . 53.9 ttt180 -121.43 138.39 54.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.729 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.37 -43.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.578 -176.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 p -117.8 158.66 24.38 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.112 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.51 68.73 0.16 Allowed 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.928 1.691 . . . . 0.0 111.302 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 8.8 p30 -148.42 144.43 18.59 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.0 Cg_exo -78.93 12.52 2.22 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 122.848 2.365 . . . . 0.0 114.469 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.679 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -109.23 -64.7 1.22 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.6 -6.03 7.52 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -90.04 165.05 14.26 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.636 0.775 . . . . 0.0 110.535 177.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.559 ' CG ' HG22 ' A' ' 79' ' ' THR . 40.2 m0 -97.84 169.89 9.35 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.768 0.827 . . . . 0.0 110.741 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.851 HD22 HD11 ' A' ' 21' ' ' LEU . 54.6 tp -113.99 110.25 19.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.02 155.87 15.99 Favored Glycine 0 N--CA 1.419 -2.497 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.299 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.697 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.1 ttp180 -137.96 156.66 47.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.589 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 6.8 m -111.63 156.07 22.39 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.6 33.13 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.476 1.035 . . . . 0.0 113.05 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -69.8 -3.09 14.05 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.91 86.81 0.16 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 121.728 0.627 . . . . 0.0 112.134 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.697 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.0 m -151.78 117.67 5.48 Favored 'General case' 0 N--CA 1.391 -3.388 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.697 ' HB2' HG21 ' A' ' 15' ' ' ILE . 65.3 m-85 -113.37 90.06 3.25 Favored 'General case' 1 C--N 1.228 -4.701 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.186 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.606 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -104.72 102.19 2.04 Favored Glycine 3 N--CA 1.36 -6.416 0 N-CA-C 106.906 -2.478 . . . . 0.0 106.906 176.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -50.22 98.94 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.867 0 CA-C-N 113.195 -1.503 . . . . 0.0 107.247 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.727 HD12 HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -82.25 140.25 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.431 -3.611 0 C-N-CA 125.542 1.537 . . . . 0.0 114.713 -172.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -74.88 114.3 13.18 Favored 'General case' 1 N--CA 1.365 -4.705 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 167.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.559 HG22 ' CG ' ' A' ' 65' ' ' TRP . 72.9 p -36.28 -34.82 0.07 Allowed 'General case' 1 C--N 1.234 -4.428 0 C-N-CA 128.523 2.729 . . . . 0.0 114.299 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -66.0 -24.32 66.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.2 59.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.097 -0.377 . . . . 0.0 111.57 -174.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.727 HG21 HD12 ' A' ' 77' ' ' ILE . 30.0 m -136.39 165.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.512 0.672 . . . . 0.0 111.321 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.83 118.86 15.35 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.458 -2.052 . . . . 0.0 105.458 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.3 pp -72.46 146.97 10.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.647 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.77 133.36 34.74 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -87.17 135.37 33.33 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -61.38 139.77 58.14 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 t -72.81 77.51 1.14 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -166.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -179.58 166.16 1.38 Allowed 'General case' 0 C--O 1.247 0.947 0 C-N-CA 126.812 2.045 . . . . 0.0 105.672 171.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -126.57 -63.75 1.06 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.712 ' HB3' ' HG2' ' A' ' 93' ' ' LYS . 94.8 mt -90.25 147.05 23.78 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.588 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -97.92 12.68 33.3 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 122.692 1.234 . . . . 0.0 108.12 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.712 ' HG2' ' HB3' ' A' ' 91' ' ' LEU . 72.4 mmtt -70.42 -47.35 61.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.557 177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -166.34 156.28 11.97 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.719 ' H ' HD23 ' A' ' 95' ' ' LEU . 1.6 pt? -85.88 75.34 10.02 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 . . . . . 0 C--N 1.31 -1.121 0 C-N-CA 124.469 1.108 . . . . 0.0 109.145 174.958 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--O 1.246 0.896 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -135.13 157.66 46.34 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -69.96 150.91 46.2 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 6' ' ' LYS . 48.5 mt-10 -89.03 -51.84 5.39 Favored 'General case' 0 C--N 1.285 -2.212 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.57 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.308 0.6 OUTLIER 33.59 70.15 0.12 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.471 1.108 . . . . 0.0 111.022 -172.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 4' ' ' GLU . 55.9 mtpt -87.26 109.21 19.34 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.556 -169.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.23 92.6 3.98 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.703 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -125.4 -1.29 7.55 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.037 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.833 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 9.8 tp10 -138.69 154.88 48.62 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -121.72 24.36 9.77 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.833 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 61.0 mttp 72.55 129.59 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.3 -175.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -104.1 18.57 21.79 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.399 -176.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -62.31 -30.21 70.99 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.55 0.69 . . . . 0.0 110.127 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.3 mm-40 -51.52 -34.71 37.36 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.758 173.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 1.4 pp -71.85 -34.05 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 CA-C-O 120.889 0.376 . . . . 0.0 110.115 -173.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.655 ' HA ' HD23 ' A' ' 21' ' ' LEU . 4.7 mptt -74.91 -30.97 61.43 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -90.5 -19.53 23.72 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.011 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.2 tppt? -77.26 -58.77 3.09 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.074 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.3 t80 -81.18 -22.79 38.65 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.25 90.92 0.09 Allowed 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 125.548 1.539 . . . . 0.0 109.911 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -99.51 -67.48 0.85 Allowed 'General case' 0 CA--C 1.453 -2.765 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.939 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 m 61.46 57.47 2.33 Favored 'General case' 0 N--CA 1.404 -2.763 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.658 171.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.37 176.58 26.83 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.432 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.47 108.43 2.68 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.824 2.35 . . . . 0.0 111.764 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.744 HD12 ' HB ' ' A' ' 55' ' ' ILE . 45.0 pt -102.42 -176.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -149.92 170.6 18.43 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.6 t -79.35 127.32 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.486 HG22 ' CD2' ' A' ' 29' ' ' HIS . 43.8 mm -90.35 -37.21 9.22 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.637 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.869 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 89.0 m-70 -168.88 170.64 8.98 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -172.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.32 127.32 55.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 172.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -100.46 159.63 14.99 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-O 121.739 0.781 . . . . 0.0 110.928 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.88 131.39 54.02 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.65 106.94 1.28 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.8 t -91.37 -5.8 53.92 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.194 0.997 . . . . 0.0 108.335 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 81' ' ' ALA . 82.8 m -147.2 147.41 30.45 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.775 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 7.2 p-10 -93.14 103.53 15.8 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.486 HG21 ' OE2' ' A' ' 43' ' ' GLU . 8.6 p -114.66 156.71 15.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.103 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.52 34.04 5.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.989 0.423 . . . . 0.0 110.51 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 99.9 60.65 0.84 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.131 -1.509 . . . . 0.0 113.251 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.79 95.66 1.14 Allowed Glycine 0 C--N 1.313 -0.721 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 57.24 78.44 0.23 Allowed 'General case' 0 C--O 1.252 1.215 0 C-N-CA 124.707 1.203 . . . . 0.0 111.041 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.49 71.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.407 1.067 . . . . 0.0 109.768 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.632 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 15.9 tt0 -132.72 -173.78 3.28 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.464 -172.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' N ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.15 151.07 20.17 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.9 m -97.95 124.68 42.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.411 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 25.5 p90 -159.64 160.99 34.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.722 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 57.0 mtmt -117.56 151.37 37.29 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -53.39 123.26 11.48 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.17 0.919 . . . . 0.0 110.657 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.84 17.22 52.62 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.087 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -87.92 -30.69 19.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.954 0.877 . . . . 0.0 113.171 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 2.1 mp0 75.45 128.98 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.535 1.159 . . . . 0.0 112.386 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.589 HD12 ' CG1' ' A' ' 82' ' ' VAL . 10.9 mt -129.08 165.11 29.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -114.66 142.23 46.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.5 tp -100.69 124.24 54.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.744 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -110.51 -40.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.662 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 48.2 ttt180 -134.8 136.96 42.94 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.136 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.1 -36.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 124.439 1.096 . . . . 0.0 111.778 -177.243 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -96.64 154.84 17.05 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.93 67.86 0.72 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.907 1.283 . . . . 0.0 107.963 -174.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -134.39 115.4 12.7 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.626 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.91 -28.71 29.16 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.393 2.729 . . . . 0.0 115.394 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.11 -15.49 23.33 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.799 0.809 . . . . 0.0 110.146 -177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.01 0.19 83.5 Favored Glycine 0 C--N 1.308 -0.992 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.152 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.639 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 17.8 ptmt -95.06 161.68 14.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.546 ' CD2' HG22 ' A' ' 79' ' ' THR . 43.2 m0 -97.8 176.03 5.95 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.947 0.899 . . . . 0.0 111.478 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -115.52 108.72 16.82 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -111.43 156.57 15.48 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.563 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 73' ' ' SER . 62.5 ttt-85 -134.62 147.55 50.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.515 0.674 . . . . 0.0 111.593 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 27.0 m -100.75 162.13 13.12 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.0 18.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -89.16 3.15 52.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 76.66 87.86 0.33 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.764 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.8 m -152.48 117.75 5.25 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 79.9 m-85 -115.21 91.35 3.58 Favored 'General case' 1 C--N 1.224 -4.882 0 O-C-N 124.25 0.969 . . . . 0.0 108.459 -173.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.613 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -107.45 102.52 1.82 Allowed Glycine 2 N--CA 1.366 -5.992 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.639 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -42.16 101.14 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 112.959 -1.621 . . . . 0.0 108.52 171.078 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.632 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.2 pt -85.39 145.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.948 0 C-N-CA 126.248 1.819 . . . . 0.0 113.312 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -80.92 122.79 27.68 Favored 'General case' 1 N--CA 1.348 -5.538 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 164.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' CD2' ' A' ' 65' ' ' TRP . 47.7 p -36.47 -30.71 0.02 OUTLIER 'General case' 1 C--N 1.243 -4.039 0 C-N-CA 128.341 2.656 . . . . 0.0 112.653 176.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -63.72 -32.47 73.98 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.892 1.277 . . . . 0.0 110.835 -177.534 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -86.49 -4.9 59.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.778 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.632 HG21 HD12 ' A' ' 77' ' ' ILE . 28.9 m -133.97 159.35 42.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.46 0.648 . . . . 0.0 111.813 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.4 mt-10 -128.03 117.5 21.79 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 171.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.5 pt -78.38 160.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.388 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.77 123.64 30.08 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 172.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -58.8 -36.9 75.21 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -167.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 88' ' ' SER . 23.9 t70 -138.24 -87.19 0.26 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 19.9 t 166.07 126.38 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.12 173.53 9.62 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 120.807 0.337 . . . . 0.0 110.384 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -102.77 -34.61 8.95 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 93' ' ' LYS . 47.0 tp -90.91 106.19 18.35 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -80.84 6.33 13.41 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.727 1.251 . . . . 0.0 110.421 -173.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HB3' ' HG ' ' A' ' 91' ' ' LEU . 1.5 tmtp? -77.37 -20.18 55.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.393 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 64.74 86.34 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.125 0.97 . . . . 0.0 111.356 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' HG ' ' HG3' ' A' ' 96' ' ' GLU . 51.9 tp -160.77 -64.69 0.06 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.444 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.567 ' HG3' ' HG ' ' A' ' 95' ' ' LEU . 43.9 mt-10 . . . . . 0 N--CA 1.432 -1.334 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.513 -0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -137.34 160.89 37.77 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -110.66 136.92 49.01 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.549 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.51 142.66 31.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.436 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -77.25 0.06 Allowed 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 125.121 1.369 . . . . 0.0 108.752 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 20.5 tptm 52.66 -84.2 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.252 1.821 . . . . 0.0 113.524 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -70.08 126.09 28.67 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -57.01 -47.51 80.69 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 123.491 0.494 . . . . 0.0 112.225 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 55.42 43.33 28.9 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -80.48 -9.38 59.76 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.668 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.645 ' HG3' ' HB2' ' A' ' 13' ' ' GLN . 47.2 tptt -108.77 103.42 12.49 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.101 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.03 75.86 1.89 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.468 1.127 . . . . 0.0 108.036 172.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.645 ' HB2' ' HG3' ' A' ' 11' ' ' LYS . 64.2 tt0 -91.16 -12.25 35.99 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.904 -170.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.63 -38.07 88.81 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 74' ' ' TYR . 6.9 pt -67.33 -28.99 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.987 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -78.08 -7.37 56.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.223 0.535 . . . . 0.0 110.535 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -99.39 -30.1 12.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.23 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 4.3 tppt? -84.16 -65.55 1.0 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.065 -174.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.515 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 1.8 t80 -86.59 -28.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.0 ttmt 63.08 86.05 0.12 Allowed 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.613 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.588 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -93.69 -58.61 2.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.236 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p 54.5 83.47 0.08 Allowed 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 124.679 1.192 . . . . 0.0 114.165 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.68 161.9 8.89 Favored Glycine 0 C--N 1.297 -1.634 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.2 109.15 1.09 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.439 2.093 . . . . 0.0 109.429 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.563 HG13 ' HB ' ' A' ' 55' ' ' ILE . 7.8 tp -95.89 119.43 43.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.071 0.462 . . . . 0.0 110.546 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -86.61 166.03 15.71 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.904 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.611 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.7 p -79.59 139.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.88 -40.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.508 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.519 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.0 m80 -159.89 166.45 30.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.05 116.51 32.1 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.695 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -89.51 157.92 17.9 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 122.281 1.038 . . . . 0.0 112.196 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -107.74 126.18 52.3 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.329 -1.305 . . . . 0.0 107.918 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -67.68 109.79 3.46 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 171.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.3 m -83.86 -5.72 59.27 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.474 0.484 . . . . 0.0 111.852 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 81' ' ' ALA . 19.9 p -155.59 154.72 32.11 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 7.6 p-10 -82.83 110.65 18.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 173.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.52 160.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -112.91 0.55 15.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.569 -169.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 76.77 61.19 2.77 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.706 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.42 122.47 7.22 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.767 -0.716 . . . . 0.0 111.469 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 62.6 71.9 0.51 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.421 1.088 . . . . 0.0 110.592 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.561 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . 96.6 m-20 53.04 73.01 0.38 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.336 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 41.8 tt0 -145.66 171.02 15.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.551 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -98.95 152.74 19.45 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 m -101.61 127.64 48.25 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -156.78 170.82 21.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 99.2 mttt -119.78 153.87 35.07 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 123.93 15.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.42 13.21 65.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.685 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.6 tp10 -63.59 -37.54 87.73 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.46 0.704 . . . . 0.0 111.682 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 71.56 107.49 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.267 1.427 . . . . 0.0 108.637 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.572 HD12 ' CG1' ' A' ' 82' ' ' VAL . 15.8 mt -113.34 159.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 16.2 mt-10 -111.8 132.36 54.72 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -93.34 122.85 45.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -108.27 -36.57 3.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 32.4 ttm180 -140.79 137.87 33.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.723 175.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.514 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.86 -28.92 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 124.005 0.922 . . . . 0.0 111.816 -176.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.0 p -106.27 162.75 13.39 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.6 t70 58.29 71.2 0.6 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.795 1.283 . . . . 0.0 110.54 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 16.3 p30 -125.67 136.46 28.39 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.255 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 17.7 Cg_exo -69.4 -32.11 20.74 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.063 2.509 . . . . 0.0 113.851 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -101.8 -51.88 3.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.04 -2.47 5.14 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 16.4 ptpt -80.8 162.41 24.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.689 -0.756 . . . . 0.0 109.059 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.51 ' HB2' HG13 ' A' ' 77' ' ' ILE . 41.3 m0 -99.25 176.75 5.43 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.76 0.824 . . . . 0.0 109.789 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -117.47 112.12 20.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.21 157.11 15.22 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.121 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.734 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.6 ttp180 -135.82 156.91 48.06 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.0 110.805 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.9 m -111.95 155.72 23.25 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 68.34 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.286 1.041 . . . . 0.0 111.977 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -167.62 -35.29 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.011 -1.904 . . . . 0.0 107.66 175.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.03 90.18 1.98 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.734 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 2.5 m -151.92 116.76 5.15 Favored 'General case' 0 N--CA 1.386 -3.634 1 N-CA-C 100.097 -4.038 . . . . 0.0 100.097 -178.234 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 66' ' ' LEU . 48.2 m-85 -116.75 89.41 3.1 Favored 'General case' 1 C--N 1.216 -5.214 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -175.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.02 104.13 2.5 Favored Glycine 3 N--CA 1.352 -6.957 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.054 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CD2' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -51.31 97.51 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 O-C-N 125.305 1.238 . . . . 0.0 108.129 172.059 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.9 pt -76.17 137.49 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.437 -3.397 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.406 -173.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 22.5 pttm -79.16 112.51 16.44 Favored 'General case' 1 N--CA 1.369 -4.495 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 167.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' CD2' ' A' ' 65' ' ' TRP . 64.6 p -35.65 -34.16 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.437 0 C-N-CA 129.327 3.051 . . . . 0.0 114.818 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -62.93 -16.24 58.44 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -84.8 -17.11 39.17 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.698 -0.626 . . . . 0.0 111.723 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.572 ' CG1' HD12 ' A' ' 52' ' ' ILE . 30.4 m -135.96 168.18 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.752 0.786 . . . . 0.0 112.616 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -135.27 126.19 27.59 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.695 HG22 ' HB2' ' A' ' 31' ' ' ALA . 25.9 pt -84.77 164.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.137 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.91 111.4 20.77 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.85 -21.13 55.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 123.699 0.624 . . . . 0.0 110.804 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 64.96 -94.14 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 O-C-N 124.382 1.051 . . . . 0.0 109.935 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 m 42.47 78.98 0.04 OUTLIER 'General case' 0 C--O 1.251 1.181 0 C-N-CA 124.888 1.275 . . . . 0.0 112.941 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.586 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 81.9 mt -81.37 105.04 12.24 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 121.765 0.793 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -78.68 -8.6 58.84 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.436 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.9 tt -58.52 -34.44 70.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.203 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 89' ' ' LEU . 85.7 mttt -74.86 114.17 13.01 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 174.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.732 ' NZ ' ' HA ' ' A' ' 93' ' ' LYS . 2.4 tpmp? -116.04 163.87 15.29 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 118.427 -1.309 . . . . 0.0 112.061 -174.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.486 ' H ' ' HG3' ' A' ' 93' ' ' LYS . 4.7 m-20 -110.97 -66.1 1.11 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.569 -172.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.1 -56.48 2.17 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.732 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 118.23 -0.89 . . . . 0.0 108.909 -177.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 38.5 mm-40 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.53 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 1.3 pp -77.62 -28.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.849 0.833 . . . . 0.0 108.842 -174.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' HD23 ' A' ' 21' ' ' LEU . 15.4 mtpp -70.0 -41.49 74.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.352 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -85.04 -22.52 28.98 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.153 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.5 tppt? -76.36 -48.61 19.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.546 -175.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 13.8 t80 -94.45 -26.49 16.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.889 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? 70.91 90.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.518 1.127 . . . . 0.0 108.882 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.47 -44.96 5.71 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.28 80.2 p . . . . . 0 CA--C 1.552 1.048 0 C-N-CA 125.699 1.599 . . . . 0.0 112.384 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 C--O 1.246 0.874 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.648 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -57.18 134.04 21.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 123.714 0.634 . . . . 0.0 111.81 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.1 mm -89.2 -38.22 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.621 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 54' ' ' ILE . 32.8 m80 -162.02 156.66 22.49 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -100.57 117.1 34.02 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -92.43 155.83 17.6 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.7 0.762 . . . . 0.0 110.293 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -107.11 131.17 54.42 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.56 115.72 5.46 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.8 t -79.34 -12.05 59.93 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.946 0.779 . . . . 0.0 110.025 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -158.35 171.7 19.7 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.702 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 5.5 p-10 -105.67 104.86 14.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.698 0.761 . . . . 0.0 110.653 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.02 158.98 15.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 17.4 19.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.827 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 83.22 59.88 2.1 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.204 -0.998 . . . . 0.0 114.476 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.04 145.91 17.55 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 63.65 34.22 12.5 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.362 0.665 . . . . 0.0 109.635 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.6 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 14.3 m120 64.77 82.6 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.387 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 15.9 tt0 -140.86 -176.87 4.83 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.575 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 54.7 tp -95.65 145.17 25.47 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.4 m -94.98 119.58 33.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 52' ' ' ILE . 28.3 p90 -153.28 157.85 40.74 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.702 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 42.7 mmtm -107.97 146.78 31.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.062 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.75 118.59 2.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.912 0.885 . . . . 0.0 110.001 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 15.8 76.85 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.919 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 28.9 tt0 -69.01 -33.08 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.402 0.601 . . . . 0.0 111.58 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 80.07 122.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 110.214 -174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.468 HD13 HD23 ' A' ' 44' ' ' LEU . 4.7 mt -125.76 162.19 29.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.648 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 35.5 mt-10 -116.49 134.82 54.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 119.211 0.914 . . . . 0.0 109.093 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 65' ' ' TRP . 9.0 tp -93.05 127.15 45.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -56.61 4.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.528 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.3 tpm_? -116.18 121.97 43.67 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.524 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.603 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -118.74 -26.86 2.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.026 174.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.6 p -85.39 136.34 33.5 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.412 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t0 67.3 33.58 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.66 1.184 . . . . 0.0 110.918 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.23 128.58 93.78 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.296 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.44 -27.59 1.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.049 1.832 . . . . 0.0 114.147 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.505 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 17.5 mm-40 -109.14 -6.09 15.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.28 -18.7 56.14 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.762 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -86.3 161.39 18.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.603 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.1 m0 -98.44 163.45 12.68 Favored 'General case' 0 C--O 1.199 -1.58 0 C-N-CA 123.565 0.746 . . . . 0.0 109.633 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.736 HD11 ' HB3' ' A' ' 74' ' ' TYR . 55.7 tp -104.06 108.84 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.032 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.34 144.86 18.44 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 73' ' ' SER . 22.1 ttp180 -115.74 149.32 38.65 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.248 0.547 . . . . 0.0 110.419 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.529 ' OG1' HD11 ' A' ' 44' ' ' LEU . 89.7 m -98.17 156.52 16.64 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.84 -33.73 17.75 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -79.67 -1.81 39.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 77.14 86.14 0.42 Allowed Glycine 0 C--O 1.221 -0.695 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.8 m -152.7 127.19 9.34 Favored 'General case' 0 N--CA 1.394 -3.229 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.736 ' HB3' HD11 ' A' ' 66' ' ' LEU . 83.7 m-85 -115.59 100.08 7.8 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -174.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.575 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.29 5.09 52.04 Favored Glycine 0 C--O 1.188 -2.737 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.616 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.6 ' HE1' ' HB3' ' A' ' 42' ' ' ASN 0.314 0.3 OUTLIER 46.01 75.18 0.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 123.068 1.414 . . . . 0.0 112.844 -179.874 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 82' ' ' VAL . 1.6 pt -61.94 141.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.038 0 CA-C-N 112.199 -2.273 . . . . 0.0 113.125 -174.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -77.71 114.78 16.9 Favored 'General case' 1 N--CA 1.365 -4.711 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 166.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.507 HG22 ' CG ' ' A' ' 65' ' ' TRP . 34.0 p -35.53 -38.78 0.12 Allowed 'General case' 0 C--N 1.244 -3.99 0 C-N-CA 127.91 2.484 . . . . 0.0 113.628 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -66.67 -19.84 65.85 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.41 0.684 . . . . 0.0 111.675 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.5 -5.87 59.04 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 121.835 -0.54 . . . . 0.0 111.357 -175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.62 HG21 HD12 ' A' ' 77' ' ' ILE . 30.1 m -135.79 167.84 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.377 0.608 . . . . 0.0 110.992 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -133.96 116.17 15.24 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.781 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.3 pp -81.53 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.315 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.306 -1.299 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.554 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 46.4 mt-10 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.738 0.78 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.604 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.5 pt -88.69 -32.35 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.858 -170.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.0 ptmt -91.22 -9.44 45.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.591 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 13.4 tmtt? -92.89 -23.96 18.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 169.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.3 tppt? -82.56 -58.44 2.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.035 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 9.8 t80 -92.52 -33.98 14.25 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.4 tttm 75.11 93.48 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.34 1.025 . . . . 0.0 110.656 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.654 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.09 -28.82 12.85 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.864 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.268 69.0 p . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 126.663 1.985 . . . . 0.0 115.964 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.41 133.55 31.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.86 0.838 . . . . 0.0 111.612 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.502 HD11 HH21 ' A' ' 56' ' ' ARG . 62.6 mt -98.46 -32.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.7 m80 -162.58 165.83 25.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.87 116.39 31.87 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.691 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -95.64 150.52 20.26 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-O 121.771 0.796 . . . . 0.0 111.047 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -107.31 133.61 51.59 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -64.41 117.03 6.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 31.3 t -79.8 -18.08 51.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 124.294 0.996 . . . . 0.0 110.321 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.6 t -152.93 161.0 43.08 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.99 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 1.8 p-10 -94.51 109.57 21.45 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.016 0.912 . . . . 0.0 108.769 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.26 152.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 9.04 39.01 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.064 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.87 58.24 8.57 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.801 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.31 162.23 14.48 Favored Glycine 0 C--O 1.2 -1.982 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.864 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 6.4 mmpt? 57.71 34.28 24.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.843 1.321 . . . . 0.0 111.691 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 76' ' ' TYR . 42.6 m-80 66.01 51.81 1.28 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.89 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' OE1' ' HE3' ' A' ' 78' ' ' LYS . 1.2 mp0 -110.04 179.45 4.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.831 171.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 1.1 tt -97.75 151.26 20.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -94.87 126.57 40.28 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.189 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 14.2 p90 -158.57 163.27 37.17 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.952 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.99 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.2 mmtt -110.7 148.27 32.62 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 18.8 tm0? -52.06 119.79 4.71 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.748 0.655 . . . . 0.0 109.548 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.58 13.69 69.71 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.742 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 12.9 tp10 -63.12 -32.01 73.29 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.95 0.5 . . . . 0.0 110.901 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 77.63 99.32 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.018 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.555 HD12 HG12 ' A' ' 82' ' ' VAL . 12.1 mt -106.69 165.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 113.399 -1.728 . . . . 0.0 106.742 -173.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -127.63 136.48 51.69 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.7 tp -93.24 130.68 41.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.11 -37.84 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.369 177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -137.86 134.71 35.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.911 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.69 -13.32 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 123.954 0.902 . . . . 0.0 110.39 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -117.16 159.04 23.23 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.11 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.14 70.78 0.59 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.219 1.408 . . . . 0.0 110.089 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 15.3 p30 -127.75 139.3 34.91 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.671 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 23.6 Cg_exo -68.66 -49.2 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.938 2.426 . . . . 0.0 113.105 177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.91 -23.45 25.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 111.681 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.18 8.53 58.79 Favored Glycine 0 C--N 1.312 -0.772 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.73 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 12.7 ptmt -89.32 162.26 15.92 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.584 ' HB2' HG13 ' A' ' 77' ' ' ILE . 46.6 m0 -93.79 176.41 6.36 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.654 HD22 HD11 ' A' ' 21' ' ' LEU . 59.7 tp -121.2 112.57 18.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.73 14.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 73' ' ' SER . 48.5 ttp180 -133.56 153.69 51.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.322 0.582 . . . . 0.0 110.285 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.2 m -100.0 153.82 18.89 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -30.04 12.62 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -81.68 -12.06 58.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.812 0.339 . . . . 0.0 111.855 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.59 92.59 1.56 Allowed Glycine 0 C--N 1.315 -0.591 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.7 m -153.73 118.05 4.87 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 66' ' ' LEU . 48.2 m-85 -114.59 94.95 5.01 Favored 'General case' 1 C--N 1.222 -4.972 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -173.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.577 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -111.18 103.41 1.58 Allowed Glycine 3 N--CA 1.359 -6.434 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.525 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -45.52 100.55 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 113.133 -1.534 . . . . 0.0 108.293 173.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.584 HG13 ' HB2' ' A' ' 65' ' ' TRP . 2.0 pt -81.4 142.0 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.249 0 C-N-CA 124.341 1.057 . . . . 0.0 113.482 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 18.7 ptpt -79.28 119.01 21.74 Favored 'General case' 1 N--CA 1.361 -4.911 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 165.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.464 HG22 ' CD2' ' A' ' 65' ' ' TRP . 50.5 p -36.11 -39.46 0.17 Allowed 'General case' 1 C--N 1.242 -4.1 0 C-N-CA 127.732 2.413 . . . . 0.0 112.894 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.84 -13.35 62.06 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 123.274 0.63 . . . . 0.0 112.341 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.78 -9.08 50.59 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.359 -0.838 . . . . 0.0 111.112 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.555 HG12 HD12 ' A' ' 52' ' ' ILE . 31.5 m -133.91 167.22 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 122.152 0.977 . . . . 0.0 111.974 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.4 mt-10 -132.89 111.62 11.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.1 pt -75.36 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.686 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--N 1.288 -2.086 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.208 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 121.013 0.435 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.724 HG21 ' HB2' ' A' ' 74' ' ' TYR . 4.3 pt -79.72 -31.45 13.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.419 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 2.7 mptp? -68.62 -23.8 64.49 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 121.357 0.599 . . . . 0.0 110.768 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -103.6 6.49 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.997 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 8.8 ttmm -121.62 -43.42 2.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.098 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.574 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 2.9 t80 -94.6 -33.8 12.87 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 87.4 tttt 68.13 88.51 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.653 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 HD22 ' A' ' 66' ' ' LEU . 1.2 mm? -98.09 -29.98 12.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.675 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 CA--C 1.544 0.734 0 C-N-CA 124.985 1.314 . . . . 0.0 113.379 -179.287 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.425 ' O ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.55 136.21 25.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.2 0.524 . . . . 0.0 109.636 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 54' ' ' ILE . 49.9 mm -91.29 -35.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.79 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.799 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.403 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.2 m80 -168.64 162.56 11.91 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.26 121.14 41.33 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.715 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -96.14 155.79 16.61 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-O 121.758 0.789 . . . . 0.0 110.027 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -107.04 128.08 54.04 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -68.36 109.39 3.63 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.52 -22.5 32.44 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.23 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.4 m -133.19 144.01 49.56 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.848 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.43 104.55 16.56 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.321 1.058 . . . . 0.0 109.281 172.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 39' ' ' GLY . 8.5 p -114.47 151.49 16.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.682 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.388 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -97.97 7.24 46.65 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.201 0.6 . . . . 0.0 111.942 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 75.25 59.04 3.73 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.609 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.11 151.14 17.01 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 tttm 62.0 32.87 17.58 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.934 0.873 . . . . 0.0 108.687 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 90.6 m-20 66.55 86.64 0.13 Allowed 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.385 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.601 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 22.4 tt0 -147.09 -175.73 4.94 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.565 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.67 154.53 17.89 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.48 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 m -101.89 120.19 40.0 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 18.5 p90 -151.06 161.77 42.12 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.731 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 73.2 mmtt -107.2 151.19 25.76 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.118 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -55.59 111.65 0.95 Allowed 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.57 24.96 14.49 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.406 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -75.91 -39.96 55.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.144 0.577 . . . . 0.0 111.162 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 76.34 108.08 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.915 1.686 . . . . 0.0 109.04 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.582 HD12 ' CG1' ' A' ' 82' ' ' VAL . 8.1 mt -116.87 162.71 14.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -173.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.47 135.24 54.85 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.0 tp -93.48 128.54 44.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -113.33 -42.24 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.574 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 1.8 tpm_? -128.52 128.23 43.92 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -126.07 -6.74 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 123.612 0.765 . . . . 0.0 109.637 177.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -112.13 150.84 30.21 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.521 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 t70 56.24 56.53 5.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.743 1.258 . . . . 0.0 109.535 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 17.7 p-10 -105.83 106.31 56.19 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.535 -1.666 . . . . 0.0 112.486 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 16.6 Cg_exo -66.76 -23.52 48.3 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.814 3.009 . . . . 0.0 115.072 -173.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -111.08 0.17 16.81 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.915 0.864 . . . . 0.0 109.852 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 17.49 80.19 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.688 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.0 ptmt -110.33 161.68 15.39 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.522 ' CD2' HG22 ' A' ' 79' ' ' THR . 40.4 m0 -96.63 176.18 6.11 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 122.383 0.273 . . . . 0.0 110.367 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' A' ' 74' ' ' TYR . 64.5 tp -117.37 111.77 19.79 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.74 155.43 16.32 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.184 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.1 ttp180 -136.45 148.26 47.63 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.562 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.7 m -101.41 157.96 16.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.79 30.36 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 119.243 0.928 . . . . 0.0 113.174 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmt_? -64.01 -26.0 68.37 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.071 0.948 . . . . 0.0 110.2 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.67 89.05 1.44 Allowed Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.4 m -153.56 122.31 6.37 Favored 'General case' 0 N--CA 1.387 -3.582 0 N-CA-C 100.422 -3.918 . . . . 0.0 100.422 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.724 ' HB2' HG21 ' A' ' 15' ' ' ILE . 67.4 m-85 -114.61 96.52 5.79 Favored 'General case' 1 C--N 1.225 -4.806 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -175.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -111.04 105.31 1.86 Allowed Glycine 3 N--CA 1.357 -6.567 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 177.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -49.38 96.49 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.291 -1.455 . . . . 0.0 108.88 169.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.601 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.7 pt -76.09 143.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.276 0 C-N-CA 125.631 1.572 . . . . 0.0 113.518 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -78.93 115.88 18.89 Favored 'General case' 1 N--CA 1.371 -4.411 0 N-CA-C 102.811 -3.033 . . . . 0.0 102.811 166.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 64' ' ' LYS . 68.9 p -36.02 -35.96 0.08 Allowed 'General case' 0 C--N 1.244 -3.995 0 C-N-CA 128.167 2.587 . . . . 0.0 113.962 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -70.16 -15.13 62.91 Favored 'General case' 0 CA--C 1.567 1.625 0 C-N-CA 123.361 0.665 . . . . 0.0 112.636 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.92 -13.84 38.11 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.582 ' CG1' HD12 ' A' ' 52' ' ' ILE . 28.4 m -127.89 165.5 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-O 121.297 0.57 . . . . 0.0 110.888 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -133.8 117.3 16.72 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.715 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.1 pp -77.96 134.1 29.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 119.504 -0.879 . . . . 0.0 109.936 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--N 1.301 -1.515 0 CA-C-O 121.365 0.602 . . . . 0.0 110.416 179.626 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 . . . . . 0 N--CA 1.501 2.109 0 CA-C-O 122.493 1.139 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -87.15 -25.18 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.417 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.658 ' HB3' ' HD3' ' A' ' 17' ' ' LYS . 10.5 tptm -64.3 -41.65 96.76 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.286 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.658 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 3.4 mppt? -98.02 12.46 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.699 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 8.2 tppt? -105.67 -57.04 2.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.695 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 1.8 t80 -80.11 -25.07 40.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 49.5 mtpt 70.09 89.4 0.1 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.989 1.316 . . . . 0.0 110.6 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.542 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -98.74 -18.63 17.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.804 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 70.7 p . . . . . 0 C--N 1.306 -1.299 0 C-N-CA 126.061 1.744 . . . . 0.0 114.32 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 C--O 1.22 -0.484 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.12 136.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.379 0.609 . . . . 0.0 109.464 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.88 -33.66 3.53 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.057 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.564 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.6 m80 -161.82 168.65 22.73 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -173.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.72 115.67 30.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -98.12 155.12 17.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-O 122.281 1.038 . . . . 0.0 111.352 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 34.1 ttpt -107.91 128.83 54.97 Favored 'General case' 0 C--N 1.256 -3.465 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -64.84 116.03 5.92 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.87 -17.4 35.7 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.451 0.643 . . . . 0.0 109.658 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.1 t -144.33 156.07 44.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 8.2 p-10 -94.43 101.92 13.86 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.16 0.981 . . . . 0.0 110.169 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG12 ' CE1' ' A' ' 46' ' ' PHE . 7.3 p -112.42 153.35 14.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.35 42.94 3.13 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 111.406 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 74.39 58.84 4.08 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.14 176.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.06 126.6 8.02 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 64.4 34.79 10.12 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.598 0.713 . . . . 0.0 109.79 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.525 ' ND2' ' HE1' ' A' ' 76' ' ' TYR . 12.2 t30 71.52 87.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.702 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 20.2 tt0 -151.85 -172.45 4.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.102 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.1 tt -94.96 151.5 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.515 ' H ' HD23 ' A' ' 44' ' ' LEU . 50.1 m -102.77 118.58 37.14 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CE1' HG12 ' A' ' 37' ' ' VAL . 20.3 p90 -154.89 177.22 11.54 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.618 0.767 . . . . 0.0 109.619 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 99.1 mttt -133.69 151.18 51.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.74 119.3 2.71 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 124.322 1.014 . . . . 0.0 110.9 176.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.44 12.7 59.41 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.937 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -79.23 -15.54 57.87 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 66.34 113.93 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 O-C-N 124.394 1.059 . . . . 0.0 111.208 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.5 mt -120.69 156.25 23.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.39 138.26 51.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 65' ' ' TRP . 7.8 tp -95.16 117.43 39.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.436 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -105.53 -27.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.404 -176.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 tpp180 -141.88 125.81 17.18 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.052 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -118.78 -38.95 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.738 -177.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -106.68 154.91 20.26 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.199 -172.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 82.82 10.91 0.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.894 1.677 . . . . 0.0 109.798 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.574 ' ND2' ' HA2' ' A' ' 63' ' ' GLY . 2.9 p-10 -54.57 123.95 46.73 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.213 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 21.3 Cg_exo -68.4 -40.69 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.088 2.526 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -99.74 -49.84 4.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.574 ' HA2' ' ND2' ' A' ' 60' ' ' ASN . . . 145.18 -2.59 1.15 Allowed Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.288 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 14.8 ptpt -100.69 163.67 12.23 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 122.572 0.349 . . . . 0.0 110.314 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.678 ' HB3' HD11 ' A' ' 54' ' ' ILE . 35.9 m0 -98.03 174.33 6.6 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 124.263 0.977 . . . . 0.0 111.103 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 74' ' ' TYR . 41.4 tp -115.05 108.31 16.5 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.06 157.97 14.62 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.2 ttp180 -136.09 147.11 47.69 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.171 0.51 . . . . 0.0 111.389 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.495 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.6 p -100.83 165.31 11.42 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.052 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.55 24.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.385 1.074 . . . . 0.0 113.641 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -78.04 -18.96 55.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.301 0.572 . . . . 0.0 111.384 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.69 92.09 1.38 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.1 m -151.96 129.11 11.14 Favored 'General case' 0 N--CA 1.392 -3.36 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 66' ' ' LEU . 41.9 m-85 -119.73 61.31 0.84 Allowed 'General case' 1 C--N 1.226 -4.788 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -172.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.627 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -87.11 93.38 1.88 Allowed Glycine 1 N--CA 1.384 -4.82 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -176.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.54 ' O ' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -34.29 101.05 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 125.809 1.535 . . . . 0.0 110.324 174.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -78.07 137.01 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.342 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.661 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -73.67 114.05 11.49 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 103.576 -2.749 . . . . 0.0 103.576 166.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.536 HG22 ' CD2' ' A' ' 65' ' ' TRP . 81.4 p -36.11 -35.9 0.08 Allowed 'General case' 1 C--N 1.24 -4.189 0 C-N-CA 128.428 2.691 . . . . 0.0 113.471 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.6 t -69.04 -14.24 62.92 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.068 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.32 -7.14 51.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.443 -0.785 . . . . 0.0 111.137 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 HD12 ' A' ' 77' ' ' ILE . 26.8 m -133.96 157.46 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.93 0.871 . . . . 0.0 112.365 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -120.3 110.69 16.86 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.711 HG22 ' HB2' ' A' ' 31' ' ' ALA . 18.8 pt -79.82 163.03 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 C--N 1.282 -2.34 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.365 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 3.6 mp0 . . . . . 0 N--CA 1.442 -0.838 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.3 pp -87.98 -23.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 120.922 0.391 . . . . 0.0 110.125 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -48.1 -61.68 1.86 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.845 1.658 . . . . 0.0 112.711 -171.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -104.82 11.66 33.53 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.553 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 12.6 tppt? -84.87 -50.74 7.28 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 26.2 t80 -89.99 -28.99 18.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.626 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 8.0 mtmp? 75.0 88.25 0.09 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 125.577 1.551 . . . . 0.0 110.066 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 HD11 HD22 ' A' ' 66' ' ' LEU . 1.7 mm? -99.94 -69.9 0.75 Allowed 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.411 -2.41 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.131 173.679 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.732 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.9 p -76.85 134.67 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.349 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.77 -34.77 4.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.861 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 35.6 m80 -159.15 163.03 36.43 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.39 116.39 32.34 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.89 155.31 17.24 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 122.345 1.069 . . . . 0.0 111.67 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -106.85 126.47 52.35 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.06 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.421 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.53 109.4 2.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.6 t -80.94 -18.7 46.17 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.884 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -147.32 151.48 36.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -89.06 105.4 17.76 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.847 0.832 . . . . 0.0 109.662 173.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.32 162.28 12.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.905 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -125.18 31.52 5.58 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.537 0.684 . . . . 0.0 111.411 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 81.26 59.2 2.45 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.169 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.19 116.12 4.52 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 tttm 57.43 71.11 0.6 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.984 1.313 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.577 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 18.8 m120 51.47 79.47 0.1 Allowed 'General case' 0 C--O 1.245 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 111.493 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.3 tt0 -146.81 -175.45 4.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.649 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -97.59 155.24 17.06 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.559 ' H ' HD23 ' A' ' 44' ' ' LEU . 28.0 m -100.65 115.44 30.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.171 0.51 . . . . 0.0 109.69 174.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.5 p90 -149.48 158.22 43.98 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.819 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HG2' ' OD1' ' A' ' 36' ' ' ASP . 59.4 mttm -110.84 152.93 26.11 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 123.695 0.622 . . . . 0.0 109.922 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 110.22 0.66 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.33 27.23 10.15 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.103 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.7 tp10 -80.11 -37.05 34.43 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.086 0.555 . . . . 0.0 111.117 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 72.21 112.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.182 1.793 . . . . 0.0 110.505 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.559 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.0 mt -119.88 160.68 20.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.117 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.732 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 44.8 mt-10 -117.83 134.36 55.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.6 tp -90.14 126.53 42.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.407 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -110.22 -39.55 3.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.63 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -134.89 130.15 35.48 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 118.549 -1.261 . . . . 0.0 110.906 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.45 -1.93 5.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 123.934 0.894 . . . . 0.0 110.233 176.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.8 p -112.38 147.43 36.42 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.916 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 t70 67.08 28.59 8.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 122.75 1.262 . . . . 0.0 109.428 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 23.3 p-10 -77.98 115.05 47.28 Favored Pre-proline 0 C--N 1.302 -1.464 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.203 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 30.9 Cg_exo -62.63 -62.4 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.711 2.941 . . . . 0.0 113.877 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.35 -8.41 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.819 0.818 . . . . 0.0 110.874 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 7.88 68.05 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.0 ptmt -95.96 162.91 13.36 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 57' ' ' ILE . 46.0 m0 -97.71 175.94 6.0 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 122.365 0.266 . . . . 0.0 110.529 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 74' ' ' TYR . 60.1 tp -120.54 114.18 21.38 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -120.24 159.81 15.03 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.4 ttp180 -134.68 152.81 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.0 m -111.82 165.44 12.06 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.23 -31.96 15.36 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -89.29 -6.86 56.42 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 118.372 -1.331 . . . . 0.0 111.091 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.24 97.2 1.25 Allowed Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.874 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.4 m -153.89 124.31 7.04 Favored 'General case' 0 N--CA 1.394 -3.27 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.578 ' HB2' HG21 ' A' ' 15' ' ' ILE . 39.9 m-85 -113.85 80.56 1.4 Allowed 'General case' 1 C--N 1.223 -4.908 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -175.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.649 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -97.46 101.97 2.64 Favored Glycine 3 N--CA 1.346 -7.334 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.577 ' HE1' ' HB3' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.92 100.34 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 113.198 -1.501 . . . . 0.0 108.121 168.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.6 pt -80.44 145.68 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.442 -3.204 0 C-N-CA 126.645 1.978 . . . . 0.0 113.515 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 117.58 22.25 Favored 'General case' 1 N--CA 1.359 -5.007 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 166.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.472 HG22 ' CG ' ' A' ' 65' ' ' TRP . 62.1 p -35.34 -38.2 0.09 Allowed 'General case' 0 C--N 1.251 -3.696 0 C-N-CA 129.05 2.94 . . . . 0.0 114.014 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 t -70.27 -9.89 57.32 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.308 1.043 . . . . 0.0 112.248 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.32 -10.18 36.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.427 -0.796 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.604 HG21 HD12 ' A' ' 77' ' ' ILE . 19.0 m -129.08 152.28 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-O 121.808 0.813 . . . . 0.0 112.29 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.5 mt-10 -119.14 107.05 12.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 10.2 pt -72.82 159.3 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.198 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--N 1.287 -2.13 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.095 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 35.0 mm-40 . . . . . 0 CA--C 1.501 -0.912 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.586 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 2.4 pp -72.3 -28.3 28.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.316 -172.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HA ' HD23 ' A' ' 21' ' ' LEU . 48.7 mtpt -67.91 -36.19 79.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.015 -172.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -107.53 -16.74 14.29 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.298 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 5.8 tppt? -71.32 -45.73 62.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 31.3 t80 -90.68 -30.61 17.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . 0.254 15.2 tptp 74.61 85.58 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.695 1.236 . . . . 0.0 111.392 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.605 HD11 HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -98.99 -59.84 1.65 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.304 36.2 p . . . . . 0 C--N 1.318 -0.768 0 C-N-CA 125.792 1.637 . . . . 0.0 112.634 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.4 p -81.64 137.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.442 0.639 . . . . 0.0 111.159 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.42 -40.36 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.748 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.4 m80 -161.15 171.75 17.95 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HB3' ' NE2' ' A' ' 51' ' ' GLN . 5.8 mp -107.86 126.33 52.54 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -102.68 156.6 17.52 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.418 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -107.1 133.51 51.6 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -65.99 103.22 0.9 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.9 t -71.2 -28.93 64.57 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.3 m -132.09 156.43 46.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.708 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.7 p-10 -81.38 112.03 18.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 171.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 81' ' ' ALA . 30.8 t -112.62 140.89 30.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.789 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.34 -168.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -86.7 -14.61 42.01 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.341 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 37' ' ' VAL . . . 75.78 60.49 3.16 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.983 -1.58 . . . . 0.0 110.432 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.17 131.89 10.85 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.83 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp 58.88 71.58 0.58 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.405 1.082 . . . . 0.0 110.658 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 56.29 61.45 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.114 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 46.5 mt-10 -134.16 -179.22 5.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.548 0.339 . . . . 0.0 111.133 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -98.46 140.96 31.93 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 p -94.6 115.73 27.92 Favored 'General case' 0 C--N 1.28 -2.443 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.161 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 29.1 p90 -145.47 177.12 9.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.478 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 9.3 mtmp? -134.81 142.53 46.69 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.6 tm0? -35.79 111.97 0.15 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 125.131 1.519 . . . . 0.0 110.376 173.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.09 19.97 40.77 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.648 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.553 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -73.33 -26.0 60.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.003 0.901 . . . . 0.0 113.227 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.537 ' NE2' ' HB3' ' A' ' 30' ' ' LEU . 26.6 tp60 70.84 104.2 0.06 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.882 1.364 . . . . 0.0 108.813 -172.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.552 HD12 HG12 ' A' ' 82' ' ' VAL . 14.8 mt -110.74 165.95 5.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 24.9 mt-10 -122.65 141.11 52.1 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.8 tp -98.75 116.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.49 -41.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.387 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.592 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -133.7 136.54 44.74 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 117.782 -1.567 . . . . 0.0 111.497 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.02 -37.84 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.376 -1.283 . . . . 0.0 109.675 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -88.45 158.09 18.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t70 54.82 66.36 1.25 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 125.032 1.333 . . . . 0.0 109.192 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 31.5 p30 -112.11 136.93 21.3 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.166 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.6 Cg_exo -76.76 -32.3 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.431 2.087 . . . . 0.0 112.872 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.79 -34.89 6.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.74 -7.04 15.63 Favored Glycine 0 C--N 1.305 -1.142 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HA ' HG23 ' A' ' 79' ' ' THR . 11.4 ptmt -80.52 162.33 24.38 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.557 ' CD1' HG22 ' A' ' 57' ' ' ILE . 37.7 m0 -99.08 176.65 5.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.608 0.186 . . . . 0.0 110.801 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.605 HD22 HD11 ' A' ' 21' ' ' LEU . 61.4 tp -116.39 110.93 19.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.83 158.84 14.07 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 73' ' ' SER . 66.4 ttt-85 -140.53 147.8 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.769 0.427 . . . . 0.0 109.88 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 7.1 p -101.03 165.54 11.27 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.12 65.2 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.087 0.47 . . . . 0.0 112.254 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -71.55 -14.97 62.26 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.338 0.655 . . . . 0.0 111.749 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 81.77 88.37 0.65 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.181 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.7 m -151.99 120.82 6.57 Favored 'General case' 0 N--CA 1.394 -3.269 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.568 ' HB2' HG21 ' A' ' 15' ' ' ILE . 61.0 m-85 -108.91 90.74 3.38 Favored 'General case' 1 C--N 1.219 -5.076 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.601 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -107.05 104.81 2.21 Favored Glycine 3 N--CA 1.355 -6.748 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.586 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -46.0 96.99 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.351 -1.424 . . . . 0.0 108.29 169.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 82' ' ' VAL . 1.5 pt -78.22 147.18 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.898 0 C-N-CA 125.713 1.605 . . . . 0.0 114.398 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -76.64 113.82 14.7 Favored 'General case' 1 N--CA 1.376 -4.143 0 N-CA-C 101.712 -3.44 . . . . 0.0 101.712 165.77 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 64' ' ' LYS . 79.4 p -36.64 -41.92 0.33 Allowed 'General case' 0 C--N 1.246 -3.92 0 C-N-CA 127.769 2.427 . . . . 0.0 113.594 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -63.53 -20.42 65.61 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.258 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -82.97 -12.54 57.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.835 -0.54 . . . . 0.0 111.279 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 77' ' ' ILE . 29.1 m -127.06 166.82 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.343 0.592 . . . . 0.0 111.847 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 58.3 mt-10 -133.26 107.91 8.43 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.742 HG22 ' HB2' ' A' ' 31' ' ' ALA . 8.6 pt -75.53 155.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.391 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 C--N 1.291 -1.974 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.706 178.499 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 C--O 1.218 -0.567 0 CA-C-O 121.003 0.43 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.704 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.9 pp -67.54 -30.77 49.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-O 121.454 0.645 . . . . 0.0 111.422 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -76.48 -27.32 56.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.805 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -93.65 -8.93 39.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.019 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 12.6 tppt? -99.58 -67.01 0.87 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.073 0.463 . . . . 0.0 110.96 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.786 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 21.1 t80 -79.07 -32.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 -172.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 7.9 mtmp? 75.72 91.84 0.07 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.834 1.253 . . . . 0.0 109.692 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.058 HD12 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.35 -46.33 5.83 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.318 0.58 . . . . 0.0 109.772 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p . . . . . 0 CA--C 1.546 0.826 0 C-N-CA 125.507 1.523 . . . . 0.0 114.877 174.871 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.438 ' C ' HG22 ' A' ' 55' ' ' ILE . 12.9 pt20 . . . . . 0 N--CA 1.443 -0.798 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -53.95 133.7 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.64 -31.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.066 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.1 m80 -161.05 157.03 25.49 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.27 116.04 28.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.669 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -94.63 150.81 19.85 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 122.072 0.939 . . . . 0.0 111.127 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.81 128.27 54.11 Favored 'General case' 0 C--N 1.252 -3.652 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -63.84 116.05 5.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.553 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.9 t -81.87 -18.47 43.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.249 0.968 . . . . 0.0 109.846 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.9 m -144.61 156.09 43.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 6.3 p-10 -91.42 102.02 14.7 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.402 HG12 ' CE1' ' A' ' 46' ' ' PHE . 9.9 p -113.25 153.75 14.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.795 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -98.1 8.33 44.95 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.387 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.62 59.77 1.87 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.678 -1.248 . . . . 0.0 111.896 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.77 143.8 16.7 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttp 65.05 29.59 12.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 108.757 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.414 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 2.4 t-20 63.14 86.97 0.11 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.28 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 31.0 tt0 -141.59 -173.6 3.82 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.257 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.646 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.2 tt -95.92 145.54 25.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 m -96.01 122.21 38.59 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 16.6 p90 -154.26 174.83 14.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 60.9 mtpt -127.33 147.79 50.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.3 tm0? -51.98 125.68 16.13 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.669 0.605 . . . . 0.0 110.425 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.2 81.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.349 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -63.12 -30.9 71.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.504 0.668 . . . . 0.0 109.891 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 73.23 110.41 0.07 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.13 1.372 . . . . 0.0 111.298 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.528 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.4 mt -115.76 156.81 16.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 CA-C-N 113.557 -1.656 . . . . 0.0 106.671 -172.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 79.9 mt-10 -113.08 131.16 55.92 Favored 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.009 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.6 tp -86.32 115.81 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.523 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -103.4 -32.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.984 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 1.058 ' HG3' HD12 ' A' ' 21' ' ' LEU . 18.1 mmt180 -134.93 112.4 10.61 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.721 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.59 -19.31 6.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.038 -1.892 . . . . 0.0 107.092 171.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 57' ' ' ILE . 12.0 p -99.01 141.94 31.12 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.396 -177.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t0 75.67 26.06 1.12 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.058 1.343 . . . . 0.0 108.92 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 10.0 p30 -66.01 126.02 91.11 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.587 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.786 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 62.2 Cg_endo -81.23 -45.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.398 2.065 . . . . 0.0 113.3 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -99.3 -5.52 29.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.021 0.438 . . . . 0.0 111.177 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 99.46 -22.3 41.3 Favored Glycine 0 C--N 1.308 -1.004 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.1 ptmt -72.0 161.49 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.152 -1.024 . . . . 0.0 109.21 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.456 ' CG ' HG22 ' A' ' 79' ' ' THR . 32.3 m0 -99.5 176.34 5.53 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.073 0.233 . . . . 0.0 110.924 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 74' ' ' TYR . 62.9 tp -120.36 114.33 21.68 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.08 156.18 15.81 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 73' ' ' SER . 2.1 ttp-105 -139.03 149.11 44.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 17.2 p -99.76 165.94 11.34 Favored 'General case' 0 C--N 1.266 -3.032 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.962 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.73 -30.08 42.47 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -0.07 54.92 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.34 0.866 . . . . 0.0 113.34 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.28 92.01 0.9 Allowed Glycine 0 C--N 1.319 -0.413 0 CA-C-O 121.554 0.53 . . . . 0.0 113.535 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 20.4 m -153.01 126.15 8.53 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.73 ' HB3' HD11 ' A' ' 66' ' ' LEU . 57.1 m-85 -117.81 86.68 2.57 Favored 'General case' 1 C--N 1.227 -4.727 0 CA-C-O 122.122 0.963 . . . . 0.0 108.649 -173.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.646 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.14 101.76 2.12 Favored Glycine 3 N--CA 1.359 -6.447 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.678 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -48.92 100.36 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.58 -1.31 . . . . 0.0 108.499 170.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.602 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.8 pt -80.41 148.29 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.843 0 C-N-CA 126.277 1.831 . . . . 0.0 113.074 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -77.42 119.59 21.24 Favored 'General case' 1 N--CA 1.368 -4.533 0 N-CA-C 102.647 -3.094 . . . . 0.0 102.647 163.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 64' ' ' LYS . 82.0 p -36.13 -38.59 0.14 Allowed 'General case' 1 C--N 1.243 -4.051 0 C-N-CA 128.017 2.527 . . . . 0.0 113.168 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.5 t -71.71 -14.15 61.94 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.208 0.603 . . . . 0.0 112.155 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.97 -11.2 57.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.42 -0.8 . . . . 0.0 110.937 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.528 ' CG1' HD12 ' A' ' 52' ' ' ILE . 16.9 m -129.35 167.41 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.556 0.693 . . . . 0.0 111.336 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 mt-10 -131.34 110.55 11.15 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -75.77 159.5 5.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.251 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 C--N 1.283 -2.32 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.621 -178.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 74' ' ' TYR . 7.7 pt -67.18 -27.87 40.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.001 0.905 . . . . 0.0 108.746 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.2 ptmt -79.55 -5.38 54.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.22 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -108.66 -19.94 13.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tppt? -91.06 -68.0 0.82 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.031 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.618 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 3.1 t80 -89.12 -22.6 22.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 58.28 88.96 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.417 1.487 . . . . 0.0 111.206 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.673 HD11 HD22 ' A' ' 66' ' ' LEU . 1.9 mm? -95.65 -20.31 19.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.08 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 C--N 1.315 -0.917 0 C-N-CA 126.901 2.08 . . . . 0.0 114.666 179.263 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' C ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 . . . . . 0 N--CA 1.439 -0.995 0 CA-C-O 121.007 0.432 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.71 132.59 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.432 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -99.98 -30.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.171 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.5 m80 -165.41 161.92 19.14 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.27 116.61 33.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.681 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.03 154.54 17.64 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.813 0.816 . . . . 0.0 111.072 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.98 129.5 55.11 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.53 109.75 2.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 40.3 t -87.74 -5.96 58.42 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.619 0.723 . . . . 0.0 109.071 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.4 m -148.99 163.3 37.9 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.635 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.1 t70 -108.68 100.64 9.86 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.664 1.186 . . . . 0.0 110.734 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 46' ' ' PHE . 11.4 p -115.62 148.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.292 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.04 30.16 7.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.38 0.61 . . . . 0.0 112.461 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.92 59.85 1.55 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.236 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.81 140.97 15.07 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.53 31.0 20.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.841 0.456 . . . . 0.0 109.828 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.51 95.61 0.04 OUTLIER 'General case' 0 C--O 1.247 0.932 0 C-N-CA 125.001 1.32 . . . . 0.0 109.767 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.5 tt0 -150.13 -173.73 4.52 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.755 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.672 HD13 ' H ' ' A' ' 75' ' ' GLY . 45.6 tp -95.45 147.83 23.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 p -100.3 115.46 29.99 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.388 0.613 . . . . 0.0 110.096 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 37' ' ' VAL . 32.7 p90 -151.78 168.7 24.25 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.808 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.594 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -124.44 147.63 48.18 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -176.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 20.2 tt0 -51.45 121.84 6.99 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.804 0.335 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.77 29.94 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.295 -0.479 . . . . 0.0 114.147 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 27.6 mm-40 -85.61 -32.39 22.08 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.96 0.88 . . . . 0.0 113.047 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 73.95 111.83 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.524 1.154 . . . . 0.0 111.272 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.52 HD13 HD23 ' A' ' 44' ' ' LEU . 4.8 mt -118.49 173.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.782 -173.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.472 ' H ' HG22 ' A' ' 52' ' ' ILE . 24.6 mt-10 -128.94 134.05 48.07 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.7 tp -91.35 128.95 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.415 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -107.09 -53.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.749 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.618 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 20.2 ttm180 -127.62 137.78 52.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.495 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.74 -32.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 123.975 0.91 . . . . 0.0 112.07 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 p -102.81 164.1 11.83 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t70 71.45 19.57 5.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.876 1.322 . . . . 0.0 108.828 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.519 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 30.8 p-10 -80.51 118.1 70.84 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.869 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 12.1 Cg_exo -71.25 -33.29 11.56 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.737 2.958 . . . . 0.0 114.654 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 64' ' ' LYS . 1.5 mp0 -92.43 -17.07 25.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.135 0.493 . . . . 0.0 110.772 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.72 5.93 70.81 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.7 ptmt -102.88 162.59 12.81 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.52 ' HB2' HG13 ' A' ' 77' ' ' ILE . 44.1 m0 -95.69 176.6 6.09 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 123.393 0.677 . . . . 0.0 110.676 -176.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 21' ' ' LEU . 51.8 tp -117.04 113.58 22.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.37 147.93 18.9 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' THR . 43.9 ttp180 -120.9 154.33 36.02 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.038 0.447 . . . . 0.0 111.117 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.586 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m -99.4 153.13 19.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.24 -34.5 32.62 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 119.242 0.928 . . . . 0.0 113.272 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -71.65 -15.37 62.23 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.503 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.33 87.67 1.17 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.9 m -153.56 122.77 6.55 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' A' ' 66' ' ' LEU . 77.5 m-85 -113.37 99.21 7.61 Favored 'General case' 1 C--N 1.222 -4.951 0 O-C-N 123.902 0.751 . . . . 0.0 109.828 -171.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.672 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -104.19 101.69 2.01 Favored Glycine 1 N--CA 1.356 -6.633 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.71 103.19 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.884 0 CA-C-N 113.423 -1.389 . . . . 0.0 107.358 170.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.7 pt -87.71 143.89 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.97 0 C-N-CA 124.837 1.255 . . . . 0.0 113.728 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.09 117.6 18.81 Favored 'General case' 1 N--CA 1.371 -4.397 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 166.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.472 HG22 ' CG ' ' A' ' 65' ' ' TRP . 54.5 p -36.21 -39.48 0.18 Allowed 'General case' 0 C--N 1.244 -3.999 0 C-N-CA 128.868 2.867 . . . . 0.0 113.12 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -69.38 -12.61 61.8 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.255 1.022 . . . . 0.0 112.704 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.83 -12.75 41.06 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.591 -0.693 . . . . 0.0 110.997 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 52' ' ' ILE . 27.7 m -130.92 164.65 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-O 121.251 0.548 . . . . 0.0 111.088 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 45.6 mt-10 -132.26 113.29 13.06 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -76.27 166.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.566 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 C--N 1.304 -1.41 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.004 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 C--O 1.222 -0.366 0 CA-C-O 120.902 0.382 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.737 HG21 ' HB2' ' A' ' 74' ' ' TYR . 10.1 pt -68.8 -28.6 40.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.418 0.628 . . . . 0.0 110.903 -174.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.481 ' N ' HG13 ' A' ' 15' ' ' ILE . 25.7 mtpp -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.072 0.939 . . . . 0.0 108.493 -176.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HB3' ' NZ ' ' A' ' 17' ' ' LYS . 7.4 mtpm? -114.72 9.07 16.33 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.921 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 76' ' ' TYR . 11.9 tppt? -120.41 -60.88 1.64 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.209 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.7 t80 -91.53 -28.33 17.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 3.1 ttpm? 65.45 90.0 0.09 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.521 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 66' ' ' LEU . 1.7 mm? -98.73 -15.8 19.2 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.359 -174.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.307 80.4 p . . . . . 0 C--N 1.311 -1.075 0 C-N-CA 125.709 1.604 . . . . 0.0 113.079 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.7 p -80.04 134.78 26.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.508 0.671 . . . . 0.0 110.498 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.27 -38.86 11.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.987 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.6 m80 -161.65 165.01 28.87 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.57 124.76 49.4 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -99.34 158.89 15.4 Favored 'General case' 0 C--N 1.267 -2.99 0 CA-C-O 121.805 0.812 . . . . 0.0 111.831 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -106.83 125.58 51.19 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 109.88 2.15 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.448 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 41.9 t -84.69 -19.24 33.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.0 t -144.55 144.75 31.47 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.94 105.83 14.26 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.913 0.863 . . . . 0.0 111.234 174.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.31 151.35 18.12 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.425 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 66.78 1.11 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 121.896 0.855 . . . . 0.0 109.655 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 73.16 59.18 4.35 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.213 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.51 105.75 2.95 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 57.11 69.52 0.74 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.17 0.988 . . . . 0.0 110.95 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 54.49 83.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.781 0.832 . . . . 0.0 109.843 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 7.7 tt0 -149.59 -175.3 4.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.625 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.44 159.57 14.86 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.555 ' H ' HD23 ' A' ' 44' ' ' LEU . 14.8 m -101.42 118.68 37.46 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-O 121.566 0.698 . . . . 0.0 110.031 174.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.8 p90 -154.96 163.74 39.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.057 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.575 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 48.1 mtmt -117.72 156.17 28.71 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.86 116.07 1.8 Allowed 'General case' 0 CA--C 1.568 1.656 0 O-C-N 123.833 0.708 . . . . 0.0 109.325 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.99 17.58 40.24 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.575 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -80.34 -21.83 42.06 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 72.11 109.23 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.319 1.057 . . . . 0.0 110.871 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.6 mt -116.1 165.44 11.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' HG21 ' A' ' 27' ' ' VAL . 8.0 mt-10 -116.66 136.78 52.69 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 65' ' ' TRP . 7.4 tp -98.58 119.69 46.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.38 -53.24 7.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.9 tpm_? -122.43 123.96 42.53 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.901 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -113.66 -23.75 4.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.498 0.666 . . . . 0.0 110.599 174.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 p -90.85 150.33 21.59 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.718 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 60.11 55.27 3.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.234 1.014 . . . . 0.0 108.513 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -95.82 109.22 45.18 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.71 -59.95 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 124.008 3.139 . . . . 0.0 114.307 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.22 -17.52 56.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.687 0.28 . . . . 0.0 111.497 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.11 5.69 49.53 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -105.43 159.4 15.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.106 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.542 ' CD1' HG22 ' A' ' 57' ' ' ILE . 38.3 m0 -90.41 174.35 7.61 Favored 'General case' 0 C--O 1.198 -1.612 0 C-N-CA 123.459 0.703 . . . . 0.0 110.578 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 74' ' ' TYR . 58.0 tp -112.74 109.36 18.81 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.987 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 53' ' ' GLU . . . -114.08 155.13 16.52 Favored Glycine 0 N--CA 1.426 -1.986 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.8 ttp180 -133.95 147.1 51.01 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 73' ' ' SER . 13.4 t -104.17 163.87 12.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.58 -28.98 15.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -76.36 -21.02 56.61 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.491 0.663 . . . . 0.0 110.637 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.03 1.07 Allowed Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 59.6 m -152.54 125.5 8.5 Favored 'General case' 0 N--CA 1.386 -3.67 1 N-CA-C 100.03 -4.063 . . . . 0.0 100.03 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.83 ' HB3' HD11 ' A' ' 66' ' ' LEU . 35.1 m-85 -110.6 82.7 1.63 Allowed 'General case' 1 C--N 1.21 -5.482 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.625 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -98.44 97.48 1.9 Allowed Glycine 2 N--CA 1.363 -6.22 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.519 ' CE1' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.84 93.68 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.883 -1.659 . . . . 0.0 110.727 172.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -70.92 139.91 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 126.9 2.08 . . . . 0.0 113.617 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 118.03 18.2 Favored 'General case' 1 N--CA 1.353 -5.31 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 166.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CD2' ' A' ' 65' ' ' TRP . 73.7 p -35.1 -39.1 0.1 Allowed 'General case' 1 C--N 1.229 -4.67 0 C-N-CA 129.116 2.966 . . . . 0.0 112.807 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -72.02 -5.86 38.13 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.752 0.821 . . . . 0.0 112.26 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.0 -2.62 34.06 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.625 -0.672 . . . . 0.0 111.122 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 77' ' ' ILE . 19.3 m -134.38 159.86 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-O 121.784 0.802 . . . . 0.0 112.722 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.1 mt-10 -125.94 102.89 7.47 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.4 pp -69.14 149.21 11.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 CA--C 1.487 -1.454 0 CA-C-O 121.143 0.497 . . . . 0.0 111.162 176.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.241 0.643 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.629 HG21 ' HB2' ' A' ' 74' ' ' TYR . 10.0 pt -81.31 -23.22 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.585 1.183 . . . . 0.0 109.17 -171.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HG3' HG13 ' A' ' 15' ' ' ILE . 74.0 mttt -82.19 -9.07 59.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.32 -1.763 . . . . 0.0 110.791 -173.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 0.07 19.45 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.008 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 3.8 tppt? -114.18 -58.5 2.14 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.382 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 60' ' ' ASN . 20.1 t80 -85.94 -33.46 21.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 66.82 94.23 0.07 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.531 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.85 HD11 HD22 ' A' ' 66' ' ' LEU . 2.0 mm? -99.76 -64.85 1.0 Allowed 'General case' 0 CA--C 1.46 -2.518 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.052 -173.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.395 -3.225 0 CA-C-N 111.678 -2.51 . . . . 0.0 111.115 178.817 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -74.76 132.0 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 109.891 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.48 -33.26 5.16 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.952 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.7 m80 -166.72 165.64 16.32 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.507 HD23 HE21 ' A' ' 51' ' ' GLN . 5.2 mp -107.63 116.01 31.18 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.24 159.34 15.32 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.944 0.878 . . . . 0.0 112.243 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.39 127.94 54.02 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.377 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -64.43 107.02 1.24 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 t -75.37 -19.12 59.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.438 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.0 p -153.15 159.58 42.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 48' ' ' GLN . 4.5 p30 -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.621 0.724 . . . . 0.0 109.543 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.686 HG22 ' H ' ' A' ' 39' ' ' GLY . 11.4 p -115.72 152.54 17.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.631 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.78 8.75 39.34 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.967 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 37' ' ' VAL . . . 84.01 60.21 1.98 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.52 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.43 80.08 1.68 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.263 -174.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 66.72 82.9 0.17 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.328 1.051 . . . . 0.0 113.309 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 89.28 26.12 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 125.516 1.526 . . . . 0.0 113.114 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.82 174.81 6.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.403 0.621 . . . . 0.0 111.668 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 46.4 tp -96.42 147.91 23.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.531 1.533 . . . . 0.0 107.315 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -96.89 121.81 39.16 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 120.907 0.385 . . . . 0.0 110.313 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CG ' HD11 ' A' ' 52' ' ' ILE . 26.9 p90 -155.66 160.04 40.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.616 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -108.91 152.42 24.95 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -62.48 117.14 5.79 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.907 0.754 . . . . 0.0 109.355 -176.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.78 30.03 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.567 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.94 -25.12 16.67 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.507 HE21 HD23 ' A' ' 30' ' ' LEU . 42.7 tt0 72.83 134.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 O-C-N 124.8 1.313 . . . . 0.0 113.041 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 82' ' ' VAL . 5.3 mt -129.64 169.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.339 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -119.07 135.5 54.61 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.1 tp -93.16 127.04 45.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -110.92 -56.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HD2' HD12 ' A' ' 21' ' ' LEU . 12.6 ttt180 -119.09 131.9 55.97 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.921 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.507 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -116.83 -32.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.063 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 p -107.36 161.11 15.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 t70 64.79 69.16 0.5 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 125.522 1.529 . . . . 0.0 112.814 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 9.2 p30 -145.09 163.3 33.41 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.538 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -95.72 10.91 1.48 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.218 1.946 . . . . 0.0 115.416 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 8.4 tp10 -122.98 -29.91 3.86 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.985 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.05 57.61 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.6 ptmt -92.5 163.12 13.94 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 109.266 -177.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.542 ' CD2' HG22 ' A' ' 79' ' ' THR . 43.2 m0 -101.89 169.53 8.72 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.893 0.377 . . . . 0.0 110.592 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.85 HD22 HD11 ' A' ' 21' ' ' LEU . 45.7 tp -109.58 110.51 21.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -112.74 142.83 17.5 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 73' ' ' SER . 50.2 ttt-85 -124.32 155.02 39.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 124.319 0.658 . . . . 0.0 110.188 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.551 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 5.2 m -113.52 162.05 16.64 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.96 -28.97 7.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -172.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -69.99 -28.52 65.59 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.034 0.534 . . . . 0.0 111.577 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 96.07 69.0 1.01 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.665 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.4 m -136.62 117.09 13.75 Favored 'General case' 0 N--CA 1.383 -3.806 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.629 ' HB2' HG21 ' A' ' 15' ' ' ILE . 90.2 m-85 -116.68 105.1 12.05 Favored 'General case' 1 C--N 1.223 -4.925 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -172.027 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.84 0.75 48.42 Favored Glycine 0 C--O 1.181 -3.19 0 C-N-CA 118.372 -1.87 . . . . 0.0 116.255 -175.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.584 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.268 0.1 OUTLIER 51.2 80.44 0.08 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 123.103 1.43 . . . . 0.0 111.417 -176.976 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 82' ' ' VAL . 2.0 pt -68.57 142.17 16.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.66 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.51 115.51 20.07 Favored 'General case' 1 N--CA 1.362 -4.831 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 165.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 64' ' ' LYS . 73.1 p -34.95 -38.3 0.08 Allowed 'General case' 1 C--N 1.244 -4.008 0 C-N-CA 128.918 2.887 . . . . 0.0 114.422 -177.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -68.98 -7.1 32.11 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.951 0.9 . . . . 0.0 111.709 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.26 -6.86 43.59 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 121.466 -0.771 . . . . 0.0 110.657 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 HD12 ' A' ' 77' ' ' ILE . 26.3 m -137.52 167.88 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-O 121.618 0.723 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.8 pt -77.81 163.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.545 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.793 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 CA--C 1.494 -1.201 0 CA-C-O 120.722 0.296 . . . . 0.0 111.701 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.785 HG21 ' HB2' ' A' ' 74' ' ' TYR . 7.1 pt -62.89 -33.4 60.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.068 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' N ' HG13 ' A' ' 15' ' ' ILE . 9.4 mptt -80.02 -4.34 52.22 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.174 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 42.7 tptt -112.99 -13.79 13.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -98.51 -61.76 1.33 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.074 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -87.62 -26.56 23.0 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 mttp 66.07 83.8 0.16 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.804 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 66' ' ' LEU . 1.2 mm? -100.19 -69.76 0.76 Allowed 'General case' 0 CA--C 1.466 -2.273 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.457 ' H ' ' HB2' ' A' ' 21' ' ' LEU . 3.0 m . . . . . 0 N--CA 1.388 -3.53 0 CA-C-N 111.881 -2.418 . . . . 0.0 112.272 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.1 p -94.05 145.3 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -100.9 -38.9 6.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.5 m80 -160.64 168.57 24.65 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.19 118.38 36.86 Favored 'General case' 0 C--O 1.191 -1.998 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.0 155.75 16.96 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-O 122.14 0.971 . . . . 0.0 110.659 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -103.65 129.88 51.03 Favored 'General case' 1 C--N 1.243 -4.05 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -67.67 110.76 3.87 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 20.7 t -80.46 -18.29 49.15 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.629 0.728 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.6 m -144.33 155.09 43.65 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -93.97 105.01 17.04 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -114.74 163.46 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.445 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 10.17 28.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 100.26 61.08 0.82 Allowed Glycine 0 CA--C 1.491 -1.459 0 C-N-CA 118.262 -1.923 . . . . 0.0 109.459 -173.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.05 99.66 1.42 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -172.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? 61.91 76.88 0.35 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.387 1.475 . . . . 0.0 110.741 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 t30 57.7 70.49 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.002 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 39.8 tt0 -145.67 -175.07 4.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.876 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.539 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.52 153.73 17.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -102.27 128.06 48.98 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 120.962 0.411 . . . . 0.0 109.96 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -158.82 171.33 20.26 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.051 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 98.7 mttt -120.44 142.8 48.9 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.2 pt20 -54.99 124.48 16.9 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.53 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.61 10.34 55.6 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.717 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 6.9 tp10 -69.66 -37.87 76.87 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.883 0.849 . . . . 0.0 110.103 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 5.7 tp60 70.51 102.14 0.06 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 126.205 1.802 . . . . 0.0 108.851 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.508 HD12 ' CG1' ' A' ' 82' ' ' VAL . 13.1 mt -104.23 156.02 5.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.83 ' HB3' HG21 ' A' ' 27' ' ' VAL . 34.3 mt-10 -116.06 126.55 53.92 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -85.4 118.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -104.15 -38.35 4.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.723 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -132.73 130.51 40.1 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.811 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.616 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -125.81 -32.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.683 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -85.06 143.66 28.75 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.08 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 t70 66.99 53.41 0.82 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.818 1.295 . . . . 0.0 109.752 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -94.51 114.89 64.52 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.452 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.46 -53.67 0.28 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.917 1.745 . . . . 0.0 111.137 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 1.012 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 7.0 tp10 -66.56 -40.56 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.43 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.31 -18.11 18.48 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 1.012 ' HD2' ' HG2' ' A' ' 62' ' ' GLU . 14.0 ptmt -76.11 163.32 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.529 1.132 . . . . 0.0 109.299 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.616 ' CD1' HG22 ' A' ' 57' ' ' ILE . 27.6 m0 -95.31 164.84 12.66 Favored 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 122.862 0.465 . . . . 0.0 112.157 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -111.79 113.76 26.31 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -126.56 160.3 20.89 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.676 ' HA ' ' O ' ' A' ' 73' ' ' SER . 54.5 ttp180 -131.47 152.72 50.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 24.7 m -112.76 164.59 13.19 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.04 -18.31 9.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmm_? -82.93 -24.98 32.81 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 83.9 1.66 Allowed Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.6 m -151.69 117.58 5.49 Favored 'General case' 0 N--CA 1.383 -3.824 0 N-CA-C 101.041 -3.689 . . . . 0.0 101.041 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.785 ' HB2' HG21 ' A' ' 15' ' ' ILE . 22.2 m-85 -109.97 83.23 1.72 Allowed 'General case' 1 C--N 1.219 -5.085 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -99.84 97.35 1.76 Allowed Glycine 2 N--CA 1.369 -5.808 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.597 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -40.82 100.75 0.02 OUTLIER 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 112.555 -1.822 . . . . 0.0 109.163 171.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.725 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -81.42 147.99 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.512 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.371 -177.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 9.6 ptpp? -76.35 118.45 19.06 Favored 'General case' 1 N--CA 1.358 -5.06 0 N-CA-C 102.915 -2.995 . . . . 0.0 102.915 163.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.6 p -36.46 -39.36 0.19 Allowed 'General case' 1 C--N 1.241 -4.151 0 C-N-CA 128.193 2.597 . . . . 0.0 113.026 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.1 -10.0 55.46 Favored 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 123.882 0.873 . . . . 0.0 112.25 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.77 -9.84 36.19 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.426 -0.796 . . . . 0.0 111.028 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 52' ' ' ILE . 13.3 m -126.58 167.23 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.129 0.49 . . . . 0.0 111.482 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.98 113.02 9.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.9 pt -75.46 159.39 5.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.116 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.825 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 13.1 pt-20 . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 120.58 0.229 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.52 -24.07 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 C-N-CA 124.785 1.234 . . . . 0.0 113.119 -169.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HA ' HD23 ' A' ' 21' ' ' LEU . 12.4 mptt -54.48 -58.82 5.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 124.125 0.891 . . . . 0.0 113.139 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -83.78 8.89 13.3 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 121.058 0.456 . . . . 0.0 111.783 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 30.5 mmmt -92.16 -61.34 1.64 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.596 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.4 t80 -86.58 -21.63 26.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 tttm 71.55 83.46 0.14 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.077 0.941 . . . . 0.0 110.134 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.734 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.6 -65.0 0.99 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.393 -177.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 5.1 t . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.136 1.775 . . . . 0.0 114.047 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.04 131.8 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 109.744 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -96.57 -33.51 4.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.95 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.476 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.8 m80 -165.13 174.03 10.78 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.87 116.55 30.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.288 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.717 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -97.09 156.02 16.56 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-O 121.703 0.763 . . . . 0.0 111.688 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -107.12 123.95 48.98 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.36 106.16 1.31 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.9 t -87.25 -8.41 56.83 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.344 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -144.6 130.71 19.49 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . 7.2 p-10 -77.13 99.49 5.41 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.45 1.119 . . . . 0.0 108.339 172.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.78 163.25 11.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.566 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.51 25.37 7.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.787 0.327 . . . . 0.0 111.063 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.96 60.13 0.84 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.827 -1.178 . . . . 0.0 111.113 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 91.67 0.66 Allowed Glycine 0 C--N 1.316 -0.545 0 O-C-N 123.808 0.357 . . . . 0.0 112.948 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt 61.92 72.11 0.52 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.996 1.319 . . . . 0.0 109.797 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 58.48 80.15 0.19 Allowed 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.227 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 10.3 tt0 -145.1 -175.92 4.89 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.311 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 45' ' ' SER . 2.3 tt -96.44 149.59 21.55 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.443 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.2 m -98.21 115.3 28.05 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.342 0.591 . . . . 0.0 110.052 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.537 ' HD1' ' HB1' ' A' ' 33' ' ' ALA . 22.3 p90 -144.52 161.63 38.61 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.295 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.558 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mmpt? -114.92 154.74 28.16 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 26.7 mt-30 -53.49 126.16 20.54 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.075 0.859 . . . . 0.0 110.873 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.39 20.77 74.27 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.753 -0.658 . . . . 0.0 114.451 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 30.4 mm-40 -74.83 -30.37 61.36 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.725 0.762 . . . . 0.0 112.844 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER 75.61 116.99 0.06 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.906 1.379 . . . . 0.0 109.032 -176.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.536 HD12 ' CG1' ' A' ' 82' ' ' VAL . 12.8 mt -118.26 154.52 20.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.83 139.13 47.56 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.809 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.0 tp -94.77 126.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -47.55 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.959 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.64 HH21 ' HB3' ' A' ' 59' ' ' ASP . 22.9 ttt180 -130.47 133.58 46.41 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -125.0 -33.95 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.781 -178.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -100.01 150.12 22.77 Favored 'General case' 0 C--O 1.25 1.106 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.896 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.64 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.7 t70 62.32 69.27 0.62 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.566 1.166 . . . . 0.0 108.264 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.53 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 7.2 p30 -112.75 139.37 22.73 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.379 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 11.9 Cg_exo -73.61 -58.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.893 2.395 . . . . 0.0 114.345 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.93 -42.74 38.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.647 0.737 . . . . 0.0 111.07 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.53 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 121.13 17.86 3.97 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.671 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 16.2 ptmt -117.24 162.56 17.68 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.598 ' CD2' HG22 ' A' ' 79' ' ' THR . 35.8 m0 -97.21 171.37 8.49 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.103 0.561 . . . . 0.0 111.63 -173.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.734 HD22 HD11 ' A' ' 21' ' ' LEU . 50.4 tp -112.11 105.88 14.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.44 161.02 12.83 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' A' ' 73' ' ' SER . 53.8 ttp180 -138.81 153.64 48.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.204 0.525 . . . . 0.0 110.491 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 11.5 m -100.02 154.68 18.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.7 -33.25 60.7 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.91 0.777 . . . . 0.0 112.803 -173.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -2.77 41.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.19 96.76 0.79 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.431 0.462 . . . . 0.0 112.752 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 24.5 m -154.78 120.69 5.19 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.58 ' CZ ' ' HD3' ' A' ' 68' ' ' ARG . 70.2 m-85 -117.43 94.32 4.5 Favored 'General case' 1 C--N 1.221 -5.019 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -177.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -109.52 11.92 33.07 Favored Glycine 1 CA--C 1.437 -4.836 0 C-N-CA 117.283 -2.389 . . . . 0.0 115.679 -173.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.671 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.275 0.1 OUTLIER 47.28 89.73 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.341 0 CA-C-O 122.764 1.269 . . . . 0.0 111.754 -178.413 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.696 HD12 HG21 ' A' ' 82' ' ' VAL . 2.3 pt -70.5 140.39 18.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.573 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 64' ' ' LYS . 7.5 ptpp? -80.1 118.55 21.91 Favored 'General case' 1 N--CA 1.372 -4.343 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.598 HG22 ' CD2' ' A' ' 65' ' ' TRP . 70.7 p -34.96 -33.05 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.939 0 C-N-CA 128.905 2.882 . . . . 0.0 114.435 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -77.02 -11.81 59.85 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 123.293 0.637 . . . . 0.0 112.229 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.24 -3.76 53.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.213 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.696 HG21 HD12 ' A' ' 77' ' ' ILE . 16.4 m -133.23 170.21 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 121.538 0.685 . . . . 0.0 110.93 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.45 107.56 7.18 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.717 HG22 ' HB2' ' A' ' 31' ' ' ALA . 18.5 pt -80.81 165.62 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.508 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 C--N 1.287 -2.126 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.933 175.604 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.8 mt-10 . . . . . 0 CA--C 1.491 -1.311 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.607 ' HA ' ' HE1' ' A' ' 76' ' ' TYR . 1.9 pp -65.85 -29.66 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.386 0.612 . . . . 0.0 110.413 -173.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 55.4 mtpt -71.49 -34.86 70.52 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.062 -1.427 . . . . 0.0 112.011 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -102.45 -12.82 17.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.959 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 7.4 tppt? -82.32 -54.26 5.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.593 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 9.9 t80 -86.36 -28.09 23.85 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 25.7 ttpt 71.33 89.99 0.1 Allowed 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.565 1.146 . . . . 0.0 110.328 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.726 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.66 -56.47 2.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.316 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 C--N 1.312 -1.052 0 C-N-CA 124.701 1.2 . . . . 0.0 112.439 179.071 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 . . . . . 0 CA--C 1.512 -0.483 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.626 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.4 p -83.81 123.5 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.266 1.032 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.8 mm -85.71 -34.51 8.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -167.19 166.2 15.03 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp -105.01 116.21 31.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -90.18 154.06 20.04 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 122.087 0.946 . . . . 0.0 110.914 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -106.95 119.29 38.97 Favored 'General case' 0 C--N 1.254 -3.546 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.06 103.7 1.01 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -87.65 -10.98 49.79 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.3 m -136.12 130.55 33.49 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.765 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -76.7 102.89 6.39 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.69 0.757 . . . . 0.0 110.402 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.34 155.68 15.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.623 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 55.85 1.65 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.513 0.673 . . . . 0.0 111.413 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 60.5 1.73 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.694 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.42 78.42 1.62 Allowed Glycine 0 C--N 1.309 -0.964 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttm 67.32 81.21 0.2 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.857 1.263 . . . . 0.0 110.362 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 56.15 74.51 0.39 Allowed 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.604 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 7.4 tt0 -144.3 -175.52 4.66 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.142 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -98.42 157.86 15.94 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -102.86 115.93 31.56 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.548 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 25.2 p90 -148.06 153.97 39.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.172 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 68.0 mttm -105.75 151.3 24.62 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.298 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.533 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -55.6 113.66 1.54 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.71 21.14 22.33 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.106 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.4 tp10 -73.05 -44.27 60.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.224 0.61 . . . . 0.0 111.638 -176.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 74.71 107.3 0.07 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.96 1.412 . . . . 0.0 109.218 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.594 HD12 ' CG1' ' A' ' 82' ' ' VAL . 7.6 mt -116.61 164.07 13.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 107.721 -172.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.626 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 21.9 mt-10 -116.68 133.38 56.08 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.7 tp -92.21 124.58 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.609 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.22 -37.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.536 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 31.7 ttm180 -136.77 133.56 36.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.619 175.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -127.27 -19.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 124.789 1.235 . . . . 0.0 111.832 -176.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -99.94 143.93 29.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 59.32 67.37 0.91 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.877 1.36 . . . . 0.0 110.296 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.606 HD21 ' HD1' ' A' ' 65' ' ' TRP . 8.4 m120 -86.68 130.94 47.02 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.331 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.593 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -55.61 -66.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.734 2.289 . . . . 0.0 112.219 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.721 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 42.4 mt-10 -94.43 -3.76 49.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.26 0.553 . . . . 0.0 110.932 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.99 -17.12 35.57 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.721 ' HD2' ' HB2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.31 152.48 34.52 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.693 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.606 ' HD1' HD21 ' A' ' 60' ' ' ASN . 34.6 m0 -87.08 177.06 7.32 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 124.282 1.033 . . . . 0.0 110.344 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.726 HD22 HD11 ' A' ' 21' ' ' LEU . 52.5 tp -113.89 113.78 25.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.48 154.01 16.74 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 73' ' ' SER . 59.4 ttp180 -137.25 152.02 49.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.237 0.542 . . . . 0.0 110.786 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.587 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 21.6 m -100.71 157.15 16.9 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 175.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.43 14.94 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -73.6 -12.18 60.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.449 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 84.14 87.01 0.86 Allowed Glycine 0 N--CA 1.433 -1.546 0 CA-C-O 121.718 0.621 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.2 m -151.12 121.43 7.3 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 100.229 -3.989 . . . . 0.0 100.229 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.609 ' HE2' HG13 ' A' ' 55' ' ' ILE . 52.8 m-85 -115.84 90.21 3.28 Favored 'General case' 1 C--N 1.232 -4.501 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -171.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -106.56 96.84 1.16 Allowed Glycine 3 N--CA 1.375 -5.385 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.607 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -43.23 94.88 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 O-C-N 125.597 1.41 . . . . 0.0 110.869 174.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 82' ' ' VAL . 2.6 pt -70.64 143.24 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.222 0 C-N-CA 127.2 2.2 . . . . 0.0 114.824 -174.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' NZ ' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -78.46 116.63 18.99 Favored 'General case' 1 N--CA 1.351 -5.38 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 166.976 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.5 p -36.13 -29.86 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.955 0 C-N-CA 128.411 2.684 . . . . 0.0 113.83 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 t -84.14 -0.74 53.17 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 123.206 0.603 . . . . 0.0 111.649 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.53 -12.49 21.18 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 120.78 -1.2 . . . . 0.0 110.286 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.634 HG21 HD12 ' A' ' 77' ' ' ILE . 35.3 m -135.16 166.82 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.471 0.653 . . . . 0.0 110.757 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -140.24 123.03 16.43 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 171.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 pt -70.64 161.26 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.225 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--N 1.29 -2.014 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.591 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 31.0 mm-40 . . . . . 0 C--O 1.222 -0.364 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -92.73 -28.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 20.8 ptmt -66.57 -41.96 87.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.008 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -94.18 -0.35 55.26 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.899 0.857 . . . . 0.0 109.77 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 76' ' ' TYR . 10.7 tppt? -85.53 -65.22 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 11.4 t80 -78.85 -25.94 44.06 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 32.2 mtmm 68.18 88.23 0.11 Allowed 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.497 1.119 . . . . 0.0 110.32 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.746 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -97.17 -25.65 15.23 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.318 -175.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 74.9 p . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 126.525 1.93 . . . . 0.0 113.896 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 . . . . . 0 CA--C 1.526 0.021 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.3 p -81.77 133.01 30.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.172 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.55 -38.25 10.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.709 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 24.3 m80 -161.3 171.35 18.49 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.35 132.59 54.91 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -104.76 161.64 13.99 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.984 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -106.88 129.26 54.74 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.37 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -74.05 102.41 4.18 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.404 ' SG ' ' HG3' ' A' ' 83' ' ' GLU . 69.2 m -86.29 -5.06 59.26 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.82 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -133.99 140.37 46.68 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.23 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 48' ' ' GLN . 15.1 p-10 -91.07 99.09 12.18 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.327 1.061 . . . . 0.0 108.994 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.85 150.05 16.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -119.5 33.94 5.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.733 0.778 . . . . 0.0 110.202 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 95.83 58.86 1.09 Allowed Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.823 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.13 117.27 4.76 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 65.46 37.12 6.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.353 1.061 . . . . 0.0 110.858 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 t30 63.71 89.21 0.09 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.313 1.054 . . . . 0.0 109.794 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.572 ' HG3' ' H ' ' A' ' 44' ' ' LEU . 2.1 tp10 -136.95 -172.98 3.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.045 -168.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.669 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.7 tt -95.08 148.15 22.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.426 ' H ' HD23 ' A' ' 44' ' ' LEU . 16.1 m -96.71 115.76 27.98 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.827 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 22.6 p90 -147.01 158.99 44.1 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.268 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 9.3 mtmp? -108.39 156.7 19.13 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.433 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -59.44 118.77 6.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.85 25.78 28.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 11.5 tp10 -74.56 -36.85 63.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 122.844 0.458 . . . . 0.0 110.66 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 72.41 109.17 0.07 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 125.448 1.499 . . . . 0.0 108.849 -172.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.576 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.7 mt -115.29 162.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.618 ' HB3' HG21 ' A' ' 27' ' ' VAL . 11.9 mt-10 -116.76 140.59 49.25 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.527 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.9 tp -101.77 125.01 55.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -111.02 -46.25 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.672 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.807 HH21 ' HB3' ' A' ' 59' ' ' ASP . 47.6 ttt180 -130.61 138.51 50.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.95 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.502 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.6 -37.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 123.805 0.842 . . . . 0.0 111.16 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 p -98.4 156.04 16.94 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.807 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.9 t70 67.3 71.59 0.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.439 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.779 HD21 ' HG2' ' A' ' 64' ' ' LYS . 32.0 t30 -154.16 117.44 2.61 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.218 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 60' ' ' ASN . 18.0 Cg_endo -59.31 -23.0 67.99 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.649 2.9 . . . . 0.0 114.073 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.89 -16.67 61.1 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.128 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.41 27.76 70.88 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.779 ' HG2' HD21 ' A' ' 60' ' ' ASN . 7.1 ptmt -118.79 161.4 20.2 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.56 ' HB2' HG13 ' A' ' 77' ' ' ILE . 42.5 m0 -99.86 176.46 5.43 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 -178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.746 HD22 HD11 ' A' ' 21' ' ' LEU . 62.8 tp -117.13 110.52 18.29 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.59 158.19 14.45 Favored Glycine 0 N--CA 1.419 -2.449 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.89 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.5 ttp180 -139.16 151.68 46.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -106.34 165.6 11.14 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.7 62.91 0.82 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.352 1.073 . . . . 0.0 111.664 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -170.29 -27.4 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.911 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.29 88.52 1.96 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 26.3 m -152.72 117.91 5.2 Favored 'General case' 0 N--CA 1.381 -3.877 0 N-CA-C 100.805 -3.776 . . . . 0.0 100.805 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.604 ' HB3' HD11 ' A' ' 66' ' ' LEU . 64.5 m-85 -110.78 81.87 1.5 Allowed 'General case' 1 C--N 1.216 -5.221 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -173.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.669 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -101.57 99.09 1.87 Allowed Glycine 2 N--CA 1.347 -7.276 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -44.39 101.17 0.02 OUTLIER 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 112.185 -2.007 . . . . 0.0 108.215 169.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.608 HD12 HG21 ' A' ' 82' ' ' VAL . 2.0 pt -82.41 147.27 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.98 0 C-N-CA 126.822 2.049 . . . . 0.0 113.478 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HZ3' ' CD ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -80.93 118.83 22.76 Favored 'General case' 1 N--CA 1.354 -5.268 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 166.38 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.503 HG22 ' CG ' ' A' ' 65' ' ' TRP . 55.0 p -35.96 -39.81 0.18 Allowed 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 128.113 2.565 . . . . 0.0 112.984 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -72.09 -10.52 59.89 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.348 1.059 . . . . 0.0 112.891 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.04 -12.94 39.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.578 0.704 . . . . 0.0 110.159 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 HD12 ' A' ' 77' ' ' ILE . 30.7 m -130.97 173.48 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.785 0.802 . . . . 0.0 111.412 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 44.1 mt-10 -137.95 122.64 18.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 31' ' ' ALA . 12.4 pt -86.48 158.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.935 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.616 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 pp -78.55 -27.04 14.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.4 0.619 . . . . 0.0 109.52 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -55.5 -55.43 31.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.213 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -87.6 4.43 43.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.539 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 9.9 tppt? -94.46 -53.06 4.05 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.798 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t80 -90.25 -24.81 20.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp 70.71 86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.105 1.362 . . . . 0.0 110.616 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 66' ' ' LEU . 1.4 mm? -99.05 -53.21 3.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.37 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--N 1.314 -0.962 0 C-N-CA 125.267 1.427 . . . . 0.0 113.66 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.644 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -71.78 130.14 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.885 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.6 mm -83.47 -40.32 15.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.754 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.0 m80 -160.72 167.79 26.15 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.04 120.48 41.89 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.694 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -98.24 151.35 20.55 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.495 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -107.61 135.38 49.15 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.83 112.78 3.42 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 49.5 t -86.07 -12.47 50.06 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.616 0.722 . . . . 0.0 109.925 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -149.34 155.93 41.27 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.854 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 4.5 p-10 -99.42 112.89 25.01 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.738 0.78 . . . . 0.0 109.088 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.48 163.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.085 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.61 21.43 7.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.895 0.379 . . . . 0.0 111.604 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.37 59.69 1.9 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.72 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.03 138.52 13.96 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm 66.91 33.65 5.79 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.92 0.867 . . . . 0.0 108.903 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 61.49 84.81 0.13 Allowed 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.235 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.528 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 19.4 tt0 -138.04 -175.22 4.02 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 73' ' ' SER . 0.7 OUTLIER -96.64 153.19 18.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.507 ' H ' HD23 ' A' ' 44' ' ' LEU . 8.6 p -105.89 124.87 50.27 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -157.9 166.92 31.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.398 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.854 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 66.9 mmtt -112.63 147.03 37.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 19.2 tt0 -52.24 124.27 12.75 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.295 0.638 . . . . 0.0 110.292 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 13.63 75.14 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.911 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 30.9 tt0 -70.89 -39.83 72.56 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 26.8 tt0 92.52 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.247 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.1 mt -120.27 160.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.375 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.644 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 17.4 mt-10 -116.22 142.59 46.63 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.3 tp -102.42 127.65 55.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.77 -49.2 6.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.798 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 10.8 ttm180 -126.48 140.49 52.42 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.112 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.56 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -128.85 -37.27 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 123.833 0.853 . . . . 0.0 111.016 -177.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 p -117.21 168.85 9.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.0 t70 60.43 65.5 1.06 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.466 1.127 . . . . 0.0 110.137 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -140.84 172.45 6.15 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.632 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -94.45 13.04 1.52 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.011 1.807 . . . . 0.0 114.272 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.725 ' HG3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 tm-20 -135.12 -72.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.56 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -25.76 2.14 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.725 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 13.7 ptmt -61.87 162.76 8.45 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.862 1.265 . . . . 0.0 110.779 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.56 ' CD1' HG22 ' A' ' 57' ' ' ILE . 49.0 m0 -102.31 166.6 10.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.98 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -112.7 108.11 17.02 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -113.28 160.73 12.97 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.735 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.3 ttp180 -135.29 141.2 45.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.646 0.736 . . . . 0.0 111.801 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 p -101.37 167.25 10.29 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.421 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.28 37.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.162 0.985 . . . . 0.0 113.292 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.74 -19.29 55.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.029 0.443 . . . . 0.0 110.188 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.94 86.25 0.87 Allowed Glycine 0 CA--C 1.489 -1.561 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.6 m -151.22 125.16 9.18 Favored 'General case' 0 N--CA 1.381 -3.884 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.643 ' HB3' HD11 ' A' ' 66' ' ' LEU . 50.0 m-85 -108.5 73.84 0.89 Allowed 'General case' 1 C--N 1.213 -5.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -176.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -92.44 97.64 2.3 Favored Glycine 2 N--CA 1.375 -5.429 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -178.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -44.04 96.38 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 125.408 1.299 . . . . 0.0 110.253 172.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.647 HD12 HG21 ' A' ' 82' ' ' VAL . 1.6 pt -77.38 144.82 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.436 -3.414 0 C-N-CA 126.625 1.97 . . . . 0.0 113.232 -175.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -79.95 118.4 21.66 Favored 'General case' 1 N--CA 1.359 -5.008 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 165.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.544 HG23 ' HA ' ' A' ' 64' ' ' LYS . 69.3 p -35.8 -39.09 0.14 Allowed 'General case' 1 C--N 1.241 -4.12 0 C-N-CA 128.369 2.668 . . . . 0.0 112.815 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -69.85 -1.4 9.33 Favored 'General case' 0 CA--C 1.564 1.5 0 C-N-CA 124.085 0.954 . . . . 0.0 112.213 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.23 -8.47 21.26 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.737 -0.602 . . . . 0.0 111.213 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 77' ' ' ILE . 22.3 m -137.05 165.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 CA-C-O 121.312 0.577 . . . . 0.0 112.221 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 50.4 mt-10 -129.47 119.59 24.01 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.694 HG22 ' HB2' ' A' ' 31' ' ' ALA . 8.6 pt -89.55 162.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.173 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 C--N 1.297 -1.691 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.603 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.886 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -85.79 -26.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 122.33 -0.231 . . . . 0.0 111.326 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -54.86 -45.13 74.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 124.234 0.959 . . . . 0.0 112.818 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.28 -9.35 27.77 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.243 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 13.4 tppt? -78.28 -63.84 1.3 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.648 -173.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.668 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.2 t80 -81.09 -24.46 37.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 38.1 ttpt 66.86 87.79 0.12 Allowed 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.384 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.551 HD12 ' HD2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -98.3 -65.54 0.96 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 C--N 1.317 -0.841 0 C-N-CA 125.025 1.33 . . . . 0.0 113.745 175.83 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.87 134.05 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.746 0.784 . . . . 0.0 109.271 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.434 ' HB ' HG23 ' A' ' 54' ' ' ILE . 36.2 mm -97.24 -35.2 5.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.435 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 28.3 m80 -168.38 169.98 10.22 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.53 119.49 39.33 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.06 158.17 15.92 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.025 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -106.99 127.82 53.8 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.654 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.65 106.76 2.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.0 m -83.58 -5.08 59.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.8 t -158.75 143.15 15.72 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -80.21 107.94 13.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.721 175.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.67 163.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.919 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.81 23.32 12.03 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.933 -0.48 . . . . 0.0 110.814 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.31 60.16 1.58 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.035 -1.555 . . . . 0.0 111.291 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.82 120.07 5.11 Favored Glycine 0 C--N 1.306 -1.113 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.086 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.599 ' N ' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER 63.65 45.71 4.47 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.287 0.635 . . . . 0.0 110.48 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.3 t30 63.49 85.95 0.13 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.041 0.936 . . . . 0.0 109.616 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.673 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 5.4 tt0 -145.67 -173.92 4.26 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.082 -174.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.656 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -95.72 155.67 16.65 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.439 ' H ' HD23 ' A' ' 44' ' ' LEU . 7.2 m -101.56 116.03 31.84 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.493 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 26.6 p90 -149.73 159.34 44.42 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 49.3 mttm -112.93 156.45 22.97 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -59.09 127.34 31.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.891 0.377 . . . . 0.0 110.078 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.89 21.14 61.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.088 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.5 mm-40 -88.57 -23.99 22.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 70.78 129.91 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.57 1.169 . . . . 0.0 111.363 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 82' ' ' VAL . 7.8 mt -127.51 162.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -112.28 136.08 52.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 66' ' ' LEU . 9.7 tp -94.35 123.33 46.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.69 -36.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.668 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -135.5 130.13 34.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.713 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -130.85 2.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 124.578 1.151 . . . . 0.0 109.725 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -117.47 154.15 31.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.655 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 64.58 18.89 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.98 1.312 . . . . 0.0 111.337 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 21.4 p-10 -77.55 111.46 17.56 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.284 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 22.1 Cg_exo -66.56 -58.41 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.783 2.989 . . . . 0.0 113.134 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.519 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 23.8 tt0 -66.54 -30.58 70.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.984 0.421 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.62 12.24 25.08 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.325 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 12.9 ptmt -101.9 162.13 13.14 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 57' ' ' ILE . 42.6 m0 -95.82 176.13 6.25 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 123.255 0.622 . . . . 0.0 110.577 -175.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 74' ' ' TYR . 61.2 tp -119.21 113.7 21.28 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.92 157.32 15.12 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.7 ttt-85 -135.56 153.3 51.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.558 0.694 . . . . 0.0 111.61 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 35.2 m -105.61 154.37 20.51 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.23 -33.96 13.85 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -53.97 -43.02 69.57 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.207 1.004 . . . . 0.0 110.663 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.29 83.26 1.7 Allowed Glycine 0 N--CA 1.413 -2.834 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.196 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.654 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 49.6 m -151.53 123.3 8.01 Favored 'General case' 1 N--CA 1.376 -4.138 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.886 ' HB2' HG21 ' A' ' 15' ' ' ILE . 57.9 m-85 -113.87 92.67 4.06 Favored 'General case' 1 C--N 1.216 -5.221 0 O-C-N 125.108 1.505 . . . . 0.0 107.07 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.656 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -102.02 103.14 2.44 Favored Glycine 3 N--CA 1.359 -6.499 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.84 98.09 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 112.946 -1.627 . . . . 0.0 108.213 170.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.673 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.1 pt -85.15 143.46 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.814 0 C-N-CA 126.283 1.833 . . . . 0.0 114.127 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -77.62 118.34 19.92 Favored 'General case' 1 N--CA 1.372 -4.345 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 164.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.494 HG22 ' CG ' ' A' ' 65' ' ' TRP . 48.4 p -35.26 -38.49 0.1 Allowed 'General case' 1 C--N 1.236 -4.333 0 C-N-CA 129.253 3.021 . . . . 0.0 113.588 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.1 -15.49 63.75 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 0.0 112.698 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.99 48.81 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.954 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 52' ' ' ILE . 30.3 m -137.11 172.07 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 CA-C-O 121.779 0.8 . . . . 0.0 111.411 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.79 122.81 17.89 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.651 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 pt -77.55 171.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.001 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.317 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.509 -0.623 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.4 pp -66.04 -31.08 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.4 mptt -69.28 -23.37 63.82 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.667 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.15 -29.91 11.86 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.243 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.52 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 6.9 tppt? -73.12 -61.15 1.92 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.845 0.355 . . . . 0.0 111.13 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -79.1 -34.17 43.76 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 68.7 99.23 0.06 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.947 -178.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.014 HD12 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.79 -57.34 2.2 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.633 0.73 . . . . 0.0 110.15 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 29.2 p . . . . . 0 C--N 1.308 -1.205 0 C-N-CA 125.399 1.48 . . . . 0.0 113.098 -176.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.431 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.7 pt20 . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -59.37 126.34 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 122.056 0.932 . . . . 0.0 111.174 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.2 -31.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.475 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 27.1 m80 -163.22 157.33 20.25 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.51 118.1 34.44 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -96.1 156.12 16.47 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-O 122.014 0.911 . . . . 0.0 111.202 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 35.1 ttpt -106.68 128.27 54.05 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.745 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.96 105.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.72 -18.33 61.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.674 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -160.53 156.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.41 119.25 20.02 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.02 163.72 10.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.666 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -102.06 -4.94 25.15 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.98 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 77.64 60.58 2.76 Favored Glycine 0 C--O 1.241 0.568 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.092 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.409 ' N ' ' HB3' ' A' ' 43' ' ' GLU . . . -104.67 131.33 10.6 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 115.084 -0.558 . . . . 0.0 113.035 -172.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.8 69.97 0.68 Allowed 'General case' 0 C--O 1.249 1.041 0 C-N-CA 125.301 1.44 . . . . 0.0 109.743 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.05 68.62 0.83 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.223 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 31.9 tt0 -136.42 172.98 12.21 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.537 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 73' ' ' SER . 1.7 tt -97.9 141.29 31.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 p -98.78 118.24 35.07 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.864 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.464 ' HE2' HG22 ' A' ' 77' ' ' ILE . 22.5 p90 -142.35 170.11 16.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.708 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 98.3 mttt -119.55 161.44 20.6 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -63.62 129.29 39.56 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.43 46.53 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.345 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 31.6 mm-40 -89.42 -26.14 21.16 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 70.3 120.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.933 1.396 . . . . 0.0 111.307 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.61 HD12 ' CG1' ' A' ' 82' ' ' VAL . 8.9 mt -119.31 158.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.86 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 14.7 mt-10 -116.67 132.68 56.62 Favored 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 57' ' ' ILE . 8.6 tp -93.08 125.7 45.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.431 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -110.13 -47.88 6.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.442 176.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 1.014 ' HG3' HD12 ' A' ' 21' ' ' LEU . 18.2 mmt180 -120.06 107.8 13.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.822 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -104.53 -30.16 2.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 113.252 -1.795 . . . . 0.0 107.192 172.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 57' ' ' ILE . 15.6 p -86.68 142.05 28.49 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.565 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 71.55 31.09 2.32 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.451 1.12 . . . . 0.0 110.957 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 8.8 p30 -72.87 126.24 90.69 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.941 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 2.1 Cg_endo -80.58 -61.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.618 2.212 . . . . 0.0 113.256 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.4 tt0 -79.21 -2.96 43.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.302 0.572 . . . . 0.0 111.268 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 87.51 21.17 49.13 Favored Glycine 0 CA--C 1.497 -1.087 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.513 -176.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.688 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.3 ptmt -118.21 156.88 28.01 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 57' ' ' ILE . 25.6 m0 -98.12 171.9 7.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.145 0.278 . . . . 0.0 110.94 -174.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 21' ' ' LEU . 65.4 tp -111.1 107.33 16.66 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.46 158.57 14.23 Favored Glycine 0 N--CA 1.416 -2.664 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 73' ' ' SER . 45.8 ttp180 -135.17 144.73 47.19 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.694 0.797 . . . . 0.0 109.888 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -101.4 165.14 11.42 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.89 -29.78 65.34 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -74.83 -9.62 58.72 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.03 89.82 0.49 Allowed Glycine 0 N--CA 1.434 -1.454 0 CA-C-O 121.908 0.727 . . . . 0.0 111.754 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.705 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.1 m -153.16 117.46 4.9 Favored 'General case' 0 N--CA 1.389 -3.514 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.596 ' HB2' HG21 ' A' ' 15' ' ' ILE . 64.8 m-85 -110.76 96.67 6.31 Favored 'General case' 1 C--N 1.221 -4.999 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.501 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -110.98 11.85 29.36 Favored Glycine 1 CA--C 1.445 -4.313 0 C-N-CA 117.77 -2.157 . . . . 0.0 115.516 -174.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.688 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 48.13 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.853 1.311 . . . . 0.0 111.651 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.601 HD12 HG21 ' A' ' 82' ' ' VAL . 2.1 pt -67.8 145.92 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.1 0 C-N-CA 126.029 1.731 . . . . 0.0 113.584 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 8.7 ptpp? -81.36 112.99 19.15 Favored 'General case' 1 N--CA 1.379 -4.01 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 165.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.477 HG22 ' CG ' ' A' ' 65' ' ' TRP . 43.2 p -36.3 -36.75 0.1 Allowed 'General case' 0 C--N 1.251 -3.685 0 C-N-CA 128.006 2.522 . . . . 0.0 113.757 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.82 -9.88 56.36 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.802 0.841 . . . . 0.0 112.318 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.51 -6.38 49.84 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.652 -0.655 . . . . 0.0 109.979 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.61 ' CG1' HD12 ' A' ' 52' ' ' ILE . 31.3 m -131.17 162.77 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.94 111.36 11.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 14.3 pt -76.71 171.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.047 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 . . . . . 0 C--N 1.301 -1.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 171.278 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.7 mp0 . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 120.869 0.366 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.697 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.4 pp -90.22 -20.56 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.416 ' HA ' HD23 ' A' ' 21' ' ' LEU . 37.9 mmtm -66.96 -54.8 18.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.808 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -79.99 1.92 25.67 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.847 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 9.3 tppt? -98.79 -53.41 3.3 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.873 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.429 ' HE2' ' HG2' ' A' ' 56' ' ' ARG . 38.2 t80 -91.2 -27.98 18.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.939 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 42.2 tttt 77.59 90.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.686 1.195 . . . . 0.0 109.934 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.851 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -100.96 -41.66 6.72 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.607 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 126.656 1.982 . . . . 0.0 112.543 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.408 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.6 pt20 . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.763 0.316 . . . . 0.0 110.526 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.17 134.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.322 1.058 . . . . 0.0 112.294 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.2 mm -102.19 -36.64 4.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.133 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.4 m80 -168.12 -178.19 3.59 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.75 139.6 45.89 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -112.46 158.32 20.01 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -107.01 130.42 54.65 Favored 'General case' 0 C--N 1.263 -3.154 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.88 112.61 3.35 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 39.9 t -82.35 -19.09 39.97 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 124.185 0.928 . . . . 0.0 109.635 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.13 156.73 46.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.887 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -96.39 107.85 20.29 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 173.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.441 HG12 ' CE1' ' A' ' 46' ' ' PHE . 10.4 p -113.19 145.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.66 12.42 21.2 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.775 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 78.84 46.85 8.16 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.714 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -96.9 151.52 19.86 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp 68.27 31.87 4.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.299 1.047 . . . . 0.0 108.833 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.456 ' ND2' ' HE2' ' A' ' 76' ' ' TYR . 0.2 OUTLIER 68.31 46.3 1.1 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.678 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -103.55 -175.16 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.606 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 tt -95.74 147.47 23.59 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.47 ' H ' HD23 ' A' ' 44' ' ' LEU . 5.7 m -96.05 115.48 27.5 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.777 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.441 ' CE1' HG12 ' A' ' 37' ' ' VAL . 17.9 p90 -150.37 177.62 9.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.196 0.522 . . . . 0.0 111.006 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.887 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.5 mmtt -124.83 149.61 47.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.73 122.43 11.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 124.145 0.903 . . . . 0.0 108.737 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.42 23.88 52.69 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.759 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.5 mm-40 -78.64 -26.67 45.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 74.63 104.43 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.414 1.578 . . . . 0.0 110.33 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 31' ' ' ALA . 7.9 mm -101.96 158.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.196 0 CA-C-N 111.697 -2.501 . . . . 0.0 105.659 -174.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -112.49 134.21 54.15 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 7.0 tp -99.75 121.04 49.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.408 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -106.1 -54.13 6.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.213 -178.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG2' ' HE2' ' A' ' 19' ' ' PHE . 53.9 ttt180 -121.43 138.39 54.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.729 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.37 -43.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.578 -176.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 p -117.8 158.66 24.38 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.112 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.51 68.73 0.16 Allowed 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.928 1.691 . . . . 0.0 111.302 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 8.8 p30 -148.42 144.43 18.59 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.0 Cg_exo -78.93 12.52 2.22 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 122.848 2.365 . . . . 0.0 114.469 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.679 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -109.23 -64.7 1.22 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.6 -6.03 7.52 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -90.04 165.05 14.26 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.636 0.775 . . . . 0.0 110.535 177.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.559 ' CG ' HG22 ' A' ' 79' ' ' THR . 40.2 m0 -97.84 169.89 9.35 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.768 0.827 . . . . 0.0 110.741 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.851 HD22 HD11 ' A' ' 21' ' ' LEU . 54.6 tp -113.99 110.25 19.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.02 155.87 15.99 Favored Glycine 0 N--CA 1.419 -2.497 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.299 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.697 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.1 ttp180 -137.96 156.66 47.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.589 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 6.8 m -111.63 156.07 22.39 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.6 33.13 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.476 1.035 . . . . 0.0 113.05 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -69.8 -3.09 14.05 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.91 86.81 0.16 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 121.728 0.627 . . . . 0.0 112.134 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.697 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.0 m -151.78 117.67 5.48 Favored 'General case' 0 N--CA 1.391 -3.388 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.697 ' HB2' HG21 ' A' ' 15' ' ' ILE . 65.3 m-85 -113.37 90.06 3.25 Favored 'General case' 1 C--N 1.228 -4.701 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.186 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.606 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -104.72 102.19 2.04 Favored Glycine 3 N--CA 1.36 -6.416 0 N-CA-C 106.906 -2.478 . . . . 0.0 106.906 176.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -50.22 98.94 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.867 0 CA-C-N 113.195 -1.503 . . . . 0.0 107.247 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.727 HD12 HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -82.25 140.25 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.431 -3.611 0 C-N-CA 125.542 1.537 . . . . 0.0 114.713 -172.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -74.88 114.3 13.18 Favored 'General case' 1 N--CA 1.365 -4.705 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 167.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.559 HG22 ' CG ' ' A' ' 65' ' ' TRP . 72.9 p -36.28 -34.82 0.07 Allowed 'General case' 1 C--N 1.234 -4.428 0 C-N-CA 128.523 2.729 . . . . 0.0 114.299 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -66.0 -24.32 66.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.2 59.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.097 -0.377 . . . . 0.0 111.57 -174.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.727 HG21 HD12 ' A' ' 77' ' ' ILE . 30.0 m -136.39 165.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.512 0.672 . . . . 0.0 111.321 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.83 118.86 15.35 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.458 -2.052 . . . . 0.0 105.458 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.3 pp -72.46 146.97 10.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.647 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 C--N 1.282 -2.355 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.151 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.3 mm-40 . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.541 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 1.4 pp -71.85 -34.05 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 CA-C-O 120.889 0.376 . . . . 0.0 110.115 -173.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.655 ' HA ' HD23 ' A' ' 21' ' ' LEU . 4.7 mptt -74.91 -30.97 61.43 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -90.5 -19.53 23.72 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.011 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.2 tppt? -77.26 -58.77 3.09 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.074 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.3 t80 -81.18 -22.79 38.65 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.25 90.92 0.09 Allowed 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 125.548 1.539 . . . . 0.0 109.911 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -99.51 -67.48 0.85 Allowed 'General case' 0 CA--C 1.453 -2.765 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.939 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.404 -2.763 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.658 171.903 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 N--CA 1.438 -1.038 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.6 t -79.35 127.32 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -90.35 -37.21 9.22 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.637 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.869 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 37.6 m80 -168.88 170.64 8.98 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -172.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.32 127.32 55.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 172.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -100.46 159.63 14.99 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-O 121.739 0.781 . . . . 0.0 110.928 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.88 131.39 54.02 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.65 106.94 1.28 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.8 t -91.37 -5.8 53.92 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.194 0.997 . . . . 0.0 108.335 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 81' ' ' ALA . 82.8 m -147.2 147.41 30.45 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.775 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 7.2 p-10 -93.14 103.53 15.8 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.486 HG21 ' OE2' ' A' ' 43' ' ' GLU . 8.6 p -114.66 156.71 15.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.103 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.52 34.04 5.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.989 0.423 . . . . 0.0 110.51 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 99.9 60.65 0.84 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.131 -1.509 . . . . 0.0 113.251 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.79 95.66 1.14 Allowed Glycine 0 C--N 1.313 -0.721 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 57.24 78.44 0.23 Allowed 'General case' 0 C--O 1.252 1.215 0 C-N-CA 124.707 1.203 . . . . 0.0 111.041 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.49 71.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.407 1.067 . . . . 0.0 109.768 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.632 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 15.9 tt0 -132.72 -173.78 3.28 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.464 -172.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' N ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.15 151.07 20.17 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.9 m -97.95 124.68 42.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.411 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 25.5 p90 -159.64 160.99 34.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.722 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 57.0 mtmt -117.56 151.37 37.29 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -53.39 123.26 11.48 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.17 0.919 . . . . 0.0 110.657 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.84 17.22 52.62 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.087 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -87.92 -30.69 19.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.954 0.877 . . . . 0.0 113.171 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 2.1 mp0 75.45 128.98 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.535 1.159 . . . . 0.0 112.386 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.589 HD12 ' CG1' ' A' ' 82' ' ' VAL . 10.9 mt -129.08 165.11 29.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -114.66 142.23 46.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.5 tp -100.69 124.24 54.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -110.51 -40.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.662 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 48.2 ttt180 -134.8 136.96 42.94 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.136 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.1 -36.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 124.439 1.096 . . . . 0.0 111.778 -177.243 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -96.64 154.84 17.05 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.93 67.86 0.72 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.907 1.283 . . . . 0.0 107.963 -174.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -134.39 115.4 12.7 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.626 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.91 -28.71 29.16 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.393 2.729 . . . . 0.0 115.394 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.11 -15.49 23.33 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.799 0.809 . . . . 0.0 110.146 -177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.01 0.19 83.5 Favored Glycine 0 C--N 1.308 -0.992 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.152 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.639 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 17.8 ptmt -95.06 161.68 14.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.546 ' CD2' HG22 ' A' ' 79' ' ' THR . 43.2 m0 -97.8 176.03 5.95 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.947 0.899 . . . . 0.0 111.478 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -115.52 108.72 16.82 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -111.43 156.57 15.48 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.563 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 73' ' ' SER . 62.5 ttt-85 -134.62 147.55 50.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.515 0.674 . . . . 0.0 111.593 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 27.0 m -100.75 162.13 13.12 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.0 18.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -89.16 3.15 52.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 76.66 87.86 0.33 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.764 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.8 m -152.48 117.75 5.25 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 79.9 m-85 -115.21 91.35 3.58 Favored 'General case' 1 C--N 1.224 -4.882 0 O-C-N 124.25 0.969 . . . . 0.0 108.459 -173.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.613 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -107.45 102.52 1.82 Allowed Glycine 2 N--CA 1.366 -5.992 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.639 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -42.16 101.14 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 112.959 -1.621 . . . . 0.0 108.52 171.078 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.632 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.2 pt -85.39 145.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.948 0 C-N-CA 126.248 1.819 . . . . 0.0 113.312 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -80.92 122.79 27.68 Favored 'General case' 1 N--CA 1.348 -5.538 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 164.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' CD2' ' A' ' 65' ' ' TRP . 47.7 p -36.47 -30.71 0.02 OUTLIER 'General case' 1 C--N 1.243 -4.039 0 C-N-CA 128.341 2.656 . . . . 0.0 112.653 176.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -63.72 -32.47 73.98 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.892 1.277 . . . . 0.0 110.835 -177.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -86.49 -4.9 59.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.778 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.632 HG21 HD12 ' A' ' 77' ' ' ILE . 28.9 m -133.97 159.35 42.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.46 0.648 . . . . 0.0 111.813 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.4 mt-10 -128.03 117.5 21.79 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 171.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.5 pt -78.38 160.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.388 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--N 1.289 -2.054 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 172.512 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 CA--C 1.518 -0.269 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 74' ' ' TYR . 6.9 pt -67.33 -28.99 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.987 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -78.08 -7.37 56.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.223 0.535 . . . . 0.0 110.535 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -99.39 -30.1 12.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.23 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 4.3 tppt? -84.16 -65.55 1.0 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.065 -174.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.515 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 1.8 t80 -86.59 -28.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.0 ttmt 63.08 86.05 0.12 Allowed 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.613 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.588 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -93.69 -58.61 2.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.236 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 C--N 1.313 -1.013 0 C-N-CA 124.679 1.192 . . . . 0.0 114.165 -179.823 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.611 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.7 p -79.59 139.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.88 -40.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.508 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.519 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.0 m80 -159.89 166.45 30.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.05 116.51 32.1 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.695 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -89.51 157.92 17.9 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 122.281 1.038 . . . . 0.0 112.196 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -107.74 126.18 52.3 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.329 -1.305 . . . . 0.0 107.918 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -67.68 109.79 3.46 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 171.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.3 m -83.86 -5.72 59.27 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.474 0.484 . . . . 0.0 111.852 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 81' ' ' ALA . 19.9 p -155.59 154.72 32.11 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 7.6 p-10 -82.83 110.65 18.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 173.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.52 160.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -112.91 0.55 15.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.569 -169.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 76.77 61.19 2.77 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.706 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.42 122.47 7.22 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.767 -0.716 . . . . 0.0 111.469 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 62.6 71.9 0.51 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.421 1.088 . . . . 0.0 110.592 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.561 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . 96.6 m-20 53.04 73.01 0.38 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.336 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 41.8 tt0 -145.66 171.02 15.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.551 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -98.95 152.74 19.45 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.455 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 m -101.61 127.64 48.25 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -156.78 170.82 21.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 99.2 mttt -119.78 153.87 35.07 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 123.93 15.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.42 13.21 65.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.685 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.6 tp10 -63.59 -37.54 87.73 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.46 0.704 . . . . 0.0 111.682 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 71.56 107.49 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.267 1.427 . . . . 0.0 108.637 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.572 HD12 ' CG1' ' A' ' 82' ' ' VAL . 15.8 mt -113.34 159.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 16.2 mt-10 -111.8 132.36 54.72 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -93.34 122.85 45.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -108.27 -36.57 3.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 32.4 ttm180 -140.79 137.87 33.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.723 175.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.514 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.86 -28.92 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 124.005 0.922 . . . . 0.0 111.816 -176.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.0 p -106.27 162.75 13.39 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.6 t70 58.29 71.2 0.6 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.795 1.283 . . . . 0.0 110.54 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 16.3 p30 -125.67 136.46 28.39 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.255 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 17.7 Cg_exo -69.4 -32.11 20.74 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.063 2.509 . . . . 0.0 113.851 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -101.8 -51.88 3.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.04 -2.47 5.14 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 16.4 ptpt -80.8 162.41 24.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.689 -0.756 . . . . 0.0 109.059 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.51 ' HB2' HG13 ' A' ' 77' ' ' ILE . 41.3 m0 -99.25 176.75 5.43 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.76 0.824 . . . . 0.0 109.789 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -117.47 112.12 20.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.21 157.11 15.22 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.121 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.734 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.6 ttp180 -135.82 156.91 48.06 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.0 110.805 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.9 m -111.95 155.72 23.25 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 68.34 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.286 1.041 . . . . 0.0 111.977 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -167.62 -35.29 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.011 -1.904 . . . . 0.0 107.66 175.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.03 90.18 1.98 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.734 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 2.5 m -151.92 116.76 5.15 Favored 'General case' 0 N--CA 1.386 -3.634 1 N-CA-C 100.097 -4.038 . . . . 0.0 100.097 -178.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 66' ' ' LEU . 48.2 m-85 -116.75 89.41 3.1 Favored 'General case' 1 C--N 1.216 -5.214 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -175.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.02 104.13 2.5 Favored Glycine 3 N--CA 1.352 -6.957 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CD2' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -51.31 97.51 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 O-C-N 125.305 1.238 . . . . 0.0 108.129 172.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.9 pt -76.17 137.49 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.437 -3.397 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.406 -173.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 22.5 pttm -79.16 112.51 16.44 Favored 'General case' 1 N--CA 1.369 -4.495 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 167.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' CD2' ' A' ' 65' ' ' TRP . 64.6 p -35.65 -34.16 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.437 0 C-N-CA 129.327 3.051 . . . . 0.0 114.818 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -62.93 -16.24 58.44 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -84.8 -17.11 39.17 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.698 -0.626 . . . . 0.0 111.723 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.572 ' CG1' HD12 ' A' ' 52' ' ' ILE . 30.4 m -135.96 168.18 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.752 0.786 . . . . 0.0 112.616 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -135.27 126.19 27.59 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.695 HG22 ' HB2' ' A' ' 31' ' ' ALA . 25.9 pt -84.77 164.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.137 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--N 1.291 -1.94 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 174.505 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.241 0.64 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -91.97 106.34 18.39 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 173.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -106.03 27.68 8.36 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 122.023 0.916 . . . . 0.0 108.815 -172.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -94.4 63.62 3.03 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.083 -174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -163.93 135.49 4.7 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -115.2 -33.65 5.27 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 9' ' ' GLU . 7.2 mm-40 -143.69 179.35 7.2 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 125.614 1.565 . . . . 0.0 107.551 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.09 -0.47 41.72 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 170.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' H ' ' HB3' ' A' ' 7' ' ' GLU . 43.0 mt-10 67.82 84.96 0.15 Allowed 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.907 -1.951 . . . . 0.0 113.123 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 10' ' ' LYS . 33.6 ttpt -113.44 26.06 10.74 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -91.77 4.81 51.96 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.385 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.529 ' HB2' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -83.72 46.58 1.18 Allowed 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 124.645 1.178 . . . . 0.0 110.595 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -60.71 -29.73 69.53 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.073 -172.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 38.5 mm-40 -68.58 -29.1 67.57 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.53 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 1.3 pp -77.62 -28.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.849 0.833 . . . . 0.0 108.842 -174.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' HD23 ' A' ' 21' ' ' LEU . 15.4 mtpp -70.0 -41.49 74.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.352 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -85.04 -22.52 28.98 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.153 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 3.5 tppt? -76.36 -48.61 19.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.546 -175.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.528 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 13.8 t80 -94.45 -26.49 16.46 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.889 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? 70.91 90.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.518 1.127 . . . . 0.0 108.882 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.671 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.47 -44.96 5.71 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.28 80.2 p 68.81 -72.38 0.1 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.699 1.599 . . . . 0.0 112.384 -173.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.36 108.8 2.17 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.22 139.77 47.07 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.277 1.985 . . . . 0.0 111.877 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.45 HD12 HD11 ' A' ' 28' ' ' ILE . 42.4 pt -115.83 -171.23 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.311 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -96.01 169.65 9.83 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.648 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -57.18 134.04 21.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 123.714 0.634 . . . . 0.0 111.81 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.45 HD11 HD12 ' A' ' 25' ' ' ILE . 49.1 mm -89.2 -38.22 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.621 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.43 ' O ' HG22 ' A' ' 54' ' ' ILE . 32.8 m80 -162.02 156.66 22.49 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.4 mp -100.57 117.1 34.02 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -92.43 155.83 17.6 Favored 'General case' 0 C--N 1.275 -2.673 0 CA-C-O 121.7 0.762 . . . . 0.0 110.293 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -107.11 131.17 54.42 Favored 'General case' 0 C--N 1.257 -3.453 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.56 115.72 5.46 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.8 t -79.34 -12.05 59.93 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.946 0.779 . . . . 0.0 110.025 -177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -158.35 171.7 19.7 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.702 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 5.5 p-10 -105.67 104.86 14.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.698 0.761 . . . . 0.0 110.653 177.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.02 158.98 15.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 17.4 19.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.827 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 83.22 59.88 2.1 Favored Glycine 0 C--N 1.317 -0.515 0 C-N-CA 120.204 -0.998 . . . . 0.0 114.476 177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.04 145.91 17.55 Favored Glycine 0 C--N 1.303 -1.29 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.1 mttm 63.65 34.22 12.5 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.362 0.665 . . . . 0.0 109.635 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.6 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 14.3 m120 64.77 82.6 0.18 Allowed 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.387 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 15.9 tt0 -140.86 -176.87 4.83 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.575 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 54.7 tp -95.65 145.17 25.47 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.4 m -94.98 119.58 33.74 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 52' ' ' ILE . 28.3 p90 -153.28 157.85 40.74 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.702 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 42.7 mmtm -107.97 146.78 31.97 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.062 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.75 118.59 2.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.912 0.885 . . . . 0.0 110.001 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.75 15.8 76.85 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.919 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 28.9 tt0 -69.01 -33.08 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.402 0.601 . . . . 0.0 111.58 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 80.07 122.05 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.851 1.26 . . . . 0.0 110.214 -174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.468 HD13 HD23 ' A' ' 44' ' ' LEU . 4.7 mt -125.76 162.19 29.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.648 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 35.5 mt-10 -116.49 134.82 54.41 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 119.211 0.914 . . . . 0.0 109.093 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 65' ' ' TRP . 9.0 tp -93.05 127.15 45.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.8 -56.61 4.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.528 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.3 tpm_? -116.18 121.97 43.67 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.524 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.603 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -118.74 -26.86 2.4 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.026 174.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.6 p -85.39 136.34 33.5 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.412 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.9 t0 67.3 33.58 5.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.66 1.184 . . . . 0.0 110.918 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -67.23 128.58 93.78 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.296 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.44 -27.59 1.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.049 1.832 . . . . 0.0 114.147 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.505 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 17.5 mm-40 -109.14 -6.09 15.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.28 -18.7 56.14 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.762 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -86.3 161.39 18.77 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.603 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.1 m0 -98.44 163.45 12.68 Favored 'General case' 0 C--O 1.199 -1.58 0 C-N-CA 123.565 0.746 . . . . 0.0 109.633 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.736 HD11 ' HB3' ' A' ' 74' ' ' TYR . 55.7 tp -104.06 108.84 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.032 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.34 144.86 18.44 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.643 ' HA ' ' O ' ' A' ' 73' ' ' SER . 22.1 ttp180 -115.74 149.32 38.65 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.248 0.547 . . . . 0.0 110.419 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.529 ' OG1' HD11 ' A' ' 44' ' ' LEU . 89.7 m -98.17 156.52 16.64 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.84 -33.73 17.75 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -79.67 -1.81 39.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 77.14 86.14 0.42 Allowed Glycine 0 C--O 1.221 -0.695 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.8 m -152.7 127.19 9.34 Favored 'General case' 0 N--CA 1.394 -3.229 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.736 ' HB3' HD11 ' A' ' 66' ' ' LEU . 83.7 m-85 -115.59 100.08 7.8 Favored 'General case' 1 C--N 1.223 -4.899 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -174.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.575 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.29 5.09 52.04 Favored Glycine 0 C--O 1.188 -2.737 0 C-N-CA 118.487 -1.816 . . . . 0.0 115.616 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.6 ' HE1' ' HB3' ' A' ' 42' ' ' ASN 0.314 0.3 OUTLIER 46.01 75.18 0.12 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 123.068 1.414 . . . . 0.0 112.844 -179.874 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 82' ' ' VAL . 1.6 pt -61.94 141.36 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.038 0 CA-C-N 112.199 -2.273 . . . . 0.0 113.125 -174.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -77.71 114.78 16.9 Favored 'General case' 1 N--CA 1.365 -4.711 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 166.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.507 HG22 ' CG ' ' A' ' 65' ' ' TRP . 34.0 p -35.53 -38.78 0.12 Allowed 'General case' 0 C--N 1.244 -3.99 0 C-N-CA 127.91 2.484 . . . . 0.0 113.628 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -66.67 -19.84 65.85 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 123.41 0.684 . . . . 0.0 111.675 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.5 -5.87 59.04 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 121.835 -0.54 . . . . 0.0 111.357 -175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.62 HG21 HD12 ' A' ' 77' ' ' ILE . 30.1 m -135.79 167.84 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 CA-C-O 121.377 0.608 . . . . 0.0 110.992 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -133.96 116.17 15.24 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.781 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.3 pp -81.53 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.315 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -70.62 117.46 12.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -77.35 153.64 33.56 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.114 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 88' ' ' SER . 17.7 t70 89.23 -92.77 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.156 1.782 . . . . 0.0 110.529 -178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 39.2 t 168.16 -82.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.982 0.913 . . . . 0.0 108.773 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.9 mt -153.09 -54.95 0.12 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 103.439 -2.8 . . . . 0.0 103.439 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -148.4 77.3 1.39 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.404 -1.725 . . . . 0.0 108.4 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 45.5 tp -70.53 -28.42 64.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -100.32 102.71 14.03 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 170.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -124.4 89.53 3.09 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 122.3 1.048 . . . . 0.0 111.902 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.23 29.55 1.4 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.467 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 69.74 27.15 4.72 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.211 1.404 . . . . 0.0 111.607 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 . . . . . 0 C--N 1.307 -1.265 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.697 178.229 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 . . . . . 0 C--O 1.235 0.332 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -88.28 0.45 56.12 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 118.159 0.436 . . . . 0.0 112.009 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -145.62 158.46 43.84 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -93.4 171.32 8.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -119.36 159.08 24.86 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 43.8 mmtm -89.76 94.24 9.76 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -98.88 -63.08 1.15 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.973 -1.467 . . . . 0.0 108.888 -173.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -178.48 -47.61 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 72.18 -68.92 0.2 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.565 1.546 . . . . 0.0 109.752 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.2 127.2 45.31 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -77.03 126.08 30.39 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 122.958 0.503 . . . . 0.0 111.224 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -107.23 -172.62 2.11 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.605 ' HB3' HG23 ' A' ' 15' ' ' ILE . 64.6 tt0 -80.04 -2.0 42.3 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 46.4 mt-10 83.72 29.45 0.08 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 127.038 2.135 . . . . 0.0 109.39 -175.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.605 HG23 ' HB3' ' A' ' 13' ' ' GLN . 2.5 pt -88.69 -32.35 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.858 -170.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.0 ptmt -91.22 -9.44 45.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.591 -173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 13.4 tmtt? -92.89 -23.96 18.6 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 169.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.3 tppt? -82.56 -58.44 2.91 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.035 -177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 9.8 t80 -92.52 -33.98 14.25 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.4 tttm 75.11 93.48 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.34 1.025 . . . . 0.0 110.656 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.654 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -100.09 -28.82 12.85 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.864 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.268 69.0 p 64.97 -38.3 0.24 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.663 1.985 . . . . 0.0 115.964 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.08 162.31 24.24 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.41 117.43 4.47 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 122.68 2.253 . . . . 0.0 110.349 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.418 HG23 ' HB ' ' A' ' 55' ' ' ILE . 9.4 tp -109.95 140.71 27.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.979 -176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -98.05 175.99 5.92 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.248 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.41 133.55 31.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.86 0.838 . . . . 0.0 111.612 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.502 HD11 HH21 ' A' ' 56' ' ' ARG . 62.6 mt -98.46 -32.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.7 m80 -162.58 165.83 25.45 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.87 116.39 31.87 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.691 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -95.64 150.52 20.26 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-O 121.771 0.796 . . . . 0.0 111.047 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -107.31 133.61 51.59 Favored 'General case' 0 C--N 1.259 -3.337 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -64.41 117.03 6.7 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 31.3 t -79.8 -18.08 51.81 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 124.294 0.996 . . . . 0.0 110.321 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.6 t -152.93 161.0 43.08 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.99 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 1.8 p-10 -94.51 109.57 21.45 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.016 0.912 . . . . 0.0 108.769 177.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.26 152.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.714 -177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.91 9.04 39.01 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.064 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.87 58.24 8.57 Favored Glycine 0 C--N 1.318 -0.464 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.801 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.31 162.23 14.48 Favored Glycine 0 C--O 1.2 -1.982 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.864 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 6.4 mmpt? 57.71 34.28 24.27 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.843 1.321 . . . . 0.0 111.691 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HD2' ' A' ' 76' ' ' TYR . 42.6 m-80 66.01 51.81 1.28 Allowed 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.89 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.532 ' OE1' ' HE3' ' A' ' 78' ' ' LYS . 1.2 mp0 -110.04 179.45 4.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.831 171.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 1.1 tt -97.75 151.26 20.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 m -94.87 126.57 40.28 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.189 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 14.2 p90 -158.57 163.27 37.17 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.952 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.99 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.2 mmtt -110.7 148.27 32.62 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 18.8 tm0? -52.06 119.79 4.71 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.748 0.655 . . . . 0.0 109.548 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.58 13.69 69.71 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.742 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 12.9 tp10 -63.12 -32.01 73.29 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.95 0.5 . . . . 0.0 110.901 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 77.63 99.32 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.018 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.555 HD12 HG12 ' A' ' 82' ' ' VAL . 12.1 mt -106.69 165.29 4.22 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 113.399 -1.728 . . . . 0.0 106.742 -173.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -127.63 136.48 51.69 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.7 tp -93.24 130.68 41.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.418 ' HB ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -115.11 -37.84 2.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.369 177.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -137.86 134.71 35.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 118.547 -1.261 . . . . 0.0 110.911 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.515 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -127.69 -13.32 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 123.954 0.902 . . . . 0.0 110.39 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 p -117.16 159.04 23.23 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.11 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.5 t70 55.14 70.78 0.59 Allowed 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 125.219 1.408 . . . . 0.0 110.089 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 15.3 p30 -127.75 139.3 34.91 Favored Pre-proline 0 C--N 1.288 -2.087 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.671 -177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 23.6 Cg_exo -68.66 -49.2 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.938 2.426 . . . . 0.0 113.105 177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.91 -23.45 25.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.988 0.423 . . . . 0.0 111.681 -176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.18 8.53 58.79 Favored Glycine 0 C--N 1.312 -0.772 0 C-N-CA 120.228 -0.987 . . . . 0.0 110.73 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 12.7 ptmt -89.32 162.26 15.92 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.584 ' HB2' HG13 ' A' ' 77' ' ' ILE . 46.6 m0 -93.79 176.41 6.36 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.654 HD22 HD11 ' A' ' 21' ' ' LEU . 59.7 tp -121.2 112.57 18.82 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 176.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.16 157.73 14.78 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 73' ' ' SER . 48.5 ttp180 -133.56 153.69 51.45 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.322 0.582 . . . . 0.0 110.285 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 20.2 m -100.0 153.82 18.89 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.67 -30.04 12.62 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -81.68 -12.06 58.81 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.812 0.339 . . . . 0.0 111.855 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.59 92.59 1.56 Allowed Glycine 0 C--N 1.315 -0.591 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 22.7 m -153.73 118.05 4.87 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 101.483 -3.525 . . . . 0.0 101.483 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 66' ' ' LEU . 48.2 m-85 -114.59 94.95 5.01 Favored 'General case' 1 C--N 1.222 -4.972 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -173.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.577 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -111.18 103.41 1.58 Allowed Glycine 3 N--CA 1.359 -6.434 0 N-CA-C 107.634 -2.186 . . . . 0.0 107.634 177.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.525 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -45.52 100.55 0.02 OUTLIER 'General case' 0 C--N 1.265 -3.083 0 CA-C-N 113.133 -1.534 . . . . 0.0 108.293 173.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.584 HG13 ' HB2' ' A' ' 65' ' ' TRP . 2.0 pt -81.4 142.0 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.249 0 C-N-CA 124.341 1.057 . . . . 0.0 113.482 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HE3' ' OE1' ' A' ' 43' ' ' GLU . 18.7 ptpt -79.28 119.01 21.74 Favored 'General case' 1 N--CA 1.361 -4.911 0 N-CA-C 103.16 -2.904 . . . . 0.0 103.16 165.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.464 HG22 ' CD2' ' A' ' 65' ' ' TRP . 50.5 p -36.11 -39.46 0.17 Allowed 'General case' 1 C--N 1.242 -4.1 0 C-N-CA 127.732 2.413 . . . . 0.0 112.894 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.84 -13.35 62.06 Favored 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 123.274 0.63 . . . . 0.0 112.341 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.78 -9.08 50.59 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.359 -0.838 . . . . 0.0 111.112 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.555 HG12 HD12 ' A' ' 52' ' ' ILE . 31.5 m -133.91 167.22 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 CA-C-O 122.152 0.977 . . . . 0.0 111.974 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.54 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.4 mt-10 -132.89 111.62 11.21 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 29.1 pt -75.36 173.19 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 118.764 -1.174 . . . . 0.0 110.686 -177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.28 98.79 5.28 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -87.23 149.25 24.72 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.041 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -126.89 87.7 2.7 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -111.52 -20.23 12.26 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.62 -172.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.493 HD23 ' HG2' ' A' ' 92' ' ' LYS . 53.2 tp -145.92 107.17 4.19 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.423 ' HE2' ' HB2' ' A' ' 90' ' ' LYS . 14.3 tppt? -71.31 -38.26 71.75 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.055 0.455 . . . . 0.0 110.396 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.52 97.15 6.54 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.15 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HG2' HD23 ' A' ' 89' ' ' LEU . 98.1 mttt -85.45 127.55 34.43 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.06 102.16 14.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.239 0.542 . . . . 0.0 112.022 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -139.92 7.34 2.26 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.993 0.901 . . . . 0.0 108.947 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 62.0 tp -104.64 130.21 52.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.803 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 . . . . . 0 C--N 1.299 -1.615 0 CA-C-O 118.197 -0.906 . . . . 0.0 108.581 177.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.4 tptt 64.66 77.18 0.32 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.891 0.876 . . . . 0.0 110.832 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -111.27 90.02 3.22 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.54 113.56 26.29 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -124.84 15.4 8.63 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -171.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 6' ' ' LYS . 54.8 mtpt -118.4 -37.51 3.32 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -92.48 114.51 27.08 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.595 0.712 . . . . 0.0 110.81 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.36 68.8 1.26 Allowed 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 171.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.648 ' HG3' ' HG3' ' A' ' 10' ' ' LYS . 9.9 pt-20 -57.44 -32.37 66.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.732 -1.576 . . . . 0.0 113.485 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.648 ' HG3' ' HG3' ' A' ' 9' ' ' GLU . 62.5 mttp -104.03 176.07 5.28 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.439 -176.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 70.42 93.17 0.08 Allowed 'General case' 0 C--N 1.322 -0.59 0 O-C-N 124.65 1.219 . . . . 0.0 109.574 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' O ' HG12 ' A' ' 15' ' ' ILE . 5.5 mp0 -80.18 79.36 6.75 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.323 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' HA ' ' HD3' ' A' ' 16' ' ' LYS . 6.7 tp60 -72.4 -23.83 61.15 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.88 0.848 . . . . 0.0 110.046 -175.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -60.91 -30.0 69.93 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.24 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.724 HG21 ' HB2' ' A' ' 74' ' ' TYR . 4.3 pt -79.72 -31.45 13.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.13 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.419 -173.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 2.7 mptp? -68.62 -23.8 64.49 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 121.357 0.599 . . . . 0.0 110.768 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -103.6 6.49 37.24 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.997 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 8.8 ttmm -121.62 -43.42 2.38 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.098 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.574 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 2.9 t80 -94.6 -33.8 12.87 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 87.4 tttt 68.13 88.51 0.11 Allowed 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.653 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 HD22 ' A' ' 66' ' ' LEU . 1.2 mm? -98.09 -29.98 12.94 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.675 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p 60.24 23.89 13.28 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.985 1.314 . . . . 0.0 113.379 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.78 172.94 32.86 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -87.39 170.07 6.89 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.879 2.386 . . . . 0.0 111.167 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG23 ' HB ' ' A' ' 55' ' ' ILE . 14.9 tt -163.62 154.98 2.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.309 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.425 ' O ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 -83.63 178.41 7.98 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.255 0.622 . . . . 0.0 109.398 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.55 136.21 25.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.2 0.524 . . . . 0.0 109.636 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.477 ' HB ' HG23 ' A' ' 54' ' ' ILE . 49.9 mm -91.29 -35.58 7.23 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.79 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.799 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.403 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.2 m80 -168.64 162.56 11.91 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.7 mp -101.26 121.14 41.33 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.715 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -96.14 155.79 16.61 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-O 121.758 0.789 . . . . 0.0 110.027 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -107.04 128.08 54.04 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.478 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -68.36 109.39 3.63 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.52 -22.5 32.44 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.23 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.4 m -133.19 144.01 49.56 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.848 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -87.43 104.55 16.56 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.321 1.058 . . . . 0.0 109.281 172.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 39' ' ' GLY . 8.5 p -114.47 151.49 16.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.682 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.388 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -97.97 7.24 46.65 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.201 0.6 . . . . 0.0 111.942 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 75.25 59.04 3.73 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.609 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.11 151.14 17.01 Favored Glycine 0 C--N 1.3 -1.466 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 tttm 62.0 32.87 17.58 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.934 0.873 . . . . 0.0 108.687 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 90.6 m-20 66.55 86.64 0.13 Allowed 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.385 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.601 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 22.4 tt0 -147.09 -175.73 4.94 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.565 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.67 154.53 17.89 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.48 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 m -101.89 120.19 40.0 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 18.5 p90 -151.06 161.77 42.12 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.731 -176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 36' ' ' ASP . 73.2 mmtt -107.2 151.19 25.76 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.118 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -55.59 111.65 0.95 Allowed 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.57 24.96 14.49 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.406 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -75.91 -39.96 55.24 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.144 0.577 . . . . 0.0 111.162 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 76.34 108.08 0.08 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.915 1.686 . . . . 0.0 109.04 -172.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.582 HD12 ' CG1' ' A' ' 82' ' ' VAL . 8.1 mt -116.87 162.71 14.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -173.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -119.47 135.24 54.85 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.0 tp -93.48 128.54 44.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -113.33 -42.24 3.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 112.397 0.518 . . . . 0.0 112.397 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.574 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 1.8 tpm_? -128.52 128.23 43.92 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.726 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -126.07 -6.74 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 123.612 0.765 . . . . 0.0 109.637 177.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.1 p -112.13 150.84 30.21 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.521 -174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 t70 56.24 56.53 5.72 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 122.743 1.258 . . . . 0.0 109.535 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 17.7 p-10 -105.83 106.31 56.19 Favored Pre-proline 0 C--N 1.308 -1.215 0 CA-C-N 113.535 -1.666 . . . . 0.0 112.486 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 16.6 Cg_exo -66.76 -23.52 48.3 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.814 3.009 . . . . 0.0 115.072 -173.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -111.08 0.17 16.81 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.915 0.864 . . . . 0.0 109.852 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.28 17.49 80.19 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.688 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.0 ptmt -110.33 161.68 15.39 Favored 'General case' 0 N--CA 1.412 -2.333 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.522 ' CD2' HG22 ' A' ' 79' ' ' THR . 40.4 m0 -96.63 176.18 6.11 Favored 'General case' 0 C--O 1.201 -1.465 0 C-N-CA 122.383 0.273 . . . . 0.0 110.367 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' A' ' 74' ' ' TYR . 64.5 tp -117.37 111.77 19.79 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.74 155.43 16.32 Favored Glycine 0 N--CA 1.422 -2.288 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.184 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.1 ttp180 -136.45 148.26 47.63 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.562 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.7 m -101.41 157.96 16.42 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.79 30.36 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 119.243 0.928 . . . . 0.0 113.174 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmt_? -64.01 -26.0 68.37 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.071 0.948 . . . . 0.0 110.2 178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.67 89.05 1.44 Allowed Glycine 0 CA--C 1.489 -1.537 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.4 m -153.56 122.31 6.37 Favored 'General case' 0 N--CA 1.387 -3.582 0 N-CA-C 100.422 -3.918 . . . . 0.0 100.422 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.724 ' HB2' HG21 ' A' ' 15' ' ' ILE . 67.4 m-85 -114.61 96.52 5.79 Favored 'General case' 1 C--N 1.225 -4.806 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -175.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -111.04 105.31 1.86 Allowed Glycine 3 N--CA 1.357 -6.567 0 N-CA-C 108.576 -1.81 . . . . 0.0 108.576 177.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -49.38 96.49 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.892 0 CA-C-N 113.291 -1.455 . . . . 0.0 108.88 169.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.601 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.7 pt -76.09 143.87 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.276 0 C-N-CA 125.631 1.572 . . . . 0.0 113.518 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -78.93 115.88 18.89 Favored 'General case' 1 N--CA 1.371 -4.411 0 N-CA-C 102.811 -3.033 . . . . 0.0 102.811 166.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 64' ' ' LYS . 68.9 p -36.02 -35.96 0.08 Allowed 'General case' 0 C--N 1.244 -3.995 0 C-N-CA 128.167 2.587 . . . . 0.0 113.962 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -70.16 -15.13 62.91 Favored 'General case' 0 CA--C 1.567 1.625 0 C-N-CA 123.361 0.665 . . . . 0.0 112.636 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.92 -13.84 38.11 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 121.782 -0.574 . . . . 0.0 111.471 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.582 ' CG1' HD12 ' A' ' 52' ' ' ILE . 28.4 m -127.89 165.5 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-O 121.297 0.57 . . . . 0.0 110.888 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -133.8 117.3 16.72 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.715 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.1 pp -77.96 134.1 29.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 119.504 -0.879 . . . . 0.0 109.936 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.88 123.71 23.95 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.365 0.602 . . . . 0.0 110.416 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -85.54 146.06 27.08 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.815 -171.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -103.72 6.13 36.68 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 123.141 1.448 . . . . 0.0 107.275 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 t -122.22 176.24 5.95 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 113.743 -1.571 . . . . 0.0 107.082 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.1 mp 63.95 27.51 14.36 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.975 0.91 . . . . 0.0 110.679 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -83.93 100.18 10.85 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.153 0.501 . . . . 0.0 110.088 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.33 109.48 6.84 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -127.84 95.26 4.16 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.99 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.846 ' HA ' ' HE3' ' A' ' 93' ' ' LYS . 1.0 OUTLIER 57.63 95.18 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 125.1 1.36 . . . . 0.0 112.526 177.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -92.99 169.66 10.25 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.145 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.8 tp -154.14 109.78 3.19 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 C--N 1.296 -1.748 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.692 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 120.823 0.344 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -98.51 93.93 6.42 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 120.844 0.354 . . . . 0.0 110.152 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 3' ' ' LYS . 71.5 mmtt -132.59 102.0 5.53 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.493 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -93.18 17.97 10.17 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.861 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -80.71 104.09 10.99 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.464 0.649 . . . . 0.0 110.789 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -121.97 -149.48 0.43 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 61.36 65.95 0.92 Allowed 'General case' 0 C--O 1.248 0.998 0 C-N-CA 124.1 0.96 . . . . 0.0 111.439 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' O ' ' HD2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.19 132.07 44.01 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.981 178.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.57 107.44 15.8 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -173.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -88.89 106.56 18.48 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.372 -2.085 . . . . 0.0 105.372 171.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -142.44 146.53 34.91 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.177 -173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.73 -178.77 4.79 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.148 0.499 . . . . 0.0 112.233 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.584 HE21 ' HA ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -70.83 -3.01 16.75 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.612 2.078 . . . . 0.0 116.612 -174.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 30.0 mm-40 85.29 21.62 0.09 Allowed 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 125.21 1.404 . . . . 0.0 108.879 -173.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 pp -87.15 -25.18 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 CA-C-N 113.484 -1.689 . . . . 0.0 108.417 -176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.658 ' HB3' ' HD3' ' A' ' 17' ' ' LYS . 10.5 tptm -64.3 -41.65 96.76 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.286 -174.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.658 ' HD3' ' HB3' ' A' ' 16' ' ' LYS . 3.4 mppt? -98.02 12.46 34.23 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.699 -176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 8.2 tppt? -105.67 -57.04 2.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.695 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 1.8 t80 -80.11 -25.07 40.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 174.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 49.5 mtpt 70.09 89.4 0.1 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.989 1.316 . . . . 0.0 110.6 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.542 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -98.74 -18.63 17.9 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.804 -175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 70.7 p 69.88 -69.6 0.16 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 126.061 1.744 . . . . 0.0 114.32 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.12 -130.81 5.55 Favored Glycine 0 N--CA 1.436 -1.306 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.324 -175.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.59 163.23 39.11 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.808 2.338 . . . . 0.0 111.984 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.525 HG13 ' HB ' ' A' ' 55' ' ' ILE . 8.9 tp -134.88 126.02 46.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -123.35 166.61 15.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.12 136.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-O 121.379 0.609 . . . . 0.0 109.464 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.88 -33.66 3.53 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.057 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.564 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.6 m80 -161.82 168.65 22.73 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -173.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.72 115.67 30.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -98.12 155.12 17.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-O 122.281 1.038 . . . . 0.0 111.352 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 34.1 ttpt -107.91 128.83 54.97 Favored 'General case' 0 C--N 1.256 -3.465 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -64.84 116.03 5.92 Favored 'General case' 0 N--CA 1.425 -1.724 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.7 t -85.87 -17.4 35.7 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.451 0.643 . . . . 0.0 109.658 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.1 t -144.33 156.07 44.09 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 8.2 p-10 -94.43 101.92 13.86 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 122.16 0.981 . . . . 0.0 110.169 175.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG12 ' CE1' ' A' ' 46' ' ' PHE . 7.3 p -112.42 153.35 14.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.35 42.94 3.13 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 111.406 -177.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 74.39 58.84 4.08 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.136 -0.938 . . . . 0.0 113.14 176.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.06 126.6 8.02 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt 64.4 34.79 10.12 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.598 0.713 . . . . 0.0 109.79 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.525 ' ND2' ' HE1' ' A' ' 76' ' ' TYR . 12.2 t30 71.52 87.38 0.11 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.702 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 20.2 tt0 -151.85 -172.45 4.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.102 -172.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 75' ' ' GLY . 1.1 tt -94.96 151.5 19.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.515 ' H ' HD23 ' A' ' 44' ' ' LEU . 50.1 m -102.77 118.58 37.14 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.626 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CE1' HG12 ' A' ' 37' ' ' VAL . 20.3 p90 -154.89 177.22 11.54 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.618 0.767 . . . . 0.0 109.619 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 99.1 mttt -133.69 151.18 51.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -47.74 119.3 2.71 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 124.322 1.014 . . . . 0.0 110.9 176.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.44 12.7 59.41 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.937 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -79.23 -15.54 57.87 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 66.34 113.93 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.884 0 O-C-N 124.394 1.059 . . . . 0.0 111.208 -177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.5 mt -120.69 156.25 23.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.39 138.26 51.92 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 65' ' ' TRP . 7.8 tp -95.16 117.43 39.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.525 ' HB ' HG13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -105.53 -27.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.404 -176.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 66' ' ' LEU . 5.3 tpp180 -141.88 125.81 17.18 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.052 177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.508 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -118.78 -38.95 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.738 -177.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -106.68 154.91 20.26 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.199 -172.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 82.82 10.91 0.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.894 1.677 . . . . 0.0 109.798 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' ND2' ' HA2' ' A' ' 63' ' ' GLY . 2.9 p-10 -54.57 123.95 46.73 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.213 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 21.3 Cg_exo -68.4 -40.69 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.088 2.526 . . . . 0.0 113.044 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -99.74 -49.84 4.24 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.928 0.394 . . . . 0.0 110.838 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.574 ' HA2' ' ND2' ' A' ' 60' ' ' ASN . . . 145.18 -2.59 1.15 Allowed Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.288 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 14.8 ptpt -100.69 163.67 12.23 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 122.572 0.349 . . . . 0.0 110.314 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.678 ' HB3' HD11 ' A' ' 54' ' ' ILE . 35.9 m0 -98.03 174.33 6.6 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 124.263 0.977 . . . . 0.0 111.103 -173.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 74' ' ' TYR . 41.4 tp -115.05 108.31 16.5 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.06 157.97 14.62 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.681 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.2 ttp180 -136.09 147.11 47.69 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.171 0.51 . . . . 0.0 111.389 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.495 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.6 p -100.83 165.31 11.42 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.052 175.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.89 -33.55 24.59 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.385 1.074 . . . . 0.0 113.641 -175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -78.04 -18.96 55.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.301 0.572 . . . . 0.0 111.384 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.69 92.09 1.38 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.681 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 30.1 m -151.96 129.11 11.14 Favored 'General case' 0 N--CA 1.392 -3.36 0 N-CA-C 101.461 -3.533 . . . . 0.0 101.461 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 66' ' ' LEU . 41.9 m-85 -119.73 61.31 0.84 Allowed 'General case' 1 C--N 1.226 -4.788 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -172.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.627 ' O ' ' HB2' ' A' ' 44' ' ' LEU . . . -87.11 93.38 1.88 Allowed Glycine 1 N--CA 1.384 -4.82 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -176.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.54 ' O ' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -34.29 101.05 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 O-C-N 125.809 1.535 . . . . 0.0 110.324 174.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.724 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -78.07 137.01 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.342 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.661 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -73.67 114.05 11.49 Favored 'General case' 1 N--CA 1.367 -4.595 0 N-CA-C 103.576 -2.749 . . . . 0.0 103.576 166.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.536 HG22 ' CD2' ' A' ' 65' ' ' TRP . 81.4 p -36.11 -35.9 0.08 Allowed 'General case' 1 C--N 1.24 -4.189 0 C-N-CA 128.428 2.691 . . . . 0.0 113.471 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.6 t -69.04 -14.24 62.92 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.068 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.32 -7.14 51.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 O-C-N 121.443 -0.785 . . . . 0.0 111.137 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 HD12 ' A' ' 77' ' ' ILE . 26.8 m -133.96 157.46 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.93 0.871 . . . . 0.0 112.365 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -120.3 110.69 16.86 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 170.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.711 HG22 ' HB2' ' A' ' 31' ' ' ALA . 18.8 pt -79.82 163.03 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.14 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -86.67 109.87 19.49 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -80.83 -52.58 7.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -167.17 61.45 0.08 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 m -95.7 -62.11 1.35 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.727 -172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.33 28.94 2.75 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 90' ' ' LYS . 4.4 tmtm? -71.97 -38.31 69.76 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 91' ' ' LEU . 3.3 pp -71.24 109.51 5.32 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.292 1.044 . . . . 0.0 111.167 176.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -119.94 146.7 45.56 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? 60.55 79.06 0.25 Allowed 'General case' 0 C--N 1.312 -1.053 0 O-C-N 124.409 1.068 . . . . 0.0 110.81 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -106.64 109.78 21.79 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.1 mt -71.42 106.51 3.95 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.542 0.686 . . . . 0.0 112.279 -172.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.41 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.712 0.292 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -91.39 -33.47 15.25 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.404 0.282 . . . . 0.0 111.689 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt 69.31 86.99 0.12 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -170.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -84.17 109.41 17.71 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.073 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 8' ' ' LYS . 45.0 mt-30 -115.69 128.82 56.18 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -96.22 -29.85 13.8 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.945 -173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -88.23 24.47 1.86 Allowed 'General case' 0 C--O 1.242 0.678 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 5' ' ' GLN . 47.8 mtmt -80.62 -75.47 0.27 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.844 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -115.86 100.54 8.07 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.59 0.709 . . . . 0.0 109.865 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 11' ' ' LYS . 17.8 ptmt -146.19 -19.83 0.44 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.775 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 10' ' ' LYS . 41.4 ttmt 74.49 150.88 0.11 Allowed 'General case' 0 C--O 1.241 0.642 0 C-N-CA 124.767 1.227 . . . . 0.0 110.796 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' HB3' HG12 ' A' ' 15' ' ' ILE . 6.1 mm-40 -74.34 91.85 2.24 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.319 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 15.4 mm100 -91.09 -34.73 14.96 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 122.395 1.093 . . . . 0.0 109.19 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 3.6 mp0 -70.56 -12.06 61.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.438 -174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.3 pp -87.98 -23.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 120.922 0.391 . . . . 0.0 110.125 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 24.9 tptt -48.1 -61.68 1.86 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.845 1.658 . . . . 0.0 112.711 -171.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -104.82 11.66 33.53 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.553 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 12.6 tppt? -84.87 -50.74 7.28 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 60' ' ' ASN . 26.2 t80 -89.99 -28.99 18.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.626 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 8.0 mtmp? 75.0 88.25 0.09 Allowed 'General case' 0 CA--C 1.491 -1.322 0 C-N-CA 125.577 1.551 . . . . 0.0 110.066 -177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 HD11 HD22 ' A' ' 66' ' ' LEU . 1.7 mm? -99.94 -69.9 0.75 Allowed 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 m 54.02 84.37 0.06 Allowed 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 112.575 -2.102 . . . . 0.0 114.131 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 134.55 -143.47 15.15 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.232 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.76 127.82 16.9 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.518 2.812 . . . . 0.0 111.386 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.598 HD11 ' HB ' ' A' ' 55' ' ' ILE . 10.4 tp -136.35 127.14 42.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -147.92 162.27 39.63 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.732 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.9 p -76.85 134.67 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.349 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.77 -34.77 4.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.861 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.407 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 35.6 m80 -159.15 163.03 36.43 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.39 116.39 32.34 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.89 155.31 17.24 Favored 'General case' 0 C--N 1.279 -2.499 0 CA-C-O 122.345 1.069 . . . . 0.0 111.67 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -106.85 126.47 52.35 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.06 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.421 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.53 109.4 2.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.6 t -80.94 -18.7 46.17 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.884 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -147.32 151.48 36.65 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -89.06 105.4 17.76 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.847 0.832 . . . . 0.0 109.662 173.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -114.32 162.28 12.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.905 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -125.18 31.52 5.58 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.537 0.684 . . . . 0.0 111.411 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 81.26 59.2 2.45 Favored Glycine 0 N--CA 1.436 -1.351 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.169 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.19 116.12 4.52 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 tttm 57.43 71.11 0.6 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.984 1.313 . . . . 0.0 110.156 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.577 ' HB3' ' HE1' ' A' ' 76' ' ' TYR . 18.8 m120 51.47 79.47 0.1 Allowed 'General case' 0 C--O 1.245 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 111.493 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.3 tt0 -146.81 -175.45 4.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.649 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -97.59 155.24 17.06 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.559 ' H ' HD23 ' A' ' 44' ' ' LEU . 28.0 m -100.65 115.44 30.23 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.171 0.51 . . . . 0.0 109.69 174.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.5 p90 -149.48 158.22 43.98 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.819 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.633 ' HG2' ' OD1' ' A' ' 36' ' ' ASP . 59.4 mttm -110.84 152.93 26.11 Favored 'General case' 0 C--N 1.287 -2.147 0 O-C-N 123.695 0.622 . . . . 0.0 109.922 -178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 110.22 0.66 Allowed 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.33 27.23 10.15 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.103 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.7 tp10 -80.11 -37.05 34.43 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.086 0.555 . . . . 0.0 111.117 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 72.21 112.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.182 1.793 . . . . 0.0 110.505 -173.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.559 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.0 mt -119.88 160.68 20.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.117 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.732 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 44.8 mt-10 -117.83 134.36 55.01 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.6 tp -90.14 126.53 42.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.598 ' HB ' HD11 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.22 -39.55 3.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.63 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -134.89 130.15 35.48 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 118.549 -1.261 . . . . 0.0 110.906 179.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.45 -1.93 5.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 123.934 0.894 . . . . 0.0 110.233 176.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.8 p -112.38 147.43 36.42 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.916 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.8 t70 67.08 28.59 8.27 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 122.75 1.262 . . . . 0.0 109.428 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 23.3 p-10 -77.98 115.05 47.28 Favored Pre-proline 0 C--N 1.302 -1.464 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.203 -178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 30.9 Cg_exo -62.63 -62.4 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.711 2.941 . . . . 0.0 113.877 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -76.35 -8.41 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.819 0.818 . . . . 0.0 110.874 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 7.88 68.05 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.0 ptmt -95.96 162.91 13.36 Favored 'General case' 0 N--CA 1.41 -2.452 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 57' ' ' ILE . 46.0 m0 -97.71 175.94 6.0 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 122.365 0.266 . . . . 0.0 110.529 -175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 74' ' ' TYR . 60.1 tp -120.54 114.18 21.38 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -120.24 159.81 15.03 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 73' ' ' SER . 38.4 ttp180 -134.68 152.81 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.0 m -111.82 165.44 12.06 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.23 -31.96 15.36 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -171.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -89.29 -6.86 56.42 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 118.372 -1.331 . . . . 0.0 111.091 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.24 97.2 1.25 Allowed Glycine 0 N--CA 1.433 -1.527 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.874 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.692 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 18.4 m -153.89 124.31 7.04 Favored 'General case' 0 N--CA 1.394 -3.27 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.578 ' HB2' HG21 ' A' ' 15' ' ' ILE . 39.9 m-85 -113.85 80.56 1.4 Allowed 'General case' 1 C--N 1.223 -4.908 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -175.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.649 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -97.46 101.97 2.64 Favored Glycine 3 N--CA 1.346 -7.334 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.577 ' HE1' ' HB3' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -48.92 100.34 0.02 OUTLIER 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 113.198 -1.501 . . . . 0.0 108.121 168.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.6 pt -80.44 145.68 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.442 -3.204 0 C-N-CA 126.645 1.978 . . . . 0.0 113.515 -175.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 117.58 22.25 Favored 'General case' 1 N--CA 1.359 -5.007 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 166.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.472 HG22 ' CG ' ' A' ' 65' ' ' TRP . 62.1 p -35.34 -38.2 0.09 Allowed 'General case' 0 C--N 1.251 -3.696 0 C-N-CA 129.05 2.94 . . . . 0.0 114.014 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 t -70.27 -9.89 57.32 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 124.308 1.043 . . . . 0.0 112.248 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.32 -10.18 36.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.427 -0.796 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.604 HG21 HD12 ' A' ' 77' ' ' ILE . 19.0 m -129.08 152.28 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-O 121.808 0.813 . . . . 0.0 112.29 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.5 mt-10 -119.14 107.05 12.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 10.2 pt -72.82 159.3 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.198 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.529 ' OD2' ' HA ' ' A' ' 88' ' ' SER . 28.4 t70 -94.11 101.64 13.66 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -51.94 -45.3 64.26 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 124.785 1.234 . . . . 0.0 112.23 -172.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 2.1 m-20 -116.0 88.7 2.94 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 174.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.529 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 50.8 m -74.26 104.94 5.22 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.0 tp 79.2 -39.4 0.22 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.916 1.686 . . . . 0.0 110.277 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . 46.8 tttm 70.11 79.94 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.607 1.163 . . . . 0.0 109.411 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -135.17 155.18 51.12 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.759 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -157.37 96.73 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 123.773 0.829 . . . . 0.0 109.275 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 76.3 174.77 0.22 Allowed 'General case' 0 C--O 1.245 0.831 0 C-N-CA 125.105 1.362 . . . . 0.0 110.623 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -113.86 28.51 8.7 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.719 0.771 . . . . 0.0 109.944 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.8 tp -69.23 -31.74 70.52 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.033 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 C--N 1.303 -1.417 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.216 -178.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 120.942 0.401 . . . . 0.0 112.016 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -120.82 114.54 21.76 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -93.73 118.93 32.07 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -140.51 73.66 1.43 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 168.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 67.29 166.99 0.23 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.194 -175.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.58 89.1 2.89 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.708 0.765 . . . . 0.0 111.209 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -107.76 109.11 20.6 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -133.03 94.83 3.43 Favored 'General case' 0 C--O 1.255 1.354 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.38 -175.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 74.1 -59.64 0.55 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.197 1.399 . . . . 0.0 112.488 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.7 tttt 75.86 103.6 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.623 1.569 . . . . 0.0 112.011 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -97.33 12.15 34.06 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 83.09 140.31 0.06 Allowed 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 126.444 1.897 . . . . 0.0 111.079 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -90.2 -32.22 16.7 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.315 0.579 . . . . 0.0 111.175 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 35.0 mm-40 -59.63 -34.59 72.98 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.182 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.586 ' HA ' ' HE2' ' A' ' 76' ' ' TYR . 2.4 pp -72.3 -28.3 28.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.316 -172.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HA ' HD23 ' A' ' 21' ' ' LEU . 48.7 mtpt -67.91 -36.19 79.75 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 113.741 -1.572 . . . . 0.0 112.015 -172.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -107.53 -16.74 14.29 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.298 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 5.8 tppt? -71.32 -45.73 62.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.444 ' HB2' ' HD2' ' A' ' 76' ' ' TYR . 31.3 t80 -90.68 -30.61 17.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . 0.254 15.2 tptp 74.61 85.58 0.1 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.695 1.236 . . . . 0.0 111.392 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.605 HD11 HD22 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -98.99 -59.84 1.65 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.304 36.2 p 62.75 100.23 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 125.792 1.637 . . . . 0.0 112.634 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.08 144.3 10.19 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -173.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.97 125.97 20.86 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 123.311 2.674 . . . . 0.0 111.599 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.3 tp -107.97 136.33 43.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.33 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -103.59 167.49 9.76 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.65 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.4 p -81.64 137.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.442 0.639 . . . . 0.0 111.159 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.3 mm -92.42 -40.36 12.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.748 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.4 m80 -161.15 171.75 17.95 Favored 'General case' 0 CA--C 1.481 -1.701 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -175.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HB3' ' NE2' ' A' ' 51' ' ' GLN . 5.8 mp -107.86 126.33 52.54 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -102.68 156.6 17.52 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.418 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -107.1 133.51 51.6 Favored 'General case' 0 C--N 1.267 -3.009 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -65.99 103.22 0.9 Allowed 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 44.9 t -71.2 -28.93 64.57 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.647 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.3 m -132.09 156.43 46.34 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.708 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.7 p-10 -81.38 112.03 18.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 171.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 81' ' ' ALA . 30.8 t -112.62 140.89 30.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.789 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.34 -168.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -86.7 -14.61 42.01 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.341 -173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' H ' HG12 ' A' ' 37' ' ' VAL . . . 75.78 60.49 3.16 Favored Glycine 0 CA--C 1.503 -0.673 0 C-N-CA 118.983 -1.58 . . . . 0.0 110.432 -176.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.17 131.89 10.85 Favored Glycine 0 N--CA 1.429 -1.785 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.83 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp 58.88 71.58 0.58 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.405 1.082 . . . . 0.0 110.658 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 56.29 61.45 2.71 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.114 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 76' ' ' TYR . 46.5 mt-10 -134.16 -179.22 5.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.548 0.339 . . . . 0.0 111.133 175.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.6 tt -98.46 140.96 31.93 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 p -94.6 115.73 27.92 Favored 'General case' 0 C--N 1.28 -2.443 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.161 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 29.1 p90 -145.47 177.12 9.09 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.478 -177.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 9.3 mtmp? -134.81 142.53 46.69 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.6 tm0? -35.79 111.97 0.15 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 125.131 1.519 . . . . 0.0 110.376 173.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.09 19.97 40.77 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 114.648 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.553 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -73.33 -26.0 60.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 118.003 0.901 . . . . 0.0 113.227 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.537 ' NE2' ' HB3' ' A' ' 30' ' ' LEU . 26.6 tp60 70.84 104.2 0.06 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.882 1.364 . . . . 0.0 108.813 -172.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.552 HD12 HG12 ' A' ' 82' ' ' VAL . 14.8 mt -110.74 165.95 5.76 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 24.9 mt-10 -122.65 141.11 52.1 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.8 tp -98.75 116.64 42.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -103.49 -41.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.387 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.592 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -133.7 136.54 44.74 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 117.782 -1.567 . . . . 0.0 111.497 178.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -125.02 -37.84 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.376 -1.283 . . . . 0.0 109.675 177.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 p -88.45 158.09 18.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t70 54.82 66.36 1.25 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 125.032 1.333 . . . . 0.0 109.192 -176.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 31.5 p30 -112.11 136.93 21.3 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.166 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.6 Cg_exo -76.76 -32.3 3.58 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.431 2.087 . . . . 0.0 112.872 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.79 -34.89 6.33 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.87 0.367 . . . . 0.0 111.688 -173.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.74 -7.04 15.63 Favored Glycine 0 C--N 1.305 -1.142 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.586 ' HA ' HG23 ' A' ' 79' ' ' THR . 11.4 ptmt -80.52 162.33 24.38 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.557 ' CD1' HG22 ' A' ' 57' ' ' ILE . 37.7 m0 -99.08 176.65 5.49 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.608 0.186 . . . . 0.0 110.801 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.605 HD22 HD11 ' A' ' 21' ' ' LEU . 61.4 tp -116.39 110.93 19.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.83 158.84 14.07 Favored Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 73' ' ' SER . 66.4 ttt-85 -140.53 147.8 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 122.769 0.427 . . . . 0.0 109.88 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 7.1 p -101.03 165.54 11.27 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.23 -31.12 65.2 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.087 0.47 . . . . 0.0 112.254 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -71.55 -14.97 62.26 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.338 0.655 . . . . 0.0 111.749 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.436 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 81.77 88.37 0.65 Allowed Glycine 0 N--CA 1.428 -1.876 0 CA-C-N 116.255 -0.43 . . . . 0.0 112.181 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.7 m -151.99 120.82 6.57 Favored 'General case' 0 N--CA 1.394 -3.269 0 N-CA-C 101.109 -3.663 . . . . 0.0 101.109 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' HB2' HG21 ' A' ' 15' ' ' ILE . 61.0 m-85 -108.91 90.74 3.38 Favored 'General case' 1 C--N 1.219 -5.076 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.601 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -107.05 104.81 2.21 Favored Glycine 3 N--CA 1.355 -6.748 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.586 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -46.0 96.99 0.01 OUTLIER 'General case' 0 C--N 1.273 -2.76 0 CA-C-N 113.351 -1.424 . . . . 0.0 108.29 169.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 82' ' ' VAL . 1.5 pt -78.22 147.18 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.898 0 C-N-CA 125.713 1.605 . . . . 0.0 114.398 -173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -76.64 113.82 14.7 Favored 'General case' 1 N--CA 1.376 -4.143 0 N-CA-C 101.712 -3.44 . . . . 0.0 101.712 165.77 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 64' ' ' LYS . 79.4 p -36.64 -41.92 0.33 Allowed 'General case' 0 C--N 1.246 -3.92 0 C-N-CA 127.769 2.427 . . . . 0.0 113.594 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -63.53 -20.42 65.61 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 124.542 1.137 . . . . 0.0 112.258 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 37' ' ' VAL . . . -82.97 -12.54 57.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.835 -0.54 . . . . 0.0 111.279 -175.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 77' ' ' ILE . 29.1 m -127.06 166.82 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.343 0.592 . . . . 0.0 111.847 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 58.3 mt-10 -133.26 107.91 8.43 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.742 HG22 ' HB2' ' A' ' 31' ' ' ALA . 8.6 pt -75.53 155.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.391 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -97.25 108.86 21.68 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.706 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.46 -5.5 0.84 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.135 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 t70 48.9 92.04 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 126.166 1.787 . . . . 0.0 114.445 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.1 m -96.94 39.41 1.18 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.819 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.2 mt -71.28 -53.23 15.02 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.157 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt 54.56 72.98 0.43 Allowed 'General case' 0 C--O 1.245 0.848 0 O-C-N 124.788 1.305 . . . . 0.0 110.07 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.56 123.93 18.44 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.091 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -77.11 125.87 30.03 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.138 178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.16 174.98 10.11 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.424 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -114.64 -160.94 0.75 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.6 mt -75.88 106.42 7.45 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 119.005 0.82 . . . . 0.0 110.892 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 N--CA 1.416 -2.132 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -179.613 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.909 0.385 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -92.26 95.93 9.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' HG2' ' HG2' ' A' ' 4' ' ' GLU . 64.5 tttp -112.03 -63.31 1.44 Allowed 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 176.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 3' ' ' LYS . 12.2 pt-20 170.35 151.69 0.04 OUTLIER 'General case' 0 C--O 1.246 0.876 0 C-N-CA 125.957 1.703 . . . . 0.0 107.43 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.53 134.98 57.19 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 173.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -48.16 -38.22 17.5 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -172.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.87 103.36 3.36 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -107.72 -82.55 0.55 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 50.39 30.82 4.82 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.699 1.2 . . . . 0.0 111.667 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -130.87 80.22 1.93 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -86.14 122.72 30.54 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.897 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' A' ' 15' ' ' ILE . 14.1 tt0 -133.02 56.87 1.83 Allowed 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.587 ' HG3' ' HD3' ' A' ' 16' ' ' LYS . 28.5 tt0 -74.96 -13.48 60.53 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.705 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -59.4 -29.92 68.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.827 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.704 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.9 pp -67.54 -30.77 49.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-O 121.454 0.645 . . . . 0.0 111.422 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.587 ' HD3' ' HG3' ' A' ' 13' ' ' GLN . 21.8 mtpp -76.48 -27.32 56.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.805 -175.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -93.65 -8.93 39.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.253 -1.34 . . . . 0.0 110.019 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 12.6 tppt? -99.58 -67.01 0.87 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.073 0.463 . . . . 0.0 110.96 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.786 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 21.1 t80 -79.07 -32.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.813 -172.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 7.9 mtmp? 75.72 91.84 0.07 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.834 1.253 . . . . 0.0 109.692 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.058 HD12 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.35 -46.33 5.83 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.318 0.58 . . . . 0.0 109.772 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p 56.88 21.41 6.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.507 1.523 . . . . 0.0 114.877 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.86 143.67 7.19 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.48 97.0 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.747 2.298 . . . . 0.0 111.109 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.454 HD13 ' HB ' ' A' ' 55' ' ' ILE . 2.3 pp -114.54 163.73 11.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.305 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.438 ' C ' HG22 ' A' ' 55' ' ' ILE . 12.9 pt20 -124.53 -172.69 2.61 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.5 p -53.95 133.7 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.64 -31.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.066 173.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 29.1 m80 -161.05 157.03 25.49 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.27 116.04 28.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.669 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -94.63 150.81 19.85 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-O 122.072 0.939 . . . . 0.0 111.127 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.81 128.27 54.11 Favored 'General case' 0 C--N 1.252 -3.652 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -63.84 116.05 5.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.553 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.9 t -81.87 -18.47 43.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.249 0.968 . . . . 0.0 109.846 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.9 m -144.61 156.09 43.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 6.3 p-10 -91.42 102.02 14.7 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.402 HG12 ' CE1' ' A' ' 46' ' ' PHE . 9.9 p -113.25 153.75 14.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.568 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.795 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -98.1 8.33 44.95 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.387 -177.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.62 59.77 1.87 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.678 -1.248 . . . . 0.0 111.896 -177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.77 143.8 16.7 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttp 65.05 29.59 12.06 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 108.757 -176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.414 ' OD1' ' HE3' ' A' ' 18' ' ' LYS . 2.4 t-20 63.14 86.97 0.11 Allowed 'General case' 0 C--O 1.244 0.785 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.28 -175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 31.0 tt0 -141.59 -173.6 3.82 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.257 -172.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.646 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.2 tt -95.92 145.54 25.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 m -96.01 122.21 38.59 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 16.6 p90 -154.26 174.83 14.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.789 -176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 60.9 mtpt -127.33 147.79 50.25 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 19.3 tm0? -51.98 125.68 16.13 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.669 0.605 . . . . 0.0 110.425 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.86 5.2 81.46 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.349 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -63.12 -30.9 71.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.504 0.668 . . . . 0.0 109.891 -179.149 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 73.23 110.41 0.07 Allowed 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.13 1.372 . . . . 0.0 111.298 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.528 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.4 mt -115.76 156.81 16.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 CA-C-N 113.557 -1.656 . . . . 0.0 106.671 -172.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 79.9 mt-10 -113.08 131.16 55.92 Favored 'General case' 0 C--N 1.273 -2.751 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.009 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.6 tp -86.32 115.81 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.523 ' H ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -103.4 -32.57 3.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.984 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 1.058 ' HG3' HD12 ' A' ' 21' ' ' LEU . 18.1 mmt180 -134.93 112.4 10.61 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.721 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.59 -19.31 6.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 113.038 -1.892 . . . . 0.0 107.092 171.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 57' ' ' ILE . 12.0 p -99.01 141.94 31.12 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.396 -177.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 t0 75.67 26.06 1.12 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.058 1.343 . . . . 0.0 108.92 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 10.0 p30 -66.01 126.02 91.11 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.587 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.786 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 62.2 Cg_endo -81.23 -45.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.398 2.065 . . . . 0.0 113.3 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -99.3 -5.52 29.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.021 0.438 . . . . 0.0 111.177 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 99.46 -22.3 41.3 Favored Glycine 0 C--N 1.308 -1.004 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -174.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 15.1 ptmt -72.0 161.49 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.152 -1.024 . . . . 0.0 109.21 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.456 ' CG ' HG22 ' A' ' 79' ' ' THR . 32.3 m0 -99.5 176.34 5.53 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.073 0.233 . . . . 0.0 110.924 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 74' ' ' TYR . 62.9 tp -120.36 114.33 21.68 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -114.08 156.18 15.81 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 73' ' ' SER . 2.1 ttp-105 -139.03 149.11 44.26 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.407 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 17.2 p -99.76 165.94 11.34 Favored 'General case' 0 C--N 1.266 -3.032 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.962 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.73 -30.08 42.47 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -174.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -0.07 54.92 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.34 0.866 . . . . 0.0 113.34 -178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.28 92.01 0.9 Allowed Glycine 0 C--N 1.319 -0.413 0 CA-C-O 121.554 0.53 . . . . 0.0 113.535 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.696 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 20.4 m -153.01 126.15 8.53 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 101.08 -3.674 . . . . 0.0 101.08 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.73 ' HB3' HD11 ' A' ' 66' ' ' LEU . 57.1 m-85 -117.81 86.68 2.57 Favored 'General case' 1 C--N 1.227 -4.727 0 CA-C-O 122.122 0.963 . . . . 0.0 108.649 -173.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.646 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.14 101.76 2.12 Favored Glycine 3 N--CA 1.359 -6.447 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 178.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.678 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -48.92 100.36 0.02 OUTLIER 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 113.58 -1.31 . . . . 0.0 108.499 170.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.602 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.8 pt -80.41 148.29 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.451 -2.843 0 C-N-CA 126.277 1.831 . . . . 0.0 113.074 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -77.42 119.59 21.24 Favored 'General case' 1 N--CA 1.368 -4.533 0 N-CA-C 102.647 -3.094 . . . . 0.0 102.647 163.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 64' ' ' LYS . 82.0 p -36.13 -38.59 0.14 Allowed 'General case' 1 C--N 1.243 -4.051 0 C-N-CA 128.017 2.527 . . . . 0.0 113.168 179.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.5 t -71.71 -14.15 61.94 Favored 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 123.208 0.603 . . . . 0.0 112.155 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.97 -11.2 57.19 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.42 -0.8 . . . . 0.0 110.937 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.528 ' CG1' HD12 ' A' ' 52' ' ' ILE . 16.9 m -129.35 167.41 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 121.556 0.693 . . . . 0.0 111.336 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 42.3 mt-10 -131.34 110.55 11.15 Favored 'General case' 0 C--N 1.279 -2.486 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.669 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -75.77 159.5 5.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 118.282 -1.367 . . . . 0.0 109.251 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.18 102.12 14.84 Favored 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.621 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -86.12 169.39 13.16 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -101.97 86.41 2.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.4 m -96.73 -3.67 42.07 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.638 -1.165 . . . . 0.0 112.139 -172.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 mp 68.48 -69.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.955 0.902 . . . . 0.0 111.748 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 65.66 24.17 11.61 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.766 1.269 . . . . 0.0 110.341 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.2 tp -126.37 115.18 19.24 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.38 79.89 5.8 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -172.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -150.47 82.22 1.36 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -106.94 -175.17 2.72 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.437 -172.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.57 101.74 1.69 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.598 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.253 1.259 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.456 178.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.48 25.78 2.19 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.382 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 3' ' ' LYS . 73.3 mmtt -70.08 85.25 0.53 Allowed 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 122.363 1.077 . . . . 0.0 111.261 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -159.89 -47.33 0.05 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.25 109.71 21.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 169.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -118.02 148.28 42.4 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.038 0.447 . . . . 0.0 111.553 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -149.28 147.21 28.09 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.597 ' HD3' ' HE2' ' A' ' 10' ' ' LYS . 87.4 tttt -137.68 129.11 28.05 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 42' ' ' ASN . 7.7 pt-20 -79.69 102.66 9.1 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.733 0.778 . . . . 0.0 109.271 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.597 ' HE2' ' HD3' ' A' ' 8' ' ' LYS . 84.4 mttt -110.88 -78.25 0.59 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.642 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.93 102.35 7.49 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -89.41 143.15 27.05 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.021 0.439 . . . . 0.0 109.981 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -90.03 -20.36 23.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 170.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.34 8.12 0.66 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.181 -1.827 . . . . 0.0 112.346 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 74' ' ' TYR . 7.7 pt -67.18 -27.87 40.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.001 0.905 . . . . 0.0 108.746 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' N ' HG13 ' A' ' 15' ' ' ILE . 19.2 ptmt -79.55 -5.38 54.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.22 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -108.66 -19.94 13.26 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 2.8 tppt? -91.06 -68.0 0.82 Allowed 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.031 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.618 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 3.1 t80 -89.12 -22.6 22.79 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 58.28 88.96 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.417 1.487 . . . . 0.0 111.206 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.673 HD11 HD22 ' A' ' 66' ' ' LEU . 1.9 mm? -95.65 -20.31 19.04 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.08 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p 66.28 -5.55 0.57 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 126.901 2.08 . . . . 0.0 114.666 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.26 -167.08 37.49 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.656 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.66 113.09 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.282 2.655 . . . . 0.0 110.86 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.408 HG22 ' HB ' ' A' ' 55' ' ' ILE . 44.5 mm -103.79 127.72 57.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' C ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 -92.23 170.28 9.93 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.358 -176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.2 t -70.71 132.59 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.432 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -99.98 -30.03 3.33 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.749 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.171 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 30.5 m80 -165.41 161.92 19.14 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.27 116.61 33.01 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.681 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.03 154.54 17.64 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-O 121.813 0.816 . . . . 0.0 111.072 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.98 129.5 55.11 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.53 109.75 2.08 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 40.3 t -87.74 -5.96 58.42 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.619 0.723 . . . . 0.0 109.071 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.4 m -148.99 163.3 37.9 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.635 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.1 t70 -108.68 100.64 9.86 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 124.664 1.186 . . . . 0.0 110.734 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG12 ' CZ ' ' A' ' 46' ' ' PHE . 11.4 p -115.62 148.1 18.56 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.818 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.292 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.04 30.16 7.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.38 0.61 . . . . 0.0 112.461 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.92 59.85 1.55 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.037 -1.078 . . . . 0.0 113.236 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.81 140.97 15.07 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.53 31.0 20.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.841 0.456 . . . . 0.0 109.828 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 2.6 t-20 62.51 95.61 0.04 OUTLIER 'General case' 0 C--O 1.247 0.932 0 C-N-CA 125.001 1.32 . . . . 0.0 109.767 -176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.644 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 4.5 tt0 -150.13 -173.73 4.52 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.755 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.672 HD13 ' H ' ' A' ' 75' ' ' GLY . 45.6 tp -95.45 147.83 23.12 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 p -100.3 115.46 29.99 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 121.388 0.613 . . . . 0.0 110.096 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.421 ' CZ ' HG12 ' A' ' 37' ' ' VAL . 32.7 p90 -151.78 168.7 24.25 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.808 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.594 ' O ' ' HG2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -124.44 147.63 48.18 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 -176.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.456 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 20.2 tt0 -51.45 121.84 6.99 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.804 0.335 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.77 29.94 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 121.295 -0.479 . . . . 0.0 114.147 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 27.6 mm-40 -85.61 -32.39 22.08 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 117.96 0.88 . . . . 0.0 113.047 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 73.95 111.83 0.07 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.524 1.154 . . . . 0.0 111.272 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.52 HD13 HD23 ' A' ' 44' ' ' LEU . 4.8 mt -118.49 173.38 5.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.782 -173.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' H ' HG22 ' A' ' 52' ' ' ILE . 24.6 mt-10 -128.94 134.05 48.07 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.7 tp -91.35 128.95 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.415 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -107.09 -53.07 6.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.749 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.618 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 20.2 ttm180 -127.62 137.78 52.65 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.495 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.74 -32.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 123.975 0.91 . . . . 0.0 112.07 -176.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.8 p -102.81 164.1 11.83 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.4 t70 71.45 19.57 5.16 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.876 1.322 . . . . 0.0 108.828 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.519 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 30.8 p-10 -80.51 118.1 70.84 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.869 -174.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 12.1 Cg_exo -71.25 -33.29 11.56 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.737 2.958 . . . . 0.0 114.654 -175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 64' ' ' LYS . 1.5 mp0 -92.43 -17.07 25.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.135 0.493 . . . . 0.0 110.772 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.72 5.93 70.81 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 13.7 ptmt -102.88 162.59 12.81 Favored 'General case' 0 N--CA 1.414 -2.267 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.52 ' HB2' HG13 ' A' ' 77' ' ' ILE . 44.1 m0 -95.69 176.6 6.09 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 123.393 0.677 . . . . 0.0 110.676 -176.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 21' ' ' LEU . 51.8 tp -117.04 113.58 22.53 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.37 147.93 18.9 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 69' ' ' THR . 43.9 ttp180 -120.9 154.33 36.02 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.038 0.447 . . . . 0.0 111.117 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.586 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 10.6 m -99.4 153.13 19.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 174.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.24 -34.5 32.62 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 119.242 0.928 . . . . 0.0 113.272 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -71.65 -15.37 62.23 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.503 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.33 87.67 1.17 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 17.9 m -153.56 122.77 6.55 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 100.46 -3.904 . . . . 0.0 100.46 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.62 ' HB3' HD11 ' A' ' 66' ' ' LEU . 77.5 m-85 -113.37 99.21 7.61 Favored 'General case' 1 C--N 1.222 -4.951 0 O-C-N 123.902 0.751 . . . . 0.0 109.828 -171.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.672 ' H ' HD13 ' A' ' 44' ' ' LEU . . . -104.19 101.69 2.01 Favored Glycine 1 N--CA 1.356 -6.633 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 177.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.71 103.19 0.04 OUTLIER 'General case' 0 C--N 1.27 -2.884 0 CA-C-N 113.423 -1.389 . . . . 0.0 107.358 170.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.644 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 1.7 pt -87.71 143.89 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.97 0 C-N-CA 124.837 1.255 . . . . 0.0 113.728 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -77.09 117.6 18.81 Favored 'General case' 1 N--CA 1.371 -4.397 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 166.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.472 HG22 ' CG ' ' A' ' 65' ' ' TRP . 54.5 p -36.21 -39.48 0.18 Allowed 'General case' 0 C--N 1.244 -3.999 0 C-N-CA 128.868 2.867 . . . . 0.0 113.12 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -69.38 -12.61 61.8 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.255 1.022 . . . . 0.0 112.704 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.83 -12.75 41.06 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 121.591 -0.693 . . . . 0.0 110.997 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 52' ' ' ILE . 27.7 m -130.92 164.65 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-O 121.251 0.548 . . . . 0.0 111.088 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 45.6 mt-10 -132.26 113.29 13.06 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 19.4 pt -76.27 166.77 2.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.566 -176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.83 103.26 12.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 174.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -82.03 109.54 16.46 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.07 120.66 25.11 Favored 'General case' 0 C--N 1.275 -2.672 0 CA-C-O 121.645 0.735 . . . . 0.0 110.131 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.6 p -92.37 154.08 18.78 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.877 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.18 127.26 32.78 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.629 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -100.73 4.16 42.85 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.719 0.771 . . . . 0.0 110.363 -178.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.579 HD22 ' HG2' ' A' ' 90' ' ' LYS . 3.1 mm? -137.44 175.57 9.48 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -87.52 -51.73 5.75 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.49 ' HE2' ' HG2' ' A' ' 96' ' ' GLU . 87.2 tttt 171.83 78.73 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -72.97 -67.23 0.58 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.67 -1.15 . . . . 0.0 113.198 -170.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.7 tp -84.55 85.78 7.38 Favored 'General case' 0 C--O 1.253 1.251 0 CA-C-O 121.291 0.567 . . . . 0.0 111.661 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HG2' ' HE2' ' A' ' 93' ' ' LYS . 6.3 tp10 . . . . . 0 N--CA 1.434 -1.226 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 5' ' ' GLN . 42.9 mt-10 . . . . . 0 CA--C 1.494 -1.21 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -101.78 151.74 21.7 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.863 ' HE2' ' HA ' ' A' ' 3' ' ' LYS . 10.0 mmpt? 68.17 72.67 0.3 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.235 1.014 . . . . 0.0 112.098 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 60.05 75.76 0.39 Allowed 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.142 -1.39 . . . . 0.0 113.508 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.55 ' HB2' ' HB2' ' A' ' 1' ' ' GLU . 27.9 tt0 -72.92 142.56 47.87 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.294 172.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -91.42 124.68 35.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.25 79.87 0.24 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.545 0.688 . . . . 0.0 112.15 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -94.8 7.49 45.71 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.479 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 35.2 tt0 -80.03 -22.57 42.24 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.692 175.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -74.51 92.04 2.34 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -120.19 13.89 12.09 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.782 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.98 65.84 0.77 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.262 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -90.16 -23.82 21.22 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -54.54 -31.36 56.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.36 -1.745 . . . . 0.0 111.43 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.737 HG21 ' HB2' ' A' ' 74' ' ' TYR . 10.1 pt -68.8 -28.6 40.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 CA-C-O 121.418 0.628 . . . . 0.0 110.903 -174.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.481 ' N ' HG13 ' A' ' 15' ' ' ILE . 25.7 mtpp -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.072 0.939 . . . . 0.0 108.493 -176.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HB3' ' NZ ' ' A' ' 17' ' ' LYS . 7.4 mtpm? -114.72 9.07 16.33 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.921 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 76' ' ' TYR . 11.9 tppt? -120.41 -60.88 1.64 Allowed 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.209 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.7 t80 -91.53 -28.33 17.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HB3' ' NZ ' ' A' ' 20' ' ' LYS . 3.1 ttpm? 65.45 90.0 0.09 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.521 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 66' ' ' LEU . 1.7 mm? -98.73 -15.8 19.2 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.359 -174.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.307 80.4 p 69.83 -55.19 0.6 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.709 1.604 . . . . 0.0 113.079 -176.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.15 -147.87 5.58 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -81.12 173.59 11.68 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.663 2.242 . . . . 0.0 111.557 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.9 tp -160.15 130.37 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.545 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -79.52 168.61 19.19 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 53' ' ' GLU . 14.7 p -80.04 134.78 26.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 121.508 0.671 . . . . 0.0 110.498 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.27 -38.86 11.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.987 -178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.42 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.6 m80 -161.65 165.01 28.87 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.57 124.76 49.4 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.672 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -99.34 158.89 15.4 Favored 'General case' 0 C--N 1.267 -2.99 0 CA-C-O 121.805 0.812 . . . . 0.0 111.831 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -106.83 125.58 51.19 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.6 109.88 2.15 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.448 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 41.9 t -84.69 -19.24 33.13 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.3 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.0 t -144.55 144.75 31.47 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -82.94 105.83 14.26 Favored 'General case' 0 CA--C 1.49 -1.353 0 CA-C-O 121.913 0.863 . . . . 0.0 111.234 174.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.31 151.35 18.12 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.425 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.99 66.78 1.11 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 121.896 0.855 . . . . 0.0 109.655 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 73.16 59.18 4.35 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.213 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.51 105.75 2.95 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 57.11 69.52 0.74 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.17 0.988 . . . . 0.0 110.95 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 54.49 83.85 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.781 0.832 . . . . 0.0 109.843 -176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 7.7 tt0 -149.59 -175.3 4.96 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.625 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.8 OUTLIER -98.44 159.57 14.86 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.555 ' H ' HD23 ' A' ' 44' ' ' LEU . 14.8 m -101.42 118.68 37.46 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-O 121.566 0.698 . . . . 0.0 110.031 174.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.462 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 24.8 p90 -154.96 163.74 39.88 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.057 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.575 ' H ' ' CG ' ' A' ' 50' ' ' GLU . 48.1 mtmt -117.72 156.17 28.71 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -50.86 116.07 1.8 Allowed 'General case' 0 CA--C 1.568 1.656 0 O-C-N 123.833 0.708 . . . . 0.0 109.325 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.99 17.58 40.24 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.809 0.683 . . . . 0.0 114.809 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.575 ' CG ' ' H ' ' A' ' 47' ' ' LYS . 15.3 mm-40 -80.34 -21.83 42.06 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 72.11 109.23 0.07 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.319 1.057 . . . . 0.0 110.871 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.6 mt -116.1 165.44 11.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.518 ' HB3' HG21 ' A' ' 27' ' ' VAL . 8.0 mt-10 -116.66 136.78 52.69 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 65' ' ' TRP . 7.4 tp -98.58 119.69 46.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.38 -53.24 7.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 3.9 tpm_? -122.43 123.96 42.53 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.901 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -113.66 -23.75 4.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.498 0.666 . . . . 0.0 110.599 174.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 p -90.85 150.33 21.59 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.718 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 60.11 55.27 3.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.234 1.014 . . . . 0.0 108.513 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -95.82 109.22 45.18 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.478 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.71 -59.95 0.25 Allowed 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 124.008 3.139 . . . . 0.0 114.307 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.22 -17.52 56.63 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.687 0.28 . . . . 0.0 111.497 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.11 5.69 49.53 Favored Glycine 0 N--CA 1.435 -1.382 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -105.43 159.4 15.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.106 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.542 ' CD1' HG22 ' A' ' 57' ' ' ILE . 38.3 m0 -90.41 174.35 7.61 Favored 'General case' 0 C--O 1.198 -1.612 0 C-N-CA 123.459 0.703 . . . . 0.0 110.578 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 74' ' ' TYR . 58.0 tp -112.74 109.36 18.81 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.717 -0.393 . . . . 0.0 109.987 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 53' ' ' GLU . . . -114.08 155.13 16.52 Favored Glycine 0 N--CA 1.426 -1.986 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 73' ' ' SER . 57.8 ttp180 -133.95 147.1 51.01 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.586 HG22 ' HB2' ' A' ' 73' ' ' SER . 13.4 t -104.17 163.87 12.11 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -51.58 -28.98 15.61 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.479 ' NH2' ' HG2' ' A' ' 9' ' ' GLU . 1.1 tmt_? -76.36 -21.02 56.61 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.491 0.663 . . . . 0.0 110.637 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.03 1.07 Allowed Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 59.6 m -152.54 125.5 8.5 Favored 'General case' 0 N--CA 1.386 -3.67 1 N-CA-C 100.03 -4.063 . . . . 0.0 100.03 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.83 ' HB3' HD11 ' A' ' 66' ' ' LEU . 35.1 m-85 -110.6 82.7 1.63 Allowed 'General case' 1 C--N 1.21 -5.482 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.28 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.625 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -98.44 97.48 1.9 Allowed Glycine 2 N--CA 1.363 -6.22 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 -178.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.519 ' CE1' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.84 93.68 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 112.883 -1.659 . . . . 0.0 110.727 172.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 3.2 pt -70.92 139.91 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 126.9 2.08 . . . . 0.0 113.617 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 118.03 18.2 Favored 'General case' 1 N--CA 1.353 -5.31 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 166.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CD2' ' A' ' 65' ' ' TRP . 73.7 p -35.1 -39.1 0.1 Allowed 'General case' 1 C--N 1.229 -4.67 0 C-N-CA 129.116 2.966 . . . . 0.0 112.807 178.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -72.02 -5.86 38.13 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 123.752 0.821 . . . . 0.0 112.26 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.0 -2.62 34.06 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.625 -0.672 . . . . 0.0 111.122 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 77' ' ' ILE . 19.3 m -134.38 159.86 41.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 CA-C-O 121.784 0.802 . . . . 0.0 112.722 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.1 mt-10 -125.94 102.89 7.47 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 171.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' A' ' 31' ' ' ALA . 2.4 pp -69.14 149.21 11.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.63 103.78 0.72 Allowed 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 121.143 0.497 . . . . 0.0 111.162 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -71.35 115.76 10.89 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -58.11 104.83 0.22 Allowed 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -175.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.0 m -137.58 97.67 3.51 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.473 177.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 61.3 tp -121.41 108.54 13.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.528 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 64.82 69.89 0.49 Allowed 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 124.098 0.959 . . . . 0.0 112.861 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.13 167.66 14.5 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.825 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 9.6 mmpt? -91.84 -60.06 1.96 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.493 0.663 . . . . 0.0 109.343 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.53 155.1 49.63 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 173.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -135.07 76.01 1.6 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.311 1.053 . . . . 0.0 109.263 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.0 tp -110.07 -32.13 7.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 N--CA 1.422 -1.829 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 174.805 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.572 0 CA-C-O 120.766 0.317 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -83.67 89.36 7.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.464 0.65 . . . . 0.0 110.515 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.799 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -134.69 31.09 3.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.619 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 72.44 140.73 0.06 Allowed 'General case' 0 C--O 1.242 0.665 0 C-N-CA 125.517 1.527 . . . . 0.0 113.393 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 78.05 -49.26 0.48 Allowed 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.999 1.72 . . . . 0.0 112.779 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? 68.47 103.7 0.05 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 124.276 1.03 . . . . 0.0 110.136 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.25 118.37 9.18 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.906 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 68.97 -72.58 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.736 1.615 . . . . 0.0 109.524 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 176.4 -73.37 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 125.884 1.674 . . . . 0.0 106.868 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.27 42.64 0.67 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.349 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 13' ' ' GLN . 88.8 tttt -65.83 118.01 9.05 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.696 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.651 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -98.0 39.18 1.24 Allowed 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 125.402 1.481 . . . . 0.0 110.706 -176.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.518 ' HB3' ' HE2' ' A' ' 11' ' ' LYS . 11.0 pt20 -58.71 -35.29 72.42 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.23 0.538 . . . . 0.0 111.694 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -65.63 -23.77 66.89 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.673 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 12' ' ' GLU . 10.0 pt -81.31 -23.22 10.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.585 1.183 . . . . 0.0 109.17 -171.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HG3' HG13 ' A' ' 15' ' ' ILE . 74.0 mttt -82.19 -9.07 59.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.32 -1.763 . . . . 0.0 110.791 -173.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 0.07 19.45 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.008 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 3.8 tppt? -114.18 -58.5 2.14 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.382 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 60' ' ' ASN . 20.1 t80 -85.94 -33.46 21.16 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 66.82 94.23 0.07 Allowed 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.531 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.85 HD11 HD22 ' A' ' 66' ' ' LEU . 2.0 mm? -99.76 -64.85 1.0 Allowed 'General case' 0 CA--C 1.46 -2.518 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.052 -173.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 m 58.32 82.49 0.13 Allowed 'General case' 0 N--CA 1.395 -3.225 0 CA-C-N 111.678 -2.51 . . . . 0.0 111.115 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.33 116.04 2.25 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.74 137.61 42.09 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 123.701 2.934 . . . . 0.0 112.276 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.571 HG23 ' HB ' ' A' ' 55' ' ' ILE . 20.8 tt -127.9 150.62 33.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.248 0.546 . . . . 0.0 111.104 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -99.36 175.76 5.75 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.317 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -74.76 132.0 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 CA-C-O 121.967 0.889 . . . . 0.0 109.891 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.8 mm -93.48 -33.26 5.16 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.952 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.458 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.7 m80 -166.72 165.64 16.32 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.507 HD23 HE21 ' A' ' 51' ' ' GLN . 5.2 mp -107.63 116.01 31.18 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.24 159.34 15.32 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-O 121.944 0.878 . . . . 0.0 112.243 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -107.39 127.94 54.02 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.377 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.433 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -64.43 107.02 1.24 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 t -75.37 -19.12 59.75 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.438 -176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.0 p -153.15 159.58 42.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 48' ' ' GLN . 4.5 p30 -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.621 0.724 . . . . 0.0 109.543 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.686 HG22 ' H ' ' A' ' 39' ' ' GLY . 11.4 p -115.72 152.54 17.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.631 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.78 8.75 39.34 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.861 -0.735 . . . . 0.0 111.967 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.686 ' H ' HG22 ' A' ' 37' ' ' VAL . . . 84.01 60.21 1.98 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.52 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.43 80.08 1.68 Allowed Glycine 0 C--N 1.313 -0.705 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.263 -174.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 66.72 82.9 0.17 Allowed 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.328 1.051 . . . . 0.0 113.309 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 89.28 26.12 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 125.516 1.526 . . . . 0.0 113.114 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -120.82 174.81 6.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.403 0.621 . . . . 0.0 111.668 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' HA3' ' A' ' 75' ' ' GLY . 46.4 tp -96.42 147.91 23.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 125.531 1.533 . . . . 0.0 107.315 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -96.89 121.81 39.16 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 120.907 0.385 . . . . 0.0 110.313 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.458 ' CG ' HD11 ' A' ' 52' ' ' ILE . 26.9 p90 -155.66 160.04 40.08 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.616 -176.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -108.91 152.42 24.95 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -62.48 117.14 5.79 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.907 0.754 . . . . 0.0 109.355 -176.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.78 30.03 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.567 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.94 -25.12 16.67 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.507 HE21 HD23 ' A' ' 30' ' ' LEU . 42.7 tt0 72.83 134.32 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 O-C-N 124.8 1.313 . . . . 0.0 113.041 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 82' ' ' VAL . 5.3 mt -129.64 169.86 19.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.339 -173.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -119.07 135.5 54.61 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.508 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.1 tp -93.16 127.04 45.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.571 ' HB ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -110.92 -56.93 4.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HD2' HD12 ' A' ' 21' ' ' LEU . 12.6 ttt180 -119.09 131.9 55.97 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.921 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.507 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -116.83 -32.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.063 -178.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 p -107.36 161.11 15.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 38.4 t70 64.79 69.16 0.5 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 125.522 1.529 . . . . 0.0 112.814 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 9.2 p30 -145.09 163.3 33.41 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.538 175.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -95.72 10.91 1.48 Allowed 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 122.218 1.946 . . . . 0.0 115.416 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 8.4 tp10 -122.98 -29.91 3.86 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.985 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.05 57.61 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.6 ptmt -92.5 163.12 13.94 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 109.266 -177.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.542 ' CD2' HG22 ' A' ' 79' ' ' THR . 43.2 m0 -101.89 169.53 8.72 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 120.893 0.377 . . . . 0.0 110.592 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.85 HD22 HD11 ' A' ' 21' ' ' LEU . 45.7 tp -109.58 110.51 21.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -112.74 142.83 17.5 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 73' ' ' SER . 50.2 ttt-85 -124.32 155.02 39.43 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 124.319 0.658 . . . . 0.0 110.188 -177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.551 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 5.2 m -113.52 162.05 16.64 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.96 -28.97 7.57 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -172.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -69.99 -28.52 65.59 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 123.034 0.534 . . . . 0.0 111.577 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 96.07 69.0 1.01 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -174.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.665 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.4 m -136.62 117.09 13.75 Favored 'General case' 0 N--CA 1.383 -3.806 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.629 ' HB2' HG21 ' A' ' 15' ' ' ILE . 90.2 m-85 -116.68 105.1 12.05 Favored 'General case' 1 C--N 1.223 -4.925 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 -172.027 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 44' ' ' LEU . . . -102.84 0.75 48.42 Favored Glycine 0 C--O 1.181 -3.19 0 C-N-CA 118.372 -1.87 . . . . 0.0 116.255 -175.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.584 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.268 0.1 OUTLIER 51.2 80.44 0.08 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 123.103 1.43 . . . . 0.0 111.417 -176.976 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 82' ' ' VAL . 2.0 pt -68.57 142.17 16.6 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.66 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.51 115.51 20.07 Favored 'General case' 1 N--CA 1.362 -4.831 0 N-CA-C 102.316 -3.216 . . . . 0.0 102.316 165.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 64' ' ' LYS . 73.1 p -34.95 -38.3 0.08 Allowed 'General case' 1 C--N 1.244 -4.008 0 C-N-CA 128.918 2.887 . . . . 0.0 114.422 -177.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 t -68.98 -7.1 32.11 Favored 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 123.951 0.9 . . . . 0.0 111.709 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.26 -6.86 43.59 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 121.466 -0.771 . . . . 0.0 110.657 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 HD12 ' A' ' 77' ' ' ILE . 26.3 m -137.52 167.88 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-O 121.618 0.723 . . . . 0.0 112.365 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -135.78 115.61 13.05 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 18.8 pt -77.81 163.03 3.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.545 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -95.92 118.73 33.11 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.32 156.07 21.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.311 0.577 . . . . 0.0 110.53 -177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -128.96 117.62 21.26 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.9 m -85.14 142.21 29.65 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.985 0.421 . . . . 0.0 110.127 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 92' ' ' LYS . 3.0 mm? -94.59 84.23 4.25 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.975 0.416 . . . . 0.0 110.857 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -82.42 -16.85 47.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.6 mt -94.46 7.86 44.09 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 89' ' ' LEU . 37.7 ttpt -126.89 98.16 5.24 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.33 73.61 0.11 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.469 1.128 . . . . 0.0 110.709 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -81.86 77.14 8.73 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.452 -0.78 . . . . 0.0 109.784 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.98 72.01 1.45 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.196 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 . . . . . 0 C--N 1.303 -1.425 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.305 179.062 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 . . . . . 0 CA--C 1.508 -0.635 0 CA-C-O 121.228 0.537 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 5' ' ' GLN . 50.3 tttm -90.56 90.31 7.94 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -85.23 2.39 44.03 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.333 1.063 . . . . 0.0 110.486 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.407 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 13.8 pt20 -97.45 161.95 13.54 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.398 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.602 ' HG2' ' H ' ' A' ' 7' ' ' GLU . 84.8 tttt -179.32 -174.59 0.32 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 103.375 -2.824 . . . . 0.0 103.375 176.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.602 ' H ' ' HG2' ' A' ' 6' ' ' LYS . 3.3 mp0 -75.07 86.31 2.35 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 119.147 0.885 . . . . 0.0 109.73 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -83.9 83.57 7.89 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 122.977 1.37 . . . . 0.0 110.605 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.3 117.01 33.61 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.352 -178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -68.53 -45.13 73.04 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.319 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -152.82 165.99 33.67 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.639 0.733 . . . . 0.0 111.63 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HG2' ' CE1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -85.53 77.57 9.84 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.388 176.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.09 -41.96 11.37 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.25 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -57.91 -32.88 68.17 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.701 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.785 HG21 ' HB2' ' A' ' 74' ' ' TYR . 7.1 pt -62.89 -33.4 60.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.068 -176.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' N ' HG13 ' A' ' 15' ' ' ILE . 9.4 mptt -80.02 -4.34 52.22 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.174 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 42.7 tptt -112.99 -13.79 13.07 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -98.51 -61.76 1.33 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.074 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -87.62 -26.56 23.0 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.7 mttp 66.07 83.8 0.16 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.804 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 66' ' ' LEU . 1.2 mm? -100.19 -69.76 0.76 Allowed 'General case' 0 CA--C 1.466 -2.273 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.457 ' H ' ' HB2' ' A' ' 21' ' ' LEU . 3.0 m 62.44 76.94 0.35 Allowed 'General case' 0 N--CA 1.388 -3.53 0 CA-C-N 111.881 -2.418 . . . . 0.0 112.272 175.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.25 161.3 11.9 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.82 108.77 2.6 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.557 2.172 . . . . 0.0 110.486 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.502 HD13 ' HB ' ' A' ' 55' ' ' ILE . 2.5 pp -113.53 171.2 4.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.59 -171.47 2.52 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.83 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.1 p -94.05 145.3 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.5 mm -100.9 -38.9 6.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.441 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 33.5 m80 -160.64 168.57 24.65 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -101.19 118.38 36.86 Favored 'General case' 0 C--O 1.191 -1.998 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.676 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -98.0 155.75 16.96 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-O 122.14 0.971 . . . . 0.0 110.659 176.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -103.65 129.88 51.03 Favored 'General case' 1 C--N 1.243 -4.05 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 48' ' ' GLN . . . -67.67 110.76 3.87 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 169.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.542 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 20.7 t -80.46 -18.29 49.15 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.629 0.728 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.6 m -144.33 155.09 43.65 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -93.97 105.01 17.04 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.8 p -114.74 163.46 11.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.445 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.8 10.17 28.77 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 100.26 61.08 0.82 Allowed Glycine 0 CA--C 1.491 -1.459 0 C-N-CA 118.262 -1.923 . . . . 0.0 109.459 -173.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.05 99.66 1.42 Allowed Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -172.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? 61.91 76.88 0.35 Allowed 'General case' 0 C--O 1.247 0.972 0 C-N-CA 125.387 1.475 . . . . 0.0 110.741 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 t30 57.7 70.49 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.002 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.705 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 39.8 tt0 -145.67 -175.07 4.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.876 -176.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.539 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.52 153.73 17.96 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -102.27 128.06 48.98 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 120.962 0.411 . . . . 0.0 109.96 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -158.82 171.33 20.26 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.051 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 98.7 mttt -120.44 142.8 48.9 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 7.2 pt20 -54.99 124.48 16.9 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.53 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.61 10.34 55.6 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.717 -174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 6.9 tp10 -69.66 -37.87 76.87 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 121.883 0.849 . . . . 0.0 110.103 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 5.7 tp60 70.51 102.14 0.06 Allowed 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 126.205 1.802 . . . . 0.0 108.851 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.508 HD12 ' CG1' ' A' ' 82' ' ' VAL . 13.1 mt -104.23 156.02 5.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -174.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.83 ' HB3' HG21 ' A' ' 27' ' ' VAL . 34.3 mt-10 -116.06 126.55 53.92 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -85.4 118.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -104.15 -38.35 4.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.723 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -132.73 130.51 40.1 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 118.095 -1.442 . . . . 0.0 110.811 179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.616 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -125.81 -32.68 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.683 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -85.06 143.66 28.75 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.08 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.1 t70 66.99 53.41 0.82 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.818 1.295 . . . . 0.0 109.752 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -94.51 114.89 64.52 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.452 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.46 -53.67 0.28 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.917 1.745 . . . . 0.0 111.137 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 1.012 ' HG2' ' HD2' ' A' ' 64' ' ' LYS . 7.0 tp10 -66.56 -40.56 89.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.43 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.31 -18.11 18.48 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 1.012 ' HD2' ' HG2' ' A' ' 62' ' ' GLU . 14.0 ptmt -76.11 163.32 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.529 1.132 . . . . 0.0 109.299 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.616 ' CD1' HG22 ' A' ' 57' ' ' ILE . 27.6 m0 -95.31 164.84 12.66 Favored 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 122.862 0.465 . . . . 0.0 112.157 -175.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.765 HD11 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -111.79 113.76 26.31 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -126.56 160.3 20.89 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.676 ' HA ' ' O ' ' A' ' 73' ' ' SER . 54.5 ttp180 -131.47 152.72 50.46 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.444 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 24.7 m -112.76 164.59 13.19 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.04 -18.31 9.21 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 71' ' ' ARG . 2.3 tmm_? -82.93 -24.98 32.81 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 83.9 1.66 Allowed Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 14.6 m -151.69 117.58 5.49 Favored 'General case' 0 N--CA 1.383 -3.824 0 N-CA-C 101.041 -3.689 . . . . 0.0 101.041 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.785 ' HB2' HG21 ' A' ' 15' ' ' ILE . 22.2 m-85 -109.97 83.23 1.72 Allowed 'General case' 1 C--N 1.219 -5.085 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -174.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -99.84 97.35 1.76 Allowed Glycine 2 N--CA 1.369 -5.808 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -177.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.597 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -40.82 100.75 0.02 OUTLIER 'General case' 0 C--N 1.266 -3.026 0 CA-C-N 112.555 -1.822 . . . . 0.0 109.163 171.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.725 ' H ' HD13 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -81.42 147.99 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.512 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.371 -177.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 9.6 ptpp? -76.35 118.45 19.06 Favored 'General case' 1 N--CA 1.358 -5.06 0 N-CA-C 102.915 -2.995 . . . . 0.0 102.915 163.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.499 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.6 p -36.46 -39.36 0.19 Allowed 'General case' 1 C--N 1.241 -4.151 0 C-N-CA 128.193 2.597 . . . . 0.0 113.026 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.1 -10.0 55.46 Favored 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 123.882 0.873 . . . . 0.0 112.25 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.77 -9.84 36.19 Favored 'General case' 0 C--O 1.239 0.551 0 O-C-N 121.426 -0.796 . . . . 0.0 111.028 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 52' ' ' ILE . 13.3 m -126.58 167.23 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.129 0.49 . . . . 0.0 111.482 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.98 113.02 9.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 174.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.9 pt -75.46 159.39 5.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 119.106 -1.038 . . . . 0.0 112.116 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -96.28 117.18 30.28 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -78.28 165.32 24.02 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.671 -175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.09 -41.95 97.12 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.298 0.571 . . . . 0.0 109.767 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 p -107.16 142.39 36.93 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.484 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.78 101.56 13.26 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.496 0.665 . . . . 0.0 110.625 -175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.16 -165.77 1.51 Allowed 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 173.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.63 155.21 21.76 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 170.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 92' ' ' LYS . 6.1 tmtm? -118.92 20.97 12.63 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 123.727 1.727 . . . . 0.0 106.695 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -155.28 149.97 26.4 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 80.08 -41.64 0.22 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.0 0.92 . . . . 0.0 111.708 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.435 ' HG ' ' HG3' ' A' ' 96' ' ' GLU . 66.8 tp -68.52 -69.53 0.32 Allowed 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HG3' ' HG ' ' A' ' 95' ' ' LEU . 36.7 mt-10 . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 . . . . . 0 CA--C 1.499 -0.992 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -124.77 169.59 11.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.87 152.03 19.17 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.72 12.17 1.41 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 122.949 0.5 . . . . 0.0 111.77 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.664 ' HA ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -72.86 88.52 1.34 Allowed 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.708 0.766 . . . . 0.0 109.064 178.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.632 ' HD2' ' HG3' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -108.03 -15.28 14.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.434 178.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.632 ' HG3' ' HD2' ' A' ' 6' ' ' LYS . 46.9 mt-10 -92.42 77.49 5.09 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.608 0.718 . . . . 0.0 109.783 176.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 5' ' ' GLN . 97.0 mttt -109.44 -60.78 1.72 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -109.07 -173.66 2.32 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -89.06 39.92 0.96 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.683 0.754 . . . . 0.0 109.82 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.0 pttt 47.79 30.16 1.79 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.146 1.778 . . . . 0.0 113.375 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.826 ' HG2' ' HD1' ' A' ' 74' ' ' TYR . 4.4 mp0 55.17 42.02 31.01 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 124.662 1.185 . . . . 0.0 111.705 176.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -80.03 -30.79 39.57 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.715 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 13.1 pt-20 -61.83 -38.16 87.12 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.396 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 12' ' ' GLU . 2.1 pp -64.52 -24.07 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 C-N-CA 124.785 1.234 . . . . 0.0 113.119 -169.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HA ' HD23 ' A' ' 21' ' ' LEU . 12.4 mptt -54.48 -58.82 5.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 124.125 0.891 . . . . 0.0 113.139 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -83.78 8.89 13.3 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-O 121.058 0.456 . . . . 0.0 111.783 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 14' ' ' GLU . 30.5 mmmt -92.16 -61.34 1.64 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.596 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.4 t80 -86.58 -21.63 26.74 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.2 tttm 71.55 83.46 0.14 Allowed 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.077 0.941 . . . . 0.0 110.134 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.734 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.6 -65.0 0.99 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.393 -177.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 5.1 t 36.93 75.42 0.06 Allowed 'General case' 0 C--O 1.251 1.17 0 C-N-CA 126.136 1.775 . . . . 0.0 114.047 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.03 170.3 19.16 Favored Glycine 0 N--CA 1.426 -1.992 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.099 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.21 132.68 28.42 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.464 2.776 . . . . 0.0 111.545 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.8 tp -148.65 145.28 18.31 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.423 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -129.09 174.81 9.22 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.04 131.8 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.227 0 CA-C-O 121.296 0.57 . . . . 0.0 109.744 173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.6 mm -96.57 -33.51 4.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.95 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.476 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 34.8 m80 -165.13 174.03 10.78 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -173.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.87 116.55 30.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.288 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.717 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -97.09 156.02 16.56 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-O 121.703 0.763 . . . . 0.0 111.688 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -107.12 123.95 48.98 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' HD1' ' A' ' 46' ' ' PHE . . . -65.36 106.16 1.31 Allowed 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 174.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.9 t -87.25 -8.41 56.83 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.344 -174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.5 t -144.6 130.71 19.49 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' HB2' ' HE2' ' A' ' 47' ' ' LYS . 7.2 p-10 -77.13 99.49 5.41 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.45 1.119 . . . . 0.0 108.339 172.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.78 163.25 11.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.566 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -124.51 25.37 7.62 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.787 0.327 . . . . 0.0 111.063 -179.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.96 60.13 0.84 Allowed Glycine 0 CA--C 1.503 -0.671 0 C-N-CA 119.827 -1.178 . . . . 0.0 111.113 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.53 91.67 0.66 Allowed Glycine 0 C--N 1.316 -0.545 0 O-C-N 123.808 0.357 . . . . 0.0 112.948 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt 61.92 72.11 0.52 Allowed 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.996 1.319 . . . . 0.0 109.797 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 58.48 80.15 0.19 Allowed 'General case' 0 C--O 1.249 1.031 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.227 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 10.3 tt0 -145.1 -175.92 4.89 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.311 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 45' ' ' SER . 2.3 tt -96.44 149.59 21.55 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.443 ' N ' HD23 ' A' ' 44' ' ' LEU . 20.2 m -98.21 115.3 28.05 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.342 0.591 . . . . 0.0 110.052 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.537 ' HD1' ' HB1' ' A' ' 33' ' ' ALA . 22.3 p90 -144.52 161.63 38.61 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.295 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.558 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 9.5 mmpt? -114.92 154.74 28.16 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 26.7 mt-30 -53.49 126.16 20.54 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.075 0.859 . . . . 0.0 110.873 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.39 20.77 74.27 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.753 -0.658 . . . . 0.0 114.451 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 30.4 mm-40 -74.83 -30.37 61.36 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.725 0.762 . . . . 0.0 112.844 178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER 75.61 116.99 0.06 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.906 1.379 . . . . 0.0 109.032 -176.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.536 HD12 ' CG1' ' A' ' 82' ' ' VAL . 12.8 mt -118.26 154.52 20.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -111.83 139.13 47.56 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.369 -0.932 . . . . 0.0 108.809 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.0 tp -94.77 126.9 47.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -47.55 8.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.959 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.64 HH21 ' HB3' ' A' ' 59' ' ' ASP . 22.9 ttt180 -130.47 133.58 46.41 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.5 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -125.0 -33.95 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.781 -178.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -100.01 150.12 22.77 Favored 'General case' 0 C--O 1.25 1.106 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.896 -177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.64 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.7 t70 62.32 69.27 0.62 Allowed 'General case' 0 C--N 1.321 -0.658 0 O-C-N 124.566 1.166 . . . . 0.0 108.264 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.53 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 7.2 p30 -112.75 139.37 22.73 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 113.594 -1.639 . . . . 0.0 110.379 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 11.9 Cg_exo -73.61 -58.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.893 2.395 . . . . 0.0 114.345 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -76.93 -42.74 38.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.647 0.737 . . . . 0.0 111.07 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.53 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 121.13 17.86 3.97 Favored Glycine 0 C--N 1.296 -1.687 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -174.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.671 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 16.2 ptmt -117.24 162.56 17.68 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.598 ' CD2' HG22 ' A' ' 79' ' ' THR . 35.8 m0 -97.21 171.37 8.49 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 123.103 0.561 . . . . 0.0 111.63 -173.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.734 HD22 HD11 ' A' ' 21' ' ' LEU . 50.4 tp -112.11 105.88 14.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -113.44 161.02 12.83 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' A' ' 73' ' ' SER . 53.8 ttp180 -138.81 153.64 48.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.204 0.525 . . . . 0.0 110.491 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 11.5 m -100.02 154.68 18.2 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.7 -33.25 60.7 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.91 0.777 . . . . 0.0 112.803 -173.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -2.77 41.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.19 96.76 0.79 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.431 0.462 . . . . 0.0 112.752 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.689 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 24.5 m -154.78 120.69 5.19 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 175.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.826 ' HD1' ' HG2' ' A' ' 12' ' ' GLU . 70.2 m-85 -117.43 94.32 4.5 Favored 'General case' 1 C--N 1.221 -5.019 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -177.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 43' ' ' GLU . . . -109.52 11.92 33.07 Favored Glycine 1 CA--C 1.437 -4.836 0 C-N-CA 117.283 -2.389 . . . . 0.0 115.679 -173.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.671 ' O ' ' HE2' ' A' ' 64' ' ' LYS 0.275 0.1 OUTLIER 47.28 89.73 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.341 0 CA-C-O 122.764 1.269 . . . . 0.0 111.754 -178.413 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.696 HD12 HG21 ' A' ' 82' ' ' VAL . 2.3 pt -70.5 140.39 18.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.573 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 64' ' ' LYS . 7.5 ptpp? -80.1 118.55 21.91 Favored 'General case' 1 N--CA 1.372 -4.343 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 165.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.598 HG22 ' CD2' ' A' ' 65' ' ' TRP . 70.7 p -34.96 -33.05 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.939 0 C-N-CA 128.905 2.882 . . . . 0.0 114.435 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 t -77.02 -11.81 59.85 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 123.293 0.637 . . . . 0.0 112.229 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.24 -3.76 53.15 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.213 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.696 HG21 HD12 ' A' ' 77' ' ' ILE . 16.4 m -133.23 170.21 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.35 0 CA-C-O 121.538 0.685 . . . . 0.0 110.93 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -135.45 107.56 7.18 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.717 HG22 ' HB2' ' A' ' 31' ' ' ALA . 18.5 pt -80.81 165.62 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 118.85 -1.14 . . . . 0.0 111.508 -177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 88' ' ' SER . 19.4 t70 -79.0 103.28 8.84 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.933 175.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -88.42 -55.59 3.66 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.93 93.95 9.46 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.518 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.421 ' HA ' ' OD2' ' A' ' 85' ' ' ASP . 55.3 m -68.28 131.29 45.1 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.318 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.0 mt 61.59 75.75 0.39 Allowed 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 124.919 1.387 . . . . 0.0 109.688 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.91 103.72 0.61 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.122 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.2 mt -77.68 -31.69 52.66 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.266 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.18 141.66 29.18 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -122.96 90.23 3.26 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.875 0.845 . . . . 0.0 110.722 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -160.49 104.7 1.43 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 176.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.7 tp 69.37 96.89 0.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 O-C-N 124.619 1.199 . . . . 0.0 109.302 -172.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 C--N 1.292 -1.904 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.847 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 . . . . . 0 C--O 1.234 0.24 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -81.4 168.45 18.34 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.004 0.522 . . . . 0.0 111.577 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 17' ' ' LYS . 12.5 mptt -80.88 142.39 33.64 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 176.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.625 ' HG2' ' HB2' ' A' ' 9' ' ' GLU . 8.6 tp10 -82.91 107.89 15.84 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -126.86 -21.95 3.94 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.307 -174.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.58 ' HD3' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -85.64 -8.94 57.94 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 121.93 0.872 . . . . 0.0 109.899 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.82 ' HG3' ' H ' ' A' ' 9' ' ' GLU . 9.5 tp10 -146.36 167.45 23.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 177.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -97.64 -12.84 21.97 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 118.801 0.728 . . . . 0.0 109.903 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.82 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 37.5 tt0 72.56 -65.89 0.33 Allowed 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.215 1.406 . . . . 0.0 110.047 -176.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.438 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 88.2 tttt -169.38 141.65 2.51 Favored 'General case' 0 N--CA 1.419 -2.01 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 10' ' ' LYS . 86.5 mttt 67.32 -161.37 0.23 Allowed 'General case' 0 C--O 1.242 0.698 0 O-C-N 124.517 1.136 . . . . 0.0 108.716 -176.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -94.01 155.24 17.23 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.653 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -71.43 -63.44 1.12 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -174.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 40.8 mt-10 -58.72 -27.8 65.23 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -172.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.607 ' HA ' ' HE1' ' A' ' 76' ' ' TYR . 1.9 pp -65.85 -29.66 47.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.386 0.612 . . . . 0.0 110.413 -173.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 55.4 mtpt -71.49 -34.86 70.52 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 114.062 -1.427 . . . . 0.0 112.011 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.484 ' HD2' ' HG2' ' A' ' 3' ' ' LYS . 60.7 tttm -102.45 -12.82 17.56 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.959 -178.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 7.4 tppt? -82.32 -54.26 5.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 -178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.593 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 9.9 t80 -86.36 -28.09 23.85 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 25.7 ttpt 71.33 89.99 0.1 Allowed 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.565 1.146 . . . . 0.0 110.328 -178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.726 HD11 HD22 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -98.66 -56.47 2.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.316 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 p 56.83 82.42 0.12 Allowed 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 124.701 1.2 . . . . 0.0 112.439 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 122.68 139.18 5.47 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 -176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.97 112.52 1.18 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.75 2.3 . . . . 0.0 111.797 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.524 HD12 ' HB ' ' A' ' 55' ' ' ILE . 41.3 pt -94.35 -176.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.349 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.34 169.91 16.72 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.623 -175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.626 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.4 p -83.81 123.5 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 122.266 1.032 . . . . 0.0 110.543 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.8 mm -85.71 -34.51 8.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.33 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.029 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -167.19 166.2 15.03 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp -105.01 116.21 31.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -90.18 154.06 20.04 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 122.087 0.946 . . . . 0.0 110.914 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -106.95 119.29 38.97 Favored 'General case' 0 C--N 1.254 -3.546 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -66.06 103.7 1.01 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 80.0 m -87.65 -10.98 49.79 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.146 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.3 m -136.12 130.55 33.49 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.765 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -76.7 102.89 6.39 Favored 'General case' 0 CA--C 1.49 -1.364 0 CA-C-O 121.69 0.757 . . . . 0.0 110.402 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.34 155.68 15.47 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.623 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 55.85 1.65 Allowed 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.513 0.673 . . . . 0.0 111.413 177.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 60.5 1.73 Allowed Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.469 -1.348 . . . . 0.0 113.694 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.42 78.42 1.62 Allowed Glycine 0 C--N 1.309 -0.964 0 N-CA-C 112.05 -0.42 . . . . 0.0 112.05 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttm 67.32 81.21 0.2 Allowed 'General case' 0 C--O 1.25 1.081 0 C-N-CA 124.857 1.263 . . . . 0.0 110.362 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.1 m120 56.15 74.51 0.39 Allowed 'General case' 0 CA--C 1.495 -1.137 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.604 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 7.4 tt0 -144.3 -175.52 4.66 Favored 'General case' 0 N--CA 1.41 -2.435 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.142 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.548 ' HB3' ' HD2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -98.42 157.86 15.94 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -177.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 m -102.86 115.93 31.56 Favored 'General case' 0 N--CA 1.41 -2.475 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.548 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 25.2 p90 -148.06 153.97 39.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.172 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 68.0 mttm -105.75 151.3 24.62 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.298 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.533 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -55.6 113.66 1.54 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 175.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.71 21.14 22.33 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.106 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 14.4 tp10 -73.05 -44.27 60.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.224 0.61 . . . . 0.0 111.638 -176.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 74.71 107.3 0.07 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.96 1.412 . . . . 0.0 109.218 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.594 HD12 ' CG1' ' A' ' 82' ' ' VAL . 7.6 mt -116.61 164.07 13.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 114.282 -1.326 . . . . 0.0 107.721 -172.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.626 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 21.9 mt-10 -116.68 133.38 56.08 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.7 tp -92.21 124.58 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.609 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.22 -37.57 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -177.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.536 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 31.7 ttm180 -136.77 133.56 36.12 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.619 175.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -127.27 -19.85 2.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 124.789 1.235 . . . . 0.0 111.832 -176.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.3 p -99.94 143.93 29.59 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 59.32 67.37 0.91 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 124.877 1.36 . . . . 0.0 110.296 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.606 HD21 ' HD1' ' A' ' 65' ' ' TRP . 8.4 m120 -86.68 130.94 47.02 Favored Pre-proline 0 C--N 1.295 -1.763 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.331 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.593 ' HG3' ' HA ' ' A' ' 19' ' ' PHE . 9.8 Cg_endo -55.61 -66.46 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.734 2.289 . . . . 0.0 112.219 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.721 ' HB2' ' HD2' ' A' ' 64' ' ' LYS . 42.4 mt-10 -94.43 -3.76 49.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.26 0.553 . . . . 0.0 110.932 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.99 -17.12 35.57 Favored Glycine 0 C--N 1.311 -0.852 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.721 ' HD2' ' HB2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -77.31 152.48 34.52 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.693 -179.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.606 ' HD1' HD21 ' A' ' 60' ' ' ASN . 34.6 m0 -87.08 177.06 7.32 Favored 'General case' 0 C--O 1.202 -1.408 0 C-N-CA 124.282 1.033 . . . . 0.0 110.344 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.726 HD22 HD11 ' A' ' 21' ' ' LEU . 52.5 tp -113.89 113.78 25.34 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -118.48 154.01 16.74 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 73' ' ' SER . 59.4 ttp180 -137.25 152.02 49.35 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.237 0.542 . . . . 0.0 110.786 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.587 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 21.6 m -100.71 157.15 16.9 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 175.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.43 14.94 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -73.6 -12.18 60.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' HA2' ' HD2' ' A' ' 68' ' ' ARG . . . 84.14 87.01 0.86 Allowed Glycine 0 N--CA 1.433 -1.546 0 CA-C-O 121.718 0.621 . . . . 0.0 111.812 -177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.2 m -151.12 121.43 7.3 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 100.229 -3.989 . . . . 0.0 100.229 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.609 ' HE2' HG13 ' A' ' 55' ' ' ILE . 52.8 m-85 -115.84 90.21 3.28 Favored 'General case' 1 C--N 1.232 -4.501 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -171.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -106.56 96.84 1.16 Allowed Glycine 3 N--CA 1.375 -5.385 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.607 ' HE1' ' HA ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -43.23 94.88 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 O-C-N 125.597 1.41 . . . . 0.0 110.869 174.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 82' ' ' VAL . 2.6 pt -70.64 143.24 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.441 -3.222 0 C-N-CA 127.2 2.2 . . . . 0.0 114.824 -174.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' NZ ' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -78.46 116.63 18.99 Favored 'General case' 1 N--CA 1.351 -5.38 0 N-CA-C 103.644 -2.724 . . . . 0.0 103.644 166.976 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 65' ' ' TRP . 69.5 p -36.13 -29.86 0.02 OUTLIER 'General case' 0 C--N 1.245 -3.955 0 C-N-CA 128.411 2.684 . . . . 0.0 113.83 177.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 t -84.14 -0.74 53.17 Favored 'General case' 0 CA--C 1.57 1.739 0 C-N-CA 123.206 0.603 . . . . 0.0 111.649 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.53 -12.49 21.18 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 120.78 -1.2 . . . . 0.0 110.286 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.634 HG21 HD12 ' A' ' 77' ' ' ILE . 35.3 m -135.16 166.82 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.322 0 CA-C-O 121.471 0.653 . . . . 0.0 110.757 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -140.24 123.03 16.43 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 171.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 20.6 pt -70.64 161.26 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.225 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -96.96 115.86 28.17 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -74.35 162.61 28.71 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.81 99.93 0.37 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.356 0.598 . . . . 0.0 110.443 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 m -84.42 97.25 9.4 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.474 -176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.6 tp -91.13 -34.43 15.05 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -84.93 147.49 26.71 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -90.36 164.36 14.36 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.586 -178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 68.56 171.45 0.29 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.061 0.944 . . . . 0.0 110.384 -175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 93' ' ' LYS . 30.6 mmtp -120.06 63.81 0.83 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -111.21 -30.46 7.44 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.0 tp 71.87 -75.03 0.08 Allowed 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.849 1.66 . . . . 0.0 112.006 177.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 . . . . . 0 N--CA 1.423 -1.778 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -175.771 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 CA--C 1.5 -0.974 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -78.52 117.27 19.55 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 168.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -64.67 141.18 58.86 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.392 0.432 . . . . 0.0 110.788 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 2.6 mp0 -50.26 108.29 0.21 Allowed 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.792 1.237 . . . . 0.0 110.812 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.707 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 27.3 pt20 -126.74 5.2 6.7 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.776 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -76.29 -52.41 10.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -96.04 -48.31 5.73 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 5' ' ' GLN . 62.2 tttp 61.48 109.59 0.02 OUTLIER 'General case' 0 C--O 1.245 0.847 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 74.17 -70.88 0.14 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.795 1.638 . . . . 0.0 112.589 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 50.49 86.11 0.03 OUTLIER 'General case' 0 C--O 1.247 0.955 0 O-C-N 124.416 1.072 . . . . 0.0 110.109 -176.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -113.79 -176.75 2.97 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.044 -173.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.16 22.41 2.8 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 56.2 tp60 -90.2 -41.94 11.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.052 -174.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 31.0 mm-40 -76.54 20.16 0.24 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.414 -174.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.58 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -92.73 -28.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 13' ' ' GLN . 20.8 ptmt -66.57 -41.96 87.75 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.008 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -94.18 -0.35 55.26 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.899 0.857 . . . . 0.0 109.77 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 76' ' ' TYR . 10.7 tppt? -85.53 -65.22 1.03 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.444 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 11.4 t80 -78.85 -25.94 44.06 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 32.2 mtmm 68.18 88.23 0.11 Allowed 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 124.497 1.119 . . . . 0.0 110.32 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.746 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -97.17 -25.65 15.23 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.318 -175.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 74.9 p 70.63 -32.26 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.525 1.93 . . . . 0.0 113.896 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.49 178.55 20.91 Favored Glycine 0 N--CA 1.426 -1.985 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.92 169.58 21.78 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.285 1.99 . . . . 0.0 110.325 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.9 tp -155.48 133.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 120.663 0.268 . . . . 0.0 111.016 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' O ' HG22 ' A' ' 55' ' ' ILE . 11.7 pt20 -80.59 172.32 13.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 53' ' ' GLU . 12.3 p -81.77 133.01 30.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.172 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.55 -38.25 10.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.709 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 24.3 m80 -161.3 171.35 18.49 Favored 'General case' 0 CA--C 1.48 -1.733 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -176.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.35 132.59 54.91 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -104.76 161.64 13.99 Favored 'General case' 0 C--N 1.268 -2.967 0 CA-C-N 114.788 -1.097 . . . . 0.0 111.984 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -106.88 129.26 54.74 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.37 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -74.05 102.41 4.18 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 171.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.404 ' SG ' ' HG3' ' A' ' 83' ' ' GLU . 69.2 m -86.29 -5.06 59.26 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.82 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -133.99 140.37 46.68 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.23 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 48' ' ' GLN . 15.1 p-10 -91.07 99.09 12.18 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.327 1.061 . . . . 0.0 108.994 173.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.85 150.05 16.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.396 -175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -119.5 33.94 5.43 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.733 0.778 . . . . 0.0 110.202 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 95.83 58.86 1.09 Allowed Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.873 -1.156 . . . . 0.0 112.823 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.13 117.27 4.76 Favored Glycine 0 C--N 1.307 -1.075 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 65.46 37.12 6.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.353 1.061 . . . . 0.0 110.858 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.7 t30 63.71 89.21 0.09 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.313 1.054 . . . . 0.0 109.794 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.572 ' HG3' ' H ' ' A' ' 44' ' ' LEU . 2.1 tp10 -136.95 -172.98 3.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.922 -1.49 . . . . 0.0 109.045 -168.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.669 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 1.7 tt -95.08 148.15 22.66 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.426 ' H ' HD23 ' A' ' 44' ' ' LEU . 16.1 m -96.71 115.76 27.98 Favored 'General case' 0 N--CA 1.417 -2.091 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.827 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 22.6 p90 -147.01 158.99 44.1 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.268 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 9.3 mtmp? -108.39 156.7 19.13 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.433 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -59.44 118.77 6.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.85 25.78 28.64 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 11.5 tp10 -74.56 -36.85 63.09 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 122.844 0.458 . . . . 0.0 110.66 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 72.41 109.17 0.07 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 125.448 1.499 . . . . 0.0 108.849 -172.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.576 HD12 ' CG1' ' A' ' 82' ' ' VAL . 9.7 mt -115.29 162.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.618 ' HB3' HG21 ' A' ' 27' ' ' VAL . 11.9 mt-10 -116.76 140.59 49.25 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.527 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 8.9 tp -101.77 125.01 55.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -111.02 -46.25 6.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.672 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.807 HH21 ' HB3' ' A' ' 59' ' ' ASP . 47.6 ttt180 -130.61 138.51 50.15 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.03 -1.068 . . . . 0.0 109.95 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.502 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.6 -37.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 123.805 0.842 . . . . 0.0 111.16 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 p -98.4 156.04 16.94 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.807 ' HB3' HH21 ' A' ' 56' ' ' ARG . 26.9 t70 67.3 71.59 0.36 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.439 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.779 HD21 ' HG2' ' A' ' 64' ' ' LYS . 32.0 t30 -154.16 117.44 2.61 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.218 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 60' ' ' ASN . 18.0 Cg_endo -59.31 -23.0 67.99 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.649 2.9 . . . . 0.0 114.073 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -73.89 -16.67 61.1 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.128 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.41 27.76 70.88 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.779 ' HG2' HD21 ' A' ' 60' ' ' ASN . 7.1 ptmt -118.79 161.4 20.2 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.56 ' HB2' HG13 ' A' ' 77' ' ' ILE . 42.5 m0 -99.86 176.46 5.43 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.482 0.713 . . . . 0.0 109.535 -178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.746 HD22 HD11 ' A' ' 21' ' ' LEU . 62.8 tp -117.13 110.52 18.29 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -112.59 158.19 14.45 Favored Glycine 0 N--CA 1.419 -2.449 0 C-N-CA 120.355 -0.926 . . . . 0.0 110.89 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.715 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.5 ttp180 -139.16 151.68 46.82 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.8 p -106.34 165.6 11.14 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.7 62.91 0.82 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 122.352 1.073 . . . . 0.0 111.664 -176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -170.29 -27.4 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 113.476 -1.693 . . . . 0.0 109.911 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.29 88.52 1.96 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.715 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 26.3 m -152.72 117.91 5.2 Favored 'General case' 0 N--CA 1.381 -3.877 0 N-CA-C 100.805 -3.776 . . . . 0.0 100.805 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.604 ' HB3' HD11 ' A' ' 66' ' ' LEU . 64.5 m-85 -110.78 81.87 1.5 Allowed 'General case' 1 C--N 1.216 -5.221 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -173.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.669 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -101.57 99.09 1.87 Allowed Glycine 2 N--CA 1.347 -7.276 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.617 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -44.39 101.17 0.02 OUTLIER 'General case' 0 C--N 1.258 -3.402 0 CA-C-N 112.185 -2.007 . . . . 0.0 108.215 169.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.608 HD12 HG21 ' A' ' 82' ' ' VAL . 2.0 pt -82.41 147.27 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.98 0 C-N-CA 126.822 2.049 . . . . 0.0 113.478 -177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HZ3' ' CD ' ' A' ' 43' ' ' GLU . 0.1 OUTLIER -80.93 118.83 22.76 Favored 'General case' 1 N--CA 1.354 -5.268 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 166.38 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.503 HG22 ' CG ' ' A' ' 65' ' ' TRP . 55.0 p -35.96 -39.81 0.18 Allowed 'General case' 1 C--N 1.238 -4.245 0 C-N-CA 128.113 2.565 . . . . 0.0 112.984 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -72.09 -10.52 59.89 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.348 1.059 . . . . 0.0 112.891 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -89.04 -12.94 39.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.578 0.704 . . . . 0.0 110.159 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 HD12 ' A' ' 77' ' ' ILE . 30.7 m -130.97 173.48 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 CA-C-O 121.785 0.802 . . . . 0.0 111.412 -178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' HG3' ' SG ' ' A' ' 34' ' ' CYS . 44.1 mt-10 -137.95 122.64 18.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 169.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 31' ' ' ALA . 12.4 pt -86.48 158.85 3.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.935 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -88.88 131.03 35.29 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 90.4 m-85 -81.6 -34.59 30.85 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 2.9 t70 162.78 140.69 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.254 0 C-N-CA 126.463 1.905 . . . . 0.0 106.872 166.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.0 t -131.06 1.65 4.27 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.02 -44.5 2.7 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.425 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -122.78 84.95 2.34 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.904 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.0 mt -88.65 74.95 8.33 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.125 0.964 . . . . 0.0 108.459 173.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -65.0 -36.89 85.85 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.995 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.418 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 28.8 ttpp -126.34 121.58 32.96 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.31 -82.33 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 O-C-N 124.111 0.882 . . . . 0.0 112.216 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.0 mt -147.21 22.99 1.19 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' HG3' ' HD2' ' A' ' 93' ' ' LYS . 16.1 pt-20 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 118.899 -0.572 . . . . 0.0 110.716 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 C--O 1.243 0.722 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -153.08 134.49 14.32 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.429 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -123.12 114.21 20.02 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 6' ' ' LYS . 37.3 mt-10 -68.56 -11.66 60.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.479 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -70.31 93.33 0.85 Allowed 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 32.7 mtmm -84.57 129.42 34.85 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.622 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -87.02 106.61 17.96 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 175.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -124.57 115.97 21.69 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.56 0.695 . . . . 0.0 110.877 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' A' ' 11' ' ' LYS . 3.5 mp0 -87.79 -158.32 0.45 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.71 10.67 36.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.55 ' H ' ' HB2' ' A' ' 9' ' ' GLU . 44.0 tttp 67.96 87.49 0.12 Allowed 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 127.828 2.451 . . . . 0.0 109.277 -175.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -81.25 -9.76 59.72 Favored 'General case' 0 C--O 1.202 -1.415 0 CA-C-O 122.634 1.206 . . . . 0.0 108.809 -176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -70.42 -17.98 63.01 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 113.839 -1.528 . . . . 0.0 110.173 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 17.1 mm-40 -73.97 -15.42 61.11 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.441 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.9 pp -78.55 -27.04 14.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.4 0.619 . . . . 0.0 109.52 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -55.5 -55.43 31.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.009 -1.45 . . . . 0.0 112.213 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -87.6 4.43 43.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.539 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 9.9 tppt? -94.46 -53.06 4.05 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.798 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 17.7 t80 -90.25 -24.81 20.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp 70.71 86.77 0.12 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.105 1.362 . . . . 0.0 110.616 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.777 HD11 HD22 ' A' ' 66' ' ' LEU . 1.4 mm? -99.05 -53.21 3.32 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.37 -176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p 54.71 91.62 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.267 1.427 . . . . 0.0 113.66 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.31 137.69 9.09 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.616 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.93 132.89 25.69 Favored 'Trans proline' 0 C--O 1.25 1.098 0 C-N-CA 122.235 1.956 . . . . 0.0 111.323 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 28' ' ' ILE . 15.4 tt -125.8 152.44 32.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.221 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -86.89 171.73 10.6 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.644 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -71.78 130.14 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.408 0.623 . . . . 0.0 109.885 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 25' ' ' ILE . 50.6 mm -83.47 -40.32 15.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.754 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.541 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 31.0 m80 -160.72 167.79 26.15 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.04 120.48 41.89 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.694 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -98.24 151.35 20.55 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.495 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -107.61 135.38 49.15 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.83 112.78 3.42 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.562 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 49.5 t -86.07 -12.47 50.06 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.616 0.722 . . . . 0.0 109.925 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.2 t -149.34 155.93 41.27 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.854 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 4.5 p-10 -99.42 112.89 25.01 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.738 0.78 . . . . 0.0 109.088 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.48 163.07 12.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.085 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.61 21.43 7.76 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.895 0.379 . . . . 0.0 111.604 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 85.37 59.69 1.9 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.509 -0.853 . . . . 0.0 114.72 175.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.03 138.52 13.96 Favored Glycine 0 C--N 1.298 -1.553 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm 66.91 33.65 5.79 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.92 0.867 . . . . 0.0 108.903 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 61.49 84.81 0.13 Allowed 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.235 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.528 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 19.4 tt0 -138.04 -175.22 4.02 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.657 HD21 ' HB2' ' A' ' 73' ' ' SER . 0.7 OUTLIER -96.64 153.19 18.0 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.507 ' H ' HD23 ' A' ' 44' ' ' LEU . 8.6 p -105.89 124.87 50.27 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -157.9 166.92 31.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.398 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.854 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 66.9 mmtt -112.63 147.03 37.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 19.2 tt0 -52.24 124.27 12.75 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 123.295 0.638 . . . . 0.0 110.292 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.66 13.63 75.14 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.983 -0.553 . . . . 0.0 113.911 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 30.9 tt0 -70.89 -39.83 72.56 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 50' ' ' GLU . 26.8 tt0 92.52 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.11 1.764 . . . . 0.0 111.247 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.561 HD12 ' CG1' ' A' ' 82' ' ' VAL . 11.1 mt -120.27 160.45 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.375 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.644 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 17.4 mt-10 -116.22 142.59 46.63 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.542 HD12 ' O ' ' A' ' 66' ' ' LEU . 8.3 tp -102.42 127.65 55.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.77 -49.2 6.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.798 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 10.8 ttm180 -126.48 140.49 52.42 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.112 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.56 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -128.85 -37.27 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 123.833 0.853 . . . . 0.0 111.016 -177.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 p -117.21 168.85 9.94 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.0 t70 60.43 65.5 1.06 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 122.466 1.127 . . . . 0.0 110.137 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -140.84 172.45 6.15 Favored Pre-proline 0 C--N 1.31 -1.115 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.632 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -94.45 13.04 1.52 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.011 1.807 . . . . 0.0 114.272 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.725 ' HG3' ' HD2' ' A' ' 64' ' ' LYS . 1.7 tm-20 -135.12 -72.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.56 -175.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.54 -25.76 2.14 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.725 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 13.7 ptmt -61.87 162.76 8.45 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.862 1.265 . . . . 0.0 110.779 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.56 ' CD1' HG22 ' A' ' 57' ' ' ILE . 49.0 m0 -102.31 166.6 10.48 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.98 -174.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.777 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -112.7 108.11 17.02 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -113.28 160.73 12.97 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.735 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' A' ' 73' ' ' SER . 60.3 ttp180 -135.29 141.2 45.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.646 0.736 . . . . 0.0 111.801 178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 p -101.37 167.25 10.29 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.421 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.28 37.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.162 0.985 . . . . 0.0 113.292 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -77.74 -19.29 55.41 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 121.029 0.443 . . . . 0.0 110.188 177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.94 86.25 0.87 Allowed Glycine 0 CA--C 1.489 -1.561 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 19.6 m -151.22 125.16 9.18 Favored 'General case' 0 N--CA 1.381 -3.884 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 -174.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.643 ' HB3' HD11 ' A' ' 66' ' ' LEU . 50.0 m-85 -108.5 73.84 0.89 Allowed 'General case' 1 C--N 1.213 -5.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -176.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -92.44 97.64 2.3 Favored Glycine 2 N--CA 1.375 -5.429 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 -178.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' HB3' ' HD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -44.04 96.38 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 125.408 1.299 . . . . 0.0 110.253 172.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.647 HD12 HG21 ' A' ' 82' ' ' VAL . 1.6 pt -77.38 144.82 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.436 -3.414 0 C-N-CA 126.625 1.97 . . . . 0.0 113.232 -175.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -79.95 118.4 21.66 Favored 'General case' 1 N--CA 1.359 -5.008 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 165.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.544 HG23 ' HA ' ' A' ' 64' ' ' LYS . 69.3 p -35.8 -39.09 0.14 Allowed 'General case' 1 C--N 1.241 -4.12 0 C-N-CA 128.369 2.668 . . . . 0.0 112.815 179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 t -69.85 -1.4 9.33 Favored 'General case' 0 CA--C 1.564 1.5 0 C-N-CA 124.085 0.954 . . . . 0.0 112.213 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.23 -8.47 21.26 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 121.737 -0.602 . . . . 0.0 111.213 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 77' ' ' ILE . 22.3 m -137.05 165.86 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 CA-C-O 121.312 0.577 . . . . 0.0 112.221 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.562 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 50.4 mt-10 -129.47 119.59 24.01 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 173.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.694 HG22 ' HB2' ' A' ' 31' ' ' ALA . 8.6 pt -89.55 162.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.173 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.72 138.98 30.99 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.615 ' HB2' ' HB2' ' A' ' 89' ' ' LEU . 88.6 m-85 -105.53 170.26 7.99 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.42 -35.05 6.16 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.817 0.847 . . . . 0.0 109.793 175.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.4 m -102.88 36.36 2.23 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.002 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 86' ' ' TYR . 19.6 tp -87.37 18.95 3.48 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.367 0.603 . . . . 0.0 110.22 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -61.77 -29.73 70.33 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.309 1.044 . . . . 0.0 109.942 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.3 121.55 29.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -80.11 112.13 17.13 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.106 0.479 . . . . 0.0 111.43 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.39 155.58 13.27 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -123.51 -71.21 0.73 Allowed 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.58 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 50.3 tp -159.5 119.36 3.0 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.421 -1.875 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.498 -1.049 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -76.19 130.19 37.87 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 123.429 0.456 . . . . 0.0 110.026 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -109.34 84.13 1.87 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 170.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -119.25 148.25 43.34 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.542 0.687 . . . . 0.0 112.411 -171.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -103.31 126.66 50.58 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -71.38 -38.08 71.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.6 ' HB3' ' HG2' ' A' ' 9' ' ' GLU . 49.3 mt-10 -78.13 158.09 29.22 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.737 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -107.54 12.18 27.99 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.6 ' HG2' ' HB3' ' A' ' 7' ' ' GLU . 16.7 mm-40 -66.41 128.24 35.4 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 113.877 -1.511 . . . . 0.0 108.694 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -103.41 91.64 4.14 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -112.33 166.63 11.12 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.433 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.79 ' HB2' ' HA ' ' A' ' 73' ' ' SER . 7.2 tp10 -80.06 111.6 16.57 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -51.62 5.3 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.647 -171.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.38 23.71 0.11 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -169.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.886 HG21 ' HB2' ' A' ' 74' ' ' TYR . 2.4 pp -85.79 -26.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 122.33 -0.231 . . . . 0.0 111.326 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -54.86 -45.13 74.51 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 124.234 0.959 . . . . 0.0 112.818 -174.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -97.28 -9.35 27.77 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.243 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 18' ' ' LYS . 13.4 tppt? -78.28 -63.84 1.3 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.648 -173.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.668 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 3.2 t80 -81.09 -24.46 37.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 38.1 ttpt 66.86 87.79 0.12 Allowed 'General case' 0 CA--C 1.502 -0.899 0 CA-C-N 113.5 -1.682 . . . . 0.0 111.384 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.551 HD12 ' HD2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -98.3 -65.54 0.96 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.5 p 50.25 80.81 0.07 Allowed 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 125.025 1.33 . . . . 0.0 113.745 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 157.81 -165.57 33.64 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.97 101.11 0.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.266 2.644 . . . . 0.0 111.363 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.9 tt -113.34 156.21 14.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -150.94 178.01 9.58 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.7 t -75.87 134.05 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-O 121.746 0.784 . . . . 0.0 109.271 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.434 ' HB ' HG23 ' A' ' 54' ' ' ILE . 36.2 mm -97.24 -35.2 5.26 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.435 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 28.3 m80 -168.38 169.98 10.22 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.53 119.49 39.33 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 175.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -93.06 158.17 15.92 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.025 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -106.99 127.82 53.8 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.654 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -67.65 106.76 2.3 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 172.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.0 m -83.58 -5.08 59.07 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.8 t -158.75 143.15 15.72 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -80.21 107.94 13.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.721 175.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -114.67 163.07 12.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 114.119 -1.4 . . . . 0.0 108.919 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -116.81 23.32 12.03 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.933 -0.48 . . . . 0.0 110.814 -178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 88.31 60.16 1.58 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.035 -1.555 . . . . 0.0 111.291 -177.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.82 120.07 5.11 Favored Glycine 0 C--N 1.306 -1.113 0 CA-C-O 119.8 -0.444 . . . . 0.0 112.086 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.599 ' N ' ' HE3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER 63.65 45.71 4.47 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.287 0.635 . . . . 0.0 110.48 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.3 t30 63.49 85.95 0.13 Allowed 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.041 0.936 . . . . 0.0 109.616 -176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.673 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 5.4 tt0 -145.67 -173.92 4.26 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.082 -174.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.656 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -95.72 155.67 16.65 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.439 ' H ' HD23 ' A' ' 44' ' ' LEU . 7.2 m -101.56 116.03 31.84 Favored 'General case' 0 N--CA 1.408 -2.546 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.493 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 26.6 p90 -149.73 159.34 44.42 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.407 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' HB2' ' HG2' ' A' ' 50' ' ' GLU . 49.3 mttm -112.93 156.45 22.97 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -59.09 127.34 31.73 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.891 0.377 . . . . 0.0 110.078 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.89 21.14 61.9 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.088 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 28.5 mm-40 -88.57 -23.99 22.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 70.78 129.91 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.57 1.169 . . . . 0.0 111.363 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.806 HD12 HG11 ' A' ' 82' ' ' VAL . 7.8 mt -127.51 162.11 33.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -112.28 136.08 52.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 66' ' ' LEU . 9.7 tp -94.35 123.33 46.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.506 HG13 ' HE2' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -111.69 -36.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.668 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 0.9 OUTLIER -135.5 130.13 34.17 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.713 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 65' ' ' TRP . 0.1 OUTLIER -130.85 2.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 124.578 1.151 . . . . 0.0 109.725 177.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -117.47 154.15 31.9 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.655 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 64.58 18.89 11.61 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.98 1.312 . . . . 0.0 111.337 177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 21.4 p-10 -77.55 111.46 17.56 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.284 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 22.1 Cg_exo -66.56 -58.41 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.783 2.989 . . . . 0.0 113.134 -175.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.519 ' OE1' ' HD2' ' A' ' 64' ' ' LYS . 23.8 tt0 -66.54 -30.58 70.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.984 0.421 . . . . 0.0 110.715 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.62 12.24 25.08 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.325 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 12.9 ptmt -101.9 162.13 13.14 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 57' ' ' ILE . 42.6 m0 -95.82 176.13 6.25 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 123.255 0.622 . . . . 0.0 110.577 -175.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' A' ' 74' ' ' TYR . 61.2 tp -119.21 113.7 21.28 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.92 157.32 15.12 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.7 ttt-85 -135.56 153.3 51.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.558 0.694 . . . . 0.0 111.61 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 35.2 m -105.61 154.37 20.51 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.23 -33.96 13.85 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -53.97 -43.02 69.57 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 122.207 1.004 . . . . 0.0 110.663 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.29 83.26 1.7 Allowed Glycine 0 N--CA 1.413 -2.834 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.196 -173.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.79 ' HA ' ' HB2' ' A' ' 12' ' ' GLU . 49.6 m -151.53 123.3 8.01 Favored 'General case' 1 N--CA 1.376 -4.138 0 N-CA-C 101.802 -3.407 . . . . 0.0 101.802 -179.274 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.886 ' HB2' HG21 ' A' ' 15' ' ' ILE . 57.9 m-85 -113.87 92.67 4.06 Favored 'General case' 1 C--N 1.216 -5.221 0 O-C-N 125.108 1.505 . . . . 0.0 107.07 -173.39 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.656 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -102.02 103.14 2.44 Favored Glycine 3 N--CA 1.359 -6.499 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -47.84 98.09 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 112.946 -1.627 . . . . 0.0 108.213 170.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.673 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.1 pt -85.15 143.46 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.814 0 C-N-CA 126.283 1.833 . . . . 0.0 114.127 -177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -77.62 118.34 19.92 Favored 'General case' 1 N--CA 1.372 -4.345 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 164.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.494 HG22 ' CG ' ' A' ' 65' ' ' TRP . 48.4 p -35.26 -38.49 0.1 Allowed 'General case' 1 C--N 1.236 -4.333 0 C-N-CA 129.253 3.021 . . . . 0.0 113.588 179.558 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -67.1 -15.49 63.75 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 0.0 112.698 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 -13.99 48.81 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 121.563 -0.711 . . . . 0.0 110.954 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.806 HG11 HD12 ' A' ' 52' ' ' ILE . 30.3 m -137.11 172.07 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.147 0 CA-C-O 121.779 0.8 . . . . 0.0 111.411 -177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.79 122.81 17.89 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.651 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 26.7 pt -77.55 171.2 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.001 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -79.11 103.78 9.28 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.78 91.72 7.59 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.788 0.804 . . . . 0.0 109.866 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -83.02 92.39 7.36 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.055 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 t -177.6 138.86 0.23 Allowed 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.1 mt -114.94 6.33 15.32 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.673 -176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -145.42 136.21 24.48 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.4 tp -64.12 132.94 51.95 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -70.82 99.93 1.82 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.643 0.735 . . . . 0.0 112.53 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -121.11 14.62 11.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.44 -10.09 59.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.152 -1.386 . . . . 0.0 109.484 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 pp -96.97 154.04 17.54 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.884 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 118.451 -0.785 . . . . 0.0 110.411 177.451 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.24 0.561 0 CA-C-O 120.893 0.378 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -135.41 143.05 45.78 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -68.12 -66.57 0.55 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -86.52 71.49 10.41 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -69.88 -41.65 74.49 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.62 96.86 5.05 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 171.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.9 159.09 33.3 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.916 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -77.74 131.68 37.78 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.601 -174.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 90.1 7.95 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -90.34 157.97 17.37 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.035 -177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -116.65 88.51 2.91 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.933 0.873 . . . . 0.0 109.714 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.68 34.46 3.67 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.302 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -84.91 -52.77 5.77 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.602 0.715 . . . . 0.0 110.627 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.55 -14.88 63.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.713 -1.13 . . . . 0.0 112.39 -176.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.4 pp -66.04 -31.08 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.4 mptt -69.28 -23.37 63.82 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.667 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -101.15 -29.91 11.86 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.243 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.52 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 6.9 tppt? -73.12 -61.15 1.92 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.845 0.355 . . . . 0.0 111.13 -175.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -79.1 -34.17 43.76 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 68.7 99.23 0.06 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.073 -1.421 . . . . 0.0 108.947 -178.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.014 HD12 ' HG3' ' A' ' 56' ' ' ARG . 1.5 mm? -98.79 -57.34 2.2 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.633 0.73 . . . . 0.0 110.15 -175.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 29.2 p 56.13 78.42 0.2 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 125.399 1.48 . . . . 0.0 113.098 -176.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 136.91 146.0 5.07 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.845 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -75.34 141.9 26.24 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.557 2.171 . . . . 0.0 111.222 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 tt -151.4 155.55 6.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.431 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.7 pt20 -121.38 174.21 6.88 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -176.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.555 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 7.6 p -59.37 126.34 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-O 122.056 0.932 . . . . 0.0 111.174 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.2 -31.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.475 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 27.1 m80 -163.22 157.33 20.25 Favored 'General case' 0 CA--C 1.487 -1.445 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.51 118.1 34.44 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.683 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -96.1 156.12 16.47 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-O 122.014 0.911 . . . . 0.0 111.202 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 32' ' ' LYS . 35.1 ttpt -106.68 128.27 54.05 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.745 177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.96 105.09 0.95 Allowed 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.6 t -72.72 -18.33 61.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.674 -174.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -160.53 156.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.536 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.41 119.25 20.02 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -114.02 163.72 10.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.666 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -102.06 -4.94 25.15 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.98 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 77.64 60.58 2.76 Favored Glycine 0 C--O 1.241 0.568 0 C-N-CA 119.15 -1.5 . . . . 0.0 110.092 -174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.409 ' N ' ' HB3' ' A' ' 43' ' ' GLU . . . -104.67 131.33 10.6 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 115.084 -0.558 . . . . 0.0 113.035 -172.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.8 69.97 0.68 Allowed 'General case' 0 C--O 1.249 1.041 0 C-N-CA 125.301 1.44 . . . . 0.0 109.743 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 57.05 68.62 0.83 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.223 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 31.9 tt0 -136.42 172.98 12.21 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.537 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 73' ' ' SER . 1.7 tt -97.9 141.29 31.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.6 p -98.78 118.24 35.07 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.864 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.464 ' HE2' HG22 ' A' ' 77' ' ' ILE . 22.5 p90 -142.35 170.11 16.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.708 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 98.3 mttt -119.55 161.44 20.6 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -63.62 129.29 39.56 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.43 46.53 Favored Glycine 0 C--N 1.31 -0.916 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.345 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 31.6 mm-40 -89.42 -26.14 21.16 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 70.3 120.01 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 O-C-N 124.933 1.396 . . . . 0.0 111.307 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.61 HD12 ' CG1' ' A' ' 82' ' ' VAL . 8.9 mt -119.31 158.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.86 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -176.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.555 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 14.7 mt-10 -116.67 132.68 56.62 Favored 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.613 HG12 HG23 ' A' ' 57' ' ' ILE . 8.6 tp -93.08 125.7 45.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.431 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -110.13 -47.88 6.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.442 176.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 1.014 ' HG3' HD12 ' A' ' 21' ' ' LEU . 18.2 mmt180 -120.06 107.8 13.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.822 ' H ' HD13 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -104.53 -30.16 2.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 113.252 -1.795 . . . . 0.0 107.192 172.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 57' ' ' ILE . 15.6 p -86.68 142.05 28.49 Favored 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.565 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t70 71.55 31.09 2.32 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.451 1.12 . . . . 0.0 110.957 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 63' ' ' GLY . 8.8 p30 -72.87 126.24 90.69 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.941 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 2.1 Cg_endo -80.58 -61.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.618 2.212 . . . . 0.0 113.256 -177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 64' ' ' LYS . 32.4 tt0 -79.21 -2.96 43.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.302 0.572 . . . . 0.0 111.268 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 60' ' ' ASN . . . 87.51 21.17 49.13 Favored Glycine 0 CA--C 1.497 -1.087 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.513 -176.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.688 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 13.3 ptmt -118.21 156.88 28.01 Favored 'General case' 0 N--CA 1.408 -2.533 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 57' ' ' ILE . 25.6 m0 -98.12 171.9 7.94 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.145 0.278 . . . . 0.0 110.94 -174.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 21' ' ' LEU . 65.4 tp -111.1 107.33 16.66 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -114.46 158.57 14.23 Favored Glycine 0 N--CA 1.416 -2.664 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.705 ' HA ' ' O ' ' A' ' 73' ' ' SER . 45.8 ttp180 -135.17 144.73 47.19 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.694 0.797 . . . . 0.0 109.888 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -101.4 165.14 11.42 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.89 -29.78 65.34 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -74.83 -9.62 58.72 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.03 89.82 0.49 Allowed Glycine 0 N--CA 1.434 -1.454 0 CA-C-O 121.908 0.727 . . . . 0.0 111.754 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.705 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 16.1 m -153.16 117.46 4.9 Favored 'General case' 0 N--CA 1.389 -3.514 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.596 ' HB2' HG21 ' A' ' 15' ' ' ILE . 64.8 m-85 -110.76 96.67 6.31 Favored 'General case' 1 C--N 1.221 -4.999 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.501 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -110.98 11.85 29.36 Favored Glycine 1 CA--C 1.445 -4.313 0 C-N-CA 117.77 -2.157 . . . . 0.0 115.516 -174.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.688 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 48.13 82.66 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.853 1.311 . . . . 0.0 111.651 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.601 HD12 HG21 ' A' ' 82' ' ' VAL . 2.1 pt -67.8 145.92 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.1 0 C-N-CA 126.029 1.731 . . . . 0.0 113.584 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 8.7 ptpp? -81.36 112.99 19.15 Favored 'General case' 1 N--CA 1.379 -4.01 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 165.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.477 HG22 ' CG ' ' A' ' 65' ' ' TRP . 43.2 p -36.3 -36.75 0.1 Allowed 'General case' 0 C--N 1.251 -3.685 0 C-N-CA 128.006 2.522 . . . . 0.0 113.757 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -69.82 -9.88 56.36 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.802 0.841 . . . . 0.0 112.318 -178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.51 -6.38 49.84 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.652 -0.655 . . . . 0.0 109.979 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.61 ' CG1' HD12 ' A' ' 52' ' ' ILE . 31.3 m -131.17 162.77 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.908 0 CA-C-O 121.857 0.836 . . . . 0.0 112.571 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -130.94 111.36 11.99 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.683 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 14.3 pt -76.71 171.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.047 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.98 103.75 1.92 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -86.02 -48.47 8.63 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -175.85 109.65 0.1 Allowed 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.657 178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.9 m -111.84 175.32 5.48 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.184 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp 59.85 71.67 0.56 Allowed 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 124.371 1.044 . . . . 0.0 111.038 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 92' ' ' LYS . 14.7 ptmt -147.29 165.55 29.77 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.293 -174.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.8 mt -101.3 -37.87 8.31 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.954 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.732 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 9.9 mmpt? -101.64 134.03 45.42 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.158 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp 67.17 30.31 7.32 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.724 1.21 . . . . 0.0 113.473 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.406 ' HB2' ' HG3' ' A' ' 90' ' ' LYS . 34.8 t70 -89.76 98.02 11.53 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.072 0.463 . . . . 0.0 109.825 176.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 61.0 tp 61.31 78.02 0.3 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.735 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--N 1.307 -1.28 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.802 178.01 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.24 0.603 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -158.93 130.2 6.28 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.3 tttm 74.2 -46.15 0.61 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.378 1.471 . . . . 0.0 112.111 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -89.94 129.39 36.29 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 77.99 138.2 0.07 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.454 1.101 . . . . 0.0 112.127 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -118.93 177.08 4.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -118.81 87.44 2.73 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.036 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 8' ' ' LYS . 25.7 tptp -176.04 -68.6 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.15 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -77.23 81.19 3.74 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.608 0.718 . . . . 0.0 110.979 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -84.2 -56.75 3.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -170.02 82.43 0.11 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 173.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' NZ ' ' A' ' 16' ' ' LYS . 7.0 pt-20 -147.02 33.51 0.91 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.775 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 8.5 tp-100 -78.75 -20.22 50.45 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.962 -177.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 1.7 mp0 -61.89 -26.65 68.28 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.451 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.697 HG21 ' HB2' ' A' ' 74' ' ' TYR . 1.4 pp -90.22 -20.56 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -173.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.591 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 37.9 mmtm -66.96 -54.8 18.43 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.808 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -79.99 1.92 25.67 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.847 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 76' ' ' TYR . 9.3 tppt? -98.79 -53.41 3.3 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.873 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.429 ' HE2' ' HG2' ' A' ' 56' ' ' ARG . 38.2 t80 -91.2 -27.98 18.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.939 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 19' ' ' PHE . 42.2 tttt 77.59 90.42 0.07 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.686 1.195 . . . . 0.0 109.934 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.851 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -100.96 -41.66 6.72 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.607 177.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.0 p 64.32 16.21 9.98 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.656 1.982 . . . . 0.0 112.543 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.98 173.24 37.94 Favored Glycine 0 N--CA 1.417 -2.611 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.49 92.69 0.84 Allowed 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.736 2.29 . . . . 0.0 111.412 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 21' ' ' LEU . 46.3 mm -78.66 130.31 36.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' C ' HG22 ' A' ' 55' ' ' ILE . 13.6 pt20 -104.69 175.87 5.35 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.526 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.17 134.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-O 122.322 1.058 . . . . 0.0 112.294 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.2 mm -102.19 -36.64 4.61 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.133 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.4 m80 -168.12 -178.19 3.59 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -176.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.75 139.6 45.89 Favored 'General case' 0 N--CA 1.408 -2.561 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -112.46 158.32 20.01 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -107.01 130.42 54.65 Favored 'General case' 0 C--N 1.263 -3.154 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HA ' HG12 ' A' ' 82' ' ' VAL . . . -64.88 112.61 3.35 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 39.9 t -82.35 -19.09 39.97 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 124.185 0.928 . . . . 0.0 109.635 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.13 156.73 46.43 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.887 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -96.39 107.85 20.29 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 173.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.441 HG12 ' CE1' ' A' ' 46' ' ' PHE . 10.4 p -113.19 145.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.702 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' H ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -91.66 12.42 21.2 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.775 -179.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 78.84 46.85 8.16 Favored Glycine 0 CA--C 1.493 -1.337 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.714 178.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 43' ' ' GLU . . . -96.9 151.52 19.86 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp 68.27 31.87 4.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.299 1.047 . . . . 0.0 108.833 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.456 ' ND2' ' HE2' ' A' ' 76' ' ' TYR . 0.2 OUTLIER 68.31 46.3 1.1 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.678 177.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.8 OUTLIER -103.55 -175.16 2.72 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.606 ' CA ' ' HA3' ' A' ' 75' ' ' GLY . 2.3 tt -95.74 147.47 23.59 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 175.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.47 ' H ' HD23 ' A' ' 44' ' ' LEU . 5.7 m -96.05 115.48 27.5 Favored 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.777 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.441 ' CE1' HG12 ' A' ' 37' ' ' VAL . 17.9 p90 -150.37 177.62 9.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.196 0.522 . . . . 0.0 111.006 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.887 ' HD3' ' HB2' ' A' ' 36' ' ' ASP . 71.5 mmtt -124.83 149.61 47.27 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.73 122.43 11.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 124.145 0.903 . . . . 0.0 108.737 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.42 23.88 52.69 Favored Glycine 0 CA--C 1.536 1.346 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.759 -177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' A' ' 47' ' ' LYS . 10.5 mm-40 -78.64 -26.67 45.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 74.63 104.43 0.07 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 123.414 1.578 . . . . 0.0 110.33 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 31' ' ' ALA . 7.9 mm -101.96 158.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.196 0 CA-C-N 111.697 -2.501 . . . . 0.0 105.659 -174.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -112.49 134.21 54.15 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 29' ' ' HIS . 7.0 tp -99.75 121.04 49.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.408 HG22 ' C ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -106.1 -54.13 6.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.213 -178.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.429 ' HG2' ' HE2' ' A' ' 19' ' ' PHE . 53.9 ttt180 -121.43 138.39 54.3 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.729 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -123.37 -43.36 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.578 -176.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.4 p -117.8 158.66 24.38 Favored 'General case' 0 N--CA 1.423 -1.791 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.112 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.3 t70 71.51 68.73 0.16 Allowed 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 125.928 1.691 . . . . 0.0 111.302 -175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 8.8 p30 -148.42 144.43 18.59 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 3.0 Cg_exo -78.93 12.52 2.22 Favored 'Trans proline' 0 C--N 1.325 -0.694 0 C-N-CA 122.848 2.365 . . . . 0.0 114.469 -175.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.679 ' HG3' ' HE2' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -109.23 -64.7 1.22 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -177.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 126.6 -6.03 7.52 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.679 ' HE2' ' HG3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -90.04 165.05 14.26 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.636 0.775 . . . . 0.0 110.535 177.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.559 ' CG ' HG22 ' A' ' 79' ' ' THR . 40.2 m0 -97.84 169.89 9.35 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.768 0.827 . . . . 0.0 110.741 -179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.851 HD22 HD11 ' A' ' 21' ' ' LEU . 54.6 tp -113.99 110.25 19.77 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.02 155.87 15.99 Favored Glycine 0 N--CA 1.419 -2.497 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.299 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.697 ' HA ' ' O ' ' A' ' 73' ' ' SER . 61.1 ttp180 -137.96 156.66 47.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.589 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 6.8 m -111.63 156.07 22.39 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 173.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.6 33.13 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 119.476 1.035 . . . . 0.0 113.05 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -69.8 -3.09 14.05 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.91 86.81 0.16 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-O 121.728 0.627 . . . . 0.0 112.134 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.697 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 13.0 m -151.78 117.67 5.48 Favored 'General case' 0 N--CA 1.391 -3.388 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.697 ' HB2' HG21 ' A' ' 15' ' ' ILE . 65.3 m-85 -113.37 90.06 3.25 Favored 'General case' 1 C--N 1.228 -4.701 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.186 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.606 ' HA3' ' CA ' ' A' ' 44' ' ' LEU . . . -104.72 102.19 2.04 Favored Glycine 3 N--CA 1.36 -6.416 0 N-CA-C 106.906 -2.478 . . . . 0.0 106.906 176.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -50.22 98.94 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.867 0 CA-C-N 113.195 -1.503 . . . . 0.0 107.247 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.727 HD12 HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -82.25 140.25 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.431 -3.611 0 C-N-CA 125.542 1.537 . . . . 0.0 114.713 -172.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -74.88 114.3 13.18 Favored 'General case' 1 N--CA 1.365 -4.705 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 167.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.559 HG22 ' CG ' ' A' ' 65' ' ' TRP . 72.9 p -36.28 -34.82 0.07 Allowed 'General case' 1 C--N 1.234 -4.428 0 C-N-CA 128.523 2.729 . . . . 0.0 114.299 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.9 t -66.0 -24.32 66.75 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.2 59.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 122.097 -0.377 . . . . 0.0 111.57 -174.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.727 HG21 HD12 ' A' ' 77' ' ' ILE . 30.0 m -136.39 165.74 28.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.512 0.672 . . . . 0.0 111.321 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.574 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 48.4 mt-10 -136.83 118.86 15.35 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 105.458 -2.052 . . . . 0.0 105.458 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 2.3 pp -72.46 146.97 10.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.647 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -89.77 133.36 34.74 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -87.17 135.37 33.33 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -61.38 139.77 58.14 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 t -72.81 77.51 1.14 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -166.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -179.58 166.16 1.38 Allowed 'General case' 0 C--O 1.247 0.947 0 C-N-CA 126.812 2.045 . . . . 0.0 105.672 171.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -126.57 -63.75 1.06 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.712 ' HB3' ' HG2' ' A' ' 93' ' ' LYS . 94.8 mt -90.25 147.05 23.78 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.588 177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -97.92 12.68 33.3 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 122.692 1.234 . . . . 0.0 108.12 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.712 ' HG2' ' HB3' ' A' ' 91' ' ' LEU . 72.4 mmtt -70.42 -47.35 61.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.557 177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -166.34 156.28 11.97 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.719 ' H ' HD23 ' A' ' 95' ' ' LEU . 1.6 pt? -85.88 75.34 10.02 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 . . . . . 0 C--N 1.31 -1.121 0 C-N-CA 124.469 1.108 . . . . 0.0 109.145 174.958 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 C--O 1.246 0.896 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -135.13 157.66 46.34 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -69.96 150.91 46.2 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 6' ' ' LYS . 48.5 mt-10 -89.03 -51.84 5.39 Favored 'General case' 0 C--N 1.285 -2.212 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.57 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.308 0.6 OUTLIER 33.59 70.15 0.12 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.471 1.108 . . . . 0.0 111.022 -172.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 4' ' ' GLU . 55.9 mtpt -87.26 109.21 19.34 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.556 -169.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -115.23 92.6 3.98 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.703 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -125.4 -1.29 7.55 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.037 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.833 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 9.8 tp10 -138.69 154.88 48.62 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -121.72 24.36 9.77 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.833 ' H ' ' HG3' ' A' ' 9' ' ' GLU . 61.0 mttp 72.55 129.59 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.3 -175.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -104.1 18.57 21.79 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.399 -176.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -62.31 -30.21 70.99 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.55 0.69 . . . . 0.0 110.127 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 9.3 mm-40 -51.52 -34.71 37.36 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.758 173.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' HA ' ' OH ' ' A' ' 76' ' ' TYR . 1.4 pp -71.85 -34.05 50.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.154 0 CA-C-O 120.889 0.376 . . . . 0.0 110.115 -173.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.655 ' HA ' HD23 ' A' ' 21' ' ' LEU . 4.7 mptt -74.91 -30.97 61.43 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -90.5 -19.53 23.72 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.011 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 9.2 tppt? -77.26 -58.77 3.09 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.074 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' HE1' ' HG2' ' A' ' 56' ' ' ARG . 23.3 t80 -81.18 -22.79 38.65 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.25 90.92 0.09 Allowed 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 125.548 1.539 . . . . 0.0 109.911 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 66' ' ' LEU . 1.5 mm? -99.51 -67.48 0.85 Allowed 'General case' 0 CA--C 1.453 -2.765 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.939 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 m 61.46 57.47 2.33 Favored 'General case' 0 N--CA 1.404 -2.763 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.658 171.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.37 176.58 26.83 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.236 -0.983 . . . . 0.0 111.432 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.47 108.43 2.68 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.824 2.35 . . . . 0.0 111.764 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.744 HD12 ' HB ' ' A' ' 55' ' ' ILE . 45.0 pt -102.42 -176.49 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.92 170.6 18.43 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.6 t -79.35 127.32 39.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -90.35 -37.21 9.22 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.637 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.869 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.538 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 37.6 m80 -168.88 170.64 8.98 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -172.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.32 127.32 55.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 172.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 84' ' ' ILE . . . -100.46 159.63 14.99 Favored 'General case' 0 C--N 1.262 -3.199 0 CA-C-O 121.739 0.781 . . . . 0.0 110.928 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -106.88 131.39 54.02 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.65 106.94 1.28 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 171.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 48.8 t -91.37 -5.8 53.92 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.194 0.997 . . . . 0.0 108.335 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 81' ' ' ALA . 82.8 m -147.2 147.41 30.45 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.775 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 7.2 p-10 -93.14 103.53 15.8 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.486 HG21 ' OE2' ' A' ' 43' ' ' GLU . 8.6 p -114.66 156.71 15.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.103 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.52 34.04 5.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.989 0.423 . . . . 0.0 110.51 177.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 99.9 60.65 0.84 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 119.131 -1.509 . . . . 0.0 113.251 -178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.79 95.66 1.14 Allowed Glycine 0 C--N 1.313 -0.721 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 57.24 78.44 0.23 Allowed 'General case' 0 C--O 1.252 1.215 0 C-N-CA 124.707 1.203 . . . . 0.0 111.041 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.49 71.68 0.43 Allowed 'General case' 0 N--CA 1.469 0.506 0 O-C-N 124.407 1.067 . . . . 0.0 109.768 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.632 ' HG3' ' HA ' ' A' ' 77' ' ' ILE . 15.9 tt0 -132.72 -173.78 3.28 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.464 -172.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.613 ' HG ' ' N ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -97.15 151.07 20.17 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 57.9 m -97.95 124.68 42.52 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.411 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 44' ' ' LEU . 25.5 p90 -159.64 160.99 34.91 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.722 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 57.0 mtmt -117.56 151.37 37.29 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -53.39 123.26 11.48 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 124.17 0.919 . . . . 0.0 110.657 -177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.84 17.22 52.62 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.537 -0.756 . . . . 0.0 114.087 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -87.92 -30.69 19.89 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 117.954 0.877 . . . . 0.0 113.171 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.25 2.1 mp0 75.45 128.98 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 122.535 1.159 . . . . 0.0 112.386 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.589 HD12 ' CG1' ' A' ' 82' ' ' VAL . 10.9 mt -129.08 165.11 29.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -172.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -114.66 142.23 46.75 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 66' ' ' LEU . 6.5 tp -100.69 124.24 54.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.744 ' HB ' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -110.51 -40.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.662 -177.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.473 ' HG2' ' HE1' ' A' ' 19' ' ' PHE . 48.2 ttt180 -134.8 136.96 42.94 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.136 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.1 -36.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 124.439 1.096 . . . . 0.0 111.778 -177.243 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.6 p -96.64 154.84 17.05 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.3 t70 61.93 67.86 0.72 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.907 1.283 . . . . 0.0 107.963 -174.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -134.39 115.4 12.7 Favored Pre-proline 0 C--N 1.311 -1.105 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.626 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.91 -28.71 29.16 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.393 2.729 . . . . 0.0 115.394 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -95.11 -15.49 23.33 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.799 0.809 . . . . 0.0 110.146 -177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.01 0.19 83.5 Favored Glycine 0 C--N 1.308 -0.992 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.152 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.639 ' HE2' ' O ' ' A' ' 76' ' ' TYR . 17.8 ptmt -95.06 161.68 14.03 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.546 ' CD2' HG22 ' A' ' 79' ' ' THR . 43.2 m0 -97.8 176.03 5.95 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 123.947 0.899 . . . . 0.0 111.478 -172.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 21' ' ' LEU . 51.6 tp -115.52 108.72 16.82 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -111.43 156.57 15.48 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.563 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 73' ' ' SER . 62.5 ttt-85 -134.62 147.55 50.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.515 0.674 . . . . 0.0 111.593 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.463 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 27.0 m -100.75 162.13 13.12 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.53 -28.0 18.83 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -89.16 3.15 52.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.423 ' HA2' ' NE ' ' A' ' 68' ' ' ARG . . . 76.66 87.86 0.33 Allowed Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.764 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 6.8 m -152.48 117.75 5.25 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 101.937 -3.357 . . . . 0.0 101.937 -176.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 79.9 m-85 -115.21 91.35 3.58 Favored 'General case' 1 C--N 1.224 -4.882 0 O-C-N 124.25 0.969 . . . . 0.0 108.459 -173.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.613 ' N ' ' HG ' ' A' ' 44' ' ' LEU . . . -107.45 102.52 1.82 Allowed Glycine 2 N--CA 1.366 -5.992 0 N-CA-C 108.344 -1.903 . . . . 0.0 108.344 177.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.639 ' O ' ' HE2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -42.16 101.14 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 112.959 -1.621 . . . . 0.0 108.52 171.078 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.632 ' HA ' ' HG3' ' A' ' 43' ' ' GLU . 2.2 pt -85.39 145.75 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.948 0 C-N-CA 126.248 1.819 . . . . 0.0 113.312 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -80.92 122.79 27.68 Favored 'General case' 1 N--CA 1.348 -5.538 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 164.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.546 HG22 ' CD2' ' A' ' 65' ' ' TRP . 47.7 p -36.47 -30.71 0.02 OUTLIER 'General case' 1 C--N 1.243 -4.039 0 C-N-CA 128.341 2.656 . . . . 0.0 112.653 176.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -63.72 -32.47 73.98 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.892 1.277 . . . . 0.0 110.835 -177.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -86.49 -4.9 59.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.778 -172.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.632 HG21 HD12 ' A' ' 77' ' ' ILE . 28.9 m -133.97 159.35 42.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.46 0.648 . . . . 0.0 111.813 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 43.4 mt-10 -128.03 117.5 21.79 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 171.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 13.5 pt -78.38 160.08 4.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.388 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.77 123.64 30.08 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 172.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -58.8 -36.9 75.21 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -167.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 88' ' ' SER . 23.9 t70 -138.24 -87.19 0.26 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 19.9 t 166.07 126.38 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.12 173.53 9.62 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 120.807 0.337 . . . . 0.0 110.384 178.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -102.77 -34.61 8.95 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 93' ' ' LYS . 47.0 tp -90.91 106.19 18.35 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 172.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -80.84 6.33 13.41 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.727 1.251 . . . . 0.0 110.421 -173.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HB3' ' HG ' ' A' ' 91' ' ' LEU . 1.5 tmtp? -77.37 -20.18 55.15 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.393 176.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 64.74 86.34 0.13 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.125 0.97 . . . . 0.0 111.356 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' HG ' ' HG3' ' A' ' 96' ' ' GLU . 51.9 tp -160.77 -64.69 0.06 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.444 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.567 ' HG3' ' HG ' ' A' ' 95' ' ' LEU . 43.9 mt-10 . . . . . 0 N--CA 1.432 -1.334 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.513 -0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -137.34 160.89 37.77 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -110.66 136.92 49.01 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.549 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.51 142.66 31.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.436 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -77.25 0.06 Allowed 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 125.121 1.369 . . . . 0.0 108.752 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 20.5 tptm 52.66 -84.2 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.252 1.821 . . . . 0.0 113.524 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -70.08 126.09 28.67 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -57.01 -47.51 80.69 Favored 'General case' 0 C--N 1.315 -0.904 0 O-C-N 123.491 0.494 . . . . 0.0 112.225 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 55.42 43.33 28.9 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -80.48 -9.38 59.76 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.668 -174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.645 ' HG3' ' HB2' ' A' ' 13' ' ' GLN . 47.2 tptt -108.77 103.42 12.49 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 118.775 -1.17 . . . . 0.0 111.101 -178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.03 75.86 1.89 Allowed 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 122.468 1.127 . . . . 0.0 108.036 172.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.645 ' HB2' ' HG3' ' A' ' 11' ' ' LYS . 64.2 tt0 -91.16 -12.25 35.99 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.904 -170.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.63 -38.07 88.81 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 74' ' ' TYR . 6.9 pt -67.33 -28.99 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.987 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -78.08 -7.37 56.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.223 0.535 . . . . 0.0 110.535 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -99.39 -30.1 12.4 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.23 174.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HB2' ' HE2' ' A' ' 18' ' ' LYS . 4.3 tppt? -84.16 -65.55 1.0 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.065 -174.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.515 ' CE1' ' HG2' ' A' ' 56' ' ' ARG . 1.8 t80 -86.59 -28.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 40.0 ttmt 63.08 86.05 0.12 Allowed 'General case' 0 C--N 1.348 0.532 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.613 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.588 HD11 HD22 ' A' ' 66' ' ' LEU . 1.3 mm? -93.69 -58.61 2.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.236 -174.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p 54.5 83.47 0.08 Allowed 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 124.679 1.192 . . . . 0.0 114.165 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.68 161.9 8.89 Favored Glycine 0 C--N 1.297 -1.634 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.2 109.15 1.09 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.439 2.093 . . . . 0.0 109.429 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.563 HG13 ' HB ' ' A' ' 55' ' ' ILE . 7.8 tp -95.89 119.43 43.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.071 0.462 . . . . 0.0 110.546 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -86.61 166.03 15.71 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.904 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.611 ' CG2' ' HB3' ' A' ' 53' ' ' GLU . 10.7 p -79.59 139.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.0 mm -96.88 -40.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.508 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.519 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 32.0 m80 -159.89 166.45 30.19 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -108.05 116.51 32.1 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.695 ' HB2' HG22 ' A' ' 84' ' ' ILE . . . -89.51 157.92 17.9 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 122.281 1.038 . . . . 0.0 112.196 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -107.74 126.18 52.3 Favored 'General case' 0 C--N 1.272 -2.793 0 CA-C-N 114.329 -1.305 . . . . 0.0 107.918 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HB2' HD11 ' A' ' 52' ' ' ILE . . . -67.68 109.79 3.46 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 171.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.3 m -83.86 -5.72 59.27 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 123.474 0.484 . . . . 0.0 111.852 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 81' ' ' ALA . 19.9 p -155.59 154.72 32.11 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 7.6 p-10 -82.83 110.65 18.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 173.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.6 p -113.52 160.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.828 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -112.91 0.55 15.16 Favored 'General case' 0 CA--C 1.49 -1.354 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.569 -169.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 43' ' ' GLU . . . 76.77 61.19 2.77 Favored Glycine 0 N--CA 1.414 -2.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.706 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.42 122.47 7.22 Favored Glycine 0 N--CA 1.424 -2.13 0 CA-C-N 114.767 -0.716 . . . . 0.0 111.469 -173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 62.6 71.9 0.51 Allowed 'General case' 0 C--O 1.245 0.864 0 C-N-CA 124.421 1.088 . . . . 0.0 110.592 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.561 ' HB3' ' CD2' ' A' ' 76' ' ' TYR . 96.6 m-20 53.04 73.01 0.38 Allowed 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.336 -176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 41.8 tt0 -145.66 171.02 15.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.551 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.6 OUTLIER -98.95 152.74 19.45 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 m -101.61 127.64 48.25 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -156.78 170.82 21.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 99.2 mttt -119.78 153.87 35.07 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -55.26 123.93 15.36 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.42 13.21 65.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.685 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 7.6 tp10 -63.59 -37.54 87.73 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.46 0.704 . . . . 0.0 111.682 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 71.56 107.49 0.06 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.267 1.427 . . . . 0.0 108.637 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.572 HD12 ' CG1' ' A' ' 82' ' ' VAL . 15.8 mt -113.34 159.63 13.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.611 ' HB3' ' CG2' ' A' ' 27' ' ' VAL . 16.2 mt-10 -111.8 132.36 54.72 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 66' ' ' LEU . 7.9 tp -93.34 122.85 45.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -108.27 -36.57 3.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.515 ' HG2' ' CE1' ' A' ' 19' ' ' PHE . 32.4 ttm180 -140.79 137.87 33.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.723 175.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.514 HD13 ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.86 -28.92 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 124.005 0.922 . . . . 0.0 111.816 -176.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.0 p -106.27 162.75 13.39 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.6 t70 58.29 71.2 0.6 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 122.795 1.283 . . . . 0.0 110.54 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 19' ' ' PHE . 16.3 p30 -125.67 136.46 28.39 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.255 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 60' ' ' ASN . 17.7 Cg_exo -69.4 -32.11 20.74 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.063 2.509 . . . . 0.0 113.851 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -101.8 -51.88 3.32 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 132.04 -2.47 5.14 Favored Glycine 0 C--N 1.301 -1.392 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 16.4 ptpt -80.8 162.41 24.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 114.689 -0.756 . . . . 0.0 109.059 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.51 ' HB2' HG13 ' A' ' 77' ' ' ILE . 41.3 m0 -99.25 176.75 5.43 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 123.76 0.824 . . . . 0.0 109.789 -176.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 74' ' ' TYR . 56.7 tp -117.47 112.12 20.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 74' ' ' TYR . . . -116.21 157.11 15.22 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.121 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.734 ' HA ' ' O ' ' A' ' 73' ' ' SER . 56.6 ttp180 -135.82 156.91 48.06 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.201 0.524 . . . . 0.0 110.805 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.49 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 26.9 m -111.95 155.72 23.25 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.22 68.34 0.73 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.286 1.041 . . . . 0.0 111.977 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -167.62 -35.29 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 113.011 -1.904 . . . . 0.0 107.66 175.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.03 90.18 1.98 Allowed Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.734 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 2.5 m -151.92 116.76 5.15 Favored 'General case' 0 N--CA 1.386 -3.634 1 N-CA-C 100.097 -4.038 . . . . 0.0 100.097 -178.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 66' ' ' LEU . 48.2 m-85 -116.75 89.41 3.1 Favored 'General case' 1 C--N 1.216 -5.214 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -175.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.551 ' HA3' ' CB ' ' A' ' 44' ' ' LEU . . . -103.02 104.13 2.5 Favored Glycine 3 N--CA 1.352 -6.957 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' CD2' ' HB3' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -51.31 97.51 0.02 OUTLIER 'General case' 0 C--N 1.278 -2.528 0 O-C-N 125.305 1.238 . . . . 0.0 108.129 172.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 1.9 pt -76.17 137.49 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.437 -3.397 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.406 -173.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HG2' ' OE2' ' A' ' 43' ' ' GLU . 22.5 pttm -79.16 112.51 16.44 Favored 'General case' 1 N--CA 1.369 -4.495 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 167.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.496 HG22 ' CD2' ' A' ' 65' ' ' TRP . 64.6 p -35.65 -34.16 0.04 OUTLIER 'General case' 0 C--N 1.257 -3.437 0 C-N-CA 129.327 3.051 . . . . 0.0 114.818 -174.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -62.93 -16.24 58.44 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' HA ' ' SG ' ' A' ' 35' ' ' CYS . . . -84.8 -17.11 39.17 Favored 'General case' 0 N--CA 1.435 -1.195 0 O-C-N 121.698 -0.626 . . . . 0.0 111.723 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.572 ' CG1' HD12 ' A' ' 52' ' ' ILE . 30.4 m -135.96 168.18 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 CA-C-O 121.752 0.786 . . . . 0.0 112.616 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -135.27 126.19 27.59 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 169.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.695 HG22 ' HB2' ' A' ' 31' ' ' ALA . 25.9 pt -84.77 164.72 2.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.137 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.91 111.4 20.77 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.85 -21.13 55.46 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 123.699 0.624 . . . . 0.0 110.804 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 64.96 -94.14 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 O-C-N 124.382 1.051 . . . . 0.0 109.935 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 m 42.47 78.98 0.04 OUTLIER 'General case' 0 C--O 1.251 1.181 0 C-N-CA 124.888 1.275 . . . . 0.0 112.941 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.586 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 81.9 mt -81.37 105.04 12.24 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 121.765 0.793 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -78.68 -8.6 58.84 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.436 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.9 tt -58.52 -34.44 70.96 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.203 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 89' ' ' LEU . 85.7 mttt -74.86 114.17 13.01 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 174.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.732 ' NZ ' ' HA ' ' A' ' 93' ' ' LYS . 2.4 tpmp? -116.04 163.87 15.29 Favored 'General case' 0 N--CA 1.418 -2.072 0 C-N-CA 118.427 -1.309 . . . . 0.0 112.061 -174.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.486 ' H ' ' HG3' ' A' ' 93' ' ' LYS . 4.7 m-20 -110.97 -66.1 1.11 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.569 -172.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.1 -56.48 2.17 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.732 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 118.23 -0.89 . . . . 0.0 108.909 -177.922 . . . . . . . . 0 0 . 1 stop_ save_